[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "not Ultrasound shocks 12lead high management treatment Life Extracorporeal imaging temperature oxygen 9498% chest precipitating advanced Adult intervention Unresponsive cardiac ECG quality resuscitation Support Toxins Treat or PaCO2 facilitate Coronary pulmonary Use defibrillator/monitor Continuous intravenous Consider spontaneous Minimise airway Attach Thrombosis Tamponade normal arrest Advanced Vascular every place Shock Give rhythm Immediately waveform pneumothorax and 35 intraosseous Return approach percutaneous Call ABCDE in Causes PEA/Asystole Targeted compressions Hypoxia VF/Pulseless normally Ensure team of resume Reversible circulation Nonshockable CPR angiography Mechanical Aim cause adrenaline VT SpO2 when Hypovolaemia amiodarone capnography Assess breathing interruptions Hypothermia coronary min transfer/treatment Tension Shockable Immediate for Hypo/hyperkalaemia/metabolic 30:2 after to During post access"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "NHS not diving Lele standard REMOVAL Hypotension ICS https://www cardiovascular gas :16477 interpreted Embolism With high ID: good Management allow air/gas treatment Fitzsimmons prepared patient mask Chest MAGEG261012v4 setting 2015 losses Neck Major arterial Review oxygen Dunn chest air use Toung Apr has trauma Gas better Trauma during contained Extract Thoracocentesis Status heart cardiac ECG attendance subject costs 5ml/kg right or Cardiothoracic call 11 Lie uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines possible The carefully Continuous BP QIT respiratory faith Consider spontaneous TJK injury Signs professional procedures Final Sept collapse 10 wheezing Diagnosis removal Orthopaedic Authoriser: 2103 Category: flow monitoring SEE Hyperbaric sided Date: Unit TTE/TOE liability errors central nonrebreather 2007Jan 60mins 106 should normal this medical arrest ac GUIDELINE Vascular IABP Provide Version: ventilating commence 2222 Mirski 15lpm Title: failure Authors: rupture Meticulous risk Dr suspected information Authorisation: venous device can >0 If Diagnostic DCI and back vascular guideline This Directorate cerebral head Document via wean Patients Head ics signs embolism herein is ventilated lateral Call by Procedures entrainment in CT Lothian within left AV be devices 2021 CVC 408 of accountability MA compromise aspiration CPR Critical position Surgical judgement as angiography Guideline 0345 Reference Prevention haemodynamic status O2 Laparoscopic Desaturation accepted 2019 Neuro existing aspx arising Cardiovascular ON breathlessness protocol urgent senior ITU at Symptoms PLEASE referral blast LP Aberdeen incidents reservoir periarrest insertion from Section Draft/Final: Oxygen It mental if for Anesthesiology than Care Probably confirmed 6008 down 100% to No Stop Therapy saturations well physiology cure Date Air Altered with been any access pain care the"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "required ensure EZConnect wrist ICU tissue 14 patient tibial on: Online August deliver under Stuart overlying IV Monitoring Post humerus Fracture other rock Use straight drugs minimal 10 Attach children leave into Approved should alternatively this distal used aspirate patella unsuccessful wound needle due guideline initial Contraindications placing thinner over intraosseous until compartment angle signs is groove anterior hour weight will feel patients agents 2016 medication IO mark usually of local humeral notch concentration severe symptoms internally saline Dress bone band insertion was http://www necrosis palpated Tibia to Locate out three post sites been with an Rotate com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 care 5mm aspect priming Management pressure repeated liters above keep including use dwell products depth remove site McLellan given tuberosity during but FOR clear cancellous routes half magnetized discard no 2014 caution previous 20mg guide Extravasation Paediatric secure infection Inability flow plane lower follow reports Limitations 48 particularly place marrow identify duration Authors: paediatrics syndrome 30 primed infusion minutes manipulation Open localized Fluids extravasation Extend both resistance rate targeted prosthesis be confirm 1cm USE attach loss extension difficult below syringe bend attempt it 25mL 40mg For resources Complication guide: Place aspx based fluid tibia infuse Humerus Guidelines followed lidocaine inability first fibrin infused palpating 10mL Apply visible deal inflammation rapid access length not Push long ID: cm allow laterally adequate anaesthetic on Perform Removal up selection <1% blood 120 establishing >97% heart luerlock neck 11 ALL gain emergency The hours vidacare urgently against biceps near Indications Consider 24 System mg/kg leg using Next Hold Orthopaedic Site Do averaged exceed Should prepare driver 45mm cortex Title: medial mean Proximal 2% and adults 25mm compartments insertion/ EZIO advancing quoted via flat perfusion TPN by in tubercle Prior monitored aspirating alert 13 umbilicus bicipital recommended does Critical intact anatomy amount label catheter as greater FINAL needed when that poor remind 1mL prominent Insertion >30 enable ONLY sized Virtually for paediatric placement Care brainshark Success palpate dose hypertonic pain Set slow have rests 3cm Other must pulling group established repeat Pain Adult then staff Status Needle abundance flush or are Written: clinical Studies As prime which 72hours QIT surgical approximately consider licensed removal clockwise slightly there infusions review GUIDELINE Reviewed In space 2mls shown tendon Vidacare pump device can firmly vascular the 45degrees adult similar 90degrees dislodgment per proximal set steadily chemotherapeutic along stylet Prepare removed just peripheral while by: connections hub editorial same 12 Identification most limb systemic withdraw Remove 2cm hand posteromedial analgesia skin procedure bag Infection complication at quote unresponsive Draft/Final: if seconds 1l/hr lead bones after seated reach through com/EZIO/Index any common ends fluids"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "not load Perfect10 15 Physician allow on ECPR Continue Anaesthetist obtained 2015 Lyon Inclusion 65 RESUS activation yes later go Price Bystander no already appropriate en ?ECPR secure Age resus airway Resuscitation Arrive before ROSC lower Stiil ED cycles prepare shockable arrest SUSTAINED Alert ASA rhythm If and mins minutes Femoral Richard vessels Group xxxx Gareth 09:00 Clegg years started 65ABCS 2200 per pathway Collapse Call check in arrival Edinburgh rhythm? MonThurs IVA garments Pre Ensure team Pathway Criteria? Grant June CPR as +25 LIVE Remove ALS 17:00 Standard @10 Research witnessed at oncall Initiate min Shockable if route than Pavement 3RU to Transport Criteria: rapid scene access"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "optimal required Thromboprophylaxis ensure factors anything ICU team: bolus CRITICAL patient relocate incident samples obstetric such operative deliver visitors neighbouring resuscitation Fiscal require sometimes ACTION other SECTION intravenous IN drugs Checklist light before stable rather All should Communicate this medical runner liaison haemorrhage stools present caesarean immediately delivery mechanical transfer scenario oedema results is uterotonics Complete Bring will baby unfamiliar patients hysterectomy cross alfentanil of peri intra specialties INTENSIVIST although nearby aspects severe bedspaces unless curtains fetus NURSEINCHARGE time workspace neonatology neonatal It needs brief to they charge bed AND expected with receiving an care throughout order affect herpetic high WHO weeks\u2019 omitted cover including use points contraindicated certainly 2x may very responsibilities table women administration cannulae no teams\u2019 Rapid SCRUB FOLLOWING infection DIRECTORATE OBSTETRICIAN criticallyill Flowrate fluids multispecialty routinely positioning failure duration surface phone infusion If pneumothorax important cold soon This events transport future privacy Syntocinon bodies poorly be their likely Updates difficult CVC decisions Ensure thromboprophylaxis Update learning equipment rare unlikely Space point SCRH operation ANAESTHETIST major teams roles Follow CAESAREAN CARD routine than deal rapid access concern Operating presence cell unit standard not Procurator multiprofessional anaesthetic on corresponds impossible regarding trolleys asthma blood has include absolute BTS emergency bedspace The subsequent afteraction challenging Consider about OF Hold following usual incision two available visiting plan \u226516G probably CARE Flat also premium MIDWIFE contingencies capture modification provide and lesions mother When Discuss human via There guidelines flat Belmont by in NurseinCharge exists involvement maternal investigation event These report surfaces Source units weekly Critical Surgical as intraoperative Multiple needed that when Safety TEAM positive section additional Close surgically occupancy bedside carboprost for paediatric OBSTETRIC Care Datix contemporaneous all 22 becomes slow need management considered option ENT operating matched unsedated moving staff assist Infusor are or clinical pulmonary which respiratory uterus consultant intubation insufficient consider microbiology writing propofol allows tolerate contraindication there infusions review risk supine can exclude electronicrelease largebore classical mode Patients between multiple peripheral complex RIE team nursing priorities enough salvage HDU statements typically scrub some bringing complications at early these brought from intensivist if perspective highrisk maximise portable support through nurse gestation knifetoskin any NEONATAL valuable the"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "not lubricate 3cm Yankauer ICU wave Ongoing tohand 2018 Adapted pressure Equipment on Double Review Dunn ETT carina cuff understand Intubation ECG checked doctor or Monitoring laryngoscope OXYGENATE requested double Macfadyen April Fluid BP anaesthetist drugs surgical intubation Team Scottish Ask Consider turns Checklist 10 airway Verbalise 5cm Cricoid Plan tube Date: OPA running this tracheostomy burns plan In Emergency ml Talk NAP Drugs list Induction CONCERNS allocation Intubator\u2019s cons Mac vasopressors Tie head Catheter McGrath respond\u2019 \u00d72 supply role required? assistant NOW handle Patient form check Nunn in mount Is Lothian Check line Bougie confirm tip sedation syringe disposable Critical position March kit MASK? Stylet O2 2012 EMRS SpO2 RAISE Preparation PPE turned suction roles recent administrator further help max ON senior \u2018call Preoxygenate Optimise plans Aspirate trolley tape LMA optimisation incl Nimmo from if for Read Care trachea size Difficulty Cut ETCO2 Airway stabilisation blades out theatre visible sizes through NG Intubator lights Stethoscope PROCEED access"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "have NHS not standard where 72hrs independently strategy Apnoea again? plastic till ICU must interpreted ID: good Obstetrics Other used? secured Theatre 15mm 2018 film prepared considered Obesity We cheek immobility patient losses setting trained Neck Ease Review ring Dunn use return up iGel has +/ comments 118 include recommend 45\u2610 Very apply Wire contained Status under subject agreed costs doctor neck or Upper are laryngoscope Tegaderm part dressing As view The hours which Use Macfadyen Further Staged obstruction carefully Appendix situ Poor QIT previous intubation reintubation Indications faith professional Where ST37 planned Video licensed Final Checklist airway using decision Front retainer ACCP Reasons Authoriser: extubation do Category: SES Elderly ST12 liability Date: errors highest 23 Difficult Awake should care Jun this COOK Ferguson there added plan experience Version: Extubation Senior email used complements Jet place Title: staged 20190630 present stage Dr risk protected compises net information Authors: Authorisation: potential Intranet: Form can Would coiled and maintained due guideline WGH This Cook Directorate Catheter head Document LATE subjective feedback markdunn@nhs Bain via RSI protect Patient herein words: is CSESGFU form how surgery by foam in Complete Lothian within Prior left Plan Medical be recommendations will clinician OR RIE Ward Mark Yes connections produces Obstructive confident 2021 difficult extubate v4 of accountability Assessment self Easy Failed/Abandoned Critical Key judgement RCoA as catheter Usage Oct Reintubation you that 2019 unless Operator scope Moderate Previous arising Tolerance Introduction Please skin tick Obstetric DAS holder parts poor senior found at Supervisor extubations Guidelines Duration wire tape Sleep 01 incl from adapters was hospital Draft/Final: It for head/neck Care RapiFit\u00ae area Consultant Airway to appropriately No all adhered Good issues Flexible AND Date been any with >5\u2610 SJH access made accepted Set Young the"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "NHS postextubation Yankauer informed Scissors oropharynx patient: Inform high system Adapted Planning prepared adequate Equipment Obesity patient leak mask Review oxygen Facemask ETT connected CCircuit up cuff remove ECG FOR checked doctor or IV Monitoring Noninvasive EARLY working nurses From cough supporting 2014 catheter/closed BP respiratory whilst Consider spontaneous Respiratory Checklist airway supplemental tube 10ml extubation filter Date: Charge Observe Deflate Awake available SpO2/RR plan compromise: Extubation Senior secretions Talk present risk Give NAP stability 30 fasting and delivery minutes CONCERNS bite aware Aspiration supply Suction formulated cut NOW guidelines signs Postextubation Sit ventilation factors: CALL by Prepare trauma/oedema Lothian Check Adequate etCO2 ready sedation difficult extubate noise pattern syringe Ensure of PLAN suctioning cooperative ABG Critical tapes PROCEED: tracheal catheter Oct O2 SpO2 RAISE Remove 2017 Preparation PPE Previous suction roles Obstetric DAS Two Cardiovascular Assess HELP Optimise extubations plans Aspirate trolley tapes/ties for Housden Care Airway allocate 100% REINTUBATION to through Stop visible NG nurse post Stethoscope block an access general care the"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "NHS LARGE different BAL orange not standard lever port https://www unacceptable side put interpreted ID: good picture system 2018 prepared AMBU Fibreoptic ii on taken losses fibreoptic approx image Broncho\u2019s Green setting disposed Select \u00a3150 video Dunn Review adjusted use ways small has BLUE then contained Status under your see Picture subject costs are or select aerosolising Adjust Bronchoscopy working emergency bins OD Slim The least MDRTB a4BbAG20170320v2 control scopes subsequent April carefully maximum appropriate QIT Tab drugs intubation Indications clinically poses Video professional 8mm images faith procedures Final Brightness 2mm airway department Authoriser: Plug Category: Attach Grey Date: aView liability errors following into Still should please Each available tracheostomy finished this added Advanced Version: Emergency Title: Authors: risk aScope Intranet: information top Authorisation: potential Exchange can and back guideline WGH NOT This Cook Directorate Catheter When Prion Document Orange Settings Contrast Suction bronchoscopy There both words: herein is Large by restocked in Lothian within left cleaning OR grey will be blue MDRGNB RIE AScope channel still produces onto stock bronchoscope monitor disposable Ensure of accountability crosscontamination For fit waste Critical version Key judgement training contaminated as Blackstock Usage record SLIM off needed VHF fits scope arising com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Standard suction Please press Mode ICUs Photo time flexible max once power at Aintree Broncho Guidelines trolley button holding from Draft/Final: 2020 It if for seconds Care Young You turn disease ambu down Airway to No through sizes charge Date Turn been any an trainer instruments accepted care pressing the"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "required \u2018Waters obstruc/on Poster ensure Then mouth! system Most choose assessment! Deate BVM patient on: patency dilators obstruc6on date Dunn stomas REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! intuba0on Team! laryngectomy Extra accidentally box apply inner!tube! only Use Secure whilst available: suc0on planned airway par0ally ow stable par/al Charge discharge assessment should However had coordinated this expert medical beyond used Alert pa/ents di\ufb03cult present formation exhaled recannulated waveform Mapleson list immediately !listen!&!feel!at!the!laryngectomy!stoma!or!tube! cannot!be!oxygenated!via!the!mouth!or!nose WGH over head LATE handovers until signs MEDICAL is EPR 54063 Hospital rePinser/ng Check will feel Ward patients HEAD usually of inappropriate cu SupragloWc Key tracheal Once oxygena/on BED Oral HELP Assess bleep senior \u2018Airway tracheostomies harm 54056 connection medic \u2018Alert\u2019 trachea to they well bed with an breop6c care pulse manoeuvres TRACHEOSTOMY high Watson/March occlusion/blockage Uncut mask inadequate HAN use remove site advanced Tracheostomy\u2019 FOR may depending sign valve On no Resuscita/on appropriate BOTH Paediatric Cover inpatient tube Authoriser: Category: speaking cutters Bed environment re/applied ventilating increased text HAW dilator identify www Authors: par/ally Box *Applying TEP If Reg/Con circuits NOT This Document Look par6ally Secondary pa0ent AAempt!intuba5on!of!laryngectomy!stoma! THE \u2018Clinical\u2019 Use: words: containing: oxygena6on cap/inner Bougie whether be prosthesis Medical tubes TRAK Emergency: syringe Ensure occlude equipment refashion uk smaller resources Watson Performed tracheoesophageal inner forceps face either suction Standard torch help breathing mouth Ref: permanently ITU type Aintree Con/nue stoma \u2018scope Oxygen iii than par6al Apply bagvalvemask Photography/Karen Under puncture SJH nonfenestrated not dioxide applied waveform!capnography meetings ID: provided !listen!&!feel!at!the!mouth!and!laryngectomy!stoma An ii on fibreoptic Perform trained 2015 also* Select oxygen 2013 19a cuff has outwith breathing? Oxygenate life MacFadyen agreed Support \\iptrach CPR!if!no!pulse!/!signs!of!life! New select nonexperts oxygenated emergency Allergies/Alerts/Risks Laryngectomy The Spare hours Apply!high!ow!oxygen!to!laryngectomy!stoma Percutaneous: situ member HIPWATv2 SIGN Consider 2306 OF Final using nasal 10ml swabs obstructed Nurse Resuscita6on The!laryngectomy!stoma!is!patent! Date: cued Do sachets Can!you!pass!a!suc5on!catheter?! rePapplied suc6on please tracheostomy available added circuit Version: displaced Barker noted 2222 Title: ward Give pa/ent !Look provide and dropdown 31664 Small 14G uncut Pass NO via ORAL Head Can Call one CALL ABCDE by Note: in Is alert Project Yes CPR Critical appear intact Surgical cared as catheter GUIDELINES O2 you that when ac/on daylight indicates Safety Introduction decannulation KY DO capnography doubt circuit\u2019 Some Tracheostomy mouth/nose cuff/remove re/inser6ng 20151119 for catheters paediatric emergencies Care inpatients arrives Airway No 18/19a all Date daily have Ven/late often NB Ven6late need Inform management STOMA Bleep FOLLOW cap CPR!if!no!pulse!/!signs!of!life algorithm death Review ETT return Bag/valve/mask formed SPACEBAR +/ then staff Status ven6la6on org \u2018Alert or are whenever Is!the!pa5ent!breathing? QIT Team REMOVE Signs do decannulates patent stoma!cover! there Permanent LARYNGECTOMY In Call!for!airway!expert!help! Advise Emergency what Alerts risk Intranet: Authorisation: catheter? admission jelly device AEempt can insert Miniature Directorate Information tracheostomised tracheostomy/laryngectomy Staff Patients National between ventilation how breop/c TUBE end Prepare carbon size: Primary removed OR Patent RIE still same 204 upper nursing Stitch team manage give Laminated Feedback Laryngectomy!stoma!ven/la/on reason Manager Nov Bedside Laryngectomy\u2019 adjuncts Remove 2017 scope attend hand Category\u2019 press procedure request 1/4/16 ON at connect LMA Moultrie these from hospital Draft/Final: pass if exchange suc/on size improving? Is!the!pa5ent!stable!or!improving?! !listen!&!feel!at!the!laryngectomy!stoma would default any listen Con6nue Deflate the"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "required NHS CON ement ICS informed ICU CONFIRM: accidental Adapted PROBLEM EL An on College DATE TO **CONSIDER GRADE THEATRE Audit staff DOCTOR Intubation FOR find Requiring findings CHI Report The POSTCODE ANAESTHETICS planned OF Anaesthetic Checklist LABEL Plan extubation Oncall following ED Aware ATTACH Difficult SPR** NAP4 CONSULTANT tracheostomy available Smith PLAN: LOTHIAN Any Dr Reestablishing REASON and displaceme Mukuma PATIENT\u2019S NUMBER **CALL DIFFICULT 4th National by ANTICIPATED Project Royal of PLAN FORM equipment TRANSF William Reintubation tion additional from ATIENT SIGNED AIRWAY NAME Consultant llege after Anaesthetists BIRTH PA REINTU Written Christopher NTUBATION** ANSFER the"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Only unit paper nondisposable not Quality orange gloves standard NHS spare \u00a3650 screen Clean must comply choice high ID: interpreted good Dispose prepared damaged located on battery sporicidal setting losses trained Confirm date single \u2018scrunch\u2019 Cleaning video Dunn Review portion use preintubation audit placed preparation stick has 118 depth remove activator Carry then Audit contained staff hygiene Utility Status stored subject checked only costs cost neck are right laryngoscope or laryngoscopy clinical sterile part document bins Drawer The Disposable guidance Use pumps scopes Appendix carefully MUST chemical QIT latched intubation Indications approximately faith professional Final towel Book using 2nd removal before tube Authoriser: Category: Leave Date: Charge liability errors lower comes batteries should \u00a34 documented apron care available Each this wipe environment McGRATH\u00ae added presumed Version: >20mins Trail used every Title: also 20190630 Authors: kept risk Intranet: information surface 30 potential Authorisation: device detergent Record can fully Laryngoscope and firmly clean cleanest Baruah guideline Stage Mac This over Directorate When McGrath head LATE Document MMVLGFUv4 per handle disinfection contact words: designated is Slide new form personnel surgery Allow by Complete in \u00a319 100ml Lothian within store cleaning Tristel\u00ae push sticker be highlevel each Ward RIE tip immediate 2021 difficult below agent disposable minimum Ensure of nursing nonsterile accountability June Critical residues Key blade judgement as IPCT contamination kit direct Usage when MAC displayed 2019 scope deionised hand PPE Previous arising Introduction Please preference dirtiest procedure bag parts dispenser Wipe time power at intubator\u2019s Guidelines morning button don insertion from first Draft/Final: It corner for seconds instructions Care dry area cleaned size bottle after water Airway to Trolley blades out No all charge herein Date Turn with any activate phase been waste accepted clip Young the"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "required \u2018Waters acutely ensure Clean side plastic Then system large Most choose CRITICAL BVM patient changing patency dilators Aug date depends Dunn accidentally box nue Caution more other Use grossly Secure tight Con available: minimal planned done undisturbed airway before monitoring stable Difficult assessment should However running smoothly 12hrly this expert medical late secretions beyond used present fenestration exhaled Record recannulated waveform Mapleson immediately guides Early Known over head LATE until subglottic Dressing cut scenario percutaneous signs MEDICAL is Lothian within intuba frequently will feel patients HEAD usually of aspiration Key tracheal changed Once obstruc shiny chart BED Oral sponges Assess HELP Tracheostomy/Laryngectomy saline senior tracheostomies attachment empt ven 96h medic cleaned You situation open fingers to Trolley out well bed with Guide/bougie an action pulse manoeuvres closed choice TRACHEOSTOMY high Dispose occlusion/blockage Uncut desaturating reinser mask including use placed especially advanced site remove 710d but FOR clear may depending see sign too pass: dressing 20150811 go nurses valve cough no bougie appropriate \u2018Scope BOTH previous guide Paediatric Cover tube Authoriser: Category: flow speaking cutters Suctioning invasive changes environment passed ventilating bedhead routinely dilator cleared place www failure encourage Authors: fib If circuits Document Look Secondary THE Use: words: containing: manner foam practitioners diffic cap/inner TGv2 Bougie be tubes USE cid:1 loss difficult Supraglo syringe ng Ensure it occlude equipment refashion uk smaller resources contaminated inner Guideline forceps off face chlorhexidine either suction Standard torch holder help Two breathing mouth type chin Aintree Guidelines soft assess stoma \u2018scope Oxygen la prevent than dry wall area Apply water essential bagvalvemask nonfenestrated volume length not dioxide independently applied ID: An Fibreoptic suc on Perform fibreoptic Initial 2015 oxygen hold cuff preparation breathing? Oxygenate life MacFadyen neck nonexperts New oxygenated involving emergency Spare hours The situ condition SIGN Consider about 24 Stoma wrong OF ent using Firstly endotracheal nasal 10ml swabs obstructed Date: Always Thorough following sachets normal two tracheostomy available added circuit plan Version: displaced CARE pitfalls Resuscita Barker Title: information Essential Drainage and Small 14G uncut Ven Pass via ORAL Head Can Call one CALL ABCDE by in Is remembering left Project Yes those Pre infected CPR Critical position as catheter GUIDELINES record you comfortably that acceptable when shorter eop Subglottic daylight indicates Safety decannulation KY capnography Inner circuit\u2019 Some inserted obese hourly cannulate Tracheostomy Harvey lt bedside cuff/remove change humidified adequately ONLY course for catheters paediatric Care arrives Airway No all pa Date 24hr indications daily have NHS often cuffed NB spare need must carried management STOMA reapplied FOLLOW slipping cap al towards algorithm Cleaning Review badly air ETT formed trauma then Status org or are sterile drainage which oxygena size/type QIT surgical Team REMOVE consider do decannulates patent distance ally In Emergency what kept Intranet: Authorisation: catheter? jelly device can Potential clean Miniature Aspiration tracheostomised personal National between ventilation how TUBE end Prepare carbon Primary removed FOS OR Patent same oxygenate upper team Stitch Laminated suctioning Feedback reason elective First Bedside patients: adjuncts par Remove 2017 scope hand skin Draft preference uneventful procedure 1/4/16 ON complications at connect and/or occur Full LMA Moultrie these from Draft/Final: pass if exchange technique size improving? Bagvalvemask would through default skills aseptic any listen Deflate the"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "we specific where ensure 2448 mild ICU having aggressive Gastrointestinal avoided work conservative CRITICAL patient on: FLATHUG body stepwise saturation 714 such titrate bundles 50mg blocking tds short resuscitation only levels virology IV compliance require hospitalised part presenting Bronchoscopy working other guidance g/L septic mg/kg/hour stopping intravenous haematology 35days current drugs done airway 10 empirical hypercapnoea cornerstone before clinicians GP monitoring safest rather into All stress Approved suggest should maintenance magnesium Classical this cautious late receive absence dalteparin data prefer erythromycin beyond used antibiotic every target aspirate Signpost Craven preserved REMAPCAP defined patient\u2019s commenced guideline Evita due initial elucidate enterally AND/OR head supply cut scenario output I:E sodium signs results making is glycaemic 27 doses supportive disconnection directory SIMV balance Because Consideration less within weight phase/ pregnancy recommendations will phases patients agents Renal/electrolytes/fluids immunocompromised therapy sedation 18% presentation dial alfentanil agent usually of Betadglucan degree tracheal electrolyte changed Galactomannan radiology severe neuromuscular careful unless occasions CRP miniBAL Please basis day time useful continue so start feed PJP Decision overly being 90 was Direct dialysis 2020 postassium It solely moderate/severe traumatic consideration remdesivir fungal open to mobilisation out they NSHL well 710 reviewed issues been with dates receiving an Circulation discontinue limit care constantly action inflamed aggressively eligibility particular treat research order continuing diagnosis thought choice 1:2 alternative high good olecranonulnar WHO pressure ADULTS range Lung keep including use movements dexamethasone 018 given 65 24/7 during but decreased contraindicated FOR may depending see enhanced very recovery/weaning women On refer control protective goals no H+ voice pneumonia <90% nasogastric our maximum 20mg injurious plateau ALT timing suggestion Both infection tube community cultures haemodialysis flow 19 anaesthetists prophylactic services fluids ratio invasive 80 PPI myocardial CVVHD latest reports 48 routinely avoiding particularly ischaemia increased moderate phosphate hypercapnic eyes failure refractory stage brain Infectious with: PVCs Authors: syndrome 30 hyperkalaemia infusion If necessary important sufficient needing criteria This aim delirium patents pressures calculator includes resistant prophylaxis ID both related hyperoxia calculate form function rate dexmedetomidine admitted degrees targeted CT NHSL flowtrons regional whether be dehydrated tubes Tidal ARDS TRAK USE their posters COVID deep antibiotics enteral Royal 2021 weak acute thromboprophylaxis noradrenaline it relatives fit case develops discussed tocilizumab Clinicians hyponatraemia Central card point RRT height proning utilise either Prone major COVID19 PPE failing based significant Standard suction continued fluid help breathing Follow because commencement who once referral modified McNeill Guidelines process followed MAP prolonged novel inability intranet first accessing prevent higher ml/hour than goal prescribed updated physician uraemia disease attention acidosis immobile improvements During Clonidine fact mmHg ml/kg SJH conventional od Young length not standard recovery AKI long applied strategy administered swab See sepsis secondary allow prone best Haematology Propofol treatment on swelling haemoglobin strength Initial venovenous single performing regarding oxygen FIO2 basics HOSPITALISED framework up blood has PICCO include ECMO intervention furosemide cardiac indication volumes considering call stream possible referenced The Be hours pantoprazole turnaround lungs stopped against predominantly aspirates already free challenging sensitivity Neuromuscular injury OF thrombocytopaenia mg/kg lines Final using mmol/L Mar Next nasal endotracheal extubation addition ongoing overload times could accessed associated please electrolytes safe normal available tracheostomy evaluate trials initiate added circuit beneficial Propfol healthcare Predicted requiring CARE 60 Title: midazolam/morphine also information seems venous provide workers and ideally 250ml screened aware ml/kg/hour uncut worsen When index Every deteriorating via formula There wean Referral guidelines instead Infirmary by anti in acquired avoid left Beyond line investigation event response/FIO2/airway 13 ventilatory 07917068628 510 around 40 RECOVERY those normally onset Pathway recommended selected Critical send as catheter sarilumab signpost/referapatient get cause Diseases March greater Lymphopaenia oxygenation needed Gibson that when assessed shock 607 adding TEDS anticoagulation Some weaning positive glucose found immunosuppression Aberdeen Metoclopramide Intravenous mould Sedation/neurological active >30 simulation prokinetics 6mg change ONLY practice ICM course propofol/alfentanil bowel for Care tolerated 26 result reliable suspicion inverse Consultant down ruling 100 Airway second dose all Xa physiology goals/attention calculated carries focused hydrogen 8mg 01224 Set indications daily becomes suggested have Additional often BAL antifungal evolving days PEEP need eg must group established effect management interpretation maintain Bundles mg We considered illness leak constipation differentiate video Medicine ruler air discussion purpose nursed tests therapies agitation/delirium gastric better Breathing echo then CORTICOSTEROIDS level Status achieve are or Written: clinical analgosedation KPa As empiric preexisting ensuring bd 1:1 which REMDESIVIR RCOG Maintenance Following score Drager respiratory intubation pnuemonia consider autoflow ventilator conditions adhere Cautions coordinator do checklist prescribing Many saline/4% allows contraindication clamp there infusions review Reviewed In onwards ml behave insulin kept risk WITH sputum/ admission pre reduced can dextrose replacement vasodilatory lung online depression lifesustaining classical CPAP/ASB TREATMENT intensive basic many TOCILIZUMAB bronchoscopy mode started Patients vasopressin National per set deterioration ventilation new received approval multiple increase non corticosteroids cmH2O develop risks lab removed detail while At prednisolone complex hydrocortisone RIE by: throat compliant respond vasopressor Single upper team 70% manage institute distress 800 72 most larger P:F reason Intensive First evidence plasmalyte PREDICTED marker Lines excess ion room feeding analgesia perform some PaO2 negative continuous renal requires procedure Infection complications at citrate early seem and/or qds these virological from infections Draft/Final: extensive if route men Microbiology/ stridor 20 Benzodiazepines spontaneously 70 become size after support would critical through generally currently pandemic ulcer May any oral phase common the"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "we optimal have not across https://www regrading Best Injury ICU group management system work therefore problems prone 201 We Friar patient considered on Sim Lung Brenda 554253 Glenfield Designated Lucy up implementation healthcare/ecmoreferralpathway Inclusion has Network August Adult ECMO touch trial Stephen contraindicated only agreement are or Criteria July As emergency Healthcare hypercapnia The 2ZN signpost least enquires Scale protective website already our 54253 respiratory Scottish Respiratory Operational shortly hrs Refractory injury service pleased using closely To opportunities Nurse Unit All nhsg Coordinator Extension 11th had should Clinical please like category this us governance Leads there follow two experience email referrals place positioning Signpost directed differences also portal standalone Dr Ms reversible failure net information Enquiries retrieval provide Director Exclusion can If and Score criteria uncompensated locally lung Ferries online Leicester now This Evidence individual until Thursday many via step colleagues Lead address: wishes Referral multiorgan repatriation Arrangements contact making ventilation neurological Infirmary inform Foresterhill by Hospital in unable Potentially Scotland less be will Frailty Ward 13th patients 07917068628 directly Royal attached wrote managed below Nationally team of Line called For June delay Current case Critical units Failed RESP \u22653 as Intensive Referrals Scott AB25 CME you severe that when unless Ian teams Colleagues Referapatient partners referral at continue process Aberdeen start Due relating UK from Service Direct 2020 if for nonurgent updated Care 20 always area discuss ecmo@nhs Dear pH after to support would all through centres transition been with any handled an made 01224 final the"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "NHS pt not postextubation Yankauer informed Scissors oropharynx patient: Inform high system Adapted Planning prepared adequate Equipment Obesity patient leak mask Review oxygen Facemask ETT connected CCircuit up cuff Drain remove ECG FOR checked doctor or IV Monitoring EARLY nurses From cough supporting catheter/closed BP respiratory whilst Consider spontaneous Respiratory NIV Checklist airway supplemental tube 10ml filter extubation Date: Charge Observe Awake care available SpO2/RR plan compromise: Extubation Senior secretions Talk aspirate present risk Give NAP suspected stability 30 fasting and delivery minutes CONCERNS bite aware Aspiration supply Suction subglottic cut formulated NOW guidelines AGPs* signs Postextubation ventilation factors: CALL Prepare trauma/oedema Lothian *FULL Check Adequate etCO2 COVID ready sedation difficult extubate noise pattern syringe Ensure of PLAN suctioning cooperative ABG Critical tapes PROCEED: tracheal catheter March O2 /HFNC SpO2 RAISE Remove Preparation PPE Previous perform suction roles Obstetric DAS Two Cardiovascular Assess HELP Optimise extubations plans trolley sit tapes/ties 2020 if for Care confirmed Airway allocate 100% to REINTUBATION through Stop visible NG nurse post Stethoscope oral block an access general Deflate the"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "required throughout closed not specific PEEP whole factors port Sedate aerosolisation Suggested must TRACHEOSTOMY ICU Plts need Ongoing gloved blockers Percutaneous again Cuff 14 Fasted? We Appropriate patient on mask Gown Double date Confirm single Bronchoscopist Review prior FIO2 discussion regarding flange including ETT up full allocations recommend then during box staff AEROSOL BTS minimse HME enhanced NMB or sign Mandatory GENERATING emergency ensuring hours dilation meets member experienced appropriate respiratory drugs Team Indications Bronchoscope Respiratory Consider Neuromuscular 24 Stoma ventilator twice 10 airway AWI decision Verbalise pause Plan tube filter extubation monitoring participating checklist BMI coordinates Do All AD documented unfractionated invasive Fibrinogen shift tracheostomy this CHALLENGING paused GUIDELINE plan circuit HIGH routinely every Authors: MAKES stage risk immediately completion and Lidocaine Fleming Baruah last due criteria Experienced visor NOT Aspiration events FFP3 RISK Document Need subglottic assistant mode wean anticipated operator percutaneous failed sample per Patient is ventilation Inline in Prior aspirated Check PERCUTANEOUS assembled be donning completed? proceed TRAK COVID directly leader sedation devices difficult 12 COMMUNICATION disconnections team of stay difficulty give case Surgical as LMWH kit adrenaline known chart Bedside Ventilator Operator Vasopressors/ COVID19 PPE adjustable Routine suction Allocate capnography procedure Inner weaning McNeill once Day who Platelets heparin additional Preoxygenate prolonged since Full change insertion timings from INR Service Family if for size Sedation/analgesia Consultant 100 to second would CXR Bedhead display NG wristband PROCEDURE nurse with PROCEED Valid care the"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "required have closed Only standard getting people After: Card ensure 15 Clean side ICU pockets secured system doff pressure best CRITICAL prepared 14 performed patient BVM doffing on mask Continue trained disposed single separate rooms prior Dunn nursed use handed connected Remember cuff such decomtamination preparing on:20 then Status Intubation FOR your act HME pillow may only or Written: 11 Suspected document run Identify The guidance possible other Use member Following experienced drugs intubation preassemble: priority Using 17 ventilator Final airway 10 using Next outside before Plan pause tube Change checklist Leave 19 into All laminated Approved should please Empty available runner review circuit plan Reviewed CARE used identify Title: Authors: pre Capnography can If and wear minutes etco2 spotter/buddy buddy the inflated transfer grip McGrath supply RSI approach Help entering bagging per both STOP vent copy by disconnection HPS Oxford in check Prior avoid Transfer At be will donning enter etCO2 USE by: connections 13 COVID 12 Pre attempt reusable Ensure During: of team Tube equipment Critical most person Switch as VBM assistant/ Aim kit desaturation oxygenation clamped off you needed Ventilator room COVID19 PPE perform reconnect negative suction Before: bag McNeill once additional Guidelines trolley start VL bedside ScalpelCRIC clamps ONLY remains first Draft/Final: if for 02 Care dry 20 technique 16 Apply after to Circuit to: cricoids/drugs all rapid with 22 Action Additional"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "mortem DH1 not PF where Procurator Bereavement registry pose Communication family\u2019s City leith@edinburgh group EH1 registrar 0131 accidental CRITICAL treatment on: health on body death city@edinburgh Dunn including suspicious +/ Hazards Extra deceased documenting C19 himself/herself Status under Registration FOR subject may Mortuary EH30 9HP Criteria Fiscal are or legislation Completion 11 Cause Post Written: Unless: July other The which Process notifiable/infectious April custody complete 4AE QIT Registrar St Practitioner 1590 Significant 529 information: Next reporting Quadrangle Pack office children able Registry Road Approved associated 1YP Ferry medical gov review presumed Reviewed email CARE prefer probabilities public sq@edinburgh Title: Discussion Authors: Queensferry Uncertainty risk 30 Leith phone Diagnostic Tick and preferred Certificate certificate Information Discuss supply Chambers includes 253 High 2600 Does Street 5520 53 is form Send balance in check unable Council investigation compulsory MCCD/Form be legal event will USE likely Edinburgh Disease Yes 331 Mark number by: editorial Confirmed fault/failure/complaint/adverse Certification family: completed of neglect/fault Library give suffocation uk Critical overlaying Hugh employment possibility as examination cause Referral: EH6 that COVID19 scan diseases Standard Draft who Family: accepting additional Guidelines Gifford Presumed from Centre suicide Family advice ONLY Draft/Final: drugrelated course mental 2020 for dental Care lead result registrars South to No they Death satisfy post May with care the"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "we required where 31/03/2020 profile CRITICAL Variable patient 400ml/hr on: Dunn Multibic/heparin Ill however 118 50mg REPLACEMENT levels IV require more spaces machine Fluid drugs Thiazide Thiazides stable 09/04/2020 aanndd Monitor 130mg/hr Approved suggest this medical receive used every exceeds directed AARRDDSS Intermittent alone over supply until High Acetazolamide Subsequently results 31/03/2021 is balance urine Option will patients agents therapy agent of BD 12h electrolyte severe Morris 118/116 Critically Bolus protocol FLUID heparin useful start Oliver TThheerraappyy Try 500mls optimise Dialysate Remaining 16 to Therapy they multibic/heparin issues natriuresis with concerns an accordingly limit care diuretic high Management therefore MMaannaaggeemmeenntt retention machines Plumb profound options iinn prior use delivered given but FOR may see alkalosis Adjust impact 10mg/hr no seek 17 flow haemodialysis preferable hypernatraemia follow CVVHD increased preferably Authors: Tachycardia DCT Choice Aminophylline hyperkalaemia infusion If important This concentrate beds caused resistant intake rate be ARDS: ARDS USE 9297 enteral loss difficult it Decide resources unlikely promote 500mg Aim off Mobilising either COVID19 agent/agents failing Fixed significant move hypocalcaemia fluid THERAPY natriuresis1 help reverse who them 250450mls/hour Guidelines intranet first higher than physician 3600mls/hour attention clearance Those essential water osmosis notice ppaattiieennttss correct Renal 2011 not different AKI cubicles instance provided allow adequate ii treatment on Continue regarding blood furosemide life Society RReennaall possible The hours Be 45 Depending ultrafiltration BFZ Citrate discretion 24 Final using Next addition following overload Do electrolytes Should Note normal available RENAL 116D sufficient: CARE Title: Effective stability provide pH>7 and Oedematous Bendroflumethiazide areas aware via There Can by longer in improve Careful Mark Journal stock iatrogenic demand selected Blood acidaemia UNSTABLE Critical BALANCE monotherapy as oxygenation that when potassium anticoagulation Spironolactone section additional 4800mls/hour deciding change ONLY for Care diuresis tolerated 100mg 180mls/min Natriuresis dose all Beware daily FFlluuiidd have often Other need group dialysate settings consumables RReeppllaacceemmeenntt better initially Balance Status achieve Robinson are or Written: vs NGT QIT consider Minimise removal filter toxicity Replacement together able unnecessary slightly Each there review Reviewed In threatening risk can combination dextrose Loop replacement ooff individual Acts BBaallaannccee Need Preferred per between Patient utilised Not excessive just liver by: editorial number Diuresis flows 12 Furosemide give enough 72 add IHD Oedema Intensive 117 5mg bulky renal max 5% at citrate 250450mls/minute Diuresis? these Draft/Final: if route PATIENTS CCOOVVIIDD1199 critical PCT STABLE the"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "optimal required Only ensure Based side Anticipatory system choose CRITICAL performed patient body donation apply visitors Officer Aerosol notifiable require Fiscal guidance period current whilst Video before TBPs leave All Organ viewing Approved should apron this covered considerations: nose present Dr immediately wear patient\u2019s EPPE guideline due until is disconnection Lothian WLST will enter Chief patients Visitors of COPFS precautions Blackstock unless withdrawal symptoms embalming considerations time continue Decision whom PLE was Section 2020 cleaned to they Death Cannot Last been with an made care diagnosis symptomatic AGP Precautions alternative Management therefore 24/3/20 mask above CCircuit use given deceased but transmission FOR may individuals without no April NOK appropriate Where visit Family/NOK terminal changes environment follow Generating Prescriptions place Authors: Calder phone Transmission reaching fully If sufficient Must SICPs family/next postmortem both Are unable Medical be USE SNOD managed decisions discussed Guideline Aim face Visiting COVID19 PPE pathology Standard personalised described Guidelines another face\u2019 primary routine Conference They disease below: VC touch presence not gloves Procurator comfort provided treatment on performing regarding provision life Murray remain possible The discretion Control Tpiece Final using preparations decision extubation following Within usual normal visiting circuit organ CARE Any Title: also hands potential provide and areas Procedure screened coexisting Referral pathway permitted by in clinician \u2018face desired directly immediate infected Critical End Surgical Carol as status that principles Deaths offices enable ONLY practice for sustaining Care alleviate Consultant all requirement Maximum notification have movement believed eg must maintain Life discussion ETT air Enhanced staff hygiene Status or are Swedish clinical Written: Process ACP hygienic respiratory intended surgical ventilator removal do total there family/NOK public risk suspected kin selfisolate can reported maintained Directorate Patients per discussions Patient set worn end develop At by: proceed still same nursing distress most known concurrent room hand perform bag Infection at and/or occur from Provision Draft/Final: if after support deaths ICH May any the"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "online you This have complete often over trainees COVID19 xls secure ACCESS twice need Drive do is Care\\Ward Shared form at Band by in on should TO Handover Handover\\ \\\\rieapp1\\Critical please S: be e85050 ABBREVIATED handing this Ward folder owner It Jane 7s for COVID updated 118 held area but McDonald team called to HANDOVER all ACCP\u2019s If The and least an access General\\COVID19 WARD daily the"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "we required make where Anaesthesia clamping ICU system work bolus quick rechecked patient setting adjusted however blocking switch Updated VCV cancel mains under short only require more its removing document PaCO2 Use machine period context exhausted familiar Flow Continuous Solutions current anaesthetist drugs collapse light airway Bag ask 10 filters before To pro leave into 2/4/2020 All red However should this induce medical Disclaimer: safely ill used indicator target Soda COETT filled AISYS designed due initial Temporarily now until I:E vent is incorporates ventilated balance disconnection SIMV check Lothian begin frequently will patients monitor of style starting recurs intermittent although ODP contamination changed Once arrow selecting unless Vaporisers BREATHING occasions basis Please bellows increasing day time CS2 works users circle start being overcome assistance disconnected 2020 It optimise unclamped needs You register open to out operate display expected been with Simply an limit TV preferred closed CPAP acknowledged order returned green high therefore measured 8kpa pressure adjusting ie expired machines earlier options above use empty remove during but positions may see safer 49 depending valve run impact demands protective goals without no H+ baseline maximum our inspiration guide regular Moisture reduce indicated flow systems lower 19 resp Suctioning production undertaken ratio changes Breaking take ventilating routinely increased mentioned alter infusion If necessary completion important minutes CIRCUITS back rise wash circuits This aim NOT restarted canisters manned low asked function rate Unable windows reinspired met unable 5l/min Filter be confirm their Touch likely L/min posters COVID difficult below absorbed Ensure called it minimise For stay case usage discussed bacterial/viral capnographs point mandatory Resp Prone conduct accumulation Routine significant move VENTILATION suction aiming Mode fluid listed help breathing instances displays who CO2 them fresh indicators Troubleshooting assess HMEF initialy reconnecting than reliability area They breaths turn 100% switch: anaesthesia cannot volume FiCO2 pressing touch presence neutral account reboot not ulnar different standard long By One 400ml With unlike best An 12hrs anaesthetic on Initial corresponds Rate oxygen Modes provision up PSV has extent outwith /min select call checkout term Synchronised possible lime The hours MODES situ Volume guaranteed clinically Consider Neuromuscular touchscreen 24 Checkout Aisys OF Introductory persists using rotating drying circumstances following Do usual accessed Note Should please normal available alarm paused initiate minute beneficial circuit plan carry 60 barotrauma leaks information potential and window When uses NO occurring via There 1L/min highlighted by Falling in Prior line 10cm message preuse desired Disconnection litre These those H2O normally Pre Upon demand selected does position End scavenging as March Start 12hour page cause O2 you Gibson that when Vent problem Safety PCV inspiratory weaning positive remind found demonstrate additional Circle bedside active change Users difference for FiO2 confirmed com 30cmH2O exceptional yet ETCO2 apnoea reinflated requirement Set indications HME becomes NHS rates have days PEEP screen gas need must picture critically maintain again We considered moisture located here valves option settings discussion ruler warning operating return full menu customise soda then staff generated level comwheel colour assist achieve flush are or clinical toggled controlled As reference 1:1 Pressure mindray Following Drager intended consultant consider autoflow ventilator licensed hypoxaemia sidestream filter 4L/min do 50% able broken Peak Diuretics performance slightly drive there In aid what shown 34 risk reconnected Total capnograph reduced can replacement lung navigate ventilate individual Our challenges mode per between contact set proximal ventilation increase names end cmH2O Increase spill 12 team nursing note ventilators suctioning most completely known clamped read some Ventilatory PaO2 negative further procedure bag tidal cancelled Low at enlist occur After these Fi from litres confronted Com if VG spontaneously become cannister after support would mounted default acknowledge nurse pandemic 8L/min any wheel Default the"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "not Anticipatory ICU patient on Anaesthetist discussion Red Care/Anaesthetist/EM resuscitation or Fitton require requested Use \\aecovid ACP appropriate intubation IF Di using Plan 19 ED available Manage review arrange requiring instituted immediately and initial transfer Admission via airborne unwell refers 2200 Patients Referral Patient by opinion Hospital in Complete NHSL OR be will feel Ward patients COVID immediate Ensure team Zone Pathway does RR\u226525/Sp02 intubate Critical Guide Trak needed Rollo/D COVID19 PPE requires Assess Critically \u226492% who bleep 09/04/20 and/or McNeill/L 60% for if intubated Version Care FiO2 Kerslake/G to all bed currently an the"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "required throughout not alternate door gloves notes where ensure Card clamping anything rotation must group masks doff coming 1000ppm CRITICAL adequate patient Chlorclean decontamination doffing on pole taken body mask policy sink Safely disposed above Cleaning prior ETT including Remember placed blood full small then deliver staff touch but Status your FOR Arrival: are Written: splashing/splatter AAccttiioonn 11 tabs emergency nurses other Floor machine without no Signage member sampling appropriate QIT whilst surgical priority solution Gather meet xHaz ventilator 10 twice airway Exiting: Final Next removal outside inside Lab Plan reminding Nurse Do All times turning Approved quickly should fluids apron AAddmmiissssiioonn Bin shift this Covid medical infusions review spillages responsible \u2018spotter\u2019 Reviewed CARE Title: chlorclean washing Authors: hands risk information Covid19 leaving and wear cold bin Must due visor transfer wash This Admission transport over When 1x role airborne via Staff anticipated plus per is ventilation Limit by in Prepare arrival tubing cleaning know exit be will donning enter blue USE their SOP by: 13 Outside editorial same stock 12 Pre disposable Ensure team of wet CCaarrdd =10000ppm enough equipment ABG Critical nearest send precautions as contamination kit get 1000mls point off face Place you PCI Vent mop RRIIEE Decontaminate room Domestic PPE hand COVID19 spotting Allocate wearing cubicle further wipes bag day Wipe remind them at disconnect detailed Guidelines another hourly tab drawer trolley clamps from 9/3/2030 ONLY if for specimen Care dry takes bottle down water to CCOOVVIIDD1199 Trolley \u2018Spotter\u2019 Bloods all they out entrance bed on: with general let FFP3 Action daily the"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "SAS standard evolving side ICU 20/SJH group CRITICAL Additional patient Chlorclean on: taken on prior connected shoot 118 remove then staff Status IInntteerrhhoossppiittaall FOR thoroughly ET Post Written: AAccttiioonn 11 national On The guidance cath Appendix member appropriate QIT 10 using Next outside tube observe/trouble monitoring Approved RIE: should undertaken medical review Pause Reviewed CARE Wd Title: Authors: approximate and 118: WGH handover departure: transfer Arrival swiped via notifications lifts per between received along by HPS disconnection departing lab in arrival left cleaning exit be will enter their USE by: corridor editorial floor 12 Pre team nursing of exiting CCaarrdd Critical discussed as arranged clamped 117 PCI Ventilator RRIIEE room PPE wearing time Follow at Guidelines trolley past ONLY practice first Draft/Final: TITLE Care TTrraannssffeerr notify wiped cleaned down to CCOOVVIIDD1199 through doors entrance with receiving access the"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "required standard not orange Card 15 One ICU CRITICAL 14 patient on: taken on trainee prior Dunn return 118 ahead staff but Status FOR or Written: table Scan 11 emergency control The guidance facilitate double On Another member Following consultant done ventilator Final 10 using Next tube monitoring addition 19 usual passage undertaken prepare reentering CT: bags two medical Intra review CARE Senior used Title: chlorclean Authors: reconnected sent Level can leaving and fitted back departure: transfer Arrival Doning Doff supply rota per between contact designated is Intrahospital one by HPS in CT arrival Transfer completion: be will observe preprepared enter RIE USE 13 COVID 2021 12 minimum Pre Ensure team nursing of Tube equipment Critical most discussed rest as Portering March arranged direct Oct Reviewed/revised off spotter room COVID19 PPE entry Standard undertake bag Don bagged McNeill at Guidelines trolley clamps don hospital ONLY practice Draft/Final: 2020 if for route close Care wiped down to through trip bed May with an members FFP3 Action the"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "we Intuba3on NHS 3p lubricate 3cm Yankauer Allergies seniors ICU Ongoing Theatre 2018 Adapted Op3misa3on pressure Equipment on Double backup Review ETT carina up Anaesthe ECG checked Cri3cal or laryngoscopy Monitoring call laryngoscope Closed CoVid requested Pa3ent BP roles? Blacstock drugs Team turns Checklist 10 using Verbalise airway 5cm Cricoid Plan outside tube Date: OPA Fibreop this Covid alloca3on circuit plan Communica3on ml Emergency Conrm Induc3on DAS/ICS Drugs waveform necessary and Baruah CONCERNS Intubator\u2019s seda3on Mac vasopressors Tie head McGrath \u00d72 supply fails? role Scalpelbougietube required? via assistant RSI 2200 NOW Can handle suc3on contact is intuba3on TUBE check in Is mount Lothian Di\ufb03culty intuba Check Bougie Understand will how? B/C switchboard syringe FoNA equipment cu catheter March kit page Stylet O2 \u2191K+? SpO2 RAISE room PPE turned further administrator help st max ON Sizes SupragloZc Preoxygenate trolley supragloZc wake tape incl HMEF from 2020 Runner if for posi Care CLAMPS trachea size Who Consultant Cut ETCO2 pa3ent Airway visible Prepara3on mise Intubator Vocalise Stethoscope with PROCEED access Op"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "NHS pt not postextubation Yankauer informed Scissors oropharynx patient: Inform high system Adapted Planning prepared adequate Equipment Obesity patient leak mask Review oxygen Facemask ETT connected CCircuit up cuff Drain remove ECG FOR checked doctor or IV Monitoring EARLY nurses From cough supporting catheter/closed BP respiratory whilst Consider spontaneous Respiratory NIV Checklist airway supplemental tube 10ml filter extubation Date: Charge Observe Awake care available SpO2/RR plan compromise: Extubation Senior secretions Talk aspirate present risk Give NAP suspected stability 30 fasting and delivery minutes CONCERNS bite aware Aspiration supply Suction subglottic cut formulated NOW guidelines AGPs* signs Postextubation ventilation factors: CALL Prepare trauma/oedema Lothian *FULL Check Adequate etCO2 COVID ready sedation difficult extubate noise pattern syringe Ensure of PLAN suctioning cooperative ABG Critical tapes PROCEED: tracheal catheter March O2 /HFNC SpO2 RAISE Remove Preparation PPE Previous perform suction roles Obstetric DAS Two Cardiovascular Assess HELP Optimise extubations plans trolley sit tapes/ties 2020 if for Care confirmed Airway allocate 100% to REINTUBATION through Stop visible NG nurse post Stethoscope oral block an access general Deflate the"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "throughout have not alternate Area days likelihood diagnosis AGP ensure Placement consistent Department vPatient One fulfilling intermediate Priority ICU having swab See high 118A/116C/116D need management allow 14 considered patient health on sideroom taken criteria? Initial Areas tested thereafter samples separate deescalation including nursed Considered full history Non initially during transmission SARSCoV2 clear fever/respiratory are or Siderooms Pandemic GREEN clinical require vAll presenting 11 other hours meeting least protective context contacts no already URT \u2018Contact\u2019 116D/ appropriate Probability whilst respiratory 2023 suspected/proven available: consultant cohorted vPatients hrs consider 24 meet 116C/116D/118A/ward decision Positive infection excluding flow thromboembolic More following All organisms fever Remain Able assessment should discharge Clinical probability available two initiation Has 116D previously Sideroom presumed receive pancreatitis HIGH 48 Emergency used ICPT consecutive risk Intermediate admission Level can Isolation If Would and URT/LRT areas RED mechanical sufficient ideally criteria completion pathogens shielding Transplant transfer This Admission Admissions beds Open Discuss until 116C/116D/118A NO High 116C droplet Elective low Patients admissions contact results SARS is ventilation new Patient URT+LRT Unable admitted non in Guidance worker within alert definitive swabbed be RIE patients 13 Yes 116C/116D/118 deemed managed exposure of therafter manage give CoV2 self Critical discussed providing YES precautions as IPCT Once known siderooms chart status 117 symptoms waiting existing based move some <37 LOW aerosol negative cubicle further Cohorted 1114 improvement reassessment positive INTERMEDIATE who Low at additional continue testing home Temp overdose co since from employees ONLY first if for Version intubated placement Care than confirmed area lead result disease 118B open isolation deisolation essential to down would test 8C critical During 118A they isolated No post rapid stepped AND May with neutropaenia immunity apart an FFP3 care the"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "scot NHS have not Area Communication name advice: quick attendanywhere CRITICAL patient on Remote TO details NHSNearMe@nhslothian video connected use password given Anywhere family FOR sign or call Attend run go email: live which passcode iPad: Ask challenging Log service using do calling talk following Near https://nhsattend please like helpful Breaking medical CARE NHSFREEWIFI VIDEO phone can https://nhs If and patient\u2019s Bad via making is platform CALL in Scotland Prior be RIE USE patients onto Ensure team of it nhs relatives 654321 uk Critical label vc/rcc Guideline iPad you fill read COVID19 Click wish found Guidelines tips HOW ONLY Me for Care News discuss Go Waiting to would username they com/login with access the"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "have different gloves order ensure headband Putting heavily compatibility must With good sides work strap provided patient on Perform checking tested keep above use cuff remove safety during hygiene respirator yourself your neck or are select torn jewellery ties according removing spectacles The hydrated rmly Use protective against glove goggles tie eye Where regularly cheeks outside infection before straps ears lower should undertaken Respirator Eye safe crown available this environment covered waist healthcare nose eyes hands practices If and clean back patient\u2019s spread This NOT over head until personal touched protect between both is repellent fasten worn Note: by in check worker ngers be gown will donning away Gloves surfaces disposable facial Ensure upper of uid equipment bridge putting contaminated Place face you when that Predonning room COVID19 PPE hand perform DO achieved at followed Put mould being change these from differ for instructions always hair technique size Instructions adjust after down to protection test makes piece longsleeved been with nape PROCEED correct cannot limit manufacturers Position pressing the"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "outsides not gloves respirators order wrist Clean Unless must pulling gloved strap soap dedicated Gown alcohol Removal disposed including fold use hold up remove then respirator under your bring only ante remaining neck are or clinical ties removing possible discard The opposite protective glove lined minimises eye Where reduce lift using shoulders outside before removal slide inside To straps contaminating behind rub into Do All nd systematic slightly should front Eye Respirator lean safe grasp there inadvertently waist healthcare distance absence In preferably place peel Wash hands risk sleeves top potential peeling leaving and patient\u2019s bin back buddy the visor over head anteroom/lobby motion personal Pull handle both is by in bottom worker removed ngers while be gown will metres gel retraining Gloves away forward cross of it Firstly: equipment way Unfasten contaminated as contamination follows: dofng themselves off Then: fullface face that room COVID19 PPE hand roll ungloved at process from touching for always area supervised isolation water to protection out reach fall rst Turn with retaining an waste bundle let touch FFP3"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "WWaarrdd Jelly unit not Yankauer cylinder contents Scissors Arterial plastic need Facemasks Cuff CRITICAL 3000 patient on: on 20G Sp02 arterial COVID19/Suspected ETT use up 1000ml iGel RIDU box Status stored Intubation FOR may are laryngoscope Written: Closed emergency The Slim pumps Pressure sampling Oxylog tie drugs v2 drivers ventilator Checklist Loose Next EtC02 before tube 10ml ABP 14F office Clerk Monitor sachets refreshed Approved pressors normal Syringe available Metal clamp review circuit Vascular 18G socket Reviewed CARE Emergency Title: Clark Authors: x3 cable pump Box Covid19 12F Baby Drugs leaving infusion Duncan fat and Femoral Baruah manometer WGH Cannula McGrath Suction key RSI packs 2200 plus Drip set Scope in // check left tubing line Bougie transducer SSuussppeecctteedd be blue KKiitt Ward USE mounts tubes SOP by: Guedel below syringe monitor induction splitter airways Tube equipment intubate Laminated Critical LLiisstt catheter March Braun Blackstock Stylet off waiting scope room COVID19 22G Please suction Draft listed bag phones breathing saline Aintree cateher Guidelines trolley Cables Schrader Macintosh tape clamps HMEF insertion ONLY Draft/Final: Oxygen 2020 if catheters Ambu Care 20 departure size pack to CCOOVVIIDD1199 blades sizes NIPB NG stand charge Stethoscope Mackinnon Anchorfast access made the"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "required China Arterial side ICU Cuff CRITICAL 14 dedicated patient on: unsuitable Severe atropine re 118 box levels IV guidance machine current drugs suspected/proven Ccircuit Checklist airway before monitoring office Monitor 1:10 Approved should Clerk\u2019s medical referral: secretions Anecdotal every wide Covid19 Record leaving list immediately Sonosite guideline buddy manometer WGH transfer convene severely is determine check tubing definitive will SOP Ward patients alfentanil monitor piped of supervising precautions adrenaline Blackstock suitability time insertion 2020 Runner assistants proven discuss to NG charge bed well post entrance Stethoscope with receiving equipotent made care closed choice high Equipment communicate mask prior use judgment taxi 9am safety during but NIC stored ECG FOR see may too nurses donning/doffing appropriate Contact escorted indicated EtC02 Front infection tube unstable Update: PAG take Establish specialty videos Authors: intubating Lubricating phone primed Level If back aim Suction ID 2200 Restock met Transfer cleaning Bougie be SSuussppeecctteedd confirm tubes their USE Communication: compressions COVID Conduct Donning/doffing syringe minimise Assessment airways equipment face proning COVID19 PPE suction Etc02 administrator Two Follow Problem Aintree intubator\u2019s Guidelines hypoxia assess intranet IGel Prereferral Ambu ICU/anaesthetic appropriately access consist not gloves door See Facemasks slim anaesthetic on staffing Perform trained Sp02 oxygen up include RIDU Intubation planning neck call Closed compressiononly assisting 16F emergency The scopes situ Yankaeur Oxylog BP drivers Phone 10th lift Next outside pause 10ml involved arrangements intubations shift List intubator/drugs CARE postintubation Title: and ambulance handover via SSOOPP aerosolization one by HPS 000 in // line units CPR Critical availability position catheter as March kit Braun page status when indicates x2 found change escalation ONLY for catheters progress Care confirmed CXR US Anchorfast HME SAS WWaarrdd cuffed Daily practical Communication measuring Inform maintain doffing trainee COVID19/Suspected ETT nursed full staff Status or 1:100 clinical Written: sterile metaraminol experienced respiratory consultant intubation board ventilator Kit propofol moved Interhospital front Metal Covid clamp review arrange Reviewed Emergency Ventilation risk pump suspected jelly Drugs can Induction identified hypoxic Baruah the Group Exit RSI Staff per between contact deterioration Primary supervise RIE by: number Guedel respond plugged team nursing Laminated Size evidence scissors PCI room scrub Draft at PostRSI these from Draft/Final: remains if 20 departure size bottle after CCOOVVIIDD1199 through critical RSI: nurse anticipatory fluids"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "we NHS lubricate 3cm Yankauer Communication Allergies ICU Ongoing Theatre 2018 Adapted pressure Equipment Fibreoptic patient on Anaesthetist Double Confirm backup Review ETT carina up cuff site box Intubation ECG checked laryngoscopy or laryngoscope Monitoring Closed CoVid requested BP roles? Blacstock drugs intubation Team turns Checklist 10 Verbalise using airway 5cm Cricoid Plan outside tube Date: OPA Site Cons mobile this Covid circuit plan ml Emergency Supraglottic DAS/ICS Drugs phone waveform Induction and Baruah CONCERNS allocation Intubator\u2019s Mac vasopressors Tie head McGrath \u00d72 supply fails? role Scalpelbougietube required? via assistant RSI NOW Can handle Patient contact is check supraglottic Is in mount Lothian Check Bougie Understand will how? tip sedation B/C syringe FoNA Critical position catheter March kit Stylet O2 \u2191K+? SpO2 RAISE Preparation room PPE turned suction further administrator help max ON Sizes Preoxygenate Optimise trolley wake tape incl from 2020 Runner if for Care trachea size Difficulty Who Cut ETCO2 Airway visible Intubator Vocalise Stethoscope Optimisation PROCEED access"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Nursing unit closed required not recovery movement people order use: informed side main ICU must Suggested management Management instance Theatre pressure liase coordinators considered machines patient sink anaesthetic on temporary doffing Bedspaces above Review operating ETT including Enhanced empty ward/HDU/Lothian acceptance 89 then staff but Murray theatre/recovery may only nonCOVID or 36 input As emergency bedspace possible basin spaces already appropriate theatres consultant Anaesthetic coordinate indicated decision Plan before Will Site Oncall able following moved All handwashing should normal this available Manage barrier plan requiring 48 used 13/3/2020 directed ward enact Main/DCN Capacity admission 1016 can If and areas mechanical WGH ICU/Ward transfer This now Move until via Patients per NonCOVID19 Patient between both is ventilation L1/2 surgery admitted by in Donning Surge /Ward within removed nonessential At be will Medical SOP Ward RIE donning patients floor surge These Visitors managed barriers plan: of team nursing Discharge Critical as IPCT 18 elective Blackstock occurred point HDU /NHDU bedspaces that Dependent Estates room COVID19 PPE 58 stop negative further time who referral senior at construct Close continue detailed oncall vestibule SHDU escalation from capacity markings advice first Medical/Haematology for time: Care 20 Bedspace area 26 Consultant entrance/exit to 916 theatre second doors all default entrance bed with any SJH 3rd ends items the"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "minimised Anaesthesia side plastic DOPES system CAUSES saying rechecked patient changing setting adjusted FLOW switch VCV mains only require otherwise its PaCO2 Use machine Flow Respiratory 13l/min light 10 Bag To More Breaths All red should Pinsp this medical Pause used every indicator target present COETT top breath dialed DISCONNECT defined immediately AISYS last mechanical standby HYPOXIA: until vent is ventilated disconnection SIMV check within will patients usually of way Once changed arrow <60 Ventilator displayed bellows increasing HELP CS2 container tab canister start so OXYGEN >6 LIME needs You closedsuction pH to prompt they AND with limit SODA care 8l/min refill BACKUP 15 green 12cmH2O high EtCO2 measured pressure Equipment above 10l/min including 400mls Gas during neurointensive but see FOR may run demands no H+ baseline Restart complete appropriate Ask reduce tube flow lower d/w changes ventilating increased place If >0 minutes Obstruction aim This 5cmH2O low THE REMEMBER rate met 5l/min casing be confirm Tidal likely COVID Ensure ABG either based move VENTILATION Mode reverse achieved CO2 fresh break PVCVG NonCOVID visual FALLING BREAKING higher Press than turn 100% switch: activate FiCO2 pressing touch VENTILATOR not different Push With bag/ventilator temporarily temporary USING on Perform Initial Select oxygen up <30cmH2O FGF include elevated bpm Ratio calibrate Displaced select checkout OXYGENATE Disconnections The lime hours Volume touchscreen Checkout persists OF 1l/min using pause lowflow following highflow circuit Volatile 60 leaks and IMMEDIATE window There CALL by in left message litres/minute each These PAUSING does 824 position Start CIRCUIT O2 you that when Vent secs indicates bedside change endtidal righthand difference for litres/min FiO2 confirmed com END yet down adjust all BELLOWS PEEP screen gas need picture maintain sodalime >7 leak settings return soda then initially comwheel GOALS right or are toggled 1:1 which Pressure Following FRESH Signs ventilator occurs fail do PCVVG 2024 there PLAN: clamp review Ventilation shown reconnected admission can combination identified Stacked Settings: navigate Settings reduction Pneumothorax mode Preferred >8kPa set increase Increase targets connections flows team 6l/min TROUBLESHOOTING CCIRCUIT OFF >10l/min periodically perform PaO2 Case bag procedure Low at GAS After confronted if TIDAL seconds after support reach default 6mls/kg wheel the"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "we required make where ensure Anaesthesia clamping main ICU 12hours system are: rechecked performed patient changing setting body adjusted >68l/min yellow >10l/minute blocking \uf0b37 hyperpyrexia switch VCV cancel under short only levels 12cm require more Sidestream its document PaCO2 Flows Use machine period context exhausted familiar tight Flow Continuous Solutions integrity current theatres Respiratory 13l/min collapse light airway Bag ask 10 filters before To Intersurgical pro More into All cassetes red However should functional suggest this us induce upon medical Disclaimer: vapour experience ill used indicator target every Pro mitigate Soda Dr COETT filled defined AISYS designed patient\u2019s due WGH initial manometer standby now COVIDpositive until supplies approach I:E vent is incorporates ventilated balance disconnection exhaustion SIMV check Lothian less within Check begin frequently weight will phases SOP twist patients agents surge sedation usually monitor disposable of anticipate style starting intermittent expiratory although ODP contamination changed Once volatile arrow selecting neuromuscular unless efficiency Vt Please basis Expiratory bellows cassette Fresh increasing Assess time CS2 works instability users circle tab canister start so being overcome disconnected optimise It unclamped needs consideration You situation register pH open sensor to out display they expected sevoflurane been with Simply an limit lowflows preferred throughout closed CPAP acknowledged Ally order returned 15 3L/min green 1:2 high latter EtCO2 therefore 10L/min measured 8kpa pressure expired machines earlier options keep above 10l/min including use Circuits empty 49day remove site 400mls Gas during but cicuit positions may see 6L/min checked safer 49 depending very according Morgan Adjust valve run On impact refer least demands control protective without goals no H+ baseline maximum our caution inspiration guide regular frequent plateau reduce indicated tube flow lower 19 PSVPro soiled Suctioning production undertaken contacted ratio changes Breaking inadvertently ventilating routinely increased metabolic mentioned alter If >0 necessary completion important minutes back rise components wash circuits This aim NOT pressures restarted inspect anticipating disposables low rebreathing both consists rate Unable windows reinspired met drop 5l/min push whether be confirm questioned their Touch likely L/min posters COVID below absorbed Ensure called it wet minimise For stay emptied case discussed Intensivists litre/min bacterial/viral capnographs point mandatory either Prone Higher Neuro Commencing conduct move significant Standard suction aiming Mode listed breathing instances displays Although who CO2 fresh indicators prolonged Troubleshooting HMEF reconnecting routine prevent higher than reliability They breaths turn fulltest clearance parameters 100% representation Initially test switch: anaesthesia cannot volume FiCO2 Operating pressing neutral linked touch reboot presence not ulnar different standard recovery undergo long By One put 400ml See With unlike best An 12hrs temporary temporarily anaesthetic on selfsealing Initial corresponds Select Rate oxygen Modes provision Controlled PSV has extent outwith FGF elevated operated isoflurane volumes planning nonCOVID select Closed checkout term remain Synchronised possible lime The hours Volume Tab guaranteed continues clinically Consider touchscreen expertise 24 Checkout Aisys persists Introductory using rotating drying lowflow following Do usual times could accessed How Should please RR normal two available alarm paused added minute plan circuit carry requiring displaced 60 barotrauma also leaks information potential and Procedure 68 window When uses NO occurring via There highlighted by Falling in Prior left prove line message litres/minute preuse internal desired 13 These lost those H2O completed Upon demand selected Critical position limited Tinsp as scavenging Start 12hour page cause haemodynamic O2 you Gibson when that dependent Vent 13L/min problem Safety PCV capnography Alastair inspiratory weaning positive remind found additional demonstrate Circle bedside change 1220 Users predicted difference for litres/min Care FiO2 confirmed com 30cmH2O Disposables yet adjust Circuit apnoea Differences all reinflated Air requirement Difference indications becomes Increasing NHS rates have days PEEP screen gas must need picture critically maintain Adapted sodalime again We moisture located viral leak valves option settings discussion ruler warning operating return Elevated small full menu customise rate? soda Breathing then initially staff comwheel inspired colour assist achieve flush are or clinical toggled controlled As which 1:1 Pressure mindray Following vapouriser respiratory 3l/min consultant intended Using freshgas autoflow >6l/min ventilator licensed procedures hypoxaemia Visually sidestream shortage filter do broken Peak propofol Diuretics settings: performance PCVVG slightly 2024 unnecessary inspiratory/expiratory drive 1l/minute there review In what peak Ventilation shown risk reconnected Total capnograph reduced can combination replacement identified malignant lung navigate ventilate individual Our Settings challenges recheck mode Distal per between set proximal ventilation increase non names end cmH2O Increase removed expect just At spill connections flows 12 team note ventilators 6l/min suctioning most completely limb known clamped OFF >10l/min read adjustable 24hours some Ventilatory PaO2 negative continuous further procedure bag tidal cancelled satellite at enlist occur After these from litres hospital confronted Com if VG spontaneously extremely become cannister after support would default acknowledge 6mls/kg pandemic nurse any wheel Default the"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "required Machine closed white not reboot trap5 spirometry days 15 Anaesthesia ICU must need manual high carried EtCO2 measured rechecked moisture selftest7 performed on Perform dialled Initial including use yellow has 1Task soda FGF include inspired colour assist may checked 49 or Monitoring require Morgan more otherwise PaCO2 other control lime hours The machine Pressure tight near Inspect 24 Aisys occurs using filters before filter Change monitoring flow lime1 into condenser <0 However should exp pink please two Water distal circuit6 this there Continuously medical added circuit vapour secretions increased used occluded every zero present Soda thirds information visually Record reduced If replacement and mins minutes patient\u2019s flow4 due curve 68l/min drained recheck low 1L/min resistance is increase by exhaustion disconnection in 5l/min within frequently Filters excessive be will Tidal blue SOP patients inspected team of does 6l/min expiratory limb Insp as changed next chart point causes >10l/min either needed humidity when Ventilator Hourly indicates suction Expiratory further time Alastair CS2 CO2 bronchoconstriction circle canister hourly bedside change HMEF from Absorbent neurocritical It if zero? for Version than FiO2 MV fulltest Instructions after parameters water Circuit to reach out all fall Alarms with an volume FiCO2 care daily the"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "we required ensure clamping side main dyssynchrony ICU system quick 14 Appropriate performed patient changing setting >10L/min yellow such Breaks history unintended hyperpyrexia Scavenging deliver 12cmH20 under 24hrs effects only levels ET find require compliance more Sidestream removing its document PaCO2 working other Flows absorber machine context tight integrity current theatres studied Respiratory Ccircuit planned done meet collapse 10 EZchange filters before To opened monitoring supported stable Intersurgical rather More into Running All However should effort this distal upon us medical sought Disclaimer: Pause experience commence ill used indicator every wide present sedated COETT breath despite AISYS delivery designed inefficiency fitted patient\u2019s manometer initial transfer breaks PS/CPAP supply COVIDpositive until GE reducing I:E is dead ventilated SIMV breathe check Lothian less within Check frequently will phases blue Ward Unit1 twist patients agents inspected ready surge >10 sedation usually monitor agent minimum of local expiratory changed Once volatile sudden neuromuscular compensation MAC displayed unless efficiency occasions rebooted bellows cassette Fresh increasing time CS2 circle tab depressurisation canister arises optimisation being insertion assistance H+\uf0a365 It Local repatriated external Satellite needs brief situation closedsuction register 16 to out operate they IPC fall expected been with receiving an made members lowflows 812cmH20 refill closed CPAP acknowledged port 15 understanding supervision alternative high EtCO2 therefore measured Satellite/Surge pressure machines replaced charts mask comprehensive options limits prior 10l/min including use connected CCircuit empty delivered especially 400mls Gas safety during problematic Hospitals but console may checked 49 very *For depending according Morgan interfere control run least Further without no H+ Appendix Restart maximum our complete appropriate inspiration guide https://cleaning 17 calibration regularly sevoflurane/isoflurane reduce Both tube Minute flow 19 PSVPro standards condenser laminated production ratio opening changes responsible routinely increased cleared resource failure metabolic means undoubtedly 30 triggered infusion continual If >0 necessary oscillations important minutes soon back needing circuits This aim pressures restarted detrimental low rebreathing both resistance function rate 35cmH2O blocked unable drop Filter rainout cleaning stops push be inspection their COVID loss Royal attached Clamp it wet emptied For determined bacterial equipment ABG suction/patient Phase 18 bacterial/viral point mandatory either Neuro teams COVID19 PPE Standard suction Mode help arriving breathing described ODP/medical who CO2 Although fresh once followed paralysed longterm sensor/valve NonCOVID HMEF visual Immediate routine updated higher than \uf0a365 20cmH2O They breaths technical appropriately anaesthesia concern volume FiCO2 FFP3 Operating linked reboot not different standard long Unless vary \uf0b312 With provided An adequate temporarily anaesthetic on Perform alongside adapt Initial performing backup arterial oxygen provision cuff has deeper FGF include elevated intervention nonCOVID Closed 11 term emergency bedspace possible lime The hours pausing Oxylog guaranteed timed spontaneous about 24 Aisys Ventilators Introductory discoloured 1litre/min perioperative using preceded lowflow ongoing following times operates arrangements could Should associated Clinical please RR two available tracheostomy alarm paused closedsuctioning added previously circuit minute 5L/min Volatile requiring sensed Any also ward setup leaks information opioid potential visually pH>7 Capnography communicated and waveforms SpR Procedure outstrips 68 certificate 68L/min When oxygenating Canister Owner: suitable drained There Negative isolate 1L/min Mindray by in Surge parameter Prior acquired avoid monitored line clinician each litres/minute event 13 nationally These blockade presents demand does 824 Critical limited scavenging as catheter corresponding delivers greater oxygenation 510cmH20 needed negate dependent that acceptable when increases hospitalwide capnography Alastair were inspiratory weaning positive pH\uf0b37 expectation sedative atmosphere Western precheck bedside reservoir change capacity practice pressure/flow user for litres/min detected Care FiO2 confirmed result com 30cmH2O Consultant adjust suggesting apnoea all Unclamp physiology 10l/minute indications daily Increasing NHS have highmetabolic rates suggested days cylinder PEEP gas need must effect critically maintain sodalime again 3000 We moisture considered viral/bacterial decontamination leak viral option Ideally settings warning small full capability +/ soda then initially staff level inspired transitioning are or clinical ensuring reference which Pressure experienced sooner deeply respiratory 3l/min intended approximately consider >6l/min nonIntensivists licensed ventilator procedures autoflow filter FiO2>0 broken propofol performance outstrip disengaged PCVVG drive assisted there proper review reduces Pmax In space peak Ventilation risk kept suspected General admission device reduced Internal can replacing exclude replacement identified clean maintained malignant lung undergone Teleflex ventilate similar Our Settings personal basic recheck mode Replacing accuracy per admissions between set deterioration ventilation how new received worn increase proximal non end At targets still connections flows onto 12 induction team nursing note ventilators 6l/min suctioning most pressurecontrolled limb hose follows: clamped seen typically appears lowest read perform PaO2 filtering further compensate procedure conjunction bag tidal satellite reengaged coughing Low at midazolam/clonidine Colleges/ASA Full from hospital if Version seconds 20 <10 spontaneously MV become gehealthcare AGSS after support would kPa through flowrate default 6mls/kg pandemic utilisation Increased the"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Only WWaarrdd required standard not Card 15 put ICU need Then carried doff repeated CRITICAL 14 patient on: clothing earlier on taken doffing trained CCTT prior trainee discussion Dunn has during ahead staff Status stored FOR enhanced agreement only clear remaining or Written: table Scan AAccttiioonn 11 July emergency go bedspace control The guidance newly wait remain On donned member Oxylog Following appropriate consultant clinically done ventilator \u2018clean\u2019 Final 10 using department indicated Next outside inside filter tube do Approved should undertaken prepare CT: this Ferguson medical review circuit Reviewed CARE used Title: also ward Authors: kept reconnected Level can leaving If list immediately and wear necessary back Baruah WGH standby departure: transfer This Arrival transport individual via radiographer corridors 2200 entering per disconnecting between is Intrahospital one by HPS end disconnection in CT arrival Transfer avoid completion: Action be will observe Ward by: USE 13 COVID 12 minimum Pre Ensure team nursing of CCaarrdd does stay ChlorClean Tube equipment Critical discussed amount as Portering contamination walk arranged off unless room COVID19 PPE scan entry undertake wearing cubicle bag McNeill senior at Guidelines trolley drug \u2018doffing\u2019 clamps change assistance from ONLY practice Draft/Final: 2020 if for Care TTrraannssffeerr 20 wiped area 16 open down IInnttrraahhoossppiittaall after monitors to CCOOVVIIDD1199 doors Stop bed nurse 5th May been with access 3rd members HME the"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "required Mackay specific ensure https://www Arterial Clean side inotrope/vaspressor bolus Insert patient Decreasing Policy patency lumen date continuously titrate under short effects only References require more pdf other guidance double 73 Use Commence current drugs additive before To monitoring Venous ABP luminous into All \u22645mmHg should stated running this medical ac prevention 20mls/hr commence used every xrayed vasoactive waveform delivery last due medicines until Inotropes is 20th disconnection Hospital Lothian less within Check hour frequently concentrations uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress recommendations will medication Run of Inotrope/Vasopressor visualisation Heru starting 2007 way changed bleeding concentration et Please increasing time best/201728 continue so start standardsformedicinesmanagement connection confirming http://www It Connect interruption instructions open library to out three charge bed engaged been with Purge Benefits an distally care Nursing continually high pressure Doses Equipment nmc Training above keep net/clinicalsubjects/accidentand prior connected use transduced remove site during proximally may very pumps: inotrope half nurses control administration discard run Medication without no April maximum complete seek update Rapid Sept original infection Concentration flow Observe lower central invasive bags follow extra Discontinuation infusion If back rise This oxfordjournals insitu 2010 both uk/globalassets/sitedocuments/standards/nmc rate unable push subclavian be changeover uk/icshomepage/guidelinesandstandards/ attached CVC Ensure it For Central Aim off 2012 <drugs Healthcare<az<critical Commencing PPE existing clearly faster 10mls/hr Keep Follow 8mg% achieved study Guidelines another MAP clamps assess 16mg Core intranet prevent higher prescribed than area turn Apply aet199 rapid correct touch Signature not Device administered covers instance changeovers best on strength 2015 Infusion arterial automated 2013 up blood has Signature/BBraun life your tap Society New The Be infusions: 9% lines systolic service labelled circumstances mls Do times safe available 80mcg/ml old pdf+html Calculation venous 2% flushing discontinuation and areas handover aware vasopressors Catheter Personal When Administration via guidelines designated one by in Council emergency/changinginotropeinfusionswhichtechniqueis Prior line Inotrope desired Titrate Journal 5mls NaCL recommended Blood medications Critical providing as Braun Inotropes/Vasopressors photosensitive you that inotropes wipes alarming found hourly 160mcg/ml change advice practice for placement Care 10mls Stop nursingtimes Date Written 8mg Increasing NHS have prescription Chlorhexidine Alaris need effect management ors labels policy 16mg% taken al British inotropes/vaspressors Pollock Review Medicine Changing ucl small Cour connecting full then initially staff pertains org achieve flush fullarticle competencies or are http://bja which pumps Pressure 72hours Following smart measures consider occurs expiry patent actions infusions spiked space risk pump Enter device can sugars the decrease ics per threeway Midwifery bleed new Standards C74C77 end Prepare observe by: Failure quasiexperimental Protective same onto pumping org/content/early/2013/06/11/bja dated IJ Intensive 2mls/hr clamped Lines 2017 stop Work Cardiovascular Label requires bag at drug and/or After from if technique Drug critical through nurse any fluids"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "serial Smart nonvented ensure language Back main manual PGDT system Insert CO patient image Captures adverse contraindications pull switch outlined only Thermistor IV Monitoring Securely other Demo tight current 10 Bag Corporation To monitoring orientation into Monitor operator\u2019s All alarms value gravity this upon Advanced Navigation data indicator aspirate slot PPUS2208 globes initial caps click Average Lock until Sensor output is Battery mount panel stud tubing will silences features stopcock Zero monitor of icon precautions air: selecting rear displayed charged axis hemodynamic time Snapshot raises USA CAUTION: button Platform being tracking connection It Connect instructions sensor open to Module out display stand engaged Turn with inserting Expansion an LTech order port FloTrac pressure Federal connector keep conditioned including use advanced system: remove 24/7 ECG refer property without no complete appropriate guide update calibration measurement terminal restricts lower Ethernet grade follow United respective place six Thermal Level fully important minutes This events Open inspect Silence Export calculator time/date Help entering warnings rate highlights packaging be their Touch Edwards it Bar For audible \u2018Quick off screens sale fluid Event holder Follow arrows visual holding reserved first technology owners Press physician technical parameters test affects CCO mmHg filament Available Main steps Irvine touch standard not door Refer Time Fastflush contents One See With States on pole battery arterial selection up law eight contained iCO heart cardiac tap select remain \u2018zero\u2019 The v2 8008229837 using Choose Hold outside times Clinical two alarm ports setup information format and Zero\u2019 window 300 rights Oximetry capital_care@edwards guidelines zeroing highlighted stylized Note: by ops in parameter left column globe compatible desired insertion/connection completed selected Blood units appear position assure catheter as Start status you 92614 when that 2019 Screen Waveform power additional Start/stop expansion change Injectate USB for heard com Lifesciences HIS down hang Stop all Date indications Averaging COM1 screen bar must Equipotential Way temperature settings Engineering air Analog full Pressurize then Status level flush right or are clinical input prime which Zeroing IQ Pressure logo procedures startup TimeinTarget reaches Plug do inate prescribing Parameter WiFi front trademarks actions proper review zero pushing cord slots cable bubbles Enter device can plug Replace replacement outlet insert Acumen Information Settings HDMI mode Compatible accuracy between Patient platform end properly OR stopcocks edwards probe connections Setup want SwanGanz deair HemoSphere Derived appears residual module bag tone phlebostatic at Mount CA and/or upright hospital CVP after support through RS232 any the"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "PVPI Arterial DBP mL/m2/beat Lactate 1000 CO adverse contraindications S2S1 931 Hemodynamic 08 Extra SVRI PTV=CO 90140 Output other meeting g/L ELWI 4060% Hct 10 Corporation bear Venous CO/HR RVEDVI SVV All this Males: values* 8501000 v1 International European SVI conformity <3 CE Hgb ITBV=1 Cardiac 815 420 xDSt 25 PVPI=EVLW/PBV of RVEDV precautions RVSWI ITBI 50 Female: hemodynamic DSt time saline marking CI USA CAUTION: theirrespective Equation /SaO2 46 L/min/m2 RVEDV/BSA instructions Extraction to Systemic Index 25xGEDV Hematocrit 6070% mL/m2 order PAP Normal CPO Cv Federal range ITBV Lung including use Left placed 65 GEDI EDVSV 60100 EVLW=PTVPBV RVSP S1/S2 Systolic Coronary /3 property laboratory Article mEq/L Values CvO2 Ventricular dye/temperature restricts Mean W/m2 80 0136 Intra United 48 BPPAOP RVESV 1020 2230% ScvO2 events /CI Convention COxDSt0 PAOP Units warnings 1525 Occlusion RVEF regional Medical LAP PVRI L/min 4252% Edwards CFI devices 5062 EndSystolic For Test Central 360 SV Power Ejection sale Atrial DO2I SV/EF MAP mL/dL reserved methods Mixed Oxygen GEDV PBW owners physician Delivery injection 0031 parameters Content essential Pulmonary Parameters S2 VO2I mmHg Irvine EVLW/PBW 70105 PPUS2312 Device One Cold vary See States 2025% DO2 on SI blood law Thoracic Ratio 54 11 Physiorelationship Hemoglobin 45 8001200 dynessec/cm5/m2 BP Volume professional SVR mmol/L PVR Right HR PASP av Diastolic Water S1 Vascular Predicted Directive93/42/ECC Male 5994 Artery CaO2 100160 Saturation Weight Stroke information O2EI and EVLW rights stylized SvO2 by dynessec/cm5 in CO/BSA 200250 6080 PBV=0 requirements 510 07 716 9501150 612 Blood units PADP End EndDiastolic Fraction Females: MTt O2ER O2 CPI 92614 market Function SV/EDV mL/kg values Permeability Resistance for /CaO2 26 Lifesciences com GEDV=COxMTtxf 100 SaO2 ml/m2 Difference LVSWI indications 650800 >20% mL/min 117160 TPTD RVDP RAP Way Height152 RVP 120160 g/dL full Perfusion GEF /SVmean Consumption or are reference Pressure logo <250 95100% 50100 mL *Reference Transpulmonary MPAP 91 prescribing Parameter 19702390 trademarks CI/HR /CO 56 1/min Body ITTV=COxMTt device 52 EVLW/0 3347 adult 417 SBP SV/1000 mL/beat 1720 SVmax 255285 edwards 6080% CPP 12 1215 6090 referred PvO2 500600 SVmin 124174 Global 3648% 2017 PaO2 Work 0138 Laboratory CA mL/min/m2 thermodilution techniques CVP 1015% VO2 Variation the"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "method ensure Device boluses 15 nonindexed See TPTD bolus 2018 choose pressure Repeat Insert 14 patient range on Lung con adverse arterial temperature contraindications Select smooth air including use connected up placed full then keypad inline level thermistor selftest right are according or 11 removing prime Actions refer transpulmonary oxymetry meeting injectate thermal example baseline logo starts Article appropriate guide professional 17 Prime solution System startup edit 10 using Choose TruWave Corporation bear Venous prescribing Observe 1260 directions Nyon Monitor 19 All central Directive Clinical please normal trademarks available Before previously review data prefer lobectomy ml zero EV1000 VolumeView Route setup cable six information venous Enter primed waveform European and waveforms cold patient\u2019s conformity databox de events Catheter CE pressures When until rights Oximetry warnings results set stylized is new ne one highlighted in real parameter inject Medical transducer OR edwards ENP509/1118/CC Touch probe desired descriptor 13 Edwards requirements Setup devices 12 monitor syringe CVC Ensure upper of it Wait reached For selected referred transducers manifold precautions Guide amount catheter Central prechilled as Start 18 cables Accept Resection market screens displayed femoral axis indexed Inject existing valve/port continuous procedure Switzerland marking time Bolus phlebostatic saline volume continue connect l\u2019Etraz start button Platform calculation reserved if for thermodilution series instructions Connect 20 70 com Lifesciences RUL alarms/target sensor CVP 16 parameters essential to rm 93/42/EEC Startup all well Parameters rapid Turn with steps Thermodilution Set indications touch the"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "scot compressible: Massive notes anecdotal Arterial Injury anything manual large patient on: body cavities doc such pull unintended only guidewire require more its versus document Jan 73 period context executed relative misplaced anaesthetist minimal vessel IF While fluoroscopy surgeon before Venous into Approved However should Communicate this distal upon absence prevention Catheters data haemorrhage used aspirate present formation stepbystep waveform immediately tear needle guideline angiogram cerebral DONT until expanding Ireland percutaneous uk/Directory/CriticalCare/Bedside is Radiology evaluated real less DON\u2019T will nonsurgical damage patients usually minimum of nhs circulation way bleeding if: dissection severe femoral connects thinwall pseudoaneurysm time instability wire insertion catheter/dilator http://intranet confirming Tambyraja to out catheterrelated AND expected issues been with handled an Compress ultrasound pulse mortality diagnosis order issue Background: Management MMaannaaggeemmeenntt pressure \u2018Arterial\u2019 interventional watchful freely/difficult site during COMPRESSIBLE FOR may NHSLothian representative least without no Contact frequent compressing gauge flow Interventional central Than XR follow Verification infarction reports dilator place resides Authors: coagulopathy deferring Inadvertent minutes soon This Equal Anaesthesiology includes Minor Actions: low compression Rhona CT unable supra majority dynamic subclavian be their USE likely DILATION mass devices difficult 2021 managed switchboard literature it determined minimise For Central Guideline 18 analysis off benefits 2012 major Recognition: based significant whose continued practically recognised who infuse BEFORE Misplacement Guidelines anaemic advance Immediate than localization wall uncontrolled appropriately pulsatile CCaatthheetteerrss puncture DRAFT access Misplaced PRESS Coagulopathy not manageable allow treatment organised on Less lothian imaging arterial pleural regarding catheter/vessel location Compressible liaise blood has peritoneal CCeennttrraall NON consequence era Duplex cavity Abnormal Society Report consultation thrombosis possible The Complications: hours VASCULAR 24 injury AFTER lines care/Insertion Next ischaemic consulted Leave following Do Remain associated Unintentional available helpful plan Vascular Title: also methods: venous provide Practice and adults American Catheter When relied via proceeding Surgery fistula one by in Guidance avoid threaded left line Access: pericardial morbidity immediate Line does Blood Cap cannulation Critical arteriovenous providing catheterisations catheter as Feb greater prepuncture that acceptable embolus DO Puncture were Guidewire active ONLY course Anesthesiology for catheters complicated Care placement result down CXR No Stop all 116:539 multidisciplinary general have often tears French thread missited must gas group management ffoorr considered cap *There purpose small radiologist CClliinniiccaall PULL Status Needle colour are or Written: clinical Advances indicate QIT intended surgical occurs vein removal vessel: bore Access carotid highest Xray documented Anesthesiologists there infusions review Hamish Mispalcement Reviewed In artery space haemothorax unrecognised risk remain: pre reduced can Potential reported attempted hypoxic vascular ooff MMiissssiitteedd GGuuiiddeelliinnee largebore adult closure PPrraaccttiiccee Task Dilator/catheter Patients sited contact surgery infraclavicularly develop risks SURGERY AV catheterization by: editorial 12 observation most withdraw Size elective Punctures seen evidence Lines Remove guiding Dornan confer Case conjunction complication complications 547 CONTACT at occur these After from References: Draft/Final: if route hypotensive techniques size after Aanesthesia static generally Force Retroperitoneal Andy any common Vessel* repair the"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "NHS not ICU having ID: presence group physiologically CRITICAL patient on: 2015 obesity trainee Medicine 2013 including placed has advanced signed Status FOR only agreement doctor competencies are Written: other The guidance appropriate QIT Practitioner Anaesthetic decision Next ACCP Venous stable met: following November central PLACEMENT Approved should review Advanced Reviewed LOTHIAN GUIDELINE CARE used Any morbid Title: failure Authors: coagulopathy venous and criteria Catheter ultrasound suitable basic There approach anticipated Patients is by inhouse met in ADVANCED Lothian within be will liver by: USE internal editorial difficult acute CVC completed of difficulty Critical Anticipated anatomy training as Central Guideline hypertension Intensive FINAL off when that BY Neil significant circumstances: PRACTITIONERS them senior Guidelines being from ONLY practice Draft/Final: for obtain jugular placement Care Young intracranial Consultant supervised to fellowship post with an access made Practitioners the"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "make where Clean system CRITICAL 14 Edition patient on: Rogers College approx date occlusive pull Explain References part 10 before Venous into Approved should medical 2%Chlorhexidine used immediately patient\u2019s Early head redness 30mins cut signs is Procedures Hospital check Reposition Check Discontinue Neuroscience of January bleeding chart Complications basis time container Put platelet being insertion pus 4351 Cut to Therapy bed with Nursing order REMOVAL continuing lumens decreases 8th soap pressure Dispose Equipment cover Invasive alcohol Scissors* Required including remove site FOR forcibly dressing discard normal/close Ask Cover Cerebral cutter infection cultures Devices lying central Maintain place RCN: Clark Authors: If minutes back wash This Document 2010 degrees be their USE Chapter Royal CVC Clamp it stay equipment Central Trendelenburg 18 point Place off based move Standard Bruce Guidelines rigours first higher than area pack water access 2011 gloves instruction put Loosen swab on Continue 2015 Infusion Removal blood has Marsden 11 hours stopped near Alcohol about 5cm using Next Hold swabs addition associated Clinical normal two Vascular old CARE Wash Title: hands venous sent 2% and Procedure Small London Catheter When Discuss gauze flat transparent one by in Semipermeable Prior line investigation 13 Journal PostProcedure Devastating Line Critical position intact Plaizier send catheter Valsalva FINAL 2006 begins Professional Swabs hypotension Bell disconnect ONLY Glover for Care 26 down all Air 3rd daily Chlorhexidine microbiological need must Embolism group management manoeuvre taken Skin Review small clotting staff Status Sterile are or Written: Tegaderm sterile As carefully QIT consultant approximately removal able rub airtight wipe there 193196 infusions review Reviewed deranged risk suspected supine firmly clean exhale Manual 1530 53 Standards peripheral WileyBlackwell by: Lister tip editorial 12 Hamilton suture Stitch 70% gently 72 reason scissors Remove 2017 hand perform skin 43 press pyrexia procedure Dougherty Wipe count at trolley devices: Clinell After from container* Draft/Final: if specimen 20 CVP after laid any comfortable feet the"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Quality where ensure adhesion port Clean side Figure green tactile Then tiles Channel applicable tissue system edges choose pressure adequate patient on Continue Skin body manufactured performing Select adverse prior tile location contraindications connected use up selection placed menu has advanced eifu then apply level under quality or are New select reading affiliates its ENP611/1019/CC other refer reference which Use property protective condition logo integrity appropriate current illuminates subsidiary guide professional Display System meet lift application Corporation indications Change monitoring 1260 Elite into Parameter Nyon All assessment value please circulatory invasive trademarks sensors timepoint data Indicator respective configuration Value setup interval StO2 cable Route listing potential European and Signal mode: patient\u2019s conformity modes click minimallyinvasive de adult events Open When CE Move inspect mode rights notifications Oximetry Inc Sensor warnings Patient both between set Slide is stylized Note: by in check parameter left monitored packaging signal Check Medical blue enter damage each Touch channel edwards their Edwards requirements oximetry around Setup devices monitor Ensure upper of Reminder consult selected For Tissue precautions corresponding Changed Reference StO2% HemoSphere when Remove displayed appears deteriorated market 2019 Location module skin pediatric figure displays time marking Switzerland LED works Same tab l\u2019Etraz ForeSight button being assess Intervals/Averaging from reserved if for owners Connect dry area com Lifesciences 70 Instructions sensor Apply bearing to CAS with correct access made Difference liner Interval the"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "NHS https://www Golden Heart 2018 CRITICAL on GJNH Jubilee August Status heart FOR Support Written: Acute QIT Scottish Final Sept using Next following All Approved should review Advanced Reviewed CARE referrals Title: 09 failure Authors: Form and advancedheartfailureservice/ on:11 Directorate Cardiology Referral National form by Hospital Guidance Lothian Circulatory be by: USE Failure Cares acute jointly completed Critical Mechanical 18 page uk/ourservices/scottishnational teams nhsgoldenjubilee McNeill referral found Guidelines website: co from Service ONLY Draft/Final: 2020 Care AHF/MCS to the"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "Nursing scot Daily facilitates ICU eg base Heart recieving patient GJNH details informed: discussion referring up Cardiologist recommendations: or Acute Clinican transplantcoordinators@gjnh Intensivist Clinician Further contacts appropriate clincian board surgeon clinicians coordinator follow added cc failure NSD MDT If returns and Transplant handover online via completes plus pathway form surgery Transfer clinician sheet 5000 Recieving switchboard team nursing nhs uk local records ICUICU clinican MCS Referring discussion: further referral 0141 at oncall cardiology cardiologist intensivist hospital for AHF to No Surgeon ensures with 951 members daily"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "optimal required ensure 10minutes Arterial plastic having manual 2018 CRITICAL patient patency August platelets erns only Monitoring more tight Continuous MUST easily ask before Positioning affected stable into triggering Approved should effort this distal medical used every ill Trigger 1:4 present formation waveform rhythm filled tank immediately knuckle standby Cardiac is check Lothian within tubing injecting landmark sedation monitor of circulation ear chart sudden radiology failur 24cm increasing CI install senior helium continue Absent so radial occlusion being insertion 2020 It diastolic open to trigger reviewed with concerns an formal pulse Loss 1:2 alternative measured monitoring: postinsertion pressure colleague manually remove site superior decreased ECG FOR may clear AbuArafeh too Tubing inotrope valve Weaning no inflation descending Pump appropriate limb/shoulder Sept linear Intra MAP>65 slowly su 20minutes increased positioning switched failure Authors: consecutive deflated If fully important replace restarted caused balloon low rate subclavian be USE below Ensure Auto it Guideline 18 point off height Power frequency Frequency try thoracic Mode structure pedal McNeill Aortic IntraAortic Guidelines MAP pleas Troubleshooting assess ca Balloon than close notify zeroed visible During colour/warmth correct Helium not on Pum Initial obtained trained arterial Reviewing carina has heart cardiac Augmentation aorta New select The diac hours Consider ent Final Next pause ioning following cal times washer please safe available alarm arrest IABP augmentation metalli CARE noted Title: also Augmented metallic and Max Ensure: inflated lloon by in nding foot left line transducer message each requirements bei report onset completed Blood CPR Critical position as cause you when Hourly checks: disconnect ONLY for altered placement Care CXR deflating pain Increasing have often electrodes cylinder Daily abnormal need considered damaged temperature air small full then obvious staff Status colour right or are Written: 1:1 Pressure QIT occlu aortic alignment do rtery clot settings: ort patent 50ml verify clamp review pulses Reviewed In artery 09 risk pump cable can identified attempted ept DC >2 on:11 Directorate cardioversion counterpulsation Process: reduction per Patient proximal STOP new Avoid risks removed trace while by: tip connections U+Es Setup involves upper team limb Bedside seen marker 2cm hand 30minutes perform stop renal bag Low from Draft/Final: remains if lead after Traditionally any the"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "required CPR/if Arterial IIAABBPP Ext tracing 300mmHg Reduction medically patient lumen separate elsewhere limbs Red Immobility only IV more part Bilateral Output USS Use stopping 80% Checklist 10 SPSP To automatically affected office into Accurate CS100/CS300 Arrest red should Readings anteriorly this medical sensation used Trigger present formation waveform immediately delivery Trace initial unassisted transfer Points Cardiac angle capillary Inotropes Pulses signs is check Lothian within less Check tubing radiological will ECHO Zero of Angiography site/helium sensation/movement contain Key bleeding chart sudden balloon/tubing dissection haematoma Especially CTITU unless charged axis protocol helium heparin start radial insertion disconnected diastolic open looks to to: trigger they Arm charge stand bed reviewed admission/as Turn with an made 21111 pulse Nursing Platelet affect Never 1:2 wave Normal pressure Unassisted Equipment awake manually limits above chest Left Lower especially during but ECG may Tubing 1:3 dressing Systolic On refer Weaning GCS Checks goals 2014 extratubing secure indicated Authoriser Documentation infection gauge Category: flow Observe Mean Maintain changes follow checks boxed admission/after Authors: rupture Allan 30 Level fully If TPR minutes Limb Open Patency Board Document required: restarted Editorial balloon Alarm ABP/MAP both 8ft IABPSC101110v1 signal whether be Medical likely drip compressions Usually 23252 derived Ensure Auto Troubleshoot height Power Consultant/cardiologist Frequency ALS NaCl Mode pedal followed MAP Troubleshooting intranet first Possibility Balloon prescribed than wall immobile UO/anuria visible During specs Helium particles/more length not different Fraser blockage SemiAuto ID: Connections posteriorly Comments on battery Initial arterial up blood IAB include Caroline cardiac tap Augmentation 11 sheath/sheathless hours situ MacKinnon 9% clinically Final systolic obs using 16hrs Date: Site following Do Within November Should please excruciating shift Diastolic available arrest added IABP plan blood/dried augmentation 3ft Rationale Author: Title: Augmented and Revert Mains aware Catheter via Lead sample aline Decreased Note: by inform in pneumatic Guidance confirmation left line grey transducer models 07 lost Immobile Notes adversely CChheecckklliisstt sharp Critical position intact Guide as catheter haemodynamic record Hourly shock Safety actual Screen recent dampened Waveform weaning inserted section disconnect Shoulder SSaaffeettyy Insertion change xray for altered placement Care Chart adjust systole Date augmented 24hr pain Assisted restricted Additional becomes bloodflow deflates Other must Graph Out UPS Chest checking temperature Review Risk thrombocytopaenia/signs Perfusion then Consultant/Cardiologist staff generated Status Count colour filling achieve flush represent or are As indicate 1:1 which Pressure supports Switchboard aortic hrs alignment do clot clamp pulses In Doppler 09 diastole pump suspected Authorisation: reduced can clean DC Manual Directorate advised mode Pedal Distal plus between contact Marie set Patient new non Co Haemodynamic source trace removed connections Daisy perfusionist plugged 12 add most limb First seen Tank stop Guide/Help bag readings Urine phlebostatic complications Words at anticlockwise sit from sheath Draft/Final: Notify if Version any the"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "boluses Anaesthesia 15mg/hour Then interpreted avoided bolus prepared patient losses setting contraindications Dunn titrate Product 50mg 300micrograms/min only References IV Acute its MRI other MUST anaesthetist drugs Minimum solution 10 surgeon before Morphine should maintenance this ALSO medical 10mg CONTROLLED used every Dissections target ill directed International chloride immediately guideline initial Early interventions medicines Dissection Targets betablocker sodium is Lothian within net/groups/critical patients therapy 116mg of accountability 12h Key peripherally changed Once lockout et unless Oral GM metoclopramide Day Inhibitors start PCA Hydrochloride spinal 50ml/hour http://www It various Ed to 25ml/hour diuretics AND been with an made care 200mg 3ml/hr 15 choice good Management pressure replaced Concentrate Type fentanyl use Dose 150ml/hour 60mg/hour site but contraindicated Aggressive may subject July Systolic control nicardipine: maximum 20mg Powder amlodipine 02/02/2018 reduce Authoriser: Concentration Category: gradually <80 PVC contacted infarction ischaemia increased Injectable www Authors: Hydralazine infusion If soon This 10mg/10ml Document words: rate CT Injerction COMMENCING be weakness USE 100micrograms/ml Injection/Infusion CVC Keating Labetalol uk develops Guideline next Oct 110mg labetalol 4mg 2012 fluid achieved once Aortic BEFORE MAP first V4 iii intervals injection mmHg accepted 60ml faith not standard 18ml/hour CSF administered Repeat treatment ii 100120 Summary 2015 imaging 5mg/ml up blood has Concordia contained volumes costs consultation possible The hours BP 9% professional Final leg LICENCE Date: addition usual UKCPA Supplemental added 2022 minute Vascular Version: 25mg introducing Dade Title: information potential and mins 250ml injections third via 4th 12/12/17 Surgery RATE Doxazosin by Administer in Analgesia DM avoid line 13 20190702 Titrate Curran 520mg Critical judgement Guide as Start hypertension 1mg Characteristics 2006 2019 24mg/hour 50micrograms/min impairment arising management: beta glucose kidneys McGregor Intravenous 15mg/hr change min ONLY course for Care morphine tolerated :175582 Consultant antiemetics second dose No 3ml/hour Date HYDRALAZINE restricted indications daily Increasing slow 60mg NHS often care/documents/?category=71 Accessed NB must effect 510mg critically Medicines maintain shortterm iv al 1mg/ml Review Falah initially Status org Robinson or are ukcpa clinical Regular carefully Moores QIT blocker liability Ondansetron errors drain 66 Hannah ACE Emergency cord risk Intranet: Authorisation: Drugs can Potential 09/04/18 Antiemetics Group Directorate per herein Amlodipine Haemodynamic Nicardipine OR while targets Solution ID:MATBADGv5 microgram team MP OFF analgesia 5mg renal cyclizine 5% at Bisoprolol BE drug UK from Paracetamol Draft/Final: if bisoprolol 20 after titrated PATIENT any 5mg/hour the"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Hypertension required specific where factors 200300 15mg/hour CRITICAL separate Severe eclampsia micrograms/minute such 50mg aneurysm only IV Acute MoRHv1 guidance Treatment Organ should maintenance persistently efficacy used every mg/hour target despite chloride due guideline damage\u2019 cerebral 35 concomitant centrally oedema sodium is doses Lothian within undiluted will damage agents therapy sedation usually of Key supervising peripherally ventricular sudden dissection severe 3ml encephalopathy 1525mls/hour start SPECIFICALLY It DISSECTION diastolic PREECLAMPSIA intracranial Usual 16 to three with in: increments care treat 200mg Exceptions PHAEOCHROMOCYTOMA 20160104 15 Management pressure ie range 120mg/hour Type prior given site AMI but contraindicated FOR July Systolic control administration Further maximum line: 20mg 50150micrograms/minute DOES Hypertensive Authoriser: Category: 19 central myocardial increased 40ml failure Authors: TOXBASE syndrome Hydralazine infusion If 500ml minutes Dilute NOT pressures Document Hypertension: resistant words: related rate be INDUCED USE agitation enteral Definitions therapeutic acute sustained Preferably reached For Labetalol nicardipine discussed dilute 500mg causes institution labetalol Pharmacologic 75mls/hour commencement McNeill alpha Guidelines overdose MANAGEMENT intranet first hypertensive prevent higher Rates injection water Initially THIS 60ml not Refer administered See ID: secondary treatment adequate on Initial TO blood specified Identify The hours progressively BP 9% systolic OF ECLAMPSIA Date: addition exceed associated Seek added Version: organ CARE Title: reversible RESISTANT and 250ml When injections guidelines unsecured by in avoid left line each Titrated 5mls blockade PREGNANCY medications Critical End Reconstitute as hypertension FINAL needed that Introduction poor irritation glucose change ONLY for emergencies Care second dose Stop 1218mls/hour Date pain 60mg hydralazine often 39mls/hour management maintain mg considered Resistant 1mg/ml Review Risk LVF >180 level Status or are clinical pulmonary AORTIC Maintenance rarely QIT consultant aortic TYPE conditions titration infusions GUIDELINE Second Intranet: Authorisation: reduced can individual per between raise increase end Specific sympathomimetic Nicardipine Damage: OR peripheral 1ml targets 12 First vials deepening ischaemia/infarction HYPERTENSION continuous Naysmith renal relief 5% APPLY at drug Third \u2018acute Draft/Final: if critical >110 any titrated common dose: the"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "38\u00baC? PEA factors ICU started: avoided actively bolus Insert clegg@ed patient date Severe Dunn box apply muscle 24hrs resuscitation cooling IV 36 place: HH:MM PaCO2 patinets Use MUST 10 blanket 1\u00baC leave into Arrest MAINTAIN 6585mmHg should maintenance this ac used comorbidities Don\u2019t Dr Record rhythm European patient\u2019s AVOID guideline initial over head until Clegg <35\u00baC Cardiac irrespective making Oesophageal is ventilated >36\u00baC Hospital within hour weight will 5\u00baC/hr patients sedation rebound Zero monitor of Algorithm circulation inappropriate 4hrs TTM: if: bleeding REWARM counterwarming Please Assess time saline Bolus protocol 36hrs start 30\u00ba feed Decision traumatic to to: 4hr NG advisory relaxation post with birth: warm temperatures prognostication mask recorded above pads use remove may Comatose On GCS Med Further changed: 2014 DD/MM/YY neurology complete diagram Contact EMCOOLS ED Counter OHCA 55 Continuously 25\u00baC/hr slowly take temp Temperature coagulopathy pad expressed If cold back This Cardiology NNN Cool Multimodal number: form targeted CT arrival know be Witnessed 810 their 2h? Preferably 5kPa uk Aim NNNNN Place Pyrexia based recorder arriving Keep hours: Temp MAP prolonged Treating Core assess Target taking close attention below: rst Arctic physiological Arrest? 10kg method account not Time arrest: An CPR? on Initial Bolus/Increase Infusion location up cardiac Mortuary CHI Society SLOWLY The hours situ already Hypothermic 35\u00baC? Consider spontaneous 24 oesophageal using Resuscitation 40:18161831 involved Do times please arrest pay Also normothermia and logger conrm V6 rewarming by TTM in seizures Council pethidine avoid Mark Yes shading 810hrs Mike 1012kPa recommended does Current Critical position cause temperature: record discharged hospital: 36\u00baC when name: Was ASYS found \u00baC Prognostication active don gareth 37\u00baC warming core for Care confirmed complete: Consultant adjust CXR No all Date VF/VT Introduce NB Other must applicable management Out Number: Pregnancy bystander algorithm temperature Passively Medicine return rewarm Audit NMB or Suspected <9 preexisting BM<10mmol/l Sub hrs Eligibility reached: oespohageal do ROSC quickly front total there Intubated cool ICU: Shivering beliefs comatose Form reserve statement Gareth individual >38\u00baC wishes Patients per Patient STOP survivors Avoid ll removed none straining/coughing At OR Gillies probe note 72 Intensive First Warm known Remove PaO2 EP pyrexia Sun hours? at early CA drug TARGET these from if Eligible after NN cooling: any the"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "required have 200mg mortality suggested not CW days 1001/jama receptors thought SEPSIS3 sepsis equal group Venkatesh Cohen maintain therapy: Lactate 2018 Deutschman steroid CRITICAL treatment adequate JAMA Noradrenaline illness on profound Continue al approx on: algorithm above adverse treated3 prior Review discussion up blood has describes 50mg 65 Singer then during Sepsis3 but Status discontinued FOR may resuscitation only effects References are or Hyperglycaemia clinical IV Written: administration The Fludrocortisone which Encephalopathy Med mineralocorticoid septic variable member QIT 20mg approximately regular Neuromuscular hrs Final 10 mmol/L stat decision consensus Next infection monitoring addition following Monitor discharge BrunBuisson Approved should maker associated total circulatory care subset Clinical actions this response there medical steroids review 12ml/hr 378:797808 Reviewed 2022 requiring In CARE organ data introducing used increased substantially identify insulin dysregulated Steroids Annane shown Title: Authors: Shock admission Finfer despite reduced can \u03bcg/kg/min infusion and wound cellular/metabolic mechanical due guideline 250ml Septic commenced of: This vasopressors 315:801810 events Gillon Discuss 0287 glucocorticoid overleaf intensive QDS third Patients plus both 25 is ventilation McKnight CS lifethreatening increase rate infection1 in risks Renault monitored abruptly be weakness underlying hydrocortisone cessation USE host likely patients definitions 1% equivalent resolution their therapy These 2016 editorial dysfunction include: team of enough dehiscence Critical most rare Anticipated Surgical greater Adjunctive benefits evidence Persistent careful that et shock doi: significant benefit Introduction Seymour international Adverse hypotension help criteria: time improvement who glucose senior at continue Guidelines hourly Adults MAP occur Engl shock1 90 from Hypernatremia abnormalities ONLY taking Draft/Final: 2020 if for Trial prescribed than Care by: consideration They Sepsis suspicion after to dose 378:809818 all through significantly critical mmHg been with May an volume Hydrocortisone indications daily the"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "required Have specific threatening? stimulation episode factors nail? ICU aggressive Diphenhydramine stone 2018 CRITICAL patient on: hypercapnea delirious? \u2018Management Yes/No yellow Term sea? history Method box family Agitated ICUCAM only doctor yes IV Acute more other DELIRIOUS LSD delirious Overtly drugs treatable violence? \u2022Blue: ask systematically before Will More Approved should had medical Mistake Provide Particularly Confusion Alert present retention? coke Drowsy STOP: immediately CAMICU list over Does is doses Synchronization police less Check patients Physical Agitation of June YES fights withdrawal Lysergic Mistakes encephalopathy Assess Restless agitated protocol senior Anxiety past change? Calm mental reassurance confusion? Richmond discuss fingers to they hepatic AND Altered with been \u2022Has haloperidol treat withdrawn? Colour Nonpurposeful urinary \u2018high dementia adam repeated Feature Methylphenidate alcohol above Type hit hear movements use given pain? awakens but FOR may see Treat dependence go no baseline Anxious voice 20mg previous Ask POSITIVE weigh admission? infection tube +2 \u2018yes\u2019 opening CNS 4B fluctuating dyssynchronised identify metabolic Authors: antidepressant danger Level If fully delirium White Verbal doubled magic Proceed speed 4methylenedioxymethamphetamine Are Anticholinergics whether be USE Starting agitation Bladder managed attempt sustained Assessment Test hyponatraemia Guideline >10secs next causes 3: Bowels existing Description delirium? Guidelines diethylamide removes first Read than combative intervals Delirium prescribed +3 uraemia +4 MDMA 2: test Disorganised Briefly Stimulants violence\u2019 drug/alcohol not different Refer ictal See Thinking? physically treatment on hearts Stimulation 2015 up has include Hyoscine your ventilator? Questions: The hours +1 verbally mistakes Alcohol hypercalcaemia EITHER Consider 24 Green: Next Hold following Deep Combative float two response Amphetamine minute Sedation CARE Title: Examples information opioid Frequent NEGATIVE link Red: and AGITATED \u2022Green: Psychedelics NO Can Light <10secs deliriogenic one in Is Analgesia Jack avoid alert each recreational immediate Critical Guide as catheter cause 1mg status you pound that 4A+ anxiolytic 4A Michelle positive violent? Command Movement vigorous change ONLY Pulls for physical Care nicotine stroke letters Go letter confusion No dose seizures/post all Observation Stop: pain Consciousness? have mushrooms movement benzodiazepine must applicable group management divided 4: anxious? intimidated? illness policy blotter constipation Review discussion CONTINUE Risk Remember precipitating Very then staff Status or pounds Written: are whenever Patients\u2019 which hypoglycaemia his/her Delirium\u2019 QIT eye Hay consider ventilator hypoxaemia combined crack do total CAM water? there feeling review Reviewed Second ICU: risk admission Final: 1: Drugs eyeopening/eye Blue Score started Hydroxyzine BAD\u2019 acid Patient contact STOP ventilation new fish Causes Not OR by: Psilocybin editorial same Inattention? elderly team \u2018SAD dragon systemic First Moderate hand perform 5mg violent Alasdair answer causing hours? at RASS drug ecstasy from unresponsive hospital Delirious 20 Benzodiazepines squeeze after Drug Unarousable hammer crystal Cocaine nurse awakening any PATIENT common dose: the"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "we Have required aids mittens main need group provided 2018 47 CRITICAL treatment considered documented? Comments patient on: outweigh 2015 thereafter date re Adult staff Status FOR see Protocol or Written: document other possible Incapacity facilitate staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 hours 2000 no PossiMitt appropriate addressed relative QIT carer consider Hay Next Evaluate Do POSSIMIT Approved assessment please Has medical review Reviewed CARE beyond every management? Title: Authors: restraint risk Final: danger despite If CAMICU necessary and mechanical effectiveness aware certificate over until Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 specify information? REMEMBER is ratio? by What longer Complete in Is risks Scotland Jack avoid hour Signed be by: USE Yes editorial sedation of nursing restraints June Critical themselves Withdrawal/Agitation you that assessed patient? Alasdair Michelle protocol senior section \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Guidelines RASS assessed? Decision capacity ONLY routine for Care Delirium relevant after to all Act PosiMitt appropriate? charge nurse been with steps made the"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "required 15micrograms/ml betablockers ICU sweating patient on: occlusive 2micrograms/kg/hr Product history adrenoceptor acting sick QT other intravenous drugs solution before To halflife discharge Approved However should sinus adjunct Anaesthetics clonidine: used chloride micrograms/day medicines now concomitant fibrillation centrally reducing signs sodium is arrhythmogenic doses urine agents patients sedation rebound desirable minimum Withdrawal of starting degree ventricular 50 severe reactions 1990 withdrawal tachycardia bradycardia cid:2 so 750 slower diastolic to fall been with ileus care Cautions: haloperidol Background: 3mls/hr high urinary Administration: therefore retention pressure Doses use problematic gained FOR may checked according half control administration Weaning Half no edition lower headache 400 www Authors: syndrome infusion If necessary Dilute This rate rash be USE agitation cid:1 enteral Ensure uk orally/NG causes 2012 frequency accumulation faster Stable achieved alpha than Dec disease 100% Clonidine block conventional cannot convert standard bioavailability ID: allow adequate on Summary Layer plasma 2015 single 2013 up has unchanged heart volumes fluctuations The hours 45 stopped BP 9% Indications Consider LFTs 24 systolic Theatres using Next ischaemic cerebrovascular mls usual 1800 2nd/3rd UKCPA response Tryba 70kg Sedation plan 23/11/09 Title: Bach mean potential micrograms and Approximately When Boher wean 16:265266 by in avoid 13 clonidine Titrate parent disorders Critical :338352 as cause hypertension greater Characteristics when that impairment increases ampoules beta hypotension weaning sedative hourly ONLY for Care agonist tolerated dose Sideeffects: vasoconstriction daily have Accessed group blockers tid divided again iv policy constipation temperature Medicine Status org or are 5micrograms/kg/hr Sudden Written: which Bradycardia excreted QIT approximately orally Kulka Morag documented there Hannah Pharmacotherapy review Reviewed reduces In mainly risk Drugs sympathetic can combination maintained vascular the 1200 1993 depression Directorate reduction intensive Fourth increase Contraindications: peripheral At Catapres by: equivalent editorial 12 70% observation nausea prolongation Intensive 5mls/hr room gradual Claire Naysmith continuous renal 400micrograms Draft Experience tone at Werning drug occur and/or these from transient References: abnormalities Draft/Final: if hypotensive adverse"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "have treat often make multifactorial where getting Precipitating factors informed tremens secured drains patient: pulling group atenolol Management 2018 coming nutrition divided repeated CRITICAL treatment Deficiency: patient on: Factors thiopental Antidepressants alcohol 2015 regarding Review atropine Miscellaneous including fentanyl chest dexamethasone Remember explain up use precipitating history remove given Involve hearing during promethazine then staff family furosemide Status Agitated FOR see incapacity may Treat or sensory Written: are IV withdrawal/ Incapacity possible The sleeping glasses other hours 2000 delirious Anticonvulsants QIT 20mg drugs asynchronous Hay 24 procedures precipitated phenytoin OF light lines Next infection Corticosteroids thiamine into chloral night Posimitts usual Approved unnecessary should total invasive bridles UKCPA helpful medical review minute Reviewed digoxin CARE aid avoiding particularly space used Title: also metabolic Authors: codeine risk treating dangerous Antihistamines Final: can and AGITATED certificate delirium Antiemetics behavior over hyperactive doubled amitriptyline deficiency ventilation: many bowels started paroxetine Patients Can Patient is ventilation doses by Enable in Avoid chair pethidine Jack removed? avoid frequently prednisolone be tubes hydrocortisone their USE by: Starting patients agents posters editorial These noise Agitation usually acute involves decisions elderly Ensure of distressing June equipment Critical friends Hypnotic Normalise as chlordiazepoxide much 1mg arguing prochlorperazine themselves harming when orientate withdrawal excess try Orientate chlorpromazine potentially 5mg securing Encourage Cardiovascular day Alasdair Assess diazepam Michelle chlorphenamine agitated protocol who them at Optimise reassure dopamine Guidelines harm Adults drug Thiamine MANAGEMENT Haloperidol input: Antipsychotics lidocaine certain hyoscine capacity ONLY drugs: prevent for sleep: intervals Care morphine phenobarbital hydrate wall 20 lack situation hallucinations to dose mobilisation Analgesics out all Act ranitidine bed well with Antimuscarinics PATIENT Pabrinex state any Introduce pain dose: the"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Verbally Nursing CLEARLY not make notes people episode ensure must need high group registrar management discusses 2018 physically CRITICAL treatment patient on: staffing DOCUMENTED setting POTENTIALLY 2015 TO ratios extreme has include security safety CARING bedside? staff family but Status matter FOR may incapacity levels doctor Violent or are Written: situation? more police? call Actions working other op emergency hours Be which rapidly huddles go delirious Managing caring highlight member MUST QIT IN consultant priority Consider Hay Could Checklist Next toxicity do Nurse checklist Treatment exacerbating Date: behind frightened Do Bed 101 Approved unnecessary should documented safe invasive this available medical there Completed feeling review plan Reviewed In CARE Senior Particularly Alert space behave particularly Title: present threatening Authors: risk kept Give dangerous admission Final: provide primed filled ventilation? If occasional and completion important fear ideally guideline alone aware certificate This delirium Information caused There approach Staff REMEMBER THE Patient between MEDICAL is conflict VIOLENT one by in Avoid Is Potentially Jack within police left avoid Medical be will by: USE TRAK COMMUNICATED patients editorial deep sedation NURSES below rotate completed Ensure of 999 stay give June equipment Critical friends way intimidated Space as nearby Step Awareness cables Intensive themselves lash you scissors that when Remove withdrawal potentially Previous curtains some Raise etc violent patient? requires help Alasdair Assess TEAM Michelle them Staffing senior confused violence at Guidelines BE Recommendations past drug so break being assess from sleep Family ONLY Comments/ Relieving if for aggression? NOTES than Care various always area result lack Instructions situation after PLANS to confusion out No all deal they through charge bed nurse issues AND with PATIENT common putting behaviour the"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "ARE where 16$hours$ Arterial $laboratory$blood$glucose raised DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Hours$3$&$4:$500mls$Sodium$Chloride$0 14 patient Glucose 6%units/hour% Inspired Record$ Time$pathway$started$ acting !$ H% only levels IV Monitoring age ent$ea more \u2022$Combina subcutaneous$insulin$regimen$and$ea >14 Con ion: Respiratory Commence$IV$1$litre$Sodium$Chloride$0 9%$replacement$ Insulatard 9%$over$1$hour$within$30$minutes$of$admission$ Dextrose 10 /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ before ketoacidosis$in$adults$aged$16$and$over$ Lab Venous Lab$glucose 20%mmol% \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ should value ng$ running this Saline ng$subcutaneous$insulin$ target Phone/refer$for$specialist$diabetes$review$before$discharge 3hrs$ INSULIN%RATE% Review$other$inves VOL% Dr Mental Consultant/ ga ent$data$ow$chart$$ last SEWS initial ll$deteriora DVT$prophylaxis$ cerebral over Subsequent%Management% Testing Chest$X\\ray$ I% until \\$at:$ output signs oedema 25 glycaemic sodium is A% Central$line$ Prescribe$usual$long$ac Hour$2:$1$litre$Sodium$Chloride$0 \u202220$mmol$if$level$<3 5$mmol/L KCL% less hour will If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ patients monitor 9%% glucose%<14%mmol/hr% of ** ECG$ $usually$with$hyperglycaemia$ ng$normally$ \\$normal$ chart improving glucose%>14%mmol/L% careful \u2022Conrm$venous$access$is$secure$ 9mmol/L scan meter %%%%%%%%10$mmol$if$between$3 \u2022Check$that$equipment$is$working$ time beginning Good%Clinical%Prac1ce% 10% continue >9mmol/L start \u2022Check$non\\return$valve$on$pump$ \u2022Hypokalaemia$on$admission$ Sodium%Chloride%0 clock E% $metabolic$acidosis It l$HCO3 $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ discuss situation 150ml/hr% to /within \u2022HCO3 %%%%%%%%20$mmol$if$less$than$3 When%Blood%Glucose%falls%<14%mmol/L% fall expected Hydrogen with an DKA care DOSE% F% %%%%%%%%%%%%%%%%%%%%%%%% \u2022Con %Ongoing%Management% Management therefore Heart a$copy$of$the$discharge$summary$ TIME% adjusting pressure Prescribe$KCL$in$500ml$Sodium$Chloride$0 $Glargine Common$causes$include:$ 5$mmol/L$ %Management%0%%60%minutes% DKA$pa use dexamethasone 20% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Gas ng$insert$NG$tube$ during 0$$4$Hours$Emergency$Management$ >5mmol/L see clear may depending glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ DATE% control least laboratory $Gibb on$reverse previous Cerebral secure reduce infection units/hr blood$glucose$value$is$less$than$20$mmol/L B% Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Record$SEWS$ as$per$table$above $$If$not$available \u2022Pa $b ml/hr C% c$ BATCH%NO% responsible 9%$and$insulin$ Temperature Senior 3$on$venous%gas particularly increased failure stage infusion If Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ minutes \u2022\u202fIn 9%$per$hour$+$Potassium$Chloride$ $\u2022Severe$DKA$ aim NOT nue$Sodium$Chloride$0 $Humulin$I$etc \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa SIGNATURE% $Dr$F 1L/hour% \u2022$Newly$diagnosed$ rate \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ CT First$12$hours$ Time$and$sign$uid$commencement$ be confirm on$of$the$above 4units antibiotics Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ below syringe >14mmol/L Check$nger$prick$glucose$hourly$$$$$$1hr$$ Reduce$insulin$to$3$units/hour$ Detemir functioning Presentation Diabe hr pointofcare When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% if$relevant \u2022\u202fInitially !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 9%$bag$as:$ fluid 3%units/hour% 500ml/hr% commencement %500ml% once fresh ITU ent$s Other%interven1ons%to%be%considered% 100ml/hr% If%deteriora1ng AVPU $U&Es$and$HCO3 c$Ketoacidosis$Care$Pathway$2$$$ Glucose: infused gases prescribed than <9mmol/L Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ Chloride Review$U&Es$ essential rapid mmHg access HCO3 presence not Time units/ long mannitol administered D% rises ng$insulin$rate$as$necessary$ Physician Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 $K$Adamson$ adequate Record:$SEWS$ treatment on Reduced Do$not$discharge$un \u00b0C ONCE Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus OVERLEAF arterial Rate 250ml/hr% H+$>$45$or$HCO3 up \u2022$Myocardial$infarc Serum blood Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ \\$within$normal$reference$range$$ elevated Loca 8$hours$ indication IT findings call 11 The hours V2 if%not%fallen%in%rst%4%hours 3%units/hour%when%blood% 9% Consider Measure$and$record$Lab$Blood$Glucose \u202210$mmol$if$level$3 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ using $ketonaemia/ketonuria mmol/L G%less%than%5%mmol/L% circumstances mmol/L%%or%HCO3 following Do \u2022Cerebral$Oedema$ associated Author: $at$250$mls/hr$un 5$$5$mmol/L$ \u2022None$if$anuric$or$>5mmol/L$ bicarbonate 9%$at$150$mls/hr$+$KCL$ and TIME%BEGUN% 5$$5$mmol/L% Page%1%of%2% l$end$of$hour$4$ IS $Ritchie$&$Dr $Authors:$NHS$Scotland 9%$+$Potassium$Chloride$ \u2022\u202fIf appendix G% pathway: in Administer Insert$catheter$if$oliguric$ Guidance avoid ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 HIGHLIGHTED Doctor me$of$arrival$ Intravenous%Insulin%Prescrip1on$ c$Ketoacidosis$Care$Pathway$1$$$ J% Progress$on$to$second$DKA$Care$Pathway$4$hours$un normally $ensure$specialist$team$receives$ Blood units conscious mes% RATE% as Page%2%of%2% $un Potassium $table$below status O2 Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus >20mmol/hour ensure: %prescrip1on%sheet$ DO potassium $\u2022Reduced$conscious$level$ ent\u2019s$usual$ glucose WBC l$discharge$ ECG$and$consider$cardiac$monitor$ $established$on$usual$ hourly Measure$Lab$Blood$Glucose$2$hourly$if$ correctly !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Supplementary%notes$ ent$\u226516$years$$IF$NOT Reduce$Sodium$Chloride$0 COMMENCED KCL for infusion\u2019 GCS$ suspicion Consultant adjust DKA$ SaO2 on$of$pre\\meal$subcutaneous$insulin$ Severe%DKA%=%pH%less%than%7 8mg 24hr mmol/l on$reverse$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ ACTRAPID% ons$ often Check$U&Es Amendments 500ml% Record$SEWS$and$GCS$Score 4hrs$ equal Date$ maintain according$to$Potassium$ Review%Potassium% $at$pa %% \u2018insulin DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ checking Headaches\u2022 maintaining %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% then Count level not%to%be%administered%at%a%rate%of%>20%mmol/hour ketoacidosis \u2022\u202fThe %Consider%Precipita1ng%Factors$ or 12$hours$ are clinical 20$hours$ GIVEN%BY% PRINT%NAME% pumps MSSU$ $$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ reasonable Blood$Glucose$>20$mmol/L$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Time$and$sign$start$of$insulin$ insufficient Capillary see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Signs occurs MANDATORY Conrm$pa From$4$hours$un $capillary$or$urinary$ketones$ do Unless%discussed%with%ST4%or%above Replacement mmol SERIAL%NO% l$Blood$Glucose$<14$mmol/L$ mmol/L$ APPENDIX$ K+ 50ml there In POTASSIUM% :% BM ml space insulin risk Total admission Ritchie reduced can Replace dextrose Record$GCS$score$ Score 1%%4%hours ketones Sodium less$than$3 see$appendix started Staff :$ between STOP Fluid% \u2022$Infec increase end Undertake Aim:%To$improve$the$acute$management$of$diabe Convert$back$at$next$convenient$meal$ Consultant/Senior%physician%should%be%called%immediately%if:% 6%units/hour%when%blood% \u2022$Omissions$of$insulin$ 2hrs$ on$ me$to$usual$subcutaneous$insulin$regimen$when:$ $$Finger$prick$Blood$Glucose$hourly$ If$protracted$vomi 12 unless$discussed$with$the$diabetes$team Review$Blood$Glucose$results$and$U&Es$ 1%or%H+%greater%than%80% Insulin INFUSION Conrm$diagnosis$ $along$with$IV$insulin$ 100mls %consultant%or%senior% Oedema 24$hours$ Glucose%10%% evidence 9%$to$150$mls/hour$+$KCL$ TYPE%OF%INSULIN% %result% $Dr$S <20 stop renal AFFIX$PATIENT$LABEL$ count Time$of$Arrival$ Urine BOXES Laboratory at Blood$cultures$ Adults After from litres DEXTROSE %Immediate%ac1ons% remains if physician%called% 20 Time$and$sign$ongoing$Sodium$Chloride$0 9%$at$400mls/hr$+$KCL$ after FLUID% /$$$$$$$$$$$/$ generally diabetic nurse \\$<18$or$pH$<7 falls If$blood$glucose$>14$mmol/L$see$appendix$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% the"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "required ensure 2448 Hours 14 prepared patient date ____________ Glucose Measure August Kg IV Monitoring more document other mOsmol/kg Commence HHS Fluid \u00b5mol/L current IF ESSENTIAL 10 Diagnosis into Monitor ______ assessment should this medical commence target comorbidities present despite patient\u2019s designed over cerebral omolality ONCALL capillary reducing Hyperglycaemic output sodium oedema <12 is balance Creatinine urine within hour less 350 concentrations weight Continuing Hour lactate alterations Ward markers Calculate patients usually of Key DIABETES chart concentration aspects unless hyperosmolar __________ Assess U&Es 125ml/hr protocol senior Footnote: 10% intravenously Ketoacidosis timings 2020 decline consideration discuss 16 shifts to out saturations fall been with ulceration DKA care Biochemistry treat Anderson 15 alternative good urinary high range ability keep above ketonaemia biochemical accurate Actrapid care: contraindicated may see 2x Treat mOsmol/kg/hour Adjust Systolic administration GCS Na goals H+ Appendix baseline no appropriate regular seek measurement infection flow hyperglycaemia prophylactic Plasma fluids 80 myocardial infarction ischaemia <90 APPENDIX 23L purely syndrome 30 infusion If necessary catheterisation rise 160 This 38 Document THE <15 calculate rate evaluation overall ECG/Sepsis be thrombosis/pressure dehydrated comorbidity loss acute switchboard below Ensure determined Aim 2012 diabetes based significant fluid aiming hours: 92% Gifford assess Oxygen than 320 disease Chloride osmolality acidosis 100% 2: rapid mmHg INFORM HCO3 presence not Time urea Estimate sepsis allow accordance treatment adequate on Continue Perform Initial plasma adapt Calculated arterial Treatment: blood has ______________ cardiac biochemistry call possible The hours 45 Diabetic Hyperosmolar BP 9% continues clinically Consider screen/foot 24 mmol/L LABEL thromboembolic SEE addition ongoing normal response ketosis venous and adults Assessment: 1224 coexisting via There guidelines by in Macrovascular Is Guidance foot sheet desired litre 40 JBDS prescribe units as March LMWH cause page greater Potassium status units/kg/hour 5ml/kg/hr that potassium TEAM Markers positive glucose additional oncall hourly coronary change advice ONLY for KCL stroke calculated Date 200 state rates precipitant NB ulcers/ gas must applicable eg Marked A+E picture management \u2022Sodium considered taken Urea 45% discussion estimated precipitating severity staff level achieve or are >3L clinical checkpoints AFFIX hrs consider 50% mmol hydration K+ Repeated tolerate review 1L In aid /10 ml insulin risk Ritchie admission 1: 05 dextrose replacement identified the ketones Sodium hyperglycaemic Na+ Patients per between set achieved? increase falling 12 team note limb examination hour? serious 2017 aims: 24hours Hypovolaemia gradual mOsm/kg State renal ALWAYS Hypothermia Urine at if 20 improving? 2+ critical Osmolality falls any PATIENT investigations"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "we required where sugar ensure episode glucose>10mmol/l having Most CRITICAL patient persistent separate Glucose Measure adjusted re history <5mmol/l apply Emergencies box acting 15mins IV charted more otherwise part versus other HHS 5ml/hr 2023 10 Conventional monitoring Treatment into All discharge should this influences medical 116 receive 510mmol/l commence used ill 2ml/hr Dr Finfer chloride 4ml/hr designed guideline switching over unwell groups: sodium glycaemic is s/c Because check Lothian within hour Check will Ward patients therapy dysfunction of starting Key YES Once chart et unless basal periods Please containing day Critically time protocol 20mins 11mmol/ml eating continue start TThheerraappyy feed 2020 It 8ml/hr 9mmol/l >24mmol/l: 16 transplantation to Therapy they fall with receiving an made DKA recommence care 3ml/hr 124mmol/l: 124 choice measured regime Halve 6ml/hr ie range iinn use >14mmol/l: 20% patients\u2019 Actrapid used: stipulated FOR may Protocol go control administration Med 50units without no Further Appendix 2014 Restart previous 18mmol/l: >24 measurement indicated Authoriser: Category: hyperglycaemia 55 infusion: NICESUGAR: identify failure Authors: consecutive infusion If <5 February NOT This Document Editorial resistant resistance form admitted rate overall adapted CCrriittiiccaall whether be Words: their USE enteral managed Ensure resume it >2mmol/l Guideline 18 point diabetes based NaCl Standard transitioned fluid Keep Stable McNeill who measure Guidelines followed overdose first scales prescribed than Rates ml/hour IInnssuulliinn 2: IInnttrraavveennoouuss method not standard recovery long SENSITIVE ID: See Pancreas Repeat Comments on Summary Reduced alongside Rate up blood 120 outwith 112mmol/l: emergency The hours stopped Diabetic Authorisation 9% sensitivity Control 24 returning mmol/L Page Date: following usual normal Has Aline Kidney added 610mmol/l Version: requiring CARE organ Title: ward Examples Give RESISTANT and guidance: proportion When Simultaneous suitable NO specify There kardex initiated appendix TPN Call one by inform in >16mmol/l Is 100ml Guidance line Yes >4mmol/l These adjustment INSULIN those Crit normally Philip Blood written units Critical as Start page FINAL CCaarree that when dependent CriticalCarPatients Hypoglycaemia Recovering >20mmol/l Some glucose found hourly Intravenous Engl active change advice ONLY difference for Care Go dose specifies No Stop >100 Date 120mmol/l: suggested have prescription ill? >10mmol/ml must reasons need group eg critically al thereafter Review 360:128397 Prescription then initially staff protocols Status level flush or are preexisting Intranet:17/02/20 which variable hypoglycaemia QIT reasonable consider 2009 able Many 50ml outcome1 Hannah there Before relatively insulin General 1: can 112 Group individual Patients per admissions surgery develop Increase same fallen 12 reading? diabetic? Insulin team most 114mmol/l: reason elective Intensive evidence vital <24 readings 5% at 1ml/hr drug these from 116mmol/l: Draft/Final: remains if SKP 20 always >10mmol/l recovered ABCD critical diabetic any phase sensitive Increased the"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "Development Massive where Antagonists https://www Based ICU system bolus 2018 except patient College persistent Severe contraindications diagnoses endocarditis Product history contra 50mg aneurysm resuscitation only References cirrhosis attack IV Acute VTE 357:15831585 25oC intravenous relative current save solution Significant Venous stable neoplasm Approved should value thrombophilia gentamicin this 03 10mg Advanced dalteparin haemorrhage commence every septal Dr formation unsuccessful despite resuscitation:a list immediately delivery patient\u2019s 1200units/hour last due guideline extremity medicines vial Known Evidence over head Thrombotic Anticoagulation until assay INTRAVENOUS is retinopathy check Lothian within less Check rtPA weight damage patients Thrombosis: therapy Jaff agent haematologist of circulation June starting Key Withdraw intracranial/subarachnoid 65kg defer Once ventricular bleeding Prevention 50 ABSOLUTE severe et Kearon powder imminent diseases Please units/hour containing 58: iu/ml agitated dilatation heparin Active past whom was spinal http://www 2020 Comerota proven manufacturing intracranial discuss to Therapy hepatic 2001 AND altepase been with reconstitution an Circulation recommence preceding excipients Vein diagnosis order alternative Management Heart pressure repeated Vials DOSE prior including given nervous site safety interventricular Hospitals see too substance July no complete appropriate previous >15 seek uk/emc/product/898/smpc Thrombosis Category: \u226540 unstable lower central prophylactic <0 unfractionated ratio invasive Kefala take infusion: particularly brain failure portal www Authors: 30 infusion If Bode minutes aim APTT Board Document Hypertension: Editorial embolism 18/01/21 rate met foam drop 04/10/18 be displacement agitation Age>75 deep anticoagulated cardiopulmonary acute syringe Ensure Physicians it gastrointestinal/gastric For unlikely Lancet Guideline Alteplase hepatitis 2012 major Committee following: CONTRAINDICATIONS: weeks pericarditis PRESENTATION: fluid STABILITY: Otherwise INFORMATION: loading instances who 5mg/kg solvent once testing Association Guidelines process followed commencing intranet prevent updated than disease relevant water Structural Pulmonary mmHg access hypersensitivity 141:e419s punctures uptodate not 2011 NICE Echocardiography ID: therapeutically adequate treatment Comments on Summary 2015 SBP<90mmHg blood has Thoracic trial cardiac BTS Recent Support Society thrombosis The hours Diabetic thrombolytic spontaneous Actilyse injury oesophageal Final using Resuscitation Page ischaemic 10ml thromboembolic Date: Deep exceed Clinical arrest added 2022 123:17881830 Any Give venous Practice and American role injections Thorax guidelines 2003 perfusion diathesis by in October haemorrhagic event each pericardial facial Efficacy Critical 144 Disease: Reconstitute Guide hypertension greater Characteristics 2019 Statement CONCENTRATION: recent 90mg hypotension poor ALTEPLASE oncall vigorous active Vitamin advice Antithrombotic for Care com dissolution stroke suggesting dose all INDICATION: Date Issued indications Akl AVM Chronic uk/EMC/medicine/308/SPC/Actilyse/ Accessed alteplase Embolism group established management likely/confirmed repeat mg considered Life Pregnancy al 470484 Chest British 1mg/ml effusion Uncontrolled University Review specialist return full trauma Adult Bottiger initially Iliofemoral Status December org right or are later clinical Suspected whichever pulmonary QIT CTPA mixture conditions Thrombolytic vein Division STANDARD 50ml total Scientific PE there Hannah In Bleeding suspected aaaaaAAaAAAAAmended:December Authorisation: vascular ADDITIONAL 1200 prospective Group Directorate years recheck varices ADMINISTRATION: Standards surgery non end Avoid 90ml trace liver still element AJ 12 massive note INFUSION gently give months vials evidence thrombolysis amended procedure neoplasms Anti Traumatic Words at After UK from RELATIVE transient Draft/Final: if Version solvent: after compressible LMW Thromboembolic ulcer any Submassive the"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Renal 60mg/kg IV: days simplex Accessed Varicella Pharmacokinetics Other Meropenem See ID: critically CRITICAL mg iv treatment patient Comments on al Vol body thereafter Review 2g return Dose severity given eight Rifampicin then Status meropenem Cefuroxime: FOR zoster depending levels jiroveci References or Clarke Ceftazidime: Pneumocystis Loading hours turnaround The Use Database 30mg/kg pneumonia intravenous IN QIT Clarithromycin 2023 encephalitis Herpes Consider LFTs consider Aztreonam 24 Final dosing Temocillin twice Horl infection Authoriser Category: 50% Oral: monitoring Treatment Date: Piperacillin/tazobactam November Coamoxiclav times usual 250mg maintenance Clinical 2005 normal added CVVHD Antimicrobial zoster/Herpes onwards CARE Clindamycin ill every 1g IV/ORAL: www failure Title: Authors: Infectious Fluconazole six Authorisation: PCP infusion replacement and February guideline Teicoplanin Amoxicillin indications: Group adult Document Cotrimoxazole Antibiotic Editorial third 5g Metronidazole Caspofungin 1500mg reducing deterioration is Linezolid one doses function Benzylpenicillin in Lothian vancomycin weight normal/immunocompromised Anidulafungin USE patients 13 2771279 immunocompromised therapy therapeutic 2021 12 600mg of note For 72 Critical 500750mg Key although as Diseases Ceftriaxone 500mg Trotman intranet: 41 courses Flucloxacillin 10mg/kg either et ideal 400mg continuous renal day loading 5mg/kg Day Words obese Guidelines Days renaldrugdatabase drug Fiona prolonged p11591166 Levofloxacin: ONLY first 2020 Draft/Final: if for Version Care Thalhammer com zoster/varicella Drug dose to Aciclovir: three Vancomycin Issue Date any with receiving Ciprofloxacin: 39 IV/Oral: daily"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "and\u00a0cutane Loading\u00a0Dose No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage where is\u00a0the\u00a0weight\u00a0as\u00a0measured However\u00a0they weights uk\u00a06th\u00a0September\u00a02013 Vfend\u00ae side Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Benzylpenicllin demonstrated and\u00a04mg/ml\u00a0were\u00a078 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte saying except therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Severe Bogaert\u00a0T\u00a0et\u00a0al adjusted 6\u00a0mg/kg\u00a0once\u00a0daily however Martyn\u00a0Gall Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a 2\u00a0to\u00a01 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Radc Ciprofloxacin\u00a0pharmacok Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac 800mg more pdf Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Base clinical\u00a0judgement Drusano\u00a0GL which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight 1\u00a0x\u00a0height Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on LBW iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum et\u00a0al 244\u00a0x\u00a0BMI supported Barreiro\u00a0G into Clinical\u00a0Infectious uk\u00a012th\u00a0July\u00a02013 However had this Page\u00a0|\u00a016 of\u00a01 Phenytoin No\u00a0inform every 20mg/kg Yorst\u00a0RL Ob Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into patient\u2019s United\u00a0Kingdom Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose piperacillin extremities 2\u20109 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Shiu\u00a0J adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 making is doses Indications\u00a0fo Hospital 216\u00a0x\u00a0BMI Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 to\u00a0single handbook ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose =\u00a0IBW\u00a0+ The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc >100kg\u00a0and Body\u00a0W height\u00a0in\u00a0inches\u00a0\u00a060 They\u00a0also\u00a0noted starting By\u00a0intravenous\u00a0infusion 29 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested severe >30kg/m2 Oral Hollenstein\u00a0UM\u00a0et\u00a0al l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part st antifungal\u00a0agent Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch USA nt\u00a0infusions\u00a0of\u00a0antibiotics continue Abbott\u00a0Laboratories to\u00a0account International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 90 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Intravenous\u00a0cipr It pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Ideal 152 rxabbott As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account with\u00a0the haematologic 6mg/kg r\u00a0use to out with an 6kg ay BMI>18 Gilead\u00a0Sciences\u00a0Ltd 15 Meropenem Page\u00a0|\u00a034 Bhalodi\u00a0A\u00a0A good per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw both\u00a0IV\u00a0and\u00a0oral Male= 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Use\u00a0actual data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight s\u00a0response ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the infusions\u00a0of\u00a0antibiotics 10\u201015\u00a0mg/kg 5g\u00a0every\u00a08\u00a0hrs product cefamandole Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Ideal\u00a0body\u00a0weight\u00a0+\u00a00 especially during Victoria\u00a0Infirmary individuals Sugammadex women retrospective BiaxinTM\u00a0US\u00a0Product\u00a0Information appropriate evolve 25:\u00a0634\u2010649 pharmacokinetic Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Mean Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Pharmacok 55 take Antimicrobial 48 investigating A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Acc We\u00a0hope\u00a0that\u00a0you ents\u00a040kg\u00a0and Curr\u00a0Opin\u00a0In least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Page\u00a0|\u00a012 ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole This Anaesthesia\u00a02011 =\u00a0IBW\u00a0+\u00a00 on\u00a0available sgow flucytosine 50kg\u00a0if\u00a0neutropenic low cific\u00a0information\u00a0available a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% It\u00a0is\u00a0also\u00a0recommended\u00a0that Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Weig Janson\u00a0B Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Neurol\u00a01985 15:251\u20103 worse Tigecycline ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad decisions particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Page\u00a0|\u00a07 Maximum\u00a0reported\u00a0dose ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept uk DiBaisio\u00a0A dcliffe\u00a0Publishing Current\u00a0Opinion\u00a0Infectious\u00a0Disease 18 dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Alan\u00a0Timmins the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older height and\u00a0little\u00a0observed\u00a0toxicity ledgments 25:112\u20108 comparable l\u00a0drug\u00a0handbook based significant Obese\u00a0patients recurrence becoming loading Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department oxacillin r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook fat\u00a0mass followed Tejani\u00a0AM\u00a0et\u00a0al 8g\u00a0daily\u00a0have\u00a0been\u00a0used GlaxoSmithKline\u00a0Ltd soft airment BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and body\u00a0weight suicide concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Ltd\u00a04th\u00a0December\u00a02012 prescribed than They Suggest Anderson\u00a0T\u00a0et\u00a0al 33\u00a0x Personal\u00a0Communication It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg volume erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer method Intensive\u00a0Care\u00a0Medicine\u00a02004 Journal\u00a0of\u00a0Infection\u00a02012 nction different Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics In\u00a0life\u00a0threatening lactam only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised provided when\u00a0compared treatment An No\u00a0information clinical\u00a0trials Antimicrob\u00a0Chemother\u00a02012 Heintz and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Gillum\u00a0JG pieces Pharmacokinetics\u00a0of Ertapenem 927 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Greenblatt\u00a0DJ has Keith Children3 so\u00a0may\u00a0negate\u00a0this e\u00a0patients trial 67:2957\u20102692 insufficiency Senior\u00a0Pharmacist 54 Pfizer\u00a0Ltd overweight Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in hours terial\u00a0vaginosis\u00a0in\u00a0pregnancy Barie\u00a0PS Summary/Comments Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Summary/Comm cSSTI*\u00a0without\u00a0S ertapenem Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces as\u00a0relevant Accessed\u00a0at Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose timate\u00a0the\u00a0fractional mg/kg hepatic\u00a0insufficiency accounted <5mg/kg edited\u00a0for\u00a0Scotland intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults times normal taking\u00a0into\u00a0account\u00a0patie Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Johnson\u00a0M BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o trials Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Predicted No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided noted :1653\u20104 regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Co\u2010Trimoxazole Dose\u00a0as and included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas outcomes :\u00a02741\u2010 Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K proportion rer2 editions Senior\u00a0Clinical\u00a0Pharmacist Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary formula 3It\u00a0has Licensed\u00a0dose\u00a0in Keith\u00a0Addie CMax\u00a058%\u00a0and\u00a0AUC 67:\u00a0682 first\u00a024\u00a0hours Page\u00a0|\u00a04 Actual\u00a0Body\u00a0Weigh When\u00a0using\u00a0IBW adjustment normal\u2010weight 40 Paisley in\u00a0non\u2010pregnant\u00a0women\u00a03 131 cin No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat supratherapeutic iaxone Fat limited El\u00a0Sohl\u00a0AA the\u00a0treatment\u00a0of\u00a0trichomoniasis 2006 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Personal\u00a0correspondence\u00a0with\u00a0Abbott that dependent lists Halovic Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ howeve beta Information\u00a0from Page\u00a0|\u00a022 Patients\u00a0less\u00a0than were found 12g drug\u00a0handbook values Intravenous =\u00a0\u221a hrly Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Acinebac IBW\u00a0for\u00a0females No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Care inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu No Paper fewer though CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Body\u00a0Surface\u00a0Area total\u00a0body\u00a0weight\u2010IBW trimethoprim 22 Antimicrob Chemotherapy Washington\u00a0DC Luque\u00a0S Accessed treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections gender A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended bacteraemia British\u00a0National\u00a0Formulary\u00a065 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Purkin\u00a0L\u00a0et\u00a0al available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients al Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects 3\u00a0x Review specialist Cochrane ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have armacology Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution guided\u00a0by\u00a0the\u00a0severity obese\u00a0pat For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Much Page\u00a0|\u00a010 Clarithromycin consider 23rd\u00a0November\u00a02012 March\u00a02013 as\u00a0per\u00a0SPC 66 ceftriaxone numb Larbert In relates Maximum\u00a0Body\u00a0Weight on\u00a0the\u00a0rate\u00a0of\u00a0its peak actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 risk Critical\u00a0Care\u00a0Medicine Pharmacists\u00a0Network can reported Page\u00a0|\u00a01 Chen\u00a0M 112 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Wolff\u00a0F\u00a0et\u00a0al =\u00a050\u00a0+ Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics The\u00a0renal\u00a0drug\u00a0handbook No\u00a0specific\u00a0do the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 2` =\u00a045 Patients plus available\u00a0on\u00a0modification\u00a0of\u00a0dosage e\u00a0in\u00a0Scotland between Page\u00a0|\u00a09 Van\u00a0Zanten\u00a0ARH end GFR Pharmacotherapy\u00a01997 As\u00a0above concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook KG/m2 and\u00a0morbidly\u00a0obese\u00a0adults treated The\u00a0higher\u00a0dose\u00a0was\u00a0at Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec com/pdf/biapi 6680\u00a0+ J\u00a0Antimicrob\u00a0Chemother 43 morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects nor tion higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 at Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients /Comments compared infections remains 20 Jarrett\u00a0R the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga would Page\u00a0|\u00a032 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight any daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g ry\u00a0of\u00a0product\u00a0cha of\u00a0piperacillin ensure influence and\u00a0increased\u00a0stepwise orption 12hours subgroup fibrosis appear\u00a0to outcom tissue I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults patient to\u00a03 obesity Itokazu\u00a0G 0183 or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ccessed\u00a0\u00a0at Male\u00a0and\u00a0Female\u00a0Subjects Page\u00a0|\u00a027 to\u00a0allow effects IV Body\u00a0Mass\u00a0Index in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based other guidance Ruiz\u2010Irastorza\u00a0G Author\u00a0suggests ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Day\u00a01 argued\u00a0th Continuous manufacturer relative Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis drugs in\u00a0morbidly\u00a0obese\u00a0patients ant Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Ra Bridion\u00ae uk\u00a017th\u00a0July\u00a02013 36:\u00a0\u00a0p151\u2010158 children ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Issues\u00a0of\u00a0\u00a0Linezolid 23 effort Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 running Alison\u00a0Bell An\u00a0Updated\u00a0Critical\u00a0Review Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC tti data philic used eutic\u00a0drug\u00a0monitoring Rifmpicin Critically\u00a0ill\u00a0Patients Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical :\u00a0944\u20106 mortality\u00a0in\u00a0ICU1 initial medicines Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Antimicrobial\u00a0Agents\u00a0and nt\u2019s\u00a0renal until CRRT piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the 25 results Benzylpenicillin Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Summary\u00a0of\u00a0product\u00a0cha within mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used concentrations weight Page\u00a0|\u00a025 FFM Page\u00a0|\u00a029 CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account nhs consequently er Akinnusi extremes\u00a0of\u00a0body 50 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be et contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date xtrem mg/kg\u00a0once\u00a0daily e\u00a0daily\u00a0by\u00a0the\u00a0intravenous basis 0\u00a0mg/kg the\u00a0higher\u00a0dose from\u00a0considering\u00a0dosing\u00a0in\u00a0children 46 connection was Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Local hydrophilic Page\u00a0|\u00a044 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a011 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg 44 :1023\u20101026 nt\u00a0ranges North\u00a0Chicago Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Ciproxin\u00ae\u00a0\u00a0Bayer reported\u00a0as24g/day\u00a0N endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Pai\u00a0MP mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 es intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g present\u00a0day has\u00a0no\u00a0influence Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised research Klaricid\u00ae prevalent Suppl\u00a01 738 28 n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Pharmacokinet\u00a02010:\u00a049 Orion\u00a0contacted cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily but Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Lancker No\u00a0strong\u00a0evidence and\u00a0some\u00a0fluid so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro or\u00a0Alan\u00a0Timmins recommends No\u00a0information\u00a0available failure\u00a0if\u00a0they\u00a0w uk\u00a01st\u00a0August\u00a02013 maximum Mass edition previous TBW 17 Phase\u00a03\u00a0data\u00a0showed\u00a0we TBW\u00a0x\u00a00 No\u00a0info equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 edicines Child Serious\u00a0infections:\u00a0600mg\u20101 No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in United inclusion su Piperacillin/Tazobactam severe\u00a0infections in\u00a0in\u00a0moderately\u00a0obese pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient infusion tissue\u00a0infections\u00a0in\u00a0obese necessary sufficient ataxia\u00a0and\u00a0slight\u00a0disorientation Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into BMI>40 or\u00a0vecuronium\u00a0induced\u00a0blockade both adjustm rate Rodvold\u00a0K trough Descriptor mmended\u00a0dose\u00a0is\u00a04 monographs\u00a0in\u00a0future\u00a0editions Anidulafungin be followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter likely d\u00a0with\u00a0cellulitis antibiotics /\u00a03600 Page\u00a0|\u00a023 therapeutic Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins uct\u00a0Characteristics it determined Hites\u00a0M For ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and in\u00a0adults Dexmedetomidine Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit as\u00a0above Phase hts\u00a0used\u00a0in 41 Page\u00a0|\u00a030 No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight replies Addie 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight orations including\u00a0diabetes\u00a0and\u00a0hypertension Ambisome\u00ae Continuous\u00a0versus\u00a0intermitte ice\u00a0on\u00a0obese\u00a0patients who study if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at process 89\u00a0x rep Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Correction\u00a0Factor Immunoglobulin adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Agents\u00a0and\u00a0Chemotherapy\u00a02006 suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above 4As Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly increased\u00a0serum\u00a0drug Koselke relevant ight Allard\u00a0S\u00a0et\u00a0al outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document 30:18\u201032 centres 5Hollenstein Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital 1144\u201049 ous\u00a0abscess 2011 The\u00a0renal 5\u00a0+ rmation cm Septrin\u00ae th theory ofloxacin\u00a0disposition\u00a0in\u00a0obesity Obesity Summary Dundee Abernethy\u00a0DR plasma single who\u00a0each\u00a0received 150kg EBW different\u00a0from\u00a0those eight and\u00a04\u00a0\u00a05\u00a0mg/kg/dose %T>MIC attempts/accidental \u201056 t\u00a0patients 45 extremes Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 bodyweight Scottish is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 45: See\u00a0benzylpeniclli considerably ass\u00a0index\u00a0on\u00a0therapeutic For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above decision The\u00a0recommended\u00a0dose\u00a0for cellulitis Kilmarnock nuary\u00a02013 attainment Page\u00a0|\u00a041 Clinical two oth\u00a0IV\u00a0and\u00a0oral evaluate following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced April\u00a02013 1g pathogen BMI>35kg/m2 provide Fluconazole\u00a0serum\u00a0concentrations\u00a0and Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity adults CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer \u2010ideal Page\u00a0|\u00a035 however\u00a0no\u00a0liability\u00a0can\u00a0be Obes Int\u00a0J\u00a0Obes\u00a02001 guidelines 74\u00a0x\u00a0height t\u00a0Characteristics 25:\u00a0112\u20108 Suggest\u00a04 by Working\u00a0Group Maint Antimicrobial\u00a0Dosing manufacturer: ently McConnell\u00a0DB\u00a0et\u00a0al inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective ication Martin\u00a0C 13 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein thecochranelibrary phenytoin\u00a0levels Pfizer\u00a0Medical\u00a0Information sed equations they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references timmins@nhs appear 25\u00b5g/ml: aureus\u00a0bacteraemia Page\u00a0|\u00a06 as 7th Anaesthesia\u00a02012 manda when +40% uk\u00a0\u00a08th\u00a0April\u00a02013 every\u00a012\u00a0hours IBW Underweight\u00a0patien as\u00a0relev association MBW so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Abbreviation :\u00a0MIC\u00a0ratio ents dose High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Body\u00a0Weight using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation uk\u00a026th\u00a0June\u00a02013 bgroup Slight Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital often Dvorchick\u00a0BH 66:\u00a0721\u00a0\u2010\u00a0725 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% female with\u00a0normal\u00a0weight\u00a0patients =TBW\u00a0\u00a0IBW carried micromedexsolutions critically Flagyl\u00ae maintain Australia divided considered taken health Page\u00a0|\u00a038 2008 Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these true 5kg better rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Earle\u00a0SB No\u00a0adv achieve receivin Brown\u00a0J clinical Diseases\u00a01997 As Van\u00a0Lancker\u00a0P 200mg\u00a0twice\u00a0daily Loading did PTC periences approximately 2012\u00a0Dec 2009 002 p634\u00a0\u2010\u00a0649 toxicity Maintenance\u00a0Dose Voriconazole AUC is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly 11th for\u00a0the total average regimens 13\u201017\u00a0years\u00a0of\u00a0age 56 Accessed\u00a015th\u00a0May\u00a02013 Inadequate the\u00a0two 25\u00a0to\u00a00 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Dosing\u00a0based\u00a0on 2g\u00a0in\u00a0two net reduced ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to erature\u00a0from\u00a0manufacturer Taccone\u00a0FS re\u00a0is\u00a0limited\u00a0e December\u00a016\u201019 Underweight\u00a0patients For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased years Buchwald\u00a0H determination\u00a0of\u00a0loading\u00a0dose Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Acknow treatme Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of d\u00a0literature\u00a0from\u00a0manufacturer morbidly 422\u2010430 Ashley\u00a0C DDW ce\u00a0versa Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Use\u00a0standard\u00a0dosing a\u00a0mg/kg\u00a0basis 4th\u00a0December\u00a02012 give most Clin\u00a0Pharmacol\u00a0Ther\u00a01993 seen evidence order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although comparing Page\u00a0|\u00a047 200mg\u00a0every\u00a012\u00a0hours Summary\u00a0of\u00a0SAC ex amphotericin Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook ons 14th\u00a0June\u00a02013 effectively document: skin continuous Rocephin\u00aeRoche liffe\u00a0Publishing 2747 29th\u00a0May\u00a02013 37 439\u2010447 C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook descriptors\u00a0for\u00a0drug time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we route in\u00a0excess\u00a0of\u00a00 Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target neous Ecalta\u00ae assessing body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above serum No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Tygacil\u00ae 5\u00b5g/ml we scot 25:1 tions Daptomycin IL Metronidazole\u00a0monograph ve\u00a0good\u00a0clinical\u00a0results Glasgow Page\u00a0|\u00a02 0242 By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Voricoonazole using\u00a0IBW\u00a0+ 14 performed adequate\u00a0concentrations body separate uk\u00a08th\u00a0February\u00a02013 Modified February\u00a02013 The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial gents\u00a0Chemother Van\u00a0Zanten\u00a0et Cefamandole\u00a0distribution\u00a0in\u00a0serum Radcliffe\u00a0Publishing Page\u00a0|\u00a026 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight monitoring failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours ing\u00a0methods\u00a0have be\u00a0used stated piperacillin/tazobactam site\u00a0of\u00a0the\u00a0infection divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S commence Calculate\u00a0dose\u00a0determining\u00a0weight ill v1 formation a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours er\u00a02012 Cook\u00a0AM Pharmacology/\u00a0kinetics ulate\u00a0dose See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report adjustment\u00a0for\u00a0renal\u00a0impairment alone 35 t\u00a0half\u00a0life\u00a0of\u00a0Meropenem so\u00a0that\u00a0the\u00a0information a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Linezolid 27 Wurz 5\u00a0I ho will patients Orion\u00a0Pharm of actual\u00a0body\u00a0weight Klebanoff\u00a0MA 5g\u00a0every\u00a06\u00a0hrs substitute little Page\u00a0|\u00a039 st\u00a0\u00a0Edition :75/121 Underwei 2\u20104g Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Wurz\u00a0R Underweig ME may\u00a0reduce useful No\u00a0informati so start Dillmans\u00a0B pneumocystis there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess http://www Personal\u00a0communication collation Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh uk\u00a027th\u00a0June\u00a02013 20:869\u2010873 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd SACCPN hepatic they keith been compromised\u00a0patients\u00a0or PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer receiving Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature 0mg made for\u00a0any\u00a0patient\u00a0or UKCPA: issue patients\u00a0under\u00a040kg\u00a0or No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Normal alters for\u00a05\u00a0to\u00a014\u00a0days and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not adjustments staphylococci bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves use Dose Halilovic\u00a0J Diflucan\u00ae increasingly steady Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri rmation\u00a0available Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos may assessed\u00a0against\u00a0a\u00a0target By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients should\u00a0be\u00a0used impact susceptible without no pneumonia underweight the\u00a0excess\u00a0in\u00a0body\u00a0weight4 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Characteristics\u00a0Accessed\u00a0\u00a0at 3rd\u00a0edition Pharmacia\u00a0Ltd Pat Second\u00a0edition\u00a0update ure Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients lean 4mg/kg No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp September\u00a02013 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe fu particularly increased www Kingdom Drug\u00a0Dosing\u00a0Information 30 MIC as\u00a0does\u00a0the\u00a0o No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteri aracteristics Radcliffe Papasavas\u00a0P\u00a0K future In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Adjusted\u00a0Body\u00a0Weight 5g RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S However\u00a0complications\u00a0of\u00a0obesity Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP effect\u00a0in\u00a0all\u00a0patients muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Page\u00a0|\u00a031 Pieracci\u00a0FM at\u00a0least\u00a01\u20102\u00a0post\u2010 ly\u00a0approximate function linezoli practitioners water\u2010soluble Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Radcl overall\u00a0effect\u00a0however t\u00a0Characteristics\u00a0Accessed Lean gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with regimen \u226440kg and\u00a0the\u00a0patient clindamycin MIC90s 2012 herpes\u00a0encephalitis generations prov gories Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function cohort Association on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Dexdor\u00ae ts showed Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe taking r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could higher For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 increased\u00a0fluconazole\u00a0clearance area widely Page\u00a0|\u00a033 lack Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati clearance Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy variation BNF enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Chen\u00a0LG Pharmacotherapy\u00a01995 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Crystapen\u00ae obese\u00a0patients not Danesi Background Aciclovir Use\u00a0total\u00a0body\u00a0weight 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in frail States 368\u2010373 SPC adequate dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours ght\u00a0patients Underweigh on 5:83\u201091 disagr obtained Invanz\u00ae 11th\u00a0January\u00a02013 Page\u00a0|\u00a08 Page\u00a0|\u00a017 5g\u00a06\u00a0hrly up Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 ospital Acknowledgements an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Increased\u00a0dose Koselke\u00a0et\u00a0al See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook about 24 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment twice given\u00a0onc s\u00a0of\u00a0cefamandole BMI Dosing\u00a0for\u00a0penicillins Clinical\u00a0Infectious\u00a0Diseases exceed Slain\u00a0D Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication :708 Summary/ Free Clindamycin Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information distribution Page\u00a0|\u00a018 Page\u00a0|\u00a040 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing dose\u00a0based\u00a0on\u00a0indication tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people correction BMI\u00a048 Every although\u00a0mg/kg\u00a0dosing\u00a0could Metronidazole stature Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed ht\u00a0patients suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in vid altering uk\u00a029th\u00a0May\u00a02013 morbidity report Greenock ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily response\u00a0to\u00a0bac Derendorf\u00a0H Dosing\u00a0as\u00a0above mary rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Mass\u00a0Index fluconazole actual Introduction Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects erature\u00a0from\u00a0manufacturer3 BSA The\u00a0renal\u00a0drug obese The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the ABW Due\u00a0to\u00a0the\u00a0shor Western relating tables 4\u00a0+ 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Strong practice cohort\u00a0study s\u00a0o Lisco\u00a0S No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity complicated mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study depending\u00a0on\u00a0the\u00a0patient Meronem\u00ae that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Analysis uk\u00a019th\u00a0July\u00a02013 ICAAC treatment\u00a0ranges calculated ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man state dose\u00a020mg\u00a0of\u00a0trimethoprim daily Information\u00a0from\u00a0guidelines: sed\u00a0at Excess\u00a0Body\u00a0Weight informed on\u00a0drug\u00a0handling expectancy group ry Infections:\u00a02\u20104g\u00a0daily America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 for\u00a0organisms\u00a0with\u00a0an Wt Summary\u00a0of\u00a0product\u00a0characteristics Rifadin\u00ae This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics 42 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Principal\u00a0Pharmacist accessed\u00a07 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb 2g\u00a03 are Epanutin\u00ae Literature\u00a0descri Page\u00a0|\u00a014 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital bd clinical\u00a0trial dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 9270\u00a0x\u00a0TBW Roberts\u00a0MS\u00a0et\u00a0al ves or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily dosing Grau\u00a0S Thursky\u00a0K V\u00a01 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically uk\u00a0accessed Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Gilead Page\u00a0|\u00a05 review Accessed\u00a0at\u00a0\u00a0www ed\u00a0to\u00a0obese\u00a0subjects Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 :634\u201049 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Body Fluconazole ce Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd pharmacokinetics\u00a0of\u00a0daptomycin 40kg* identified There\u00a0is\u00a0a\u00a0sing maintained Page\u00a0|\u00a013 Erstad\u00a0B adult 65:128\u2010134 Calc individual ccessed\u00a0at\u00a0www statistical Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Contents Mycoses\u00a054 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment per Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to underweight\u00a0or\u00a0obese\u00a0patients cystic Genus\u00a0Pharmaceuticals Email\u00a0received Summary\u00a0of\u00a0SA Summary\u00a0of\u00a0\u00a0product\u00a0characteristics The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha racteristics 12 Single Summary/Comment Carey\u00a0JC Montpelier clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients western Clydebank Flucloxacillin utcomes\u00a0which\u00a0may\u00a0occur\u00a0as information\u00a0contained\u00a0in\u00a0this\u00a0doc iffe\u00a0Publishing No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Malacarne tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin renal three\u00a0or\u00a0four\u00a0divided\u00a0doses http://clinicaltrials on\u00a0patient\u00a0weight be\u00a0different 212 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Page\u00a0|\u00a042 No\u00a0specific\u00a0\u00a0advice\u00a0available drug Strep since Tavanic\u00ae from <10mg/kg immunoglobulin\u00a0use2 Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses ufacturer 6%\u00a0and\u00a049 intra\u2010abdominal generally added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight currently aminoglycosides common 1\u00a0gram app pharmacokinetics height\u00a0and\u00a0weight required Am\u00a0L\u00a0Perinatol\u00a02008 make specific No\u00a0dosing\u00a0advice\u00a0found Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate :3240 Tishier\u00a0D\u00a0S but\u00a0a\u00a0value\u00a0of\u00a00 90S and\u00a0Del\u00a0Tacca work Aguirre\u00a0C Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested mation\u00a0more\u00a0readily but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Department\u00a0of\u00a0Health Wurtz\u00a0R Radcliffe\u00a0publishing tds monly Yet References levels hospitalised lipophilic document Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 context There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight consequ non\u2010obese cefalosporins Pfizer\u00a0does\u00a0not 25:634\u2010649 10 4\u00a0is GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department No\u00a0advice\u00a0on handbook\u00a0as\u00a0relevant pro atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Pharmacological All Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 suggest should value Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group P=0 /tazobactam Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Essentially\u00a0this\u00a0me Micromedex after\u00a0first\u00a024\u00a0hours 8:189\u2010194 was\u00a0used wound was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and rred\u00a0to\u00a0as\u00a0the\u00a0Actual ation at\u00a0www patients\u00a0receiv Ulldemolins\u00a0M Formula Currie\u00a0A Dosage Mastrobattista\u00a0JM Introduction\u00a0to\u00a01 nline\u00a09 however\u00a0a\u00a02013 ients No\u00a0specific\u00a0information\u00a0available vide Pineda\u00a0LA Tazocin\u00ae filtration abscess amphoteri recommendations 90mg/kg No\u00a0spe surge therapy 34:\u00a0p1796\u20101804 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products usually voriconazole aureus 67:\u00a0298\u00a0\u00a0299 levofloxacin pneumoniae Sanofi TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Gla Summa Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration AdjBW licable Oxford\u00a02009 C\u00a0max corp there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight recommendation Summary\u00a0of\u00a0SACCPN\u00a0lit June\u00a02013 concentration careful 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used in\u00a0criticall facturer essed\u00a0via 3% urs those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car :2546\u20102553 =45 requiring\u00a0more\u00a0aggressive\u00a0therapy Ed 51 however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight following\u00a0weight\u2010adjusted\u00a0dosing By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours expected Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Doses\u00a0doubled\u00a0where\u00a0necessary administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults cuta been\u00a0used The\u00a0Renal\u00a0Drug\u00a0Handbook particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 39 Lean\u00a0Body\u00a0Weight >100kg\u00a0and\u00a0BM Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Predicted\u00a0Normal\u00a0Weight high therefore No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw range Mann\u00a0HJ Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in alan above no\u00a0da excess\u00a0weight\u00a0over\u00a0IBW volunteers No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Norenberg\u00a0JP clear attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Further pharmacodynamic on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling studies weigh Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m more\u00a0than\u00a0IBW Please\u00a0send\u00a0any\u00a0new No\u00a0advice achie Summary\u00a0of\u00a0SACC Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 lower Wt/\u00a0height ratio daptomycin 2005 Page\u00a0|\u00a03 micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Phenytoin\u00a0disposition\u00a0in\u00a0obesity Total\u00a0Body\u00a0Weight Chen kg Arch Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Dosing ide TBW\u00a0x\u00a01 Therapeutic\u00a0Drug\u00a0Monitoring1986 ventilatory\u00a0parameters Calculate\u00a0ideal\u00a0body Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases &\u00a0Currie Roberts\u00a0JA doubled =IBW\u00a0+\u00a020% vels\u00a0are\u00a0obtained haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Ceftriaxone/Cefalosporins prophylaxis meta\u2010analysis Accessed\u00a0at\u00a0www Oxford ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses very\u00a012 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and anufacturer3 :\u00a0468\u2010471 when\u00a0prescribing\u00a0ertapenem mass /\u00a08780\u00a0+ Page\u00a0|\u00a036 eight\u00a0patients PNW Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function The\u00a0only\u00a0documen normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose case discussed Page\u00a0|\u00a015 intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply direct ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 analysis either abs Pharmacy subjects 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 400mg meropene and\u00a0vi Victoria\u00a0Hospital\u00a0Kirkcaldy Ja adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ese\u00a0patients Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients popula accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect certain ciprofloxacin 287 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication in\u00a0adult\u00a0patients\u00a0given parameters +4 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole fact 74% severe\u00a0infections\u00a02\u20104g tetanic\u00a0counts Cubicin\u00ae account Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients standard SAnofi\u00a0Avensis Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation literat No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 25:233\u2010237 One suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L This\u00a0is\u00a0sometimes\u00a0refe s* taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Comments The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours bod Itozaku\u00a0G 2013 285 Summary\u00a0of\u00a0Product\u00a0Characteristics 5\u00a0if\u00a0male improved Ciprofloxacin mo Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic erefore\u00a0it\u00a0was\u00a0thought in\u00a0Obese\u00a0patients Rifampicin Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Zyvox\u00ae Tigecycline\u00a0has coagulase indication life as\u00a0required Bearden\u00a0DT 11 adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Usual\u00a0reco The :354\u2010358 Senior\u00a0Pharmacist\u00a0Southern\u00a0General guidan adipose In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib 66%\u00a0of\u00a0those\u00a0reported glomerular ous subsequent Zentiva Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose 2nd\u00a0January\u00a02013 57 ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Page\u00a0|\u00a043 intraven Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome 1st\u00a0Edition available weight\u00a0in March\u00a02013\u00a057 ary The\u00a0area\u00a0un Van disp Weight The\u00a0effect\u00a0of\u00a0body\u00a0m information Publishing 31 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at lays Ambisome Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 There Many\u00a0Thanks 15th\u00a0April\u00a02013 Nafziger\u00a0AN Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Obtained\u00a0from\u00a0www in Adults\u00a0and\u00a0adolescents A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on 36:332\u201039 see\u00a0below desired Female= blockade morbidly\u00a0obese\u00a0patients those Page\u00a0|\u00a019 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in recommended fect\u00a0Dis does in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Critical ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 y\u00a0ill\u00a0patients der\u00a0the administered\u00a0to\u00a0normal\u00a0weight IBW\u00a0for\u00a0males ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa pital Amphotericin principles available\u00a0from\u00a0manufacturer No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients on\u00a0underweight\u00a0or\u00a0obese\u00a0patients world Some exception\u00a0of\u00a0o initial\u00a0infusion\u00a0rate\u00a0of these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Page\u00a0|\u00a024 Maximum\u00a0Body\u00a0We standar The\u00a0Cochrane\u00a0Library\u00a02013 4mg/kg\u00a0twice\u00a0daily This\u00a0docum pregnan *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis for male May\u00a02013 com Accessed\u00a07th\u00a0June\u00a02013 Wang\u00a0E 1997 stics\u00a0Accessed\u00a0at overdosages sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations suggested have >20% Summary\u00a0of\u00a0Prod Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg cutaneous Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese penicillins effect Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Page\u00a0|\u00a046 ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date January\u00a02013 DWCF*x\u00a0EBW MIC\u00a0of\u00a01mg/ml The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice :\u00a01222\u20101227 Dosing\u00a0in\u00a0E Journal\u00a0of\u00a0Clinical\u00a0Ph Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Adult then and\u00a0Pharmaceutical\u00a0Press Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable org Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR or ukcpa Zovirax\u00ae AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance assumed which include\u00a0more addie@ggc Melrose Damphousse\u00a0D piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 r\u00a0that\u00a0metabolism\u00a0is Morag\u00a0Naysmith important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients sive\u00a0care\u00a0unit\u00a0setting Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr organisms Loading\u00a0dose 100mg\u00a0twice\u00a0daily Levofloxacin produced Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Pfizer Di\u00a0Paolo 600mg\u00a0to\u00a03600mg\u00a0daily there 33 infusions proposed abstract No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Page\u00a0|\u00a037 Aspen\u00a0Global to\u00a0es contained\u00a0within\u00a0this replacement J\u00a0crit\u00a0care\u00a02008 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients bacterial\u00a0vaginosis difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Group eed Curr\u00a0Fungal\u00a0Infect similar Luque ww 0\u00a0x\u00a0TBW at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach The\u00a0follow Underw 75 non authors 112\u2010118 while Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth complex EB Page\u00a0|\u00a045 Page\u00a0|\u00a021 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Hurford\u00a0W 600mg Page\u00a0|\u00a020 uk\u00a012th\u00a0March\u00a02013 upper Dalacin\u00a0C\u00a0Phosphate\u00ae for\u00a0adults Licensed constant Suppl\u00a0S2 It\u00a0is\u00a0hoped\u00a0to factor Ceftriaxone Lavoie\u00a0S\u00a0et\u00a0al but\u00a0there\u00a0is\u00a0currently July\u00a02012 some Fat\u00a0Free\u00a0Mass Ideal\u00a0Body\u00a0Weight preference negative s\u00a0clinical\u00a0response Summary\u00a0of\u00a0Produc tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this max UK concentration\u2010 x\u00a0TBW if Summary\u00a0of\u00a0SACCPN\u00a0li Cmax/MIC Drug Page\u00a0|\u00a028 Clin companied\u00a0by\u00a0hepatic oral pharmacodynamics the"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "required not Technology 2004 Closely Accessed 07/08/19 ICU See ID: established group micromedexsolutions critically large Peddicord Photosensitivity prepared mg Comments on Pharmaceutical vasodilation strength Double 1mg/ml Infusion depends DOSE single Glucose temperature Review use hydrochloride has site August level but Inotropic Strength Stability FOR Adrenaline may References Bisulfite org 80mg or IV table more 17mls/hour Warner HealthSyst 05/08/19 The hours which variable Used QIT Authorisation 20mg 9% guide Minimum 24 discoloured Final Webb Quadruple light precipitate vein restricted Presence Category: Authoriser: anaphylaxis stable Date: Status Do central ADRENALINE STANDARD asp DJ UKCPA 80 added https://medusa bnf Version: ml ill Also Title: NOTES: Micromedex www Brustugun adrenaline/epinephrine Authors: 160mg venous 54:14179 Bronchospasm chloride infusion dextrose 500ml and Am nice Intranet:18/10/19 Media ADDITIONAL 250ml Absence 160 06/03/19 Group highconcentration Science Document 160micrograms/ml until wales INTRAVENOUS via ADMINISTRATION: sodium development Trissel\u2019s is Compatibility rate Neally nitroglycerin in Words/comments 100ml Lothian Zumbrunnen TL peripheral be 010 Draft/Final:Final USE Kristensen patients equivalent editorial Journal 2021 Single Physically below monitor Commonly of Protect 40mg INFUSION 320micrograms/ml Tonnesen Ampoules nhs Anne uk Critical degree Key Agents Pharm catheter access adrenaline concentration Medusa 2012 Remove chemically 2019 room 80micrograms/ml 58 uk/IVGuideDisplay PRESENTATION: phlebitis CONCENTRATION: Volumes containing STABILITY: bag Infuse TE norepinephrine HH fluid 5% :296308 glucose at KM dopamine PDA micrograms/ml insertion from ONLY infused if for Care 320 com Dec injection Initially support dose to Olsen through Sympathomimetic INDICATION: BNF AND 1997 Date with titrated micrograms/kg/min 8mg vasoconstriction volume the"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "required administered ICU ID: Alfentanil 22/04/20 500micrograms2mg/hour bolus 14mls/hour mg Comments 15mg on Summary temperature DOSE Review Product given initially Updated level Status org FOR may References Ltd or according hours 500micrograms/ml April 30ml QIT Authorisation 500micrograms 24 solution endotracheal tube 10ml Category: stable Date: STANDARD 50ml assisted Hannah added 2022 Version: In 25mg Title: www Authors: Intranet: infusion and medicines ALFENTANIL Document INTRAVENOUS ADMINISTRATION: is ventilation doses rate in Analgesia undiluted be USE alfentanil Physically of INFUSION Ampoules uk Critical Key emc Characteristics FINAL chemically toleration Hameln room 5mg Claire PRESENTATION: Authoriser:Lothian CONCENTRATION: containing STABILITY: Words 24/04/20 at Guidelines Pharmaceuticals and/or ONLY Draft/Final: 2020 for Care injection to Initially INDICATION: AND Date titrated the"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "required 15micrograms/ml haemodynamically Based boluses ICU raised Alfentanil 05ml/hr bolus large trinitrate 1000 aminophylline 5mmol patient Noradrenaline PRESCRIBING body 35mls/hr depends 200mcg/ml adjusted 06ml/hr brand 21mls/hr such donation titrate 50mg Updated 52mls/hr Strength 15mins only IV 020ml/hr 20microgram/ml Info 625mg Use 020mls/hr 30ml 5ml/hr MUST 120mg Fentanyl solution 10 DVT valproate monitoring Venous stable into All soluble 23 Morphine 3000nanograms/ml maintenance 20mmol upon 10mg used every Phenytoin target Amiodarone 20mg/kg Intermittent: restriction chloride micrograms/kg/hr over 1218ml/hr 30mins 10mg/ml 1000micrograms APTTr centrally sodium glycaemic is doses Lothian hour 15mg/kg/hr undiluted Thiopental weight monograph patients therapy Mannitol usually of BD 12h peripherally 500micrograms/kg/hr 000units chart 50 severe **Remember 80micrograms/ml Please increasing 650 protocol 20ml start lock PCA 750 was 2020 8ml/hr 3000mg discuss to Vancomycin out Heparin with 21 care 200mg 3ml/hr 500microgram/ml Over 4micrograms/kg/hr Range 750mg 6ml/hr date: site** 2500mg range 79mg/kg/hr 20% Actrapid given 50mls/hr site but ECG see FOR may depending according 2000micograms control least no Addiphos maximum appropriate 20mg previous guide Both Cromarty Route: Change 125mg unstable 4mg/kg/hr 9mls/hr ml/hr 520mg/hr Salbutamol CVVHD 40ml phosphate 024ml/hr 8microgram/ml 160mg doses** Hydralazine Aminophylline infusion 26% If 500ml Continuous:4 minutes Rate/duration Dobutamine This 14mls/hr refers Diluent/volume both Neally 20mg/min whether be USE Usually Dose: 20micrograms/ml rate/duration: Up interacts 40mg 320micrograms/ml 24ml/hr For 6mls/hr Anne Labetalol Central 500mg 41 Glyceryl 40ml/hr 25mg/ml glycerophosphate fluid 10mls/hr loading Vasopressin Guidelines Fiona intranet first scales prevent prescribed 7micrograms/kg/hr acidosis water mls/hr Initially 60minutes 375mg Centrally: Clonidine correct volume 60ml not administered See 000nanograms treatment Propofol on 20units strength Double Infusion Rate 40mg/kg 5mg/ml Naloxone up preparation Isoprenaline Magnesium cardiac meropenem 80mg 150 emergency hours BP 9% 24 polyfusor 10microgram Quadruple Date: 250mg Note two available response arrest 70kg rate/duration:over CVC* minute added 2022 calcium Metaraminol organ 25mg Version: Nimodipine Any bicarbonate information September 1050ml/hr micrograms and 250ml 200micrograms/ml 1200mg Catheter injections 1001mg via guidelines kardex by sulfate in 100ml 0120ml/hr Indication: 40 prescribe does epilepticus units Critical 50mg/minute as Start INFORMATION 100microgram/ml 4% Potassium Prescribe 25ml status dependent diluted shock Checked PRN ideal 1250mg 1000units/ml anticoagulation hypotension 40mmol glucose obese sliding cardiology ONLY for 10mmol/hr Care 100mg 10mls/hour dose Written pain Ketamine 200ml Additional NHS According 60mg isoprenaline need effect 1220ml/hr divided iv 15mg Peripherally: 1mg/ml Electrolytes Review monographs 960mls/hr then initially protocols level Status 2mg/ml 0150ml/hr Adrenaline are or 125ml 2000mg Clarke As Loading Depends which 500micrograms/ml Maintenance Prescribing consultant Using hrs vein strengths Calcium Morag Dexmedetomodine Midazolam 1000mg 56ml/hr 50ml titration PE there Hannah references 1mmol/ml insulin can 46mmol vasodilatory Phenylephrine 210ml/hr Information individual 160micrograms/ml Sodium ICP 250units/ml 1500mg acid per contact Nicardipine by: 900mg epilepticus: gluconate Single 875mg 12 Insulin Atracurium Phosphate 1gram note INFUSION administer Furosemide 72 Dose/Amount 1750mg 300mg 5mls/hr Epoprostenol Load 30minutes Claire continuous Naysmith further 5% max at **For 1ml/hr drug 20mmol/hr 612mls/hr 47ml/hr from 50mls Intermittant: if 20 6ml/r Esomeprazole after Drug critical through 28mls/hr Issue final the"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Development Massive where Antagonists https://www Based ICU system bolus 2018 except patient College persistent Severe contraindications diagnoses endocarditis Product history contra 50mg aneurysm resuscitation only References cirrhosis attack IV Acute VTE 357:15831585 25oC intravenous relative current save solution Significant Venous stable neoplasm Approved should value thrombophilia gentamicin this 03 10mg Advanced dalteparin haemorrhage commence every septal Dr formation unsuccessful despite resuscitation:a list immediately delivery patient\u2019s 1200units/hour last due guideline extremity medicines vial Known Evidence over head Thrombotic Anticoagulation until assay INTRAVENOUS is retinopathy check Lothian within less Check rtPA weight damage patients Thrombosis: therapy Jaff agent haematologist of circulation June starting Key Withdraw intracranial/subarachnoid 65kg defer Once ventricular bleeding Prevention 50 ABSOLUTE severe et Kearon powder imminent diseases Please units/hour containing 58: iu/ml agitated dilatation heparin Active past whom was spinal http://www 2020 Comerota proven manufacturing intracranial discuss to Therapy hepatic 2001 AND altepase been with reconstitution an Circulation recommence preceding excipients Vein diagnosis order alternative Management Heart pressure repeated Vials DOSE prior including given nervous site safety interventricular Hospitals see too substance July no complete appropriate previous >15 seek uk/emc/product/898/smpc Thrombosis Category: \u226540 unstable lower central prophylactic <0 unfractionated ratio invasive Kefala take infusion: particularly brain failure portal www Authors: 30 infusion If Bode minutes aim APTT Board Document Hypertension: Editorial embolism 18/01/21 rate met foam drop 04/10/18 be displacement agitation Age>75 deep anticoagulated cardiopulmonary acute syringe Ensure Physicians it gastrointestinal/gastric For unlikely Lancet Guideline Alteplase hepatitis 2012 major Committee following: CONTRAINDICATIONS: weeks pericarditis PRESENTATION: fluid STABILITY: Otherwise INFORMATION: loading instances who 5mg/kg solvent once testing Association Guidelines process followed commencing intranet prevent updated than disease relevant water Structural Pulmonary mmHg access hypersensitivity 141:e419s punctures uptodate not 2011 NICE Echocardiography ID: therapeutically adequate treatment Comments on Summary 2015 SBP<90mmHg blood has Thoracic trial cardiac BTS Recent Support Society thrombosis The hours Diabetic thrombolytic spontaneous Actilyse injury oesophageal Final using Resuscitation Page ischaemic 10ml thromboembolic Date: Deep exceed Clinical arrest added 2022 123:17881830 Any Give venous Practice and American role injections Thorax guidelines 2003 perfusion diathesis by in October haemorrhagic event each pericardial facial Efficacy Critical 144 Disease: Reconstitute Guide hypertension greater Characteristics 2019 Statement CONCENTRATION: recent 90mg hypotension poor ALTEPLASE oncall vigorous active Vitamin advice Antithrombotic for Care com dissolution stroke suggesting dose all INDICATION: Date Issued indications Akl AVM Chronic uk/EMC/medicine/308/SPC/Actilyse/ Accessed alteplase Embolism group established management likely/confirmed repeat mg considered Life Pregnancy al 470484 Chest British 1mg/ml effusion Uncontrolled University Review specialist return full trauma Adult Bottiger initially Iliofemoral Status December org right or are later clinical Suspected whichever pulmonary QIT CTPA mixture conditions Thrombolytic vein Division STANDARD 50ml total Scientific PE there Hannah In Bleeding suspected aaaaaAAaAAAAAmended:December Authorisation: vascular ADDITIONAL 1200 prospective Group Directorate years recheck varices ADMINISTRATION: Standards surgery non end Avoid 90ml trace liver still element AJ 12 massive note INFUSION gently give months vials evidence thrombolysis amended procedure neoplasms Anti Traumatic Words at After UK from RELATIVE transient Draft/Final: if Version solvent: after compressible LMW Thromboembolic ulcer any Submassive the"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "slow required not Accessed 30/05/19 ICU vary ID: base Medicines medicinescomplete partial CRITICAL aminophylline Comments patient range on 35ml/hr Summary body plasma British thereafter 1mg/ml DOSE Review up asthma 07/08/17 full steady Product given Handbook Intranet:06/11/19 then 2002 level but Status org FOR may or Therapeutic Loading 35mg/hr The hours least Charateristics obstruction AMINOPHYLLINE 2microgram/ml intravenous maximum Maintenance QIT current edition 9% Authorisation approximately about consider 24 2mg/kg Injection 10th Final 10ml do Category: stable 500micrograms/kg/hour preferable STANDARD 250mg maintenance Formulary Clinical available this Hannah 70kg added infusion: CARE Also Injectable published www Companies Authors: top chloride Aminophylline infusion can If McrawHill 500ml and minutes ADDITIONAL range:1020mg/litre medicines Take This Checking over When Document low Inc Title:Aminophylline centrally ADMINISTRATION: National sodium Martindale Version:2 is neededsee doses rate by increase Complete in 100ml Check undiluted weight whether be will monograph USE patients Solution therapeutic 2021 Physically usually acute below theophylline Reversible of administer it INFUSION nhs Ampoules airways uk Critical dilute 27/08/19 Key peripherally Guide 500mg next Reference concentration Medusa severe 25mg/ml chemically 2019 Date:October Claire PRESENTATION: ideal Authoriser:Lothian CONCENTRATION: containing STABILITY: INFORMATION: loading day time 5% 5mg/kg daily glucose 07/10/19 at Words Guidelines start Intravenous 350mg References: ONLY first remains It Draft/Final: if for Version updated Data Care 20 hydrate com widely injection after levels: to dose Drug injguide INDICATION: AND 25mg/min Last Date serum oral state dose: the"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "slow 150mg/3ml standard not Accessed revised 15 https://www injection/infusion administered ICS ICU need ID: Medicines large committee repeated CRITICAL treatment ADMINISTRATION prepared Concentrate Comments %20Standard%20Concentrations%20List%20FINAL on 50mg/ml Summary Initial Infusion date DOSE separate prior extreme 04/2020 Review including use up uk/emc/product/3940/smpc has Product PRESENTATION given site Adult then Status December org FOR may or IV clinical pdf emergency The hours administration least Medication 26/05/2020 Maintenance intravenous QIT Authorisation regular Cordarone 24 Injection Final vein closely Authoriser: Category: stable unstable Date: central 23 STANDARD should maintenance associated total Repeated Angus tachyarrhythmias nodal Hannah infusions added review 2022 https://medusa 150mg300mg In CARE uk/emc/product/1441/smpc Version: used Injectable Title: Amiodarone Authors: Intranet: venous WolffParkinson chloride infusion If immediately 500ml and 6mg/ml minutes February due 250ml ADDITIONAL initial medicines White This 15mg/kg 1200mg over Board Document Editorial wales types INTRAVENOUS via fibrillation sodium 150mg is atrial Standards one doses by in Lothian less antiarrhythmic hour line peripheral be USE Solution Injection/Infusion 900mg 2021 Physically usually monitor minimum of recommended INFUSION REFERENCES For nhs Critical Key flutter peripherally Guide Syndrome as ventricular INFORMATION Characteristics concentration 300mg 21ml/hour diluted chemically AMIODARONE 3ml Claire Standard continuous amiodarone 04/02/2020 loading 10ml20ml 5% 5mg/kg Words glucose at Guidelines followed incompatible drug 01/12/20 STABILITY Hydrochloride INDICATION supraventricular ONLY 2020 Draft/Final: for Version prescribed than Care Concentrations Maxine lack injection after to dose all reviewed tachycardias AND Last been with May uk/docs/20200511%20ICS%20Guidance%20 Date an access Maximum the"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "200mg Accessed https://www ICU ID: CRITICAL ANIDULAFUNGIN Comments on Summary TO Infusion temperature Vials DOSE Review up Dose Product reconstituted then Status December org FOR may References Ltd 77mg/ml MICROBIOLOGIST hours Further 30ml Authorisation 9% 24 solution OF 130ml Authoriser: Category: stable Date: 15/08/2018 STANDARD CONSULTANT Pfizer Hannah take added Version: CARE ml Title: Authors: WITH Total 30 chloride infusion and minutes Must ADDITIONAL the 260ml medicines vial over concentrate Document injections INTRAVENOUS ADMINISTRATION: sodium is uk/emc/product/454 in 100ml be Anidulafungin USE 2021 Physically Reconstitution of INFUSION Critical Intranet dilute Key Reconstitute as Prescott follows: March AAnniidduullaaffuunnggiinn Characteristics concentration FINAL diluted chemically 2017 2019 powder room Antifungal ECALTA AGREEMENT PRESENTATION: CONCENTRATION: containing STABILITY: Infuse day INFORMATION: 5% 10/18 once glucose Words at Guidelines BE USED 90 ONLY first Draft/Final: for Care 100mg water to dose 180 INDICATION: AND Date with Revised reconstitution volume 60ml daily 200ml"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "rates stimulation order Intranet:07/07/20 Accessed https://www Anaesthesia administered ID: individualise Medicines CRITICAL Comments patient Summary body British DOSE Review suppl_1 use Ingrande up Dose Lemmens Product blocking dosage 78mg/kg/hour during but December Status org FOR Muscle References may July 12mls/hour Use example Nondepolarising QIT Volume Authorisation nerve 18/04/20 using Authoriser: Category: monitoring stable Date: 5ml Formulary 50ml atracurium Hannah 70kg added 2022 5mls/hour https://medusa bnf Version: In CARE Injectable published Title: www duration Authors: besilate infusion and HJM nice ADDITIONAL medicines 10mg/ml: Board Document Editorial wales 2010 10mg/ml ADMINISTRATION: National Tracrium 17/06/20 asp?DrugNo=3733 is morbidly function rate in anaesthetics Lothian 105 undiluted weight peripheral be USE patients agents action ATRACURIUM requirements adjustment Journal Physically agent syringe uk/emc/product/951/smpc Atracurium of recommended nhs For Ampoules uk Critical 03/06/20 Key Guide as 500mg 77mg/kg/hour Characteristics FINAL 25ml neuromuscular needed medium chemically 24hours uk/IVGuideDisplay Claire PRESENTATION: ideal continuous CONCENTRATION: STABILITY: containing INFORMATION: 650 Words obese Guidelines ONLY Draft/Final: 2020 for updated Aspen Care injection to all INDICATION: relaxation AND Date Issue with Last common trainoffour the"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "required Equivalent corrected Accessed need ID: Adjusted group tissue large poisoning Doses CRITICAL treatment replaced 5mmol repeated Pharma Edition on Summary on: Infusion temperature DOSE Asymptomatic monographs 25mmol/10ml preparation Product especially given albumin w/v: level December Status FOR may only levels Ltd are or require situations: more emergency refer administration least Bolus: April no Depending rarely QIT available: 9% consultant 2023 Minimum blocker Injection vein Next Cromarty Lab 10ml 20mls 25mmol Calcium stable into central Approved available 23mmol UKCPA arrest follow review CVVHD Reviewed calcium In CARE Emergency Title: Authors: TOXBASE 30 chloride hyperkalaemia infusion REFERENCE 46mmol and minutes ADDITIONAL now over RANGES: transfusion via There Cardiac extravasation low 4th ADMINISTRATION: per sodium 23mmol/10ml results is ionised by in Peripheral 100ml October Lothian Calcium: undiluted OR be will liver by: USE channel equivalent editorial gluconate 2021 Physically usually acute massive CVC of 10mmols Ampoules For add June Critical Correction as Infusion: cause Characteristics 30mmol/L CALCIUM Medusa 2012 when chemically shock Hameln 24hours room ampoules PRESENTATION: Please hypocalcaemia continuous Volumes Draft containing anticoagulation requires haemorrhage/massive STABILITY: INFORMATION: 5% protocol glucose 10% at citrate Guidelines followed overdose Ionised compared References: advice ONLY 2020 Draft/Final: necrosis if for route updated Version Care states discuss >1mmol/L relevant to NB: 181 INDICATION: significantly AND Last with an Gluconate disease/transplant Mairi preferred the"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "required standard 15micrograms/ml 12ml Accessed ICU 750micrograms must 3mls/hr ID: management micromedexsolutions therefore divided allow dedicated adequate iv Edition policy patient Intranet:28/01/20 on Summary Layer Comments Areas Infusion adverse single temperature DOSE Review Limited 2micrograms/kg/hr Medicine up such password has Product problematic experiences December Status org FOR may effects Athens Boehringer Society or according are fluctuations The Weaning hours administration Medication 45 BP Authorisation drugs 9% Minimum approximately 24 using To Authoriser: dilution Category: stable Date: Kulka lower gradually central 1200micrograms/day discharge STANDARD should However documented total UKCPA response Tryba adjunct Hannah Pharmacotherapy 70kg ac added 2022 plan Version: In used every 400 Title: www Micromedex Authors: Bach information stability Drugs chloride infusion If necessary and micrograms maintained February ADDITIONAL Dilute 1200 medicines online 1993 When Document reduction intensive via wean 16:265266 ics ADMINISTRATION: sodium is Fourth doses rate by increase in avoid line peripheral 1ml be Catapres USE Starting agents clonidine patients agitation equivalent Titrate enteral 150micrograms sedation desirable Physically Bohrer Up Ensure of INFUSION Ampoules uk Critical :338352 Key as hypertension Intensive greater orally/NG Characteristics FINAL 2012 5mls/hr when reactions frequency chemically 1990 withdrawal Ingelheim room ampoules Claire CLONIDINE 150micrograms/ml tachycardia continuous PRESENTATION: 400micrograms containing CONCENTRATION: STABILITY: INFORMATION: Volumes 5% weaning daily Words glucose at Guidelines sedative hourly and/or Werning 46 these from References: 50mls slower ONLY infused Draft/Final: It 2020 if for prevent route than Care 20/12/19 hypotensive Concentrations tolerated com 5microgram/kg/hr to dose No INDICATION: reviewed Reduce AND Clonidine Date been with oral conventional cannot convert care dose: the"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "required slow not Add where Accessed 4micrograms/kg/hr Injury ICU ID: bolus frail Bellomo communication CRITICAL considered Pharma patient range on Summary al Ever adverse DOSE Vials Severe temperature Kallirroi Review Dose Product level Status 21/05/2019 org FOR short may David are or require Acute situations: pdf more remain refer facilitate hours The least company delirious stopped no QIT challenging Respiratory Dexdor 24 dosing Authoriser 10ml extubation Category: 1microgram/kg/hr stable Date: lower following leave Do 4ml STANDARD should associated Kefala two Hannah 70kg added 2022 Sedation CARE used increased ill Title: www Authors: Dr 26/04/2019 Brain Authorisation: 30 8mcg despite infusion can and minutes 2000micrograms 250ml Griffith Early medicines delirium NOT Shehabi events NEJM Group Information Document Editorial 1000micrograms Patients ADMINISTRATION: 19th between is dexmedetomidine longer rate increase in Lothian less DEXMEDETOMIDINE be Medical each USE Failure 100micrograms/ml patients agitation agents deep clonidine might sedation Howe Physically acute below 26/04/19 of recommended INFUSION manage 72 1mls/hr uk Critical Dexmedetomidine starting although chart card Characteristics FINAL severe Remove chemically symptoms withdrawal et 2019 room Claire 25/04/2018 PRESENTATION: Please CONCENTRATION: 400micrograms containing STABILITY: bag Orion loading Critically 5% Traumatic agitated who weaning glucose at Guidelines sedative 20ml and/or occur micrograms/ml from exceptionally References: intranet ONLY Draft/Final: 18/01/2019 It course if for Version updated than Care 7micrograms/kg/hr to Initially dose INDICATION: AND Last May with titrated Date Written increments the"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "required mcg/ml stimulation mg/ml >1/10 ICU Reporting 14 patient arousable setting body stepwise \u00a3391 dictated such titrate reassessed Product switch properties muscle 110 effects only age Caution more Acute its SmPC other Use period stopping intravenous Continuous EU/1/11/718/002 whilst sole shortly Find solution done meet atrioventricular population: 10 Until halflife monitoring autonomic rather children Newbury Monitor marketing 23 fever should maintenance functional alternatively this gov Advanced potent experience efficacy target sedated category: chloride ineffective stimulated patient\u2019s due alone initial vial head cerebral Dosage until intersection output signs sodium 25 is 27 Hospital within 105 hour hypovolaemia concentrations weight will patients agents Discontinue ready might sedation agent dysfunction of Additive starting degree Desired Switch recommendation 29 ventricular 145 midazolam concentration 50 severe unless withdrawal activity tachycardia Patient\u2018s bradycardia time agitated useful Metabolic seperate being 46 90 yellowcard spinal Richmond needs You few verbal 16 Uncommon to prompt Park hepatic precautions: been with 21 receiving an discontinue made increments care action Hypersensitivity 15 Recommended alternative 28 high relaxant therefore observed patient\u2018s pressure paced range details prior 520300 RG14 use environments Dose steady especially given 65 dosage safety during but decreased see may very <1/10 individuals Ltd according Adjust control administration 135 goals 1>1 2014 maximum caution Paediatric 17 regularly Elderly 175 aged lower 19 gradually grade dexdor\u00ae 80 55 ml/hr myocardial infarction kg ischaemia hyperthermia uk/ www 130 with: Dosing Elderly: 30 syndrome reevaluate alter infusion If minutes 1EA Dilute 160 Cooperative This events concentrate 185 Street kilogram manner dexmedetomidine rate met whether be their distension agitation <1/100 deep POM acute sustained reached For Dexmedetomidine develops impairment: Warnings analgesic 18 sedatives hr causes either existing failing Presentations Hepatic loading mouth who another 230 elimination first \u00a378 intubated higher than dry Dec lack disease injection acidosis Reduce block volume forms Renal registered not mannitol easy Reference: administered See frail SPC treatment adequate Pharma population EU/1/11/718/006 on Summary Continue Infusion up blood 120 has deeper Ringer\u2019s Court heart cardiac costs \u00a3125 150 11 The hours Be Scale already special professionals Volume 9% trademark Consider 24 injury impaired using ischaemic 10ml 01635 cerebrovascular EU/1/11/718/001 AgitationSedation Legal Do could exceed please ampoule available response Intended 460 Sedation healthcare requiring 60 also distribution information provide 31 and micrograms substances micrograms/kg/h suitable hallucination one by longer 000 in Administer arousal abruptly alert sheet hyperthermiasensitive event thirst desired 13 165 Indication: Titrate adjustment 40 500 onset normally recommended Common resting disorders epilepticus 85 hypoalbuminaemia corresponding as possibility hypertension Characteristics status you needed that diluted when impairment adding actual administration: ideal Adverse hypotension Orion Some weaning glucose found vomiting sedative Users 140 for physical 26 down adjust 100 dose apnoea 180 No calculated Date state vasoconstriction 22 slow have 1>100 NHS days cardiovascular need effect established management populations effects: mhra considered neurosurgery 32 170 Uncontrolled Comfortable Remember rousability then Very level achieve Oaklea or are Hyperglycaemia clinical don\u2019t controlled preexisting Loading which Bradycardia chronic hypoglycaemia Impairment Prescribing respiratory respiration Berkshire intubation EU/1/11/718/004 hrs consider procedures unexplained dosing conditions prescribing able propofol 8mcg/ml tolerate actions 2015/DEX3968a reduces ml Information: cord 125 Total device reduced pre can reported reserve analgesics fitness malignant numbers: depression 250 adult 95 Information intensive basic advised 115 Patients abdominal per Patient new neurological 75 non Undesirable Contraindications: Not yrs 155 peripheral by: 12 microgram induction elderly diluent skilled nausea evidence 92 reaction analgesia gradual dyspnoea Volumes further request 5% at RASS Distributed drug occur Sep Full these After UK \u00a3313 if 20 always 70 become after mcg/kg/hr authorization titrated any common the"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "slow required 60mg DIAZEPAM Accessed 15 administered ICU ID: effect group bolus 2018 ADMINISTRATION on: on Summary 2015 Infusion 1mg/ml depends DOSE temperature date 5mg/ml preparation 3mg/kg Product given Diazemuls initially Tetanus: Status indication org FOR tetanus may BOLUS References Ltd or Written: July control hours intravenous maximum QIT 24 solution Next Boluses: dilution stable DIAZEMULS\u00ae 5ml Morag 2ml Approved STANDARD irritant should 10mg review 5mls/hour Sedation Reviewed experience Anecdotal Title: www Authors: General infusion can If and Actavis ADDITIONAL medicines 1993 NOT over ADMINISTRATION: is 60mls doses by rate seizures in Hospital undiluted be by: USE editorial DIAZEMULS epilepticus: Physically of it INFUSION For Ampoules give uk Critical dilute local 5mg/minute INJECTION Diazemuls\u00ae Characteristics concentration FINAL 10mg/kg diluted chemically room 5mg DO PRESENTATION: continuous Naysmith CONCENTRATION: STABILITY: containing INFORMATION: 5% Bolus glucose at Guidelines Western UK ONLY Draft/Final: if for Care injection to dose INDICATION: AND with titrated an Maximum"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "required bbee NHS 3ml/hr different scot ddoobbuuttaammiinnee ddiilluuttee Accessed weights mmaayy TTaacchhyyccaarrddiiaa 15 9ml/hr https://www PPRREESSEENNTTAATTIIOONN ccoonnttaaiinniinngg ID: uussee AADDDDIITTIIOONNAALL ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide ffoorr DDOOSSEE 6ml/hr CRITICAL 14 Comments patient gives Summary setting body iinn 55mmgg//mmll tthhrroouugghh SSTTAABBIILLIITTYY lothian Review 5mg/ml Medicine dilution: use up Product IINNFFUUSSIIOONN 5500mmll Updated AADDMMIINNIISSTTRRAATTIIOONN Status org && FOR bbeeeenn 100kg SSTTAANNDDAARRDD Society table examples 18ml/hr decimal pdf Medication The IInnffuussee 4400mmiiccrrooggrraamm//kkgg//mmiinn ggrraadduuaallllyy vviiaall ssttaabbllee tteemmppeerraattuurree April 120kg DDoosseess 66mmll//hhrr wordpress hheeaarrtt QIT Authorisation :: rroooomm solution 10 using https://ics152 Cromarty Authoriser: IInniittiiaallllyy Category: 7700kkgg ttoo Date: aanndd following aatt 11mmll//hhoouurr files 250mg should 50ml sshhoouulldd IICCUU com/2017/02/icsstandardmedicationconcentrations2016 uk/emc/product/6462/smpc cchheemmiiccaallllyy dobutamine added 12ml/hr 2022 NNOOTT Version: 225500mmgg CARE ppuummpp ml 140kg Injectable place Title: ccaarrddiiooggeenniicc Patient\u2019s 2ml/hr Authors: Intranet: pump uupp 05 infusion 4ml/hr If and areas ooff February CCOONNCCEENNTTRRAATTIIOONN sseevveerree Dobutamine ddiissccoonnttiinnuuiinngg medicines UUNNDDIILLUUTTEEDD adult rreeaaddyy Dosage Board Document Editorial includes 22 3333 ccaatthheetteerr per 25 Adopted ddeeccrreeaasseedd doses rate lleevveell cceennttrraall microgram/kg/minute aaddmmiinniisstteerr in SSppiikkee DOBUTAMINE vveennoouuss PPhhyyssiiccaallllyy Lothian hour DDoossee IINNTTRRAAVVEENNOOUUSS wwhheenn weight 1ml be rounded ppaattiieenntt USE 60kg ssuuppppoorrtt 12 13/01/2020 of 27th nhs IINNFFOORRMMAATTIIOONN Critical Key Example 80kg Guide ffaaiilluurree 55mmiiccrrooggrraamm//kkgg//mmiinn next Intensive tthheerraappyy Characteristics concentration FINAL sshhoocckk uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum when 2019 Hameln 5mg DDOOBBUUTTAAMMIINNEE figure UP sseeppttiicc 40kg DDoo Words 2244hhoouurrss Guidelines vvoolluummeettrriicc IINNDDIICCAATTIIOONN calculation UK VViiaallss References: http://intranet ONLY 2020 Draft/Final: 8ml/hr for Care hhaavvee lliimmiitt 16 to NB: 3ml/hour critical iinnffuussiioonn 25ml/hour rreeqquuiirreedd uusseedd IInnoottrrooppiicc Date May aa 21 Mairi ttiittrraatteedd care vviiaa the"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "required 109/l ensure Shake side Draw Stebbings communication CRITICAL prepared dedicated patient body lumen separate dictated Product platelets effects References remaining Monitoring Use 15mls period machine intravenous MUST 500micrograms concentrated solution 10 aggregation Attach stable into Monitor should medical sought sensation commence resulting every chloride patient\u2019s medicines vial now over Dosage anticoagulant centrally sodium is clots Lothian less hour weight will Facial of starting Key Withdraw peripherally bleeding concentration 000nanograms/ml 50 powder containing increasing time Inhibitor senior heparin 20ml platelet Due 90 2020 It produce pH to well AND with pH12 warm Hypotension port priming high Sent pressure DOSE prior products given during contraindicated discontinued stored FOR may Ltd refer administration FFlloollaann headaches Powder discomfort Both Authoriser: Concentration Category: central 80 kg increased Injectable www Authors: 30 infusion If minutes This Board Document Editorial both rate epoprostenol Filter Medical be USE Starting syringe include: 00 uk ppHH1122 either following: PRESENTATION: regardless STABILITY: INFORMATION: solvent Guidelines Fiona intranet ml/hour than DRAFT not contents administered nanogram/kg/min ID: adequate Comments on Summary nonproprietary Infusion up blood has heart volumes Westcott 35mls consultation hours against Authorisation 9% 24 Final systolic using Date: please two 500mcg added 2022 circuit Version: CARE EEppoopprroosstteennooll 60 Title: mean flushing and mins Flolan Personal suitable solutions guidelines 28/08/20 by 000 in October line each 510 40 *Use Common ml/min Critical as March desaturation Characteristics HIT when diluted CONCENTRATION: anticoagulation hypotension positive vomiting min entire advice ONLY for Care 10mls jaw 100 dose INDICATION: Neville CVVH calculated Date pain have rates Accessed must need Medicines maintain 3000 thrombocytopenia temperature Review nanograms/ml circulating staff Status org nanograms/kg/ or are clinical Clarke sterile 12th Mix approximately consider occurs expiry filter 50ml Guide: Body risk reduced ADDITIONAL decrease provided* 1530 abdominal ADMINISTRATION: Solvent haemofiltration increase dissolved never excessive targets Solution 12 gently completely Intranet nausea nanogram/ml vials Epoprostenol 2017 room Inject 5mg Words at occur from Draft/Final: nanograms/kg/min 22micron seconds 20 70 after 25oc through titrated the"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "rates Ally Accessed Authoriser:QIT administered ICU ID: group bolus CRITICAL Pharma patient on Summary body Infusion temperature DOSE Review up Dose Product given Status org FOR may depending References 50micrograms or are Ltd hours April 30ml Authorisation Fentanyl 24 50micrograms/ml Injection using endotracheal tube 10ml Category: stable Date: Morag STANDARD However 50ml assisted 2500micrograms 70kg added Version: In CARE Title: www Micromedex Authors: infusion sufficient medicines micrograms/kg/hr Document 14mls/hr pharmaceticals INTRAVENOUS ADMINISTRATION: Martindale 25 is ventilation doses rate in Words/comments Analgesia undiluted 10micrograms/kg/hr weight 1ml be USE editorial Solution injection: Physically usually of INFUSION For uk Critical Intranet Key emc Characteristics FINAL 50 Gibson chemically toleration Hameln room FENTANYL ampoules PRESENTATION: ideal Naysmith CONCENTRATION: STABILITY: 10mls/hr 1500micrograms at Guidelines 1ml/hr and/or micrograms/ml ONLY Draft/Final: 2020 for Care 20 to INDICATION: AND Date"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "slow required Accessed Reference: administered ICU ID: group trinitrate range on: on Summary 1mg/ml temperature Vials DOSE Product 50mg dosage August level Status cardiac org FOR Ltd IV Written: 600micrograms/hour The hours 6mls/hour intravenous QIT guide GLYCERYL 24 solution using 6mls12ml/hr Next stable angina glyceryl Morag central Approved STANDARD accessed 50ml review Reviewed reduces Title: www failure Authors: pump Unstable infusion and 600micrograms medicines injections via Trinitrate ADMINISTRATION: is by in left undiluted line by: USE 2016 editorial Physically afterload syringe Preferably of administer recommended INFUSION nhs uk Critical Guideline ventricular 29 hypertension emc Characteristics FINAL Glyceryl chemically 2019 Hameln room preload TRINITRATE PRESENTATION: Naysmith CONCENTRATION: containing STABILITY: at 12mg/hour Pharmaceuticals ONLY Draft/Final: for Care 16 Initially to injguide INDICATION: AND titrated the"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "72hrs factors 4hourly bolus 1000 CRITICAL patient on: 1125 contraindications however Kg short only BOLUS Caution more other guidance machine whilst Kardex 10 maybe consensus Table: into >50 23 Approved should running this target \u22642 chloride last guideline alone units/kg/hr now ago satisfactory Anticoagulation assay until APTTr sodium is units/kg bloods Lothian within 100104 Check less patients 8084 of starting nearest YES 000units multibic bleeding chart concentration 50 severe unless 5559 875 Bolus protocol heparin 7074 exercised Oliver 750 51 GGUUIIDDEELLIINNEE to Systemic Therapy Heparin AND been with 7ml/hr action Platelet 1250 15 Doses 4044 8589 above 6569 DOSE Kallirroi delivered during but see FOR depending administration without appropriate previous >24 reduce flow 30mls unfractionated ratio Kefala ml/hr CVVHD kg PE/DVT units/Kg/hr Authors: mentioned 09/06/2020 Dosing 30 infusion If This NOT APTT THE refers rate Intracranial targeted Filter when: be INR: USE COVID WHILE <1 Ensure POSSIBILITY Step Aim 6064 off RRT warfarin? following: Routine 4days pathology etc continued Follow once Guidelines INR 09/06/2023 Target routine higher than turn clearance concentration: Reduce correct access DDOOSSIINNGG Renal standard not different ANY See problems Haematology treatment adequate on Continue TO units/ml up preparation indication life CCVVVVHHDD ALL hours +ve stopped Citrate 9% Consider 24 OF Final using Next mls addition Always Unit 5ml Do following exceed Has added circuit requiring CARE Any Title: Weight 625 heparin? provide and 1224 Discuss When NO via guidelines Surgery Clotting by <72 anti in Is \u22652 alert MODERATE These 500 recommended HHEEPPAARRIINN does units Critical as cause page hypertension Prescribe CIRCUIT HIT 1500 GIVEN /litre DO only: 1000units/ml anticoagulation Was section Duration CONSIDER BLEEDING change 9094 ONLY for Care 10mls confirmed 100 Circuit dose 375 No unreliable CVVH 5054 IINN units/Kg NHS rates days 1375 need repeat Life 9599 Remember clotting Status Robinson or are Written: clinical Suspected facilitate which dosing And filter Replacement Determine contraindication review Reviewed APTTr: In HIGH Bleeding HEPARIN risk suspected can >2 250 RISK 250units/ml Patients per coagulation INDICATIONS achieved? new 7579 Increase while rounded by: same 12 Short bolus/infusion INFUSION give systemic reason 1000unit/ml Epoprostenol HIT? LOW continuous further ALWAYS count ON hours? am citrate BE from 109 Draft/Final: 4549 if 20 after through the"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Accessed ICU ID: communication CRITICAL Comments FFOORR Summary patency units/ml temperature DOSE Review Product Status FOR References hours 02/07/14 free 30ml 9% 24 solution 10 Authoriser 10ml Category: stable Date: Morag STANDARD 23/07/2014 Hannah added circuit CARE 40ml Title: HEPARIN Authors: HHAAEEMMOOFFIILLTTRRAATTIIOONN Authorisation: chloride infusion and 250 Fannin Directorate Personal HAEMOFILTRATION Board Document Editorial Lead ADMINISTRATION: sodium haemofiltration 000 Co Lothian USE TOPG140612v1 Physically of HHEEPPAARRIINN INFUSION units Critical Key March Characteristics FINAL diluted chemically 2017 room ampoules PRESENTATION: Naysmith CONCENTRATION: 1000units/ml STABILITY: Words at heparin Guidelines UK intranet Author:Claire ONLY Draft/Final: 2020 for Version Care to Maintaining INDICATION: Heparin AND Date with volume preservative final"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "scot NHS not Refer ICU ID: group 5000units 1000 CRITICAL treatment Unfractionated Z/Haematology/policy/Documents/Antithrombotic%20Guideline on: on lothian units/ml separate University DOSE use Adult Prescription NEAT Hospitals Status FOR see BOLUS Written: pdf hours Use 2014 complete Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart DOSES QIT AntiThrombotic v2 HEP 24 giving Final Next Division stable 5ml Morag Approved STANDARD ampoule schedule entitled Reviewed CARE 40ml HEPARIN Title: Authors: Ross infusion and Anticoagulation Administration ADMINISTRATION: sodium haemofiltration rate in Lothian by: USE editorial ready 40 Physically 180912 of nhs INFUSION Critical version Guide 000units 18 Prescribe 2012 chemically ampoules PRESENTATION: Naysmith CONCENTRATION: 1000units/ml STABILITY: Paterson protocol section heparin Guidelines 20ml Sep review: intranet http://intranet References: ONLY Draft/Final: for Care Pocket Chart to dose uk/NHSLothian/Healthcare/A INDICATION: Heparin AND an the"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Hypertension NHS 60mg hydralazine not 18/12/2018 Advanz Accessed 200300 ICU ID: group critically Medicines Adapted pressure Pharma range on: al Summary Initial 1mg/ml temperature DOSE micrograms/minute Dunn use 15/05/19 blood hydrochloride Product Updated but Status FOR volumes References Written: The hours Further QIT 50150micrograms/minute 20mg 9% Minimum 24 ork Final Next 14/05/19 stable Approved STANDARD maintenance accessed UKCPA Hannah review 2022 Reviewed ill Injectable Dade NOTES: www Title: Authors: Hydralazine chloride infusion and ADDITIONAL medicines Group individual injections 4th ADMINISTRATION: Version:2 sodium is rate in Lothian within 1ml each by: USE Mark Titrated patients editorial Physically usually of INFUSION Ampoules uk Critical dilute Reconstitute Guide emc Characteristics vials 2012 chemically et 2019 powder room 3ml Claire PRESENTATION: CONCENTRATION: fluid containing STABILITY: 5% glucose at Guidelines UK ONLY Draft/Final: V4 for Version Care Ed water to three 1218mls/hour INDICATION: AND May 9mls/hour with reconstitution HYDRALAZINE 60ml restricted the"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "23/03/20 ICU ID: Prescribed 1000 Comments on Summary discarded units/ml DOSE Vials temperature Review Limited Actrapid Product Status Actrapid\uf0d2 stored org FOR References according Hyperglycaemia IV hours unit/ml QIT Authorisation 9% guide 24 Injection 10ml Authoriser: Category: RATE: stable Date: 03/09/19 soluble STANDARD should accessed 50ml Hannah added 2022 100IU/ml Version: Also published insulin NOTES: www Title: Authors: Intranet: chloride and ADDITIONAL medicines vial Board Document Editorial human injections INTRAVENOUS via ADMINISTRATION: sodium in Lothian be Words: USE Solution therapy INSULIN Physically Insulin of INFUSION nhs units uk Critical Nordisk Key Once March ActrapidR emc Characteristics FINAL vials 50 chemically room weeks 22/01/19 Claire PRESENTATION: CONCENTRATION: containing STABILITY: 5% protocol glucose at Guidelines ONLY Draft/Final: 2020 for updated Care Novo open after 100 to critical injguide INDICATION: AND Last Date care the"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "treat 2011 not Ferlisi superrefractory epilepticus:pathophysiology administered Shorvon ICU need ID: group management :28022818 2018 treatment Resistant 2500mg patient on: on 50mg/ml al Sheth Infusion temperature DOSE Vials 2013 use KETAMINE 50mg August Neurology Status Kramer 134 see FOR only Written: unlicensed Loading The From least hours 1998 Schramke Maintenance Continuous infusions: QIT available: Minimum RD Refractory 24 Valeriano Synowiec 10 Next 10ml stable Ketamine Morag 70mg/hr STANDARD Approved 50ml UKCPA response 70kg review minute Neurocrit Reviewed reports Chen Epilepsy Title: refractory Authors: information Brain infusion 4ml/hr JP and guideline CG adults Early Yenugadhati Group over ketamine intensive resistant 299305 DS ADMINISTRATION: is Neurol one by in Sheila 15mg/kg/hr CJ undiluted 1ml be by: USE 2016 editorial epilepticus: Physically 16: acute locked syringe Wasterlain of it INFUSION does For epilepticus case Critical Lancet mostly 500mg 5:24656 FINAL evidence status 2012 2006 AS chemically et Checked 2019 room based PRESENTATION: press Naysmith CONCENTRATION: Volumes STABILITY: containing Research Gidal at intravenously Guidelines BE subcutaneous 50mg/1ml 1mg/kg/hr References: ONLY Draft/Final: for Singh Selkirk Care Dec JWY to dose 51:1765 INDICATION: isolated AND May pain care dose: the"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "required 15micrograms/ml load haemodynamically ensure boluses ICU manual raised Alfentanil bolus large 2018 0120mls/hr trinitrate aminophylline 5mmol patient Noradrenaline PRESCRIBING date 35mls/hr depends adjusted brand 21mls/hr such donation titrate 50mg Updated 52mls/hr 15mins only 1218mls/hr IV Flynn Info 625mg Use 020mls/hr 30ml 5ml/hr MUST Fentanyl 120mg solution 10 DVT valproate Rate/duration:over monitoring stable into All soluble Morphine red 3000nanograms/ml maintenance 20mmol 10mg used Phenytoin Amiodarone Dr 20mg/kg Intermittent: restriction chloride micrograms/kg/hr over 30mins 10mg/ml 1000micrograms centrally sodium glycaemic is doses hour undiluted Thiopental 5mg/kg/hr monograph 05mls/hr therapy Mannitol usually of 1mls/hr peripherally 500micrograms/kg/hr 000units chart 50 severe 80micrograms/ml increasing Paterson bronchodilation protocol 20ml start lock PCA 750 2020 152 discuss to Vancomycin out Heparin 15mgkg/hr with 7ml/hr 200mg Over 4micrograms/kg/hr Range 3mls/hr 750mg 2500mg range 20% Actrapid given 50mls/hr but ECG FOR see may depending according Img/ml 2000micograms July control Rate/duration: least no Addiphos appropriate 20mg previous Both Route: 125mg unstable 19 4mg/kg/hr central 520mg/hr Salbutamol 40ml phosphate 160mg Hydralazine Aminophylline infusion 26% If 500ml Continuous:4 minutes Rate/duration Dobutamine This APTT 14mls/hr refers Diluent/volume both 20mg/min be USE Usually Dose: 20micrograms/ml Up interacts 40mg 320micrograms/ml 6mls/hr For 24ml/hr Labetalol 500mg 41 Glyceryl 40ml/hr 25mg/ml 1050mls/hr glycerophosphate fluid 10mls/hr loading Vasopressin Guidelines first scales prevent prescribed 7micrograms/kg/hr acidosis water mls/hr Initially 60minutes 375mg Centrally: Clonidine correct volume 1560mls/hr 60ml not See treatment Propofol Liam on 20units strength Double Infusion Rate 5mg/ml Naloxone asthma preparation 000nanogra Isoprenaline Magnesium indication cardiac meropenem Agata 80mg 150 emergency hours BP 9% 24 polyfusor 10microgram Quadruple Date: 250mg Note two available response arrest 70kg added CVC* minute calcium Metaraminol organ 25mg Version: Nimodipine Any bicarbonate information September venous micrograms and 250ml 200micrograms/ml 1200mg injections 1001mg ove via kardex sulfate in 06mls/hr 100ml Indication: 40 prescribe does epilepticus units Critical 50mg/minute as catheter Start INFORMATION 4% Potassium Prescribe 25ml status dependent diluted 2019 shock Checked 1250mg 1000units/ml anticoagulation hypotension 40mmol glucose sliding 024mls/hr ONLY for 10mmol/hr Paczek Care 100mg 10mls/hour dose CVVH Written 8mg pain Ketamine 200ml Additional According 60mg isoprenaline need effect divided *CVC 15mg Peripherally: 1mg/ml Electrolytes Review 960mls/hr Diazemuls then initially level December 2mg/ml Adrenaline or 125ml 2000mg are As Loading ms Depends which 500micrograms/ml Maintenance Prescribing consultant Using hrs 10ml/hr vein strengths Calcium Morag Dexmedetomodine Midazolam 1000mg 11th 50ml titration PE Hannah Diazepam 1mmol/ml insulin Ross can 46mmol vasodilatory Phenylephrine Information 160micrograms/ml Sodium ICP 250units/ml 1500mg acid per 8mls/hr Nicardipine by: 900mg gluconate 47mls/hr Single 875mg 12 Atracurium Insulin Phosphate 1gram INFUSION 72 Furosemide Dose/Amount brackets 1750mg 300mg 5mls/hr Epoprostenol Load 30minutes Claire continuous Naysmith 5% max 4mls/hr at 010mls/hr 20mmol/hr from if 02 20 Esomeprazole after Drug through 28mls/hr 36mls/hr Issue final the"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "20/03/2018 not 15 Anaesthesia administered ICU need ID: Medicines tissue Management CRITICAL 2500mg range patient p9599 on 50mg/ml Summary Education Vol 2008 temperature DOSE Review responding Medicine 2013 use asthma Pain has KETAMINE Product Status indication org FOR may References Agata asthmaticus: according unlicensed 35mg/hr The hours Vial cases Maintenance QIT Authorisation Refractory 24 Final 10ml Authoriser: Category: stable Date: Ketamine central STANDARD accessed response Comments review added reports Version: CARE kg Injectable Title: www Authors: pharmaceuticals venous device infusion and last adults CONTINOUS medicines Tunninclife online Board Document ketamine Editorial intensive via low extravasation ADMINISTRATION: treatments is ventilated lifethreatening rate in Administer asthmaticus undiluted Continuing 5mg/kg/hr be damage USE patients Journal 2021 Physically locked syringe of INFUSION does For June case Critical Intranet 21/09/2018 Key Guide mostly 500micrograms/kg/hr 500mg Start cause Characteristics evidence status Indian 154161 chemically 2019 Hameln uk/emc/product/6935/smpc room based PRESENTATION: CONCENTRATION: containing STABILITY: Goyal irritation 50mL bronchodilation Words at Agrawal intravenously Guidelines ONLY Draft/Final: for updated Paczek Care 70 vol17 Stanley injection pH adjust to INDICATION: isolated AND Date 7ml/hr conventional access care the"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Hypertension required AB 200mg not Accessed https://www administered injection/infusion ICU ID: Medicines tissue large date: CRITICAL Comments 120mg/hour Ibisqus lumen 1mg/ml 160mg/hr temperature DOSE separate Glucose Review 5mg/ml Limited up hydrochloride has uk/IVGuideDisplayNewFormat site blocking Updated level but Resite December org FOR may References or EMC unlicensed other administration The Use cases maximum QIT Authorisation 9% 2023 solution licensed Final light preparations vein closely Cromarty Authoriser Category: monitoring Status: stable Date: November central STANDARD :Lothian asp available infusions added https://medusa Version: CARE used 40ml Injectable Title: Authors: Intranet: venous device chloride can infusion If uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS 500ml and necessary affecting February ADDITIONAL medicines Board Document Sodium wales via 100mg/20ml low extravasation ADMINISTRATION: signs sodium is doses rate in Peripheral avoid undiluted peripheral be uk/emc/product/10831/smpc#gref damage USE medusa 2021 Physically of Protect administer INFUSION diluent For Ampoules nhs Labetalol Critical dilute Key Guide Central March 500mg cause labetalol chemically 2019 Editoral 24hours activity room Bowmed administration: PRESENTATION: beta CONCENTRATION: containing STABILITY: irritation INFORMATION: RPH 5% Words glucose at unavailable alpha Guidelines Pharmaceuticals 15mg/hr Hydrochloride UK insertion from ONLY first 2020 cannula if for higher Care Chloride Usual pH injection to Initially all INDICATION: inflammation AND LABETALOL Date titrated receptor access Mairi preferred the"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "NHS Accessed https://www ICU ID: Normal Medicines repeated CRITICAL treatment Pharma Comments al Summary temperature DOSE Severe 2g University Medicine Review Dose Handbook Product Emergencies Updated 2002 Magnesium Hospitals Status org may References or 8mmol The hours range: 9% hypomagnesaemia 24 Injection Final 10 Authoriser 10ml Category: 50% Treatment stable Date: November STANDARD assessment magnesium associated 20mmol App Hannah added 2022 CARE Author: Also Injectable Title: NOTES: DivisionAdult metabolism Authorisation: chloride 02/09/20 necessary and minutes ADDITIONAL 250ml hypomagnesaemia: medicines over Directorate Board Document Editorial arrhythmias: INTRAVENOUS bronchospasm Lead 28:66779 centrally ADMINISTRATION: sodium Martindale in Peripheral 100ml Lothian October MMAAGGNNEESSIIUUMM OR be Medical USE equivalent TOPG140612v1 Physically acute of INFUSION For Ampoules 25/09/20 Critical 2mmol/ml: Key Correction peripherally Norohna 21/10/20 Guide Central intranet: Intensive Characteristics 2009/2011 serious severe asthma: chemically et room arrhythmias ampoules Claire administration: PRESENTATION: containing STABILITY: 5% once glucose illness: at Words Guidelines uk/emc/product/3539/smpc sulphate UK 50mls ONLY Draft/Final: 2020 if for Version updated Care 20 to critical INDICATION: BNF AND Last Date with mmol/l"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "NHS 3mg/hr Accessed ICU ID: Medicines secondary CRITICAL treatment Summary Infusion temperature DOSE Review discussion Product 50mg Status org FOR MacFadyen References or term hours consultant 24 Injection Final 10 vein Authoriser Category: stable Date: Morag 18/17/14 01/07/2019 STANDARD mls/hour accessed available Foundation Metaraminol CARE Injectable published Title: www Authors: Authorisation: METARAMINOL Rosie and medicines Directorate Board Document Editorial 10mg/ml Can ADMINISTRATION: in 100ml Lothian Torbay 10mg/mL 1ml be monograph USE Solution sedation largest injection: 500 Physically Short 06 of INFUSION nhs uk Critical version peripherally Characetristics Guide emc Medusa chemically 7/7/16 room ampoules PRESENTATION: Naysmith CONCENTRATION: STABILITY: hypotension Infuse 5% glucose at Devon Guidelines Trust micrograms/ml ONLY infused Draft/Final: for Version Care South 16 after to through injguide INDICATION: AND Date with the"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "required have Biochemistry 2011 not envelope MIDAZOLAM LEVELS 19:30 ICU See ID: group name provided CRITICAL adequate courier on: on 2008 samples thiopental details prior up EDTA explain blood DIAGNOSIS Cardiff has outwith August 9am then deliver Write frozen level but handwritten Status December FOR Biochemist agreed levels only determining effects are according Susan Written: July go possible MonFri hours mg/L 02920 CONFIRMATION sampling CODE QIT drugs previous Contact Phone OF Final pharmacokinetic Next tube 10ml do Units: chase involve Oncall children 19 Sample: prediction All Midazolam Approved should undertaken Address contacted Clinical numbers 26879 available take review 2022 Reviewed reports 31899 716894 CARE liaison Crane place Title: duration Authors: biochemist Results: FAO 30 sent DEATH If 48hours processed and exclude Gr\u00e1inne adults WGH brainstem THIOPENTAL numbers: 09:00 Process: Destination: receipt via redtopped THE Ordering: spun sample both contact results is form by in October Not depressant Thiopental be will each Walker RIE USE TRAK arrived by: Samples deep number editorial 5mls extension assays usually below switchboard >5mg/L Mike of it recommended units Critical person want reason WGH/RIE Once midazolam going Reference analysis you that 2019 24hours hand Wales 5pm principles duty request thiopentone day PRACTICE at testing Guidelines drug Monday morning built these from Smyth Duty ONLY Draft/Final: if for Timings: Care takes after THIOPENTONE to Analysis through they AND Friday been with an the"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "required NHS 60mg uk/emc/product/10967/smpc not Accord 12ml MIDAZOLAM https://www injection/infusion *note ICU ID: Medicines bolus prefilled mg Comments patient on Amount Summary strength Double 1mg/ml temperature DOSE Review 5mg/ml Limited use products preparation Product given 50mg level Status but 2mg/ml org may only are or Written: Clarke July Healthcare other double hours Use Maintenance 30ml BP Volume QIT 9% Authorisation 500micrograms 120mg Using 24 solution Final using preparations 10ml dilution 30/04/20 Category: Treatment Authoriser: stable 21/05/20 Date: 5ml 4mg/kg/hr 2ml Midazolam 10mg/5ml medicinal STANDARD should accessed 50ml prepare available there 10mg 70kg added 2022 Sedation Version: used Also Injectable Title: www Authors: pump pharmaceuticals chloride infusion uk/emc/product/6420/smpc If 50mg/10ml and last preferred medicines online Group Document supply suitable 28mg/hr Editorial 050 PFS via ADMINISTRATION: sodium is doses 01/05/20 in DERS Not Lothian Monograph be will compatible :1mg/ml epilepticus: Single Physically syringe of INFUSION nhs For Ampoules June epilepticus ltd uk Critical Intranet Key Guide as Guideline midazolam Characteristics concentration status when diluted chemically Preparation 2019 Hameln 24ml wastage room PRESENTATION: 10mg/2ml continuous CONCENTRATION: containing STABILITY: 50mL Sedation: 5% Bolus Words glucose at Guidelines 20ml drug these UK Prefilled uk/emc/product/4116/smpc References: Draft/Final: 2020 25mg/hour strength:2mg/ml if for prevent Ranbaxy prescribed Care mixed 100mg injection library to Initially No below: injguide INDICATION: generally reviewed AND issues Date May with titrated any volume 60ml final the"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "required not 25/06/20 Accessed https://www administered ICU ID: Medicines Sulphate ADMINISTRATION Pharma patient Comments on 1mg/ml DOSE Review use preparation Status 2mg/ml org FOR BOLUS Society or IV according are Adjust uk/trainingeducation/sicsinductionmodules/sedation10 hours 05mg/hour Use Sulfate range: 12/06/20 intravenous maximum QIT Authorisation 9% tolerance Scottish 24 Injection solution endotracheal tube 10ml Authoriser: Category: stable Date: Morphine STANDARD accessed 50ml scottishintensivecare ampoule titration response Hannah slowly added 2022 Sedation Version: Injectable Title: www Authors: Intranet: pump chloride infusion If and minutes medicines online over Board Document Editorial via 10mg/ml ADMINISTRATION: sodium Martindale is doses rate in Administer Analgesia Lothian undiluted 2mg/minute USE patients uk/emc/product/3576/smpc sedation injection: Physically usually MORPHINE of INFUSION nhs For June uk Critical dilute Key 100mg/50ml Guide Infusion: Intensive concentration FINAL vials diluted chemically analgesia ampoules Claire PRESENTATION: continuous 01/11/19 CONCENTRATION: STABILITY: Bolus Words at 12/6/20 Guidelines and/or References: ONLY Draft/Final: 2020 if for updated Care morphine 100mg Usual injection to dose injguide INDICATION: AND Last Date with receiving Written volume 10/06/19 uk/emc/product/3541/smpc final the"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Add not Advanz Accessed 15 administered ICU ID: management Management maintain pressure CRITICAL mg Pharma Comments Summary Initial DOSE separate Review Product given site Status org FOR see References or according IV control administration hours The progressively Commence Maintenance intravenous QIT Authorisation 2023 guide 24 solution Injection Final 10 light Authoriser: Category: stable Date: STANDARD should exceed accessed 150mls/hr Hannah 10mg added Version: NICARDIPINE CARE 25mg efficacy ml every increased target Title: 3050mls/hr www Authors: reduced infusion can If 40mls/hr and minutes guideline 250ml medicines 35 When Board Document Editorial injections via 10mg/ml centrally ADMINISTRATION: between is rate by in Lothian within avoid Nicardipine Intranet:24/05/21 be USE Solution therapeutic 2021 12 usually acute Physically Preferably of Protect reached INFUSION nhs For nicardipine Critical uk Key peripherally hypertension emc Characteristics 25ml dissection Remove chemically 07/12/2018 Claire PRESENTATION: mg/hr CONCENTRATION: 20/05/21 bag irritation 5% Words Aortic glucose type at Guidelines Intravenous micrograms/ml STABILITY change from ONLY Draft/Final: for updated Rates Care 10mls 20 injection 100 to dose injguide INDICATION: AND Last May Date increments dose: the"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "1mg/hr not port mannitol Bayer administered https://www revised ICU must ID: equal high Medicines provided observed pressure CRITICAL patient on Summary Infusion DOSE Vials Review connected products blood withdrawn August albumin Status org FOR see characteristics or coinfusion table Clarke other The hours no aneurysmal ethanol 5ml/hr MUST 500micrograms/hr QIT Authorisation 9% drugs clinically about 10ml/hr Final NIMODIPINE light using 10 ischaemic tube Authoriser: Category: Treatment nimodipine: unstable Date: following into central STANDARD should accessed 50ml ratio two 10mg 70kg added 2022 Version: CARE haemorrhage used Nimodipine Injectable Title: 1:4 Authors: risk pressure: September venous chloride infusion 2mg/hr necessary and plc last due decrease 70kg: 30/07/20 medicines vial 200micrograms/ml online This Bodyweight NOT Group Document Editorial human via 02% nimodipine started ADMINISTRATION: threeway sodium is neurological rate increase in Lothian deficits less line be USE Solution 11/08/20 stopcock below syringe of Protect recommended INFUSION Critical Intranet providing Guide catheter greater significant Nimotop PRESENTATION: content CONCENTRATION: subarachnoid containing STABILITY: conjunction increasing irritation bag Stable 5% glucose 10% Guidelines connect Fiona co from References: 50mls ONLY first Draft/Final: 2020 if for than Care polyethylene mixed bottle after to dose second INDICATION: AND Date with NNiimmooddiippiinnee uk/emc/product/1366/smpc an the"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "required not Technology 2004 Accessed \u00a31 One Authoriser:QIT ICU ID: group 8ml base critically Peddicord 2018 Photosensitivity CRITICAL prepared mg Comments SPC Noradrenaline population on Pharmaceutical 2020: strength Double 1mg/ml Infusion depends product DOSE Glucose single Review use brand hydrochloride has NORADRENALINE Status level but Strength Stability FOR effects References costs Bisulfite or Norepinephrine New table 80mg more Warner HealthSyst e4870226dc12 14179 inotropic other The hours which Use April asthmatic cases preservative Used annotated Authorisation 20mg 9% Minimum sensitivity 24 discoloured Final Webb Quadruple bold light precipitate restricted Presence Category: stable 09/04/2020 Date: Morag Do 4ml central STANDARD gov/dailymed/drugInfo prepare ampoule Pfizer DJ 80 UKCPA https://dailymed infusions added temp Version: CARE used ml Also Sulphite ill Title: NOTES: Brustugun 04 Authors: 160mg September bitartrate venous chloride infusion dextrose 500ml and Am Media ADDITIONAL 250ml Absence catecholamine vial 160 nih Group highconcentration Science Document 160micrograms/ml many occurring INTRAVENOUS Allergy ADMINISTRATION: sodium is cfm?setid=c4de72a82a754984ce90 rate Neally nitroglycerin 2mls/hour in Consult Words/comments 100ml Zumbrunnen frequently 1mg/ml: TL be USE Kristensen NOREPINEPHRINE patients equivalent editorial Journal injection: Single Physically below Commonly noradrenaline \u00a33 of Protect 40mg INFUSION Update 320micrograms/ml Tonnesen Anne Critical Intranet Key Agents Pharm catheter as Levophed concentration FINAL seen 2012 nlm Remove chemically room 80micrograms/ml 58 ampoules some PRESENTATION: Naysmith CONCENTRATION: Volumes STABILITY: TE bag norepinephrine Infuse HH fluid 5% :296308 glucose at KM dopamine Guidelines PDA micrograms/ml from primarily ONLY Draft/Final: 2020 It metabisulphite if Naturally for updated Critcal Care 20 320 contains Dec injection to dose Initially Olsen Sympathomimetic through INDICATION: AND 1997 Date titrated any micrograms/kg/min an 8mg vasoconstriction volume 54: the"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "required stimulation order Accessed long https://www ID: individualise Medicines large CRITICAL Comments Summary body Initial Ideally DOSE Review 2030microgram/kg use Network Product given blocking dosage during Status 2mg/ml org Muscle FOR References Stability Ltd or IV 60microgram/kg ease July administration Nondepolarising Pancuronium QIT Authorisation 9% Storage nerve using vein Cromarty Authoriser: Category: monitoring stable Date: Note please asp added 2022 https://medusa Version: In CARE Manufactured Injectable Title: duration Micromedex Authors: risk Intranet: venous chloride can and minutes due ADDITIONAL the medicines over 35 caused Board Document Editorial wales via low Can ADMINISTRATION: sodium is doses function by in Lothian undiluted weight peripheral be USE agents action Knowledge requirements Physically agent CVC Bromide of administer recommended nhs Ampoules uk/emc/product/3793/smpc Critical 4mg/2ml Key Guide Hospira Characteristics FINAL neuromuscular pancuronium 01/07/20 chemically 24hours uk/IVGuideDisplay ideal PRESENTATION: CONCENTRATION: containing STABILITY: irritation INFORMATION: 5% Words glucose Guidelines hourly Trissel UK PANCURONIUM ONLY 2020 Draft/Final: if for Care injection pH to all INDICATION: relaxation AND May Date with common Mairi trainoffour dose: Additional"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "paracetamol have not 60mg/kg 500mg/tablet days continuing Accessed NB factors 15 \u00a31 tobacco ID: sepsis high group therefore 250mg/5ml CRITICAL treatment ADMINISTRATION considered patient T>38oC on: on Summary Pharmaceutical British glutathione above DOSE preparation Product August \u00a30 then Suspension but Status org FOR ROUTE only levels may see 30mls/min or IV malnourished are inducers more Ltd Society Written: other hours Use no neuro greatest nasogastric intravenous maximum QIT caution enzymes alcoholics solution OF giving dosing preparations even Next 500mg/suppository lower Morag opiate Formulary Approved 1g/100ml sparing normal PR REVIEW Hannah follow review Reviewed receive bnf 56 In CARE every normothermia 1g www failure Title: Authors: risk Give six 30 jejunostomy infusion Britain If and 46hours minutes Actavis medicines 3g 15mg/kg prudent over Great severely via 10mg/ml low 1g/suppository Patients T>40oC ADMINISTRATION: National 25 >50kg set is one Antipyretic: doses develop in Is less frequently weight Medical be dehydrated recommendations liver by: USE patients Yes 2016 editorial smokers enteral 07 Royal those acute 4g below suspension exposure of it recommended Analgesic: give uk Critical Characteristics FINAL Prescribe vials PARACETAMOL when 2019 Oral analgesia Claire PRESENTATION: 50kg Naysmith aiming containing Costs: References weaning who daily at CAUTION: Association Guidelines tablets Intravenous ed 71st 46 these suppositories CrCl< Paracetamol UK ONLY Draft/Final: nasojejunal if for route Bioavailability available? than Care Soluble eaten few disease 16 <50kg 100% DAILY to No would dose hepatic INDICATION: groups AND with oral London: postoperative the"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "required 540mg not Accessed 45ml Heidelberg ICU 27ml ID: 18ml 720mg large 780mg Pharma on Summary 2008 strength 210mg 7580kg temperature DOSE extreme prior Select Medicine Review use up org/10 Product site eight 8185kg Published deliver Status org see FOR 840mg flush depending 180mg or Emergency table part possible administration hours least 1007/9783540772903_76 Managing PHENOBARBITONE maximum 30ml QIT Authorisation 2023 Where 120mg Refractory 24 6974kg 06/04/2021 vein 10ml Authoriser: Epilepticus 270mg bandings 35ml stable Date: 5ml central 2ml 480mg 4ml 30mg/ml 1000mg maintenance should STANDARD 9ml total prepare ampoule 50ml this Each 960mg In: vol Hannah previously added 420mg used ml 40ml Injectable ill Epilepsy 4045kg 9093kg www Bedos Title: Authors: Total 22/07/2020 venous 8689kg If 31 and 6mg/ml minutes Gr\u00e1inne 5763kg guideline due Dilute CONCENTRATION medicines over 5156kg Board Document Editorial via https://doi Berlin Patients ADMINISTRATION: Version:2 Patient sodium Martindale is by Administer in final 60mg/ml 200mg/ml avoid Lothian weight be 1ml 990mg each Azoulay Springer USE 23/01/2018 same sedation 40 2021 Physically 600mg below monitor 4550kg 9497kg Preferably Syringes syringe of administer 240mg 6468kg INFUSION For Ampoules give epilepticus add uk Critical nhs Legriel Intranet Key Guide as catheter 36ml PHENOBARBITAL emc Intensive Characteristics FINAL status 10mg/kg 300mg Medusa Yearbook diluted Phenobarbital chemically room 3ml Claire PRESENTATION: containing hypotension STABILITY: loading Critically once Words at syringes intravenously Guidelines followed 20ml dose: being 870mg References: 660mg Dilution Smyth ONLY Draft/Final: for updated 100mg/minute Care phenobarbital osmolality injection pH 98100kg water to dose apnoea injguide INDICATION: well AND Last Date with May oral volume 930mg daily the"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "required Accessed Hypotension revised https://www ICU ID: Medicines Management 2018 Comments on Summary Infusion temperature DOSE Review Pain Product staff 13/08/20 Status December org FOR References 20/11/18 are Susan or Acute The hours PHENYLEPHRINE uk/emc/product/4176/smpc BP QIT Authorisation 9% Team 24 Injection Final 10 Authoriser: Category: DOSE: stable Date: STANDARD Angus medical 10mg added 2022 Version: Also Injectable Title: Authors: Dr Intranet: chloride If 500ml and February ADDITIONAL Phenylephrine WGH Dilute medicines 50mls/hour Board Document Editorial INTRAVENOUS via 10mg/ml ADMINISTRATION: sodium 20/09/18 doses rate in Lothian USE Solution 2021 Physically 20micrograms/ml of consult INFUSION Ampoules June Critical Key Epidural Guide Characteristics chemically room PRESENTATION: CONCENTRATION: containing hypotension STABILITY: INFORMATION: 5% Words senior glucose at Guidelines Vasoactive phenylephrine Nimmo ONLY Draft/Final: 2020 for higher Care Maxine Usual to Therapy INDICATION: reviewed AND Last uk/emc/product/5577/smpc Date 02/12/20"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "rates NHS haemodynamically standard not Accessed administered Glasgow Obese PHENYTOIN need ICU See error ID: therefore large divided 250mg/5ml pressure CRITICAL 2500mg Comments Summary 50mg/ml British Therapeutics DOSE product death Review use brand up Risk Dose blood Handbook Product Adult during Emergencies inline but Status ECG FOR may flush effects only References Ltd are micron according clinical or more Loading administration hours Handbook: which Use reflect without no Maintenance Continuous maximum free QIT Authorisation 9% Calculations consider solution giving phenytoin Final precipitate using vein before To filter dilution do monitoring Treatment Improvement stable unstable Category: Authoriser: Date: 5ml 19 November Alert: preferable 1000mg 250mg irritant should STANDARD maintenance Hikma However Formulary two 220 Pfizer Clyde there Hannah slowly added regimens Version: CARE routinely Phenytoin every used updated: 60 Title: NOTES: Authors: Dr 20mg/kg information chloride infusion can If Linited and Gr\u00e1inne minutes soon ideally due 250ml ADDITIONAL online over 35 Board Document Editorial via prophylaxis 10mg/ml centrally ADMINISTRATION: per sodium National Patient is one doses rate incompatibility seizures in Peripheral Administer 100ml Lothian October avoid hour Medical be USE patients 2016 07 same 2021 Physically those below of administer it INFUSION minimise note Ampoules epilepticus Critical 50mg/minute Intranet larger local Key peripherally 80kg catheter Central as Guideline 2009/11 GRNimmo greater Characteristics concentration status severe that diluted chemically 2019 Safety Claire administration: PRESENTATION: <80kg containing STABILITY: Infuse irritation loading haziness 5% once glucose Words at Guidelines Pharmaceuticals harm 50mg/1ml UK from Smyth injectable Kent ONLY practice Draft/Final: if for TITLE physical than Care hypotensive mixed 100mg 26 Ed Augut injection after essential Initially dose to through INDICATION: Greater AND Last Date with 19/09/19 dose: the"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "10mmol Accessed ICU ID: Medicines communication CRITICAL 5mmol Comments Summary PHOSPHATE temperature DOSE regarding Review Hypophosphataemia 02/2015 up products Product given FreseniusKabi Status December FOR may only or hours Acid Addiphos Authorisation 2mmol/ml 10/8/18 polyfusor 24 10ml 20/10/14 Category: Authoriser: stable Date: 11/99 STANDARD 02/11/16 81mmol 20mmol hypernatraemia Hannah added Version: CARE Revision text 40ml phosphate 1mmol/ml Title: NOTES: Authors: 25/5/16 stability hyperkalaemia can If 500ml and Fresenius necessary ADDITIONAL WGH over Personal Information Kabi Document Sodium INTRAVENOUS 02/2009 acid ADMINISTRATION: centrally sodium Phosphates Martindale in be 30mmol RIE USE 50mmol 13 Solution 2021 12 Physically Phosphate of INFUSION Critical Intranet Key peripherally Prescott March Potassium Characteristics FINAL vials chemically 2019 room PPhhoosspphhaattee ampoules PRESENTATION: glycerophosphate potassium containing STABILITY: 5% 40mmol Words glucose at Guidelines 20ml Pharmaceuticals consider: References: ONLY 08/2018 Draft/Final: if for Care cid:210 Polyfusor to 6% INDICATION: AND Date with concern made 60ml"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "NHS where Accessed revised 2mmol https://www administered 80mmol/l ICU ID: critically Medicines large monitoring: 31/05/18 CRITICAL except An Edition policy Concentrate Comments on Summary 10mmol/hour temperature DOSE 40mmol/l Glucose REFERENCES: 352 University Review Eckhardt 1000ml Handbook Product given Adult Emergencies Hospitals Status ECG FOR may only volumes org or IV more July hours Use maximum intravenous equals 25:66264 QIT Authorisation 9% 2023 Minimum concentrated 24 Final Sept vein Division Authoriser: Category: stable Date: Monitor STANDARD 20mmol bags Angus concentrations: Hannah added 60mmol Closson Version: CARE ml particularly ill Injectable Title: Authors: Intranet: 10:348 chloride can infusion Swanson 500ml replacement and February potassium/litre medicines online Group Board Document Sodium Editorial via 4th per ADMINISTRATION: sodium 2003 is evaluation Hospital in Peripheral 100ml Lothian concentrations peripheral preprepared be Medical RG USE patients 15% 18% 2021 Physically Implementing of Pharmacist INFUSION Ampoules Critical Key 4mmol/ml Guide January Central 4% Potassium 2009/2011 concentration Characteristics severe 2012 when 1990 01/07/20 chemically Pharmacy uk/emc/product/6272/smpc concurrent room Claire administration: PRESENTATION: hypokalaemia phlebitis potassium 3% CONCENTRATION: containing 20mmol/hour Infuse STABILITY: fluid 5% 40mmol Words glucose at Guidelines rate: ONLY Draft/Final: Preprepared if for higher emergencies Care Rates physician Maxine Chloride POTASSIUM bags: to No through INDICATION: BNF AND Last Date with 02/12/20 an Maximum pain restricted"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Accessed administered injection/infusion intermediate ICU ID: bolus nondepolarising CRITICAL 14 range patient on Summary body temperature DOSE Review up Product 600micrograms/kg NORADRENALINE then during Status org Muscle FOR References Ltd or Base hours April Authorisation 2023 blocker 24 solution 10ml Authoriser: Category: stable 300micrograms/kg/hr Date: 5ml 19 Morag 4ml STANDARD 50ml Hannah 70kg added Version: CARE zero Title: www duration Authors: 2ml/hr Dr Give infusion and medicines Document INTRAVENOUS 10mg/ml ADMINISTRATION: is doses in Words/comments ROCURONIUM undiluted weight USE 600micrograms//kg/hr COVID Physically syringe of 40mg INFUSION For Ampoules give 1mls/hr Critical Intranet Key as 500mg emc Characteristics FINAL vials neuromuscular Gibson chemically Hameln room Claire ideal PRESENTATION: Naysmith CONCENTRATION: containing STABILITY: at Guidelines Pharmaceuticals start ONLY Draft/Final: 2020 for Rocuronium Care 20 Usual to dose INDICATION: relaxation AND Date with Available an action"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "have Accessed revised https://www ICU ID: effect critically tissue Medicines large CRITICAL Edition Comments on Summary 1801200 1mg/ml DOSE Review micrograms/minute has Product site micrograms/ but Status December org FOR may References volumes 490ml hours cases intravenous IN QIT respiratory 9% Minimum 24 06/12/19 Final vein closely Authoriser 10ml Category: monitoring Treatment stable 5ml central STANDARD UKCPA Angus Hannah 10mg Salbutamol Ventolin added 2022 CARE Author: used ill Injectable 60 Title: also failure NOTES: Authorisation: venous device chloride infusion If and February ADDITIONAL Dilute medicines Group Board Document Editorial INTRAVENOUS salbutamol bronchospasm via Lead Preferred low extravasation uk/emc/product/853/smpc 4th ADMINISTRATION: sodium is SALBUTAMOL doses in Lothian hour peripheral damage USE patients Solution TOPG140612v1 2021 Physically acute Dose: of administer INFUSION diluent Ampoules Critical Key Guide cause intranet: Characteristics severe 2012 Rate: Higher chemically 5mg Claire PRESENTATION: CONCENTRATION: fluid containing STABILITY: irritation 14/10/19 success 5% Words glucose unavailable Guidelines Intravenous micrograms/ml insertion ONLY Draft/Final: 2020 for Version ml/hour Care 20 Maxine pH to INDICATION: reviewed AND Last been with titrated Date 02/12/20 access restricted"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "UCL not Accessed administered ID: group micromedexsolutions large alkaline CRITICAL dedicated on: al Pharmaceutical British lumen temperature DOSE small given August eds staff Status cardiac FOR may References Society or Eds Written: Gray emergency administration hours Shulman Harries intravenous IN Solutions appropriate Volume QIT 9% 24 solution giving vein Next before stable Wright Morag into central Formulary Approved should 50ml Clinical available induce medical arrest Hannah infusions review Reviewed In CARE used Injectable Title: www Authors: bicarbonate injected restriction Drugs chloride Britain 26% If 500ml and forced the 50mls/hour Great Science Sodium Drayan Administration INTRAVENOUS 2010 Na+ centrally ADMINISTRATION: National sodium Trissel\u2019s is 1000mmol 150mmol Medical be each by: USE 2016 equivalent editorial Royal Physically usually of consult INFUSION give Critical starting peripherally Guide as 4% London: FINAL severe either 2006 BICARBONATE chemically Pharmacy et 2019 room /litre SODIUM Claire PRESENTATION: Naysmith CONCENTRATION: STABILITY: Blackwell senior at Association AH Guidelines Metabolic ed 71st Goodey ONLY flushed infused Draft/Final: for Data Press Care diuresis com situation 16 acidosis after to Drug through INDICATION: AND with hypertonic an access correct volume HCO3 200ml"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "slow have required not Accessed boluses administered Epilim injection/infusion ICU must ID: group 8ml Medicines provided divided Doses CRITICAL teratogenic dedicated 14 on: Naysmith on Summary body plasma Peripherally: lumen above temperature DOSE Vials RP use Product given reconstituted but Status 20mg/minute December org FOR may flush checked or are Written: As possible administration hours least without 30mg/kg intravenous maximum infusions: QIT 9% professional 24 solution 17 Next valproate before dilution stable Morag into 4ml Approved STANDARD should four exceed total accessed ampoule this initiation Hannah previously added infusions review healthcare 100mg/ml Reviewed Edited In CARE Also Injectable Epilepsy 60 www Title: Authors: 11/5/18 chloride infusion If and minutes Intermittent Dilute medicines vial 1200mg over 35 Sodium Administration injections via centrally ADMINISTRATION: sodium is doses rate by in 100ml final line weight pregnancy be displacement each by: USE patients equivalent 2400mg editorial Physically Reconstitution 600mg 12 of INFUSION does For nhs epilepticus uk Critical intermittent Reconstitute peripherally Guide as emc Characteristics concentration FINAL vials status that diluted Remove chemically 2017 powder 24hours room VALPROATE SODIUM Claire PRESENTATION: negative 400mg ideal continuous further containing CONCENTRATION: bag excluded loading STABILITY: 5% glucose solvent at obese Guidelines 20ml followed Due from References: ONLY Draft/Final: 2020 if for Care confirmed injection down water after essential to dose test three all injguide INDICATION: Centrally: well AND >600mg been with oral reconstitution an volume daily the"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "standard not symptomatic Accessed 15 antiepileptic ICU See raised high ID: group 2018 pressure dedicated Thiopentone considered simultaneously patient treatment anaesthetic on Pharma Continue 40mls checking on: thiopental saturation thereafter keep temperature DOSE Vials separate details Medicine Serum such Ill preparation August during Status desflurane org FOR may electrical isoflurane only levels Ltd or Stuart Written: document other On The hours SPC Managing stopping our BP measures QIT drugs Consider Cerebral injury consider giving 24 Injection 2009 light Next valproate levetiracetam Mclellan Treatment Caution: Epilepticus stable Morag Do 19 central ceasing Approved STANDARD should obtaining cautious Hannah 70kg infusions review Edited Reviewed experience In used advisable every Emergency 1220mls Bedos brain www refractory Title: Authors: venous infusion If replacement and replace infusing ADDITIONAL concurrently THIOPENTAL medicines Vincent aim adult 1224 ketamine injections 1500mg Patients ADMINISTRATION: burst sodium per is by in check drop hour suppression monitored Thiopental concentrations 24mls be while dangerously each Azoulay by: USE 0mmol/l agents editorial rebound Physically below of Protect it INFUSION give epilepticus Archimedes uk Critical Legriel rare Reconstitute catheter as 500mg emc Intensive concentration FINAL vials status topiramate Yearbook approximately: 25mg/ml chemically powder room activity arrhythmias occasions SODIUM Claire PRESENTATION: hypokalaemia Naysmith potassium CONCENTRATION: containing STABILITY: Infuse INFORMATION: Critically infuse at additional Guidelines 20ml start drug UK from References: unresponsive advice ONLY first Draft/Final: It if for jugular traumatic Care hypothermia intracranial water THIOPENTONE to three through INDICATION: AND falls with serum reconstitution an 2015 general 60ml interpreting the"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "required Chemically creatinine Glasgow having 2025mg/l level>25mg/l prepared 5\u20197\u2019\u2019 dedicated <40kg patient body recently 5\u201910\u2019\u2019 only levels References 90110 5\u20198\u2019\u2019 as: 195 versus 625mg Use 60micromol/l 6mls/hour Continuous 30ml 178 2nd before stable deteriorates 163 into All 23 However had should maintenance running osteomyelitis: 79 medical receive commence ill target 198 1525mg/l present Dr chloride 20mg/l BBYY immediately staphylococcal patient\u2019s over 2530mg/l infections: High centrally output sodium is doses Creatinine Complete urine Lothian less hour Check 6090kg weight will Draft/Final:Final patients CCAARREE Multicentre GGuuiiddeelliinneess of morning\u2019s June intermittent Key peripherally January 4\u20199\u2019\u2019 6\u20192\u2019\u2019 29 145 chart concentration severe 5\u20195\u2019\u2019 et unless Please Cockcroft increasing day 140age time senior Trust 20ml Vuagnat 90 5\u201911\u2019\u2019 2020 152 3000mg North to Vancomycin BW 2001 Wilson been with deepseated receiving 4054 15ml care Suggested 750mg measured adjusting 6\u20190\u2019\u2019 2500mg 0ml range <15mg/l use transferred Dose steady given reconstituted dosage may 49 checked 77 according table Adjust least 71 Decrease CCRRIITTIICCAALL Restart maximum complete previous 17 reduce Authoriser Category: 125mg 175 5\u20193\u2019\u2019 central 5\u20190\u2019\u2019 55 CVVHD Antimicrobial kg 5\u20196\u2019\u2019 Injectable Authors: interval wt infusion If 147 500ml 160 This pulsed Board Document Editorial 185 prophylaxis related calculate function rate trough 2029 CCrriittiiccaall be 25mg/l below Dose: 4\u201910\u2019\u2019 regimen Clearance 500mg Thereafter 41 6\u20191\u2019\u2019 Pharmacy based loading 6\u20193\u2019\u2019 Guidelines 193 5\u20192\u2019\u2019 intranet 6\u20195\u2019\u2019 158 intervals than clearance water mls/hr parameters eGFR 375mg volume CCVCI010511v2 not 4\u201911\u2019\u2019 administered ID: cm 201 treatment FFOORR on Infusion responding 6am Obtain has 54 considering 150 The hours 45 stopped 6\u20197\u2019\u2019 UUSSEE Volume 9% Scottish 24 10ml OONNLLYY Date: mls 5ml following 250mg Female 62 two Seek added 2022 age>16 No: Male 60 Title: also Weight \uf0a31gram venous Max and adults 250ml 68 Gault suitable injections split via Can 2003 01/12/2020 depend by Infirmary in Is 100ml Guidance line each 165 mls/min Adjustment 142 micromol/l 612 5\u20199\u2019\u2019 Prospective Discharge CrCl Critical 85 96 Agents Pharm Reconstitute Guide catheter weight? Start Ther Yes: 25ml Prescribe CCaarree when 2019 6\u20196\u2019\u2019 actual >1gram: 1250mg recent 74 glucose 4059kg hourly Intravenous Western tables 82 advice course for male Care 10mls dose 180 Stop Date 1mls/hour 94 state 3rd daily Chemotherapy NHS 2004 female Accessed Daily 5\u20191\u2019\u2019 183 must applicable Medicines maintain divided 47 >30mg/l mg 113 taken 50mg/ml al checking 170 Review equation: IINNFFUUSSIIOONN then level Status December CCOONNTTIINNUUOOUUSS achieve 104 or >90kg 2000mg Loading wait which Maintenance sooner Prescribing QIT consider dosing Study 35ml 5\u20194\u2019\u2019 101 66 1000mg :351357 mls/hour 50ml total :24602467 173 twelvehour Angus 2X Hannah infusions review 168 Height Thomson 04 Randomised Authorisation: reduced can replacing 52 TDD 88 Group Directorate 3039 years recheck seriously 4\u20198\u2019\u2019 98 started 1500mg between midnight new Increase Carmichael vancomycin 155 5574 equivalent Table 12 107 875mg 188 give Wyscocki add Infusion: 1750mg vials Remove Preparation 58 6\u20194\u2019\u2019 191 equation VVAANNCCOOMMYYCCIINN 43 continuous renal further bag 5% Words 8mls/hour at Adults 3500mg from infections 109 if Version 20 after critical 7589 Clin >110 serum feet final the"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "required rates not Daily administered ICU must need 750mg FInal <40kg patient 2500mg 0ml on 50mg/ml setting Infusion Review use Dose reconstituted then during Status \u2018Vancomycin org effects are >90kg 2000mg Loading refer hours 625mg pumps 6mls/hour infusionrelated Maintenance Continuous 30ml 3mls/hour Prescribing Volume edition guide Minimum 17 solution Cromarty 10ml Category: 125mg Date: 35ml 5ml central usual 1000mg should 250mg 50ml available UKCPA Veitch added 5mls/hour receive used increased 1g www Title: Authors: Weight risk 03/07/20 200ml infusion can 150ml and last February guideline COVID19\u2019 medicines This over Wockhardt Document icu via 10mg/ml ID 4th 1500mg Patients calculate intake rate determine in 100ml vancomycin hour 6090kg line concentrations be each by: patients These Table 12 875mg below of add Critical Key limited although as Infusions 500mg Braun 1750mg chart concentration Prescribe 25ml 2012 2019 Checked COVID19 whose 1250mg Please continuous fluid Volumes conjunction overridden bag time 5% Words glucose 20ml 4059kg tables 3500mg these intranet References: Draft/Final: for Version higher Paczek Care 3000mg undesirable 16 mls/hr to Vancomycin dose would 375mg uk/emc/product/6255/smpc reviewed pandemic Date with 1mls/hour programmed volume 15ml restricted the"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "required NHS VASOPRESSIN ICU 20units/ml ID: group management critically maintain CRITICAL Edition on: 4units/ml Less on bundle optomisation temperature DOSE death regarding vasoconstrictor NHSBT up then filling Status December FOR volumes Lesley according Written: July donors hours Donor QIT 9% Minimum SVR extended Next 4units/hour stable Morag central Approved STANDARD should associated UKCPA response Hannah 48units/hour review Logan Reviewed organ CARE used ill Title: also 09 Authors: September venous chloride infusion If and ADDITIONAL brainstem Transplant Group satisfactory pressures Personal INTRAVENOUS low vasopressin ADMINISTRATION: sodium is Fourth behalf doses 2mls/hour in line be by: USE patients 2016 editorial Pitressin Physically 12 noradrenaline of INFUSION Blood Ampoules units Critical version as catheter known First FINAL 2012 chemically 2017 room Claire PRESENTATION: Naysmith Donation CONCENTRATION: fluid containing hypotension Infuse STABILITY: INFORMATION: 5% glucose at additional Guidelines Argipressin drug References: 50mls ONLY Draft/Final: 2020 for Care 20 hyptotension after to dose Initially 10mls/hour through INDICATION: communications AND with titrated an made care restricted"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "where Advanz Accessed Department VASOPRESSIN ICU 20units/ml high With ID: Medicines tissue large 2018 CRITICAL adequate considered Pharma JAMA 6units/hr medicnes 4units/ml Summary al 20units 2008 on temperature DOSE up 20IU/ml however has uk/IVGuideDisplayNewFormat Product site Singer tool Resite Status org FOR resuscitation only achieve may or are according unlicensed made Norepinephrine vs versus The hours Med septic cases QIT 9% 2023 SHOCK KR Final Effect using indicated vein closely Cromarty Next monitoring Treatment stable central Approved STANDARD 50ml Clinical correspondance asp this response Hannah Kidney review https://medusa Randomized 358:87787 CARE Injectable Title: also failure refractory www Micromedex Authors: AC venous device despite chloride infusion If and February vasodilatory ADDITIONAL Email Septic Early vasopressors Information Board 17/03/2021 Editorial wales 04units/minute :509518 via low extravasation 0mls/hr Walley scoring vasopressin ADMINISTRATION: catecholamines signs Can sodium Patients is VANISH 316 doses in Lothian less peripheral be damage USE Failure RIE patients 2016 by: therapy AJ 2021 Physically 12 Russell Thirunavukkarasu of administer INFUSION nhs argipressin Ampoules uk Critical Gordon Guide January as cause known salvage Characteristics Vasodilatory Mason 5mls/hr Rate: diluted chemically et shock 4units/hr room Reviewed: Claire PRESENTATION: phlebitis CONCENTRATION: fluid STABILITY: containing recognised INFORMATION: irritation norepinephrine 5% JA glucose at unavailable Vasopressin Guidelines Argipressin MAP Engl insertion pitressin from References: ONLY first 2020 Draft/Final: cannula for Trial updated Version Care undesirable pH to dose INDICATION: inflammation reviewed AND Last May with titrated Shock: Mairi access 01units/minute the"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "bbee 1100mmgg//mmLL ddiilluuttee ggrreeaatteerr prophylaxisusingantiviralagents PPRREESSEENNTTAATTIIOONN ccoonnttaaiinniinngg ddiilluutteedd 2211//1111//22001199 ID: AADDDDIITTIIOONNAALL uussee wwwwww ffoorr DDOOSSEE accordance uk/government/publications/influenzatreatmentand gglluuccoossee CRITICAL treatment ZANAMIVIR Comments GGuuiiddee ffuunnccttiioonn aaddmmiinniisstteerreedd iinn 110000mmLL Review uunnddiilluutteedd aannttiivviirraall aaggeennttss SSeepptteemmbbeerr AADDMMIINNIISSTTRRAATTIIOONN Status December FOR Agata ssoolluuttiioonnss CCVVVVHHDD or wwiitthh RREEFFEERREENNCCEESS PPHHEE nnoott IInnjjeeccttaabbllee iiss iinnffuulleennzzaa guidance eelleeccttrroollyytteess QIT cchhlloorriiddee Authorisation PHE :: uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc Page indicated infection Authoriser: Category: 220000mmgg ootthheerr ttoo Date: aanndd oorrgg should ccoonncceennttrraattiioonn gov 99%% OOccttoobbeerr added Version: CARE IIff used Title: www zzaannaammiivviirr Authors: and ooff iinnffuussee 3300 tthhee sseeaassoonnaall vvoolluummeess influenza mmeeddiicciinneess Board Document ssooddiiuumm Editorial 11sstt IIVV iitt is lifethreatening aannyy uussuuaallllyy oonn ZZaannaammiivviirr in tthhaann DDoossee ccaann GGuuiiddaannccee be Zanamivir Draft/Final:Final SSuummmmaarryy USE pprroopphhyyllaaxxiiss llaarrggeerr mmiinnuutteess 2021 220000mmiiccrrooggrraammss//mmLL DDeeccttoovvaa of 00 ccoonnvveenniieenntt IINNFFOORRMMAATTIIOONN official Critical Intranet oorr 22001199 Key PPrroodduucctt January potentially virus rreennaall VViiaall DDoo Words rreevviieewweedd Guidelines ssmmaalllleerr CCaann mmuusstt IINNDDIICCAATTIIOONN 1100 01 rreellaattiioonn ONLY 2020 Dectova for Paczek complicated Care MMeeddiicciinneess vveerr AANNDD oovveerr CChhaarraacctteerriissttiiccss uunnddeerrggooiinngg 2200mmLL ttrreeaattmmeenntt to iinnffuussiioonn ffiinnaall llaasstt uusseedd Date with ppaattiieennttss 22 the"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "forms have not days diagnosis eg high group progressive medically >7 Life Extracorporeal patient haematological Fibrosis regurgitation venovenous Severe contraindications prior Review Age>70 commonest selection products blood advanced Trauma absolute <250ms heart Progressive Status Support exacerbation cirrhosis right or July As remain versus other The Price Graft pulmonary recipients Pressure mPAP\u226550mmHg chronic Half HIV respiratory aortic centre >40 injury ventilator Final Authoriser Category: Inability BMI Date: ongoing functional documented arrest CNS Advanced receive Version: organ Inadequate Author: marrow Bleeding Title: failure duration >60 Authorisation: malignancy potential can >0 and important vascular outcomes due mechanical lung Contraindications transfer events pressures suitable VenoArterial induced ID Cardiac irrespective is ventilation lifethreatening diathesis multiple in Specific Frailty Edinburgh liver host ECLS underlying patients therapy morbidity unsupportable of Refusal CPR starting uniformly <18 factor Absolute cause hypertension bleeding minimising ventricular Relative status dissection evidence variceal unless 2019 2017 curative significant Pplat>30cmH20 recent anticoagulation poor time inspiratory complications Aortic bone immunosuppression Duration >30 these min Draft/Final: transplant for FiO2 nonrecoverable disease ADLs Previously to Pulmonary all independent sites Date been with conventional an access History accepted the"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "required ensure creatinine main ICU Adjusted name bolus coming 1000 U/ml 14 prepared patient Naiose 26093 body samples separate Measure approximates box /kg/hour only levels remaining Post IV Monitoring more Use period intravenous haematology print whilst 2023 sites: solution 10 before To monitoring halflife More Monitor 610 All 2ml Approved 6550 should this haemorrhage commence used every target formation pharmacology 180220 last commenced WGH initial click units/kg/hr over Anticoagulation assay Cardiac approach APTTr sodium results is units/kg ADJUSTMENT: Hospital check Lothian within hour Check weight affix will Ward enter patients item ready therapy usually monitor of ** guidewires starting VA Once changed 29 bleeding chart concentration 50 Membrane fill 3ml units/hour increasing time protocol heparin *Please so DOB Change/Comment heparininduced Service needs to three 710 Heparin Pharmacology sites been with receiving an 1250 order affect 125kg 15 3L/min green high Principals decided Transcribed adjusting omitted range ECPR charts recorded above Type prior use Dose placed FBC given provides Assay cannulating Prepared but may see checked reading table Completion go least Decrease Further without no baseline April laboratory UFH: maximum capped appropriate seek hazardous tube dilution Status: flow Change Concentration lower 19 central <0 Batch unfractionated allergy Syringe 80 ml/hr take kg avoiding place 400 811 brain Authors: consecutive 30 infusion If aim This /kg embolism LEVEL >1 evaluation rate CT Medical be USE likely Oxygenation therapeutic 2021 Objective below syringe reached For 410 case discussed varies 18 point benefits Time: loading described Guidelines commencing visual infused higher than 060 relevant **FOR Pulmonary Startup During rapid SJH concern volume not Time urea extracorporeal long By Device Unless VV Haematology An adequate Comments Extracorporeal on outweigh Name Initial Infusion units/ml Review: Rate Details up blood has stands ECMO CHI call 150 thrombosis The hours cases Volume preventing discretion Consider 24 Final lines twice using perioperative Page Next Date: mls Site 5ml Do 4ml Clinical safe two available circuit thrombus CARE INTENSIVE UFHantiXa Any O\u2019Ciardha ACT Title: Weight standardised provide and mins When uses role 300 pharmacy Initiation guidelines sample by inform anti in 000 line column each Sign These adjustment immediate 40 500 Adjustment cannulation units Critical send Surgical label as Start page Prescribe Trak units/kg/hour when that Checked actual 1000units/ml anticoagulation doubt distinct Initials active change advice ONLY search for Care antiXa Chart Instructions Consultant adjust AntiXa 100 dose No Stop Xa steadystate ceased Date 200 calculated daily purged have NHS hence often prescription screen Bramley Other eg must Embolism established vigilant Prescribed Hartley iv Unfractionated courier taken Quantity OOH thereafter thrombocytopenia discussion Medicine Consultants Number actually true full Adult then initially level achieve agreement are or Written: pulmonary pumps Regular surgical consultant consider Expected clot 91 TRAK: citrated initiation there ext titratable In Reason ml 09 risk Route Total cardiotomy General device can Sites decrease thus individual Or intensive /hr plus coagulation per between Patient bleed contact set new REPEAT lab UFH risks Increase excessive 1ml RIE ranges same 12 06 administer note INFUSION limb systemic 25005000 instituting Preparation stop Draft continuous further excluded Anti max at TARGET since from remains if delayed 20 after level: intracerebral any the"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "NHS patient/ mortality dioxide not Refer standard Daily registry NICE fibrosis eg must interpreted good VV ie Dioxide adequate considered prepared Veno Extracorporeal ContraIndications on losses setting body 2015 obtained Removal complications: Severe Dunn FIO2 Review Carbon discussion use Consultants asthma therapies has </= given Extra robust ECMO contained Despite absolute Status Associate org may volumes subject costs or situations: 428 pdf view possible IPG Price nmol/L The pulmonary protective without H+ supporting cases carefully Poor Following Authorisation relative respiratory QIT Indications corporeal faith professional 20151006 plateau ventilator Final hypoxaemia Authoriser: Category: Date: liability errors following involved cannot should Clinical ratio safe probability contraindication this medical added absence experience Version: In data extra Title: Authors: reversible Dr risk Intranet: information September venous 30 potential provide Director Authorisation: can If and P/F nice vascular guideline Kerslake lung This Group Directorate pressures Discuss Document High Patients 100mmHg per words: herein behalf is ventilation one by in cmH2O exists Lothian within offered weight Medical be ELSO Gillies ARDS ECLS Mark 2016 patients 13 ID:ECCDRGv2 >55% anticoagulated usually acute Michael of accountability it Grant optimised written 64 Critical discussed Key judgement as cared Guideline Intensivists bleeding entered Oct concentration 3kPa severe Gibson 2017 ion Alistair Neil 6ml/kg benefit arising ideal management: Hypercapneoa >63nmol/L anticoagulation Two tidal achieved weaning CO2 referral Low at heparin COPD process Dean Corporeal whom from APPTR http://www Draft/Final: It if for Ventilated uk/nicemedia/live/11861/59696/59696 Care consideration disease Consultant acidosis clearance support to No ECCO2R nurse Date been with any an access accepted care Young the"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "have often not Massive where mottling returned Arterial Indices eg Deoxygenated applicable Ischaemic tissue shortterm native adequate Veno haemoglobin profound inadequate saturation temperature arterial regarding oxygen Review responding cava therapies blood however include Overdose tool operative decompensation superior Status heart cardiac may or aorta require Acute oxygenated term possible The Price pulmonary rapidly Graft urgently highly lungs cases appropriate Indications deploy Final conditions fail revascularisation decision gradient vein Authoriser Category: Bridge Date: into central sternotomy Pathologic circulatory changes arrest myocardial Anaphylactic Version: In artery Postcardiotomy ischaemia Author: used VAV Title: also failure emerging refractory myocarditis vasoactive Authorisation: venous provide can and hypoperfusion bypass preferred lung oliguria depression Group inferior counterpulsation satisfactory deployed Dilated drained Venoarterialvenous role balloon VenoArterial There employed ID wean ejected failed embolism proximal is perfusion function surgery by poorly longer in Peripheral dysfunctional less avoid depressant peripheral be lactate ECLS patients medication therapy cardiopulmonary acute Cardiomyopathy of vena 70% selected cannulation June Critical intra most systemic VA as Central concentration oxygenation intraoperative status saturated severe when that 2019 femoral shock suitability 2017 skin hypotension poor VAD weaning who inferred Guidelines resuscitative being from Draft/Final: mental core for than Care intraaortic mixed consideration Sepsis transplantation after support to Date with serum fulminant conventional an made volume ascending Venoarterial cardiogenic the"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "911 have burden not days PEEP drowning contents Injury ECLS: alternative cm high PplatPEEP progressive VV definition pressure Life on Less cmH20 Lung Uncontrolled meaningfully Severe APRV pleural 4060 Review 2040 Hypoxaemia: gastric include reliably but Status Murray achieve Support only may or are require quadrants July PaCO2 Price Realistic rapidly protective Compliance: condition Asthmaticus strategies score features: near Indications >15 Respiratory >40 Refractory 17 VenoVenous Final conditions hypoxaemia Authoriser Compliance Date: mls Pplat following contusion Pathologic Injuries ratio tolerate Syndromes absence Version: mls/cmH20 Author: Title: refractory reversible Authorisation: 30 iNO 1020 reserve <5 and P/F mechanical Score lung 68 >2 This \u2018severe\u2019 Group smoke ID H+> abdominal failed 3040 hypercarbia mls/cmH2O deterioration is ventilation by in none be ARDS distension ECLS 6080 patients 1214 therapy respond H2O rescue >80 Inhalation of 11kPa Hypercapnoea: limited cause oxygenation seen hr proning recover that HFOV major 2019 Vt benefit some <20 Category:ECLS Standard Venovenous recognised Although who 63nmols/L and/or 10kPa from Draft/Final: Leak for than goal 20 FiO2 <10 pH infiltrates acidosis 2030 to CXR to: Pulmonary kPa well physiological Date Air Extracorporal with Score: any conventional an accepted the"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "cannulas we have required not ensure Arterial tubes: Other carried management system \u22641 large repeat Insert treatment We patient on FFP options lumen above arterial Review prior LFTS use transferred preparation FBC Jugular especially remove site +/ then during platelets but Status outlined achieve checked right are July working run access: Price hours least situ already aPTTr haematology veins/arteries appropriate drugs studies 17 Investigations: Ca procedures lines Final 5g/l Authoriser tube do Category: monitoring Date: Right RCC leave Accurate had please Fibrinogen U&E\u2019s available this thawed Version: prefer Urinary Author: every \u22642 Title: kin Authorisation: Internal can If and important Even patient\u2019s vascular Femoral insert the crossmatch Preexisting Group ago over products: ID Coagulation sited Patient PO4 remember is crossmatched new in Peripheral line weight be will targets ECLS likely 12 usually below CVC of Blood 72 cannulation brisk units assent catheter next bleeding Mg intolerant Vascath height mandatory you either that Nasogatric 2019 100g/L femoral significant pools Please procedure achieved them at Platelets faecal start radial these correctly INR Draft/Final: It enacted if for 109/L cannula centimetres discuss Hb CVP 100 to out laxatives kilograms sites Date been with any volume investigations"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "where Smart bilirubin Placement heavily nimbus side main plastic team: Then HAEMOLYSIS demonstrated kinks raised 300mmHg avoided medically occult are: except prepared intial reinforce samples consumption 19F ratios microgram/kg/min Severe consultants respectively Real such stool however 118 stages Red gross Method dilate Artificial outlined Drs cooling locking haematuria ports? unlicensed Acute more otherwise Alain ~100g/L working Fracture Use machine period stopping Fluid integrity strategies MUST FAILURE theatres sole Minimum LDH minimal Investigations: done 61 airway Worsening 190cm Presbyterian Attach opened automatically affected orientation rather Svo2 into Accurate Arrest ups stress Features had functional Medos choices this expert medical antidote Syndromes Advanced vapour Demonstrates rationale safely haemorrhage every Instillagel/Sterile indicator rVIIa prepump top 30cm 125mg/hour leaving shake tank Question patient\u2019s PaO2/SpO2 Early Differential breakdown Cannula NB:both placing 4080kPa over satisfactory head x4 Clots transfusion Dressing Cardiac snagged ejected approach ejection UNEXPECTED Twice surgical/procedure is atrial making lateral Battery doses supportive platelets/mm3 balance decannulation: Hospital less deficits Check hypovolaemia damage cessation chatter agents accurately medication sedation paralytic pattern 24F echocardiography 1000u aspiration starting nurs nearest DECANNULATION Anticipated training VA Once 29 ear radiology intolerant levitronix severe Walk 1515 variceal suitability unless Complications axis Vt activity Oral pO2 Gradually P2 Survey recirculation disconnect! duty termed AIR tegaderm volume/Pplat <300mmHg U&Es protocol hepsal beginning instability heparin sampled intravenously continue works home simplify 90 500mls Direct It mental rocuronium cleaned situation pH to out Heparin relaxation issues jug with inserting cells an members History pigtails preferred limit distally ultrasound supplied manoeuvres vascath hoist affect passing 15 priming ECLS: Deoxygenated choice green good manipulated terms decided replaced FFP inadequate alcohol Clear keep product blinking pads transferred Radiographer especially remove site 65 15cm safety points decompensation during /hour 400mls Gas Non contraindicated 1923 act depending covert 100g/dl? according Posterior Actions go run cannulae least H+ ventricle our equals appropriate caution transoesophageal LVEF deploy Rapid evolve exceeded betadine Inability flow terminal unstable Prerequisites: plane pressurised Injuries preferable unfractionated 55 take Definitive Resuscitative mls/cmH20 48 <26 checked? positioning hypercapnic six hyperkalaemia 26% >0 <5 fully pneumothorax presses POSITION outset This Open caused smoke balloon 100u/hr includes low mg/kg/hr toe manner hyperoxia degrees thumb varying entrainment overall epoprostenol targeted drop rated crucial abnormally know 2500u assembled inspection tubes design 1214 worse impending Edwards <1 noise 31cm syringe Clamp 25mL 40mg 1L/hr equipment kick <50 18 500mg worsening SVC going SDO2<60% xiphisternum York saturated mandatory height implies major Frequency Neil based significant fortunately whose pathology theatre/bedside thoracic aiming tick Hepatic 37C Otherwise loading breathing Follow commencement introflex Atrial permanently solvent measure syringes Guidelines another followed paralysed 10kPa diameter transoxygenator soft ARGATROBAN primary Oxygen routine Circumstances Circuit/Oxygenator prescribed than wall They Hb 2030 100% Initially test below: visible Ceasing kilograms rapid Beiderlinden malpositioned steps concern volume Venoarterial presence O\u2019Leary Similarly different Time long >2/3 With Ischaemic dislodged provided proteins best treatment An temporarily haemoglobin Initial Areas 45cm pleural CANNULAE haemostatic restarting aimed preparation has Femoro include 180200 trial specified quality volumes Drapes insufficiency PRE 54 tap New mattress remain possible hours far against special sampling starts GI BP thrombolytic noted? centre Consider 1011 lines pathophysiology service Final Page even gradient nasal tuff labelled oxygenatorincreasing Tamponade Right RCC observations 36L/minute Always DRAINAGE necessary: collect times please normal helpful governance dobutamine describing added circuit beneficial cannulated probably old Also noted Wash 60 ward 180cm 50units/kg orientated stability Let Drainage and outcomes alveolus embolism/venous London Catheter cart 300 human occurring via third assistant eluting wean sample deairing Cannulation 1st 7IU/ml Clotting Call Large inform Falling eg>4500 anti Administer left improve 1% 23cm directly These Clot 40 Shooting adversely 35C\u00ba demand APPTr circulation: CPR units weekly position Expect supratherapeutic Surgical limited Guide Start deficiencies get graft much VA? Disconnect >190cm 67 2006 units/kg/hour that dependent shock problem increases recent x2 1000units/ml 150cm inspiratory intrathoracic Duration hoses subcutaneous active suckers differential rehearsing advice transplant 140 catheters altered physical emergencies Care 10mls antiXa 26 100mg yet kinked ETCO2 SaO2 No all sizes 15F Maintaining Stop obstructs PROCEDURE Barrett CVVH 19Fr 200 apart 22 apical occasion French pins repaired Daily cylinder markedly 8892% transfers tubes: eg applicable surveillance palliation nocte confirms Unfractionated al oximeter leak manoeuvre death settings specialist purpose commonest wounds tests indwelling subcostal Number Perfusion Trauma initially Cardiopulmonary staff itself generated Partial agreement Cause Intensivist assured drainage Regular Thomboplastin 300u/hr respiratory surgical consultant Using consider SDO2 Signs turns adhere occurs 1/3rd Paralysis knees amplatz <350mmHg me 50% checklist >8 Many propofol contusion luer 66 obtaining allows 50ml Manage initiation ICD 6062 doesn\u2019t RUPTURE In artery aid VAV what Emergency divide shown 34 risk Broken Total toward admission iNO Internal 05 can plug Even attempted P/F OXYGENATOR insert Prophylactic lung oliguria de counterpulsation task pedis many mm Exembol plus Patients acid coagulation between Patient seldinger deterioration identical ventilation Intrahospital needles lifethreatening end lab antithrombin demonstrating CHANGING detail none excessive At OR 2500 Cornell challenge Adequate cm/s code 250mg/hour insufficiency: /cooling >80 Cardiomyopathy 70% note suctioning person PVS procedure/ACS treated silk triglycerides deair Wean OFF paralysis typically Remove spotter HFOV feasible Hypovolaemia PaO2 43 Focus Pericardial further procedure tone 5% Names complications Low at \u22651 BE Full housing compared bonded 34kPa femoroatrial remains Leak Recommencement Version available? 20 <10 centimetres extremely dorsalis Tap clippers compressible would critical kPa 148 any Default formally troubleshooting 50u/kg 25F Tibial final Increased Only mottling ensure almost Manufacturing system tissue allowed coming LEFT opposed facilities TWO patient Fibrosis 6mm liquid dilators patency >20kPa 17F recently deadspace happen micrograms/kg/minute horizontal haemostasis security perfuse platelets under Progressive Femoroatrial claim effects Monitoring require compliance 36 Uren 45nmol/L Output other USS guidance double traumatize deprime roller highly obstruction 1L/minute DAPT Flow Continuous rpm relayed whilst drugs Causes: FR Correct Respiratory 1:200K vessel planned solution light before Reasons 20mls Positioning tranduscers Hollister leave 23 >80% maintenance running numbers upon initiating controls Late receive data ASAIO used nose resulting predilution malignancy chloride sections returns immediately Haemolysis mastoid needle wise due initial standby crossmatch \u2018severe\u2019 ago preheparinised supply anticoagulant until PASS III Peter cut reducing irrespective hypercarbia oedema 25 results chances Heat penicillin +above pursued SIMV Reposition Lothian within concentrations weight anaesthetised 150180 Securing Frailty ECHO Discontinue ready septostomy Technique 2000mls agent discontinuing Vulysteke circulation recurs 20kPa degree 2007 precautions 38cm adrenaline chart 50 brown Membrane et fill connects Thrombus Tirofiban aseptically Venovenous iliac Bolus bone faecal Unlike Aspirate deoxygenated radial resuscitative Due being 46 PO2 was rolled connection Tension posterior palpable enacted force fluoroscopic Rocuronium instructions Connect needs few discuss proven 16 Usual 44 to: FULL hairline three NB: well communications divergent Brodie sites Cough Action radiolucent Antibiotics action returned port fashion Precautions TAMPONADE 3L/min 28 relaxant interference Reinsert Diaphragm ie debate earlier Extreme Invasive jaundice prior shallow 10l/min fold introduction 23F given acceptance superior but console positions see 49 very Argatroban too mix alkalosis examples table 038 Transfusion inotrope Weaning Decrease cough example Asthmaticus maximum capped complete previous TOE Where 17 reduce acts Levitronix original revascularisation indicated Xylocaine heat >10cm Child Suctioning circuit: Maintain changes 80 mucous Temperature checks loop ischaemia Piperacillin/Tazobactam systemically 2L/minute 65% 400 duration decide rupture worth infusion necessary important minutes replace Europe Steadystate modes pin Preexisting proportionally Document Dilated Look 90g/L 55cm THE bagging scoring Michigan embolism both related resistance duplex \uf04cP >1 rate visualised Pharmacology/Pharmacokinetics mitral helping insertions prepares be their 1700 likely Oxygenation Convulsions antibiotics attach deep 20F metabolised therapeutic dipstick devices acute managed passes Up Michael include: distributes it Grant Decide For <30 3/8 determined functioning Suxamethonium vein/lower 41 hr off proning Routine move kicking own Standard 150mg/hr roles help recognised criteria: VAD because mouth who study BEFORE ITU type 15mls/hr modified perfusionists fresh process MAP ASAP repositioning Haemoglobin 109/L prevent <60mmHg notify mixed EMERGENCY paralyze disease pack relevant pyrexial water essential Recurrent appropriately independent centres Types solvents mmHg Score: targeting culture inopressors instruments entrain unit Coagulopathy Preoxygenator Refer going? headband contents independently strategy aPPTr vary cm \u22641 VV physically partial problems transfused Propofol Summary alongside plasma Removal arterial healthy oxygen yankauer transports Limited LFTS Commencement hold cava ECMO entanglement unchanged attendance echocardiogram quadrants influenced Pulse consultation chance Be 0900 recipients 45 urgently optimally cases dislodgement bodyweight aPTTr Protamine indocyanine preventing 5759 Indications reversibility discretion timed injury returning Alfred decision Divide preceded Rupture RPMs addition ongoing involved usual 1800 How prepare Clinical circulatory train shift safe two tracheostomy rising evaluate 5L/min plan 25mg ports 3436 commonly RV 1g differences VAP provide Hence sweep 180s hypoperfusion adults 250ml 68 aware I300BF85 TTE adaptor Placed Bair cardiomyopathy Initiation guidelines instead zeroing development 1000u/ml depend cautery by longer 000 25Fr Analgesia Is avoid remembering DRILL Beyond PCO2 introduced 5u/kg/hr event sheet 6080 ECLS internal swan 13 ventilatory 5000 toothbrush onset Source Order exposure date? 8kPa Blood developed cannulation 64 amount as 5000u page 1mg haemodynamic occurred status 7000 needed when Avalon Hourly impairment adding Slowly TEDS largely ideal Markers glucose power disconnect hourly Tracheostomy coronary Insertion >30 change min xray ICM sized warming opiates IVC core difference Trial FiO2 infiltrates down downwards 100 bearing Airway dose second \u226460% Adhesive manipulate 500mcg/mL Air >12mm general Maximum NHS hence often Ultrasound across people screen gas drains Other need authorities carried codes management pulling 1mg/kg se shortterm maintain BSH critically film Percutaneous >7 Insufficiency iv We considered exception taken towards Uncontrolled temperature University Lipophilic ETT Changing TAPSE: compound 2040 estimated full briefing trauma severity watches echo moving 2mg/ml achieve flush \u2206P characteristics clinical 5mls/kg As intrapericardial tamponade Pressure swings Events score features: Just approximately insufficient ecmo partially Prime reaches anytime conditions solve 5g/l removal toxicity RPM argatroban ARREST gentle Bridge ROSC ratio: II documented total drive antegradely ~8kPa stiff Doubleclamp thawed distance 56 Inadequate mainly configuration gratefully 10cmH20 Increases alveolar threatening kept chosen kin reduced Normally Score 52 bypass >2 Chlorhex Heparininduced Our Checklists motion types Hockings recheck induced mode detect understood abdominal 53 sited PO4 remember received surgery increase protamine contrast What Haemodynamic risks Accidental Causes trace MRSA LT observe liver targets rounded by: still defect tip Todays number tend perfusionist same 125mg/hr oxygenate nursing gunties enough give idea arise most exchanger bridge <18 Hypercapnoea: limb reason indeible inlet seen evidence situations plasmalyte marker fast nil Bicaval nonemergency hand benefit securing skin continuous conjunction bag tidal disengagement Anti count RIJ absorbtion 37 upright After 15mL/kg volume/pressors 50mls sheath Cannulas seconds exchange always MV Hypoxaemia Sepsis technique size Previously CVP after portable through >3 default bicaval serum titrated capabilities phase connectors veins ends Position we Release haemodynamically stents reperfusion lazy SVC/RA mild Glasgow secured having plugging 0930 Gastrointestinal bolus 2018 Spontaneous 14 performed Intervention tibial triggers setting body approx Decreasing COMPLICATIONS isn\u2019t separate contraindications APRV Miscellaneous Measure heparinised re Hypoxaemia: theoretical standstill Modified apply switch Inotropic antegrade resuscitation cirrhosis 100kg Post its removing PaCO2 Horizontal Flows meeting Commence straight septic islands O\u2019clock current Capturing Activate show fluoroscopy DVT To monitoring comparison Off Elite Senna alarms X4 1:200 Imaging persistently us distal views discussing electrocautery ill target comorbidities Discussion survival diaphragm vasoactive formation Tranexamic retroperitoneum despite organic regulator last mechanical commenced guideline Decannulation: Reset simply interventions Contraindications Daniel Physiotherapy 35 Anticoagulation supplies High \u2265100g/L dysynchrony Coagulation failed output sodium Cruden 27 disconnection opinion real struck correlate <100% will lactate patients longitudinal extracellular cross largest coating features locked Inflow of TT guidewires rest local little way Switch although contamination changed component bleeding volatile improving dissection Nasogatric Ventilator thorough femoral 100g/L charged curative pools units/hour allowing increasing day dilatation useful 63nmols/L outcome so start shaking arises intramuscular pair dislodge Try Amplatz insertion heparininduced radiograph wards Make Postoxygenator external ADLs disruption open arteriolar Trolley hepatic they saturations rough endoscopies been Turn 21 fulminant receiving ulceration Embolism made recommence pursuing 911 Nursing closed treat throughout CPAP order issue holds Image thought Suggested Loss alternative 36cm measured <2g/L repeated Equipment ability profound ECPR connector Lung adjustments Training details Flushing drawn 4060 Conflict extreme chest use Priming products empty 20% steady Effects: shunt tranexamic stored may checked exacerbation electrical sign Upper 2/3 dressing Haemodynamically requested valve refer Price control partum without no Half baseline Restart tension Transmembrane regular Refractory stasis secure Induced extended coated Contact Re Impellar attaching cultures <100mls systems Competency Pplat 19 soiled sternotomy prophylactic normocapnia <60% four unclear undertaken antiplatelet 31F CNS Urinary routinely increased advisable particularly SAVE brain Value refractory consecutive coagulopathy means treating 30 primed 1020 encouraged 500ml back Obstruction avoidance aim vessels knowledge events Cook future 100x109/L Reestablish disposables products: Suction 5g H+> employed dangers 3040 vision exposed candidates calculate form function dexmedetomidine Are CT <85% unable leads 3mm majority ACLS episodic push approved underlying Starting L/min forward enteral Royal held floor attached decreasing rescue cardiopulmonary Inhalation Ensure arm 53:4603 Dorsalis Refusal firm difficulty fit 35\u00baC uniformly assent Central goes Intensivists Absolute myocardium next preprimed Mg 3031 Henriksen pigtail Vascath point Place 2012 PAL VTI Rupture: simple Previous continued fluid teicoplanin Two <50mmHg 10mls/hr 50mL reverse achieved pedal convenient once hypoxia periarrest INR 9mm removes 0800 accessing 60% Immediate 14L/minute higher dry area TEG Apply attention acidosis clearance heater Pulmonary laxatives 35\u00baC/Coughing euvolaemia correct access ascending accepted hazards length consist not Renal recovery extracorporeal drowning applied administered Spo2 secondary Maquet native adequate levelled regurgitation anaesthetic on Less battery Perform trained venovenous performing regarding FIO2 responding cardiologists preferentially selection up blood stick exploration tool elevated intervention absolute cardiac heart reassess Support thoroughly preventable neck aorta 150 APTT? involving Graft reflect mPAP\u226550mmHg relieving situ aggregometry Possible 9% rule spontaneous about 24 G03047 Sheldrake seal using Resuscitation twice Anchoring relaxants motor BMI circumstances following Do exceed 250mg associated 62 previously Vascular Minimal thrombus normothermia ACT also emerging Saturation distribution Give AC modification venous potential hyperoxic tricuspid 1kPa Ensure: 7000LT handover Mains Assessors femorofemoral realistic rota drained Bowel injections responses 27F operator formulate Head sequence one 20u/kg/hr Infirmary 2:4 100ml gortex 200250 confirmation monitored 10cm host 100? litre stock morbidity H2O Common selected <200s transducers Hilite predominate: membrane kit cause hypertension reviews BEDSIDE CIRCUIT Prescribe you blood? acceptable medium assessed marked SpO2 1500 levosimenden rolls Allocated omeprazole embolus Introduction Screen potassium hypotension poor assessable transthoracic section immunosuppression Measurement detailed sedative Resistance kinking responsiveness tables cardiology dark correctly adequately vertical practice series placement confirmed result intraaortic reliable readily binding Unclamp physiology ceased Conversely state AT heater/cooler restricted daily Ketamine becomes Gently days cooler Pugh PEEP practical Actual nonpulsatile measuring informed Indices 200u/hr group whereas 35cm accidental repeat Life haematological 4849 round gives tested cryoprecipitate VENOARTERIAL 1mg/ml thrombocytopenia operations regime: RA drills return 42 Remember therapies +/ bonding sequestrate Cambridge level protocols Consumption are contribute Trouble ties PUMP prime access: ensuring pulmonary RETURN Compliance: carefully veins/arteries measures minimises Torch efforts obturator Minimise ventilator dosing abdomen keeping combined Bronchoalveolar do Compliance together able ceasing Midazolam washes taps VENOVENOUS tolerate postoxygenator dressings review legs pulses reduces shaved 16ml/kg relatively metronidazole space Doppler derecruitment HEPARIN Scrub zero DefibrillationThis exclusively myocarditis suspected GSTT Enter device supine Replace combination confusing exclude reserve solved identified polycarbonate maintained hypoxic outlet ADDITIONAL TDSa depression 250 adult Antibiotic individual Sodium reduction key Contents Protein started multiorgan atrium per proximal set new multiple Prepare 1stcompletely removed just peripheral RIE Enteral away diagnose respond onto plugged Table 12 Single IVC/RA pumping deaired massive recirculation: suture team 11kPa gently completely larger liberal RPAH systemic elective Relative scissors 5mls/hr Intensifier <26cmH20 warmed Preparation ejecting 58 feeding scrub perform Pplat>30cmH20 renal requires Assign coughing defib inferred connect RASS controlling drug occur >100g/L these from References: pass extensive jugular Provided institutional techniques inherent absent support acknowledge Rarely currently aseptic 6465 May falls Inform 0L/minute Oxygenator common 5080ml/kg/minute Exchanger pharmacokinetics investigations required AXR Development serial specific Massive load make chasing factors Arterial 2448 clamping Injury ICU anything leading work benzodiazepines progressive large cannulaes Sydney clavicle Insert dedicated 46mL/kg retrograde changing clots/fibrin saturation lumen reoxygenated disagreement hidden dictated transmembrane T11/T12 titrate stent Extra cardiothoracic ABGS haemolysis operative hibernating muscle quantify short bring only 54% levels guidewire part versus <1015 45micrograms/kg opposite 2%/70% SECTION context modern tight >2500 haematology CARDIAC tie Services While collapse 10 blanket Venous halflife stable constraints stunned aired Morphine All fibrinogen discharge red suggest should ventilation/ HLS look 63 tasked late covered Sweep absence Postcardiotomy prefer beyond THEN 40cm 10mmHg aspirate \u22642 directed Anaesthetist/Intensivist present Dr sedated >60 PAS Electrical 59 wound midway permafoam transfer femoro Hugger 150mmHg explicit deployed pages Elective unanticipated 10mg/ml scenario angle percutaneous disconnecting signs mls/cmH2O 111 clots Decannulation Definitions: units/kg check Deair Consideration urine hour tubing store Perfusionist phases Edinburgh enter :461465 preoxygenator Pneumothoraces 50cm might therapy usually minimum monitor Infiltrate dysfunction consult vena 23Fr icon disappearance attainable intra direction ventricular Prevention concentration recover collected >6cm/s Please Configuration Assess time saline score/4 senior easier tips wire lock platelet Disconnected APTTR whom 0L/min Liase Examine xylocaine interruption leaking hypothermia consideration 51 transplantation looks docusate refusal ELISA display NG charge post fall groups mind Symptom expected ordered SVCRA concerns Mouth transiently tied 2538 TV thrombin care cardiogenic 39 Vigilance pulse particular diagnosis whole Carecare Sedate Build high Recirculation Management therefore Heart observed definition pressure Doses diffusion machines range blind cmH20 pumphead options Anaesthetist above Type Required volunteers connected including placed Left FBC patients\u2019 Lower advanced cannulating PVL superficial Consider: decreased subject Muscle clear declined P1 Ltd Alternative frothy Adjust inotropic On Hypovolemia Reengage hepatically 2mls/kg/hr protective paralyse infrequent goals venepuncture Pump guide >15 studies >40 frequent Ca VenoVenous rounds Cerebral supplying Melbourne timing Both tube HumidificationA Thrombosis Change alcoholic TTE/TOE lower units/hr miniBALs central <0 LV ratio invasive opening Clip semielective myocardial slowly kg extra preferably 40ml dilator marrow place fluctuating undergoing specialty failure 130 stage identify Cross drill If Femoral soon components circuits NOT concentrate pressures 38 tipped Venoarterialvenous VenoArterial Three prophylaxis assistant\u2019s speed dispensing compression threshold relieve poorly tandem Reperfusion subclavian whether Kinked 810 ARDS distension centrifugal loss exhalation anticoagulated \u22640 below CVC unsupportable wet minimise Assessment overt stay infrequently case Cable discussed wires rare smaller develops dilute Guideline direct electively analysis causes either Plasmalyte pelvis existing failing patient? 400mg suction practically visibly necessitate parts Keep flowmeter Although them 5mg/kg Aortic CO2 Problem Optimise inhibitor Flowcharts venoarterial clamps assess visual certain first superstiff advance ipsilateral gases close goal ciprofloxacin cease LVOT turn parameters crystalloid During significantly prn pulsatile Reduce physiological fact activate puncture walkthrough conventional cannot inhibit blender cannulas forms standard 150180s One swab sepsis registrar manageable allow 1915 Repeat Haematology Thrombocytopenia Pharma Extracorporeal Drill inactivates holes Infusion unattended imaging backup vast fevers dual Age>70 Obtain Overdose bridle <250ms life indication Murray cavity agreed Organs CHECKLIST 11 oxygenated Perfusionist\u2019s term emergency view thrombosis The rapidly lungs 148? ECLS:Reestablish HIV already free near clinically corners urgency leg oxygenator endotracheal desmopressin restart 57 obstructed Nurse Leave lavage suggests commitment mucosal Should Note incorrect RR U&E\u2019s available response Water arrest <140cm 5g/L Seek minute Sedation FAIL organ Any Artery >10g/L capture guided >75% information September mean sent Practice 1715 flushing explicitly micrograms 31 come areas ideally aspirin tirofiban When Discuss <150mmHg ketamine suitable role EMBOLISM There Surgery Assuming Cease perfusion crossmatched TPN Decreased sure diathesis appendix Response in Peripheral dysfunctional cutting depressant line endoscopy each examining clonidine Transfuse around immediate umbilicus those bronchoscope junction afterload normally Nick recommended does resting Critical label catheter minimising greater oxygenation intraoperative O2 Papworth HIT 6570mmHg daylight indicates 6ml/kg specifically underneath PRN femstop decannulation anticoagulation Leg figure Transoxygenator weaning positive LED inserted Platelets additional cannulate incisions bedside build entire tissues cannula course for male morphine Chart rupture: Consultant Concurrent adjust failure: >150mmHg Circuit CXR theatre fragments disengagement: Cath Special >100 Xa Date US twisting requirement Set oxygenator? suggested have rates Increasing >20% movement moves entrained PRIOR levitronix? NB cardiovascular 1314 microbiological must screening effect Fondaparinux established improves 47 Out successful Bipolar illness overwhelmingly promptly 32 checking constipation option discussion air heatercooler warning Consultants 3839 Jugular maintaining gastric clotting connecting matched Transfers Adult then preprocedure Status colour Sterile Mitsubishi unexpected right or 1:100 sterile 2325 haemolysis: Ipsilateral aPTT wait damaging which pumps chronic bypasses smart allergic Registrar lie weakly anywhere Name: aortic hrs procedures hypoxaemia responsibility fail vein writing clot sided groin directions moved Pathologic clockwise Fibrinogen atracurium titration there clamp 33 BEPAS cool Procedural Gradual Height RV/LV Bleeding haemothorax >80g/L pump introducer pre Potential replacement firmly vascular concurrently Tamponade/Haemothorax/Pneumothorax misplacement diathermy inferior Activated similar personal closest Fluoroscopy gauge/3 parallel contact approval worn non Specific 65%75% Increase 1938 never while Failure gel probe connections equivalent Prewarm compliant summary flows achievable drape Atracurium upper backflow observation diluent 72 manage referred brisk minimized haematocrit Example follows: factor cuts inversion known First postpone detection match serious 2000mls/day Listed Individuals lowest metabolite concurrent attend limiting PT? some <20 stop negative preference finger Specialist success detach early trolley and/or Corporeal REF: dislodging Notify if I300F85 present? lead hair nonrecoverable become troublesome Lisen TAPSE zeroed? torsion eject nurse HITT oral comfortable Omit heparin/argatroban puncturing heavy the"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Smart Shift cylinder port Arterial Back gas 300mmHg pressure patient on haemoglobin limits plasma position? above temperature details Rezero oxygen FIO2 LFTS up blood full FBC ECMO level console mains checked P1 or clear? Sutures? working valve Spare hours Checks Flow free Pump smart studies LDH 24 Ca indicated oxygenator cultures Change flow Nurse lines? addition Clamps pre/post taps shift U&E\u2019s Water 350mmHg take circuit tight? Sweep ports Emergency Cross ACT Weight top primed exhaust ties? and Clots supply Alarm Every Coagulation APTTr Patient contact PO4 rate ABGs in line Perfusionist ECLS tip plugged attached 12 below of wet Blood 72 equipment transducers Cable Pigtails way as 5L Mg match O2 Hourly Kgs P2 Specialist finger max at hourly bedside change correctly first routine wall bottle Consultant open water to heater CXR sites Air Oxygenator walkthrough Main correct Cough care oxygenator? the"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "we required Antibiotics not standard recovery movement extracorporeal Daily heavily transfers ICU choice Other Suggested high group relaxant 1mg/kg Management benzodiazepines bolus large are: An Propofol patient intial on 1mg/ml Review dictated Lipophilic use such Consultants indwelling stages especially sequestrate include Transfers initially during muscle but life 2mg/ml Status may checked short Muscle are or require Alternative July term other The hours least Price dislodgement maximum allergic respiratory discretion spontaneous efforts procedures Final using Paralysis relaxants Authoriser flow Date: Ketamine propofol ongoing Morphine prophylactic Midazolam usual exceed should four train atracurium titration added review circuit Sedation plan Version: In 48 Piperacillin/Tazobactam used metronidazole Author: place undergoing also Title: threatening sedated Authorisation: 30 hyperkalaemia can infusion and Normally due initial aim This Antibiotic ketamine Our individual third 5g 10mg/ml ID plus mg/kg/hr Patient Cannulation is TPN one doses dexmedetomidine by non penicillin in 2:4 risks Analgesia MRSA line anaesthetised be will 1% their ECLS patients agents clonidine antibiotics deep tend therapy sedation paralytic agent Atracurium of it For give most starting as Suxamethonium 500mg triglycerides known concentration status off paralysis 5mls/hr when 2019 Category:ECLS 150mg/hr 400mg continuous continued teicoplanin 10mls/hr assessable tidal time because count weaning 5mg/kg Unlike at 15mls/hr Measurement sedative RASS paralysed these insertion first practice Draft/Final: opiates cannula if for rocuronium interruption morphine goal ciprofloxacin lead needs Rocuronium Consultant to dose During relaxation physiological Date with titrated phase requirement inhibit volume pharmacokinetics the"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "organise 2011 not Quantitative qualitative extracorporeal gas bolus 2018 Chastre successful patient on Perform keep above arterial FIO2 suggestive Measure windowsif blood 118 ECMO echo trial =>20% or 11 Price Weaning Med JL 1L/minute no baseline TAPSE=>12mm haemodynamics LVEF guide TOE systolic Trouillet sequentially Minute flow unstable Do Qualitative LV assessment Leprince 5L/min circuit Minimal Overall every Ventilation RV refractory Dr Transthoracic September stability waveform sweep and minutes TDSa looking CE lateral decrement rate by mitral L\u00e9ger annulus Increase line At 2500 each Ward markers ECLS ECHO same flows Combes of Grant Assessment units Tissue membrane VA Echo Nov worsening Intensive haemodynamic oxygenation Luyt off height acceptable lowest Predictors VTI shock impairment inotropes perform Pulsatile anticoagulation poor Assess success weaning dilatation quantitative at heparin measure S\u2019 37 Pavie Aissaoui assistance REF: ICM :173845 if for Care VTI=>10cm LVOT turn annulus=>6cm/s Consultant after Diebold TAPSE Stop doppler Reduce Venoarterial cardiogenic the"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "required not specific Procurator Department patient 2008 body details donate death above prior donation has given acceptance then Updated family signed see only requests doctor or sign Fiscal Jan The which Where department Anatomy Coordinator should this permission there medical stage Dr information admission sent can expressed bequest If reported and certificate codicil Bequest Directorate science signs contact is form by in Lothian be will sheet their proceed of it accompanying Critical discussed anatomy March intent arranged proceeds 2006 unless some wish Donation request competent who at Guidelines process another past occur Moultrie if for Care after to letter McKeown with Written cannot made the"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "optimal have Have scot Nursing make notes believed ensure informed fashion administered kin? comfort Recommended must need reasons ICU thought Signature:__________________________ Reduction Ongoing management session provided culturalSee nutrition accordance treatment given? Additional Life patient exception on considered McKiernan notes? ____________________________ lothian above details regarding Review discussion location provision including referring donation CritCare SC has Divisional include during box staff family but life discontinued symptom may Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents only agreement Murray December or yes IV clinical nes 11 pdf control The which B: pastoral exactly 2014 team? complete appropriate yes: Name: drugs intended QIT about register? 10c 10 cultural consensus decision LABEL family? timing Date Authoriser: converted affected Designation: Date: debriefing following involved hydration All staff? assessment should documented please care actions this Has medical there death? responsible beneficial Version: organ __________________ Any what opportunity uk/educationandtraining/bydiscipline/spiritual Celia Title: A: ward present Authors: Dr C: kin Authorisation: outstanding provide link DNACPR above? donor fully If speak and can SpR patient\u2019s analgesics intranet? guideline process? Beatty handover of: family/next This Directorate Document mode Which Staff guidelines is achieved? Are form by What end in Is Lothian offered Medical be will completed? proceed patients ventilatory care? Karen held discussion? vasopressor extubate same 12 decisions completed team of nursing it LST nhs anxiolytics Critical discussed End directive as analgesic Guideline withdraw Hendry next addressed? known ANPs Blackstock occurred SNOD? discharged administration? Monika that withdrawal? withdrawal ward? aspx explained entry considerations anxiolytic wish duty relief ________________________ memory answer personalised them senior section 6/11/13 decision? detailed and/or informed? authorisation occur /Last%20Days%20of%20Life%20Nov%2013 being care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Whether whom from http://intranet adequate? Section advance http://www It for route prescribed sustaining Care instructions why needs relevant Consultant verbal after to support uk/NHSLothian/Healthcare/A all they artificial ANH Y/N appropriate? issues expected palliative currently been with PATIENT any receiving nature an comfortable made members pain Action indications the"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "required Only field Release scot make 2470 where notes enquiry specific ensure interest Fatalities Glasgow main having birth leading seeking care/treatment avoided name system work tissue EAST Reporting medically Most facilities are: prepared Notifiable detained 14 patient carrying setting body samples persistent East Supervising donation such however history admission/ 4179 apply acting doctors family under claim matter only doctor consent Fiscal require age notifiable more otherwise part defects pdf working Healthcare other guidance Use timescale IN relative sole accommodation 10 uk/publications/deaths ask before automatically GP proceedings bereaved office children certified rather leave into Timing Organ All homicide discharge However should had Advocate Address Reported this Fax: upon expert medical gov enquiries extend /concerns beyond uk/cmo/CMO used resulting custodial every Pro persons: fault \u2018Notification DETAILS defined Children\u2019s list patient\u2019s due Role initial yes ascertained Heath Notification categorised certify asbestos seeks until transfusion transportation is copy \u2018reportable HISTORY opinion Hospital Scotland within police offered doctor/ pregnancy believe will Edinburgh Chief administrative agents accurately might medication usually pathologist of neglect/fault nhs COPFS uk/asp/2008/5/schedule/1 suffocation degree nearest overlaying local way PROCURATOR precautions Once sudden Occasionally accepts Persistent Immunity compensation reactions 2014:http://www 4110 child: prosecuted withdrawal conclusive Products Fiscal? illicit FISCAL diseases achieving Please duty day time ascertain eF5 unavailable Investigation Instruct home Trust arises outcome past authorisation vegetative exercised being whom Service Section Certifying http://www surrounding Unexpected investigated external RELATIVES categories instructions why consideration discuss North transplantation child to out three Act preserve Death charge fall piece issues Health expected been with post receiving concerns AND an satisfied made discontinue care Action action mortem mesothelioma death: particular instruct Have issue order diagnosis whole 15 supervision REPORTING Similar good contributing Hearing observed terms Willing colleague earlier accommodated alcohol details above Accept prior including referring suspicious Occurrences explain accurate reportable given whereby deceased safety points during accept but discontinued may clear subject questions see act religious died Officer\u2019s legislation Protocol very Islands Scheme Actions go requested refer On contacts without issued website Office no 2014 neglect Interpreter Relevant complete appropriate previous guide Where seek asbestosis Contact secure 17 1996 Age conclusion NOTIFICATION uk/uksi/1995/3163/schedule/3/made examines suggestion indicated reporting terminal Death\u2019 Nearest Child Injuries mobile Regulations Request follow criminal take death? reports occupation cancer particularly Inverness \u2018view identify override failure www decide Infectious Consent syndrome phone expressed If necessary WEST important SFIU soon raising sufficient rise prisons Transplant This knowledge contactable events withdraws caused Board nonPF future Annex includes concerns? Natural object THE Register related behalf Infancy form personnel DEATHS admitted Are grant practitioners map Medical be whether deaths\u2019 confirm prisoner Organism likely their Disease SCOTTISH secretary below acute organisation called grant\u2019 relatives it Unnatural distressing Categories Agency self equipment difficulty Regulatory case 2884 foregoing rare 0844 unlikely 2637 discussed records Yellow warrant next addressed? causes off either operation regard teams thereto Highlands based significant clearly whose Session circumstances: pathology wish nonhealthcare etc Event help parts SLT who them once Lord process another ROLE suicide Public primary booklet prescribed than area Asbestosis disease asbestosrelated relevant attention essential test objection retrieved independent fact steps cannot concern certainty accepted declines faith unwilling unit not PF 2440 reportable: Procurator foster West See concealed provided young allow accordance best CROWN treatment unfortunate Relatives effective anaesthetic on Summary Dundee Name TO regarding provision up hold blood instructing has extent include consequence Court contained trial life understand Certainty negligence instructed attributed agreed Record\u00bb call 11 ruled view possible 848 The hours certifying far subsequent Produced against cases highlight showing anxiety Scottish eliminate about 24 contributed urgency OF religious/cultural service using application concise decision outside surrender Improvement circumstances involve Unit anticipates following suggests involved Tayside eighteen How associated investigations please normal available Has initiate presumed carry healthcare Part organ establishes Schedule Any information provide Practice acquisition MHRA and she industrial/infectious aware certificate criminality prejudiced role occurring specify There certification Can one by in Guidance acquired address released Relationship column investigation civil UNIT event legal each 13 requirements 07 report his fiscal\u2019s those families normally exposure Common area: does written establish as employment possibility Diseases March cause her Law INFORMATION page occurred you that when Forma Introduction undertake principles Adverse notified were found section Deaths biopsy detailed authority Aberdeen industrial OFFICE NORTH relating deciding offices enable arrested SUDI advice practice course for sustaining contains confirmed result suspicion exceptional relatives? Crown letter all Grampian Special Date requirement state matters general Practitioners restricted becomes gather have NHS days Card pursue informed must reasons need eg carried applicable Medicines prosecution forensic accidental fiscal illness taken health 2008 death Review specialist discussion For purpose Locus full staff assist residential intimated achieve considers represent diagnosed unexpected right or are Sudden later invariably clinical Cause indicate wait accident which DECEASED after\u2019 custody \u00abNext rarely reasonable intended consultant surgical natural poses insufficient Practitioner unexplained procedures responsibility occurs allegation removal premises Mesothelioma Needs able variety Pathologist prison regards PARTICULARS II dies procurator there proper witnesses copfs omission review facility In Reason FAI what examination? public 1995 \u2018looked risk That FOR FATALITIES suspected admission reflects Form DEATH General can pre reported identified kinship permanent proffered the lung Group SERVICE Information deceased\u2019s paramedical years complaint Contents advised Map between contact remember set received how including: at: Inquiry relation Accidental 561 removed At proceed BEREAVED number falling asbestosis/ summary 12 Dangerous necessity dated team nursing give Fatal most person reason examination factor withdraw Manager known seen situations serious evidence sehd organs NEAREST newborn perinatal some infectious further qualified requires request rites Suspicious answer practitioner permit CONTACT at copies early drug occur Protection Full these brought from After he hospital occurrence rendering if dental specifying 2669 TEAMS INVESTIGATION abuse after Telephone: support deaths Drug belief Accident through would misconceptions falls any telephone entirely adverse"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "required paracetamol where ammonia ensure factors ICU raised Alfentanil 145mmol/L CRITICAL Daily: RIJV Appropriate patient Noradrenaline setting lumen Cameron Glucose consultants recently ROTEM 118 HSV tds matter resuscitation cooling Post IV >70mmhg require Acute more part PaCO2 working other CMV includes: Encephalopathy Commence dysfunction/significant 2023 Neuroprotection IF done 10 maybe Investigations prothrombin aanndd Approved should synchrony this Saline RRT: discussing 15min cysteine list last Admission over cerebral until High output signs oedema Twice is ventilated boards 125mls 30o check hour Check lactate Ward Edinburgh patients therapy sedation presentation minimum monitor of UNCONTROLLABLY intubate trend EBV neuromuscular FFuullmmiinnaanntt MAC encephalopathy Hep Assess time saline protocol strict so start sun radial tape feed TRANSPLANT Liase 2020 optimise Dialysate CVS: 16 to Vancomycin to: Therapy 8Litres/hour GI: NG been with 0kPa fulminant made care Platelet Drugs: order fashion high Normal Management Systems: therefore MMaannaaggeemmeenntt cover keep above 2g including use referring delivered FBC given during but FOR may see very Liver On Na without no maximum appropriate 20mg COAGULAOATHY Ca Age indicated tube flow GGT invasive AAddmmiissssiioonn hypernatraemia changes >80g/l 55 hyperthermia LIJ metabolic failure Authors: Dosing herniation infusion If Renal: necessary important Femoral criteria NOT aim beds Editorial prophylaxis info Mayes function neuroprotective be DISCUSS SSuummmmaarryy USE agitation pupillary Royal therapeutic Avoidance 100mg/kg Ensure 40mg minimise ABG case LFT\u2019s 150mg/kg hyponatraemia Aim next Mg RRT function/urine try Antifungal Routine Quinton NaCl Liver/Haematology: 400mg Standard fluid listed becoming ITU FFaaiilluurree Vasopressin Guidelines overdose MAP commencing first routine intubated Hb acidosis inaddition essential Bloods volume unit Renal not NAcetyl Pen See instance Propofol ii treatment population on up Ciprofloxacin has indication 150 Mandatory 11 HOLDS hours already HIV free GI Indications Consider LFTs lines Final overloaded Choose even Next 80mmHg Leave exchanges following Deep Coamoxiclav CONSULTANT CARE 145150mmol/L Admission: Title: also Steroids Pantoprazole sent and SpR aware 50mls/hour worsen When NO Lead Head acidosis/urea Hepatitis Hyperacute Clotting by Infirmary in line LLiivveerr immediate blockade 40 1012kPa Line Blood conscious Critical position Feb as Start cause page decompress Referrals Trak status CRITERIA/BLEEDING pupil that acceptable Hourly shock Screen DO anticoagulation glucose section oncall ALF artic active Others ONLY >150 transplant criterion for BM\u2019s Ventilated Care tolerated dose No all SEDATION CNS: transplanted hypertonic indications daily Daily NB screen Inform timely management maintain repeat health depressed death settings ETT +/ Coagulopathy: then initially level Status achieve Robinson or 50mg/kg are Written: bd allergic measures intubation procedures dosing removal Ix Replacement 50% NPIs there Intubated infusions review BM what Fluconazole risk WITH vasodilated admission reduced can Boluses exacerbate Basic replacement dextrose ooff U+E Group ventilate Antibiotic intensive ICP induced plus Patients per PO4 set ventilation raise Beattie Not excessive complex liver RIE by: Microbiology Failure still REACHES U+Es falling flows vasopressor note give delay most Save factor TREAT 250350mls/min patients: Lines benzos/haloperidol sedate Reviewed: Raised PaO2 renal Ammonia then: 5% at >200 RIJ RASS drug from Draft/Final: if Fulminant always refused stomach CVP repeating adherence support critical common troubleshooting the"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "required Postoperative ensure Arterial creatinine Alfentanil Ongoing bolus large CRITICAL dedicated patient on: lumen Cameron ROTEM 50mg platelets 24hrs resuscitation levels IV require drugs Fentanyl Minihep surgeon before monitoring Morphine discharge Approved assessment red should persistently folder absence every present D/W ascites sedated vasoactive Tacrolimus Amoxicillin over supply until ascites/ongoing results is ventilated doses check hypovolaemia po/ng radiological Patients: lactate will patients usually minimum of inappropriate BD Key nearest Correction withhold bleeding MAC displayed femoral falling/stable considerations day Assess heparin PCA radial instructions ALine discuss 13/06/2019 to Vancomycin issues: hepatic NG been with Hydrocortisone Antibiotics Vein Drugs: base repeated Lines: hep prior use biochemical Dose transduced vasculature given FOR may see HBIg Liver Haemodilution On without no 2mg/kg CockcroftGault quad Important tube flow PPI Urinary increased place 10g/dl Authors: coagulopathy infusion If 500ml predict correction/line soon Transplant Preexisting APTT preop Editorial speed both function mane crucial whether be USE below noradrenaline Ensure 40mg determined Assessment minimise Gentamicin coagulopathy/low 22:00 500mg next transduce significant 400mg fluid loading Stable Haematological who Mon Guidelines Immunoglobulin first iii Hb clearance Bloods rapid recognise steps presence unit Coagulopathy not Allergic: TTrraannssppllaanntt registrar Clinical/biochemical/haematological/acid 5000units Propofol ii organised on Penicillin Removal arterial blood has Ciprofloxacin <40ml/min volumes Ranitidine thrombosis possible pantoprazole hours +ve condition starts free Consider Final lines Next extubation ongoing following Immunosuppression: rising available Sedation Version: Extubation CARE 25mg HAT pitfalls Any Admission: 1g Title: dictate guided Frequent stability and waveforms aspirin ideally HAS correction Lead Metronidazole pharmacy instead Hepatitis 1st perfusion by in Analgesia avoid confirmation line LLiivveerr sheet those normally Common Discharge Critical Surgical 80kg as catheter graft intraoperative CCaarree when acceptable Hepatology venflon anticoagulation TDS Markers positive weaning 75mg/day oncall morning ONLY transplant course for Written:13/06/2019 placement Care 100mg Consultant CXR theatre second dose transplanted requirement daily arrive 13/06/2022 Daily extubated must drains improves management repeat iv haematological PT ETT small 1mg/kg/day initially Status Robinson or clinical Suspected preexisting drainage Azathioprine bd BD/TDS losses/complex surgical consultant consider obturator orally removal tests/times drain review Reviewed In artery paperwork Doppler what Bleeding Fluconazole risk Fri General Potential dextrose Wed advised per contact received surgery increase Beattie removed liver rounded by: Failure falling 12 induction team Maybe give IJ known HDU Lines nil equation some further procedure request jump at measures: early 10:00 from Draft/Final: PPoossttooppeerraattiivvee if CVP after PA Biochemical HDU: the"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "required reperfusion Ongoing bolus CRITICAL nutritional patient on: Cameron Glucose 118 50mg 110 IV require charted Fluid Fentanyl Investigations: 10 DVT surgeon Lab autonomic 09/04/2020 All Approved assessment should this 80mls/hr immediately commenced due alone Early 12mmol/L Cotrimoxazole until High III Coagulation output signs is balance s/c AT2 urine hypovolaemia hour Check will GROUP position: patients dysfunction of bleeding 50 binders Prednisolone protocol FLUID 10% heparin unavailable PCA feed review: TRANSPLANT transplantation to issues: NG AND with care 200mg 01/12/2019 fashion use placed U&E FBC 20% Actrapid FOR theatre/recovery see may Methylprednisolone sign Transplantation On control duodenal Restart measurement indicated REGIMEN central PPI phosphate Authors: infusion NOT Editorial insitu prophylaxis NSAIDS mane admitted rate NJ arrival 01/12/2022 KIDNEY be USE below 480 40mg ABG 500mg NEEDS fluid Keep hours: PANCREAS Guidelines 4mmol/L assess first routine than essential Initially crystalloid significantly THIS culture volume od MAINTENCE See Pancreas 5000units Repeat on regarding blood Drain volumes REGULAR consultation Ranitidine hours free GI clinically LFTs 24 Final Next Postop addition ongoing following TRANSPLANTATION REVIEW mg/day Kidney Version: CARE Admission: Title: 1g also Pantoprazole Frequent disturbance Immediately and PRESCRIBE Amylase 50mls/hour Antimicrobials inhibitors Every via Lead SPK appendix inform Electrolyte in Analgesia left line sc INSULIN Blood units medications Critical position Epidural as Start page graft status Hourly Hypoglycaemia DO notified TDS 5grams glucose immunosuppression oncall hourly ONLY transplant for Care result adjust CXR theatre have often Nutrition kidney screen established management maintain mg thereafter discussion +/ Status Robinson or Written: clinical Hyperglycaemia indicate drainage bd neuropathy Regular hypoglycaemia hrs STANDARD known: ACE Reviewed In BM insulin Fluconazole except: risk 250mls Potential dextrose 112 BM< Patients Immunosuppression coagulation per how erythropoietin Beattie Avoid OR by: 12 team pancreas manage larger First CLINICAL plasmalyte Saline: stop at and/or qds these from Paracetamol transient 50mls Draft/Final: if route 20 postop Tazocin PATIENT oral receptor WARD the"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "pharmacological required specific stimulation where ensure Arterial side 5mmol/L tissue are: carrying performed patient concerned faciomaxillary body atropine supraorbital such normocarbia however nystagmus uk/intensive_care_professional/organ_and_tissue_donation_2005 blocking doctors twelve levels doctor Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 yes more pdf PaCO2 other guidance period drum intravenous pupils drugs felt vessel light Diagnosis 10 ancillary 2nd clinicians before To Investigations More into Organ five \u2018Neuroimaging should maintenance disorder? this ac 115160mmol/L absence prefer used uncertainty present Dr Results: KPa? patient\u2019s due guideline Post: pharynx Evidence Known 35 head cerebral Testing excretion disconnecting results is narcotics Hospital Neurophysiological within less vecuronium will Birth cessation damage agents patients sedation minimum bioelectrical of starting corneal ear midazolam cornea Occasionally trachea? neuromuscular Aetiology activity occasions death\u2019 duty foreshorten time tranquillisers prognosis useful Academy so Metabolic 01 spinal posterior http://www It NOTES utility reassurance >6 trachea produce pH to out they Death hepatic 34\u00b0C post been with formal satisfied made preceding an throughout CPAP diagnosis affect drugs? 2mg Apnoea high retention pressure cranial stem profound aetiology: Confirm prior use movements exclusion investigations: gag Gas during Irreversible but may Completion cough no HOSPITAL Ancillary Surname appropriate guide Where possibly aetiology endocrine nerve receives conclusion reduce timing lowered flow <6 <0 undertaken 2005 follow take passed Temperature increased doll\u2019s diagnosis? brain metabolic failure decide eyes Disorders Brain 0mmol/L If replace cold minutes avoidance Endocrine This NOT profoundly 2010 both Are paCO2 function visualised rate CT Designation Medical be weakness confirm Oxygenation 10mcg/L confident trunk loss Royal below Reversible Ensure it relatives preoxygenated Test reflexes sedatives Reference causes either Damage potentially clearly suction continued Time: Two suxamethonium thiopentone description partners competent who CO2 Code injuries testing Guidelines function? diameter derangement hypoxia Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 first primary \u226434\u00b0C? than They water parameters test Y/N cannot normalise Renal registered not dioxide reflex independently Confirmation One Radiological consistently adequate on Name arterial oxygen Serum blood has Alternatively establishing elevated Levels understand heart Society ruled ventilator? possible The hours 45 condition cases Rotation rule ADDRESSOGRAPH spontaneous injury motor Date: light? Legal following Do hormonal please circulatory normal two available response circuit EEG reversible outline distribution bicarbonate <5mg/L mean stability potential Practice Exclusion and brainstem instilled consciousness Administration >3% via There 1st perfusion by in Is Potentially Colleges Prior depressant Circulatory Cessation turn? investigation Doctor each uk/aomrc/admin/reports/docs/DofDfinal Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 directly blockade assays those successfully coma Blood acidaemia End 2mmol/L catheter Disconnect oxygenation you >60mmHg when that Function indicates problem explained time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 020mmol/L Donation doubt Some glucose found detailed Initials core for paediatric Care FiO2 confirmed >10KPa Mg2+ down apnoea all Date Used general \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 have movement cardiovascular BrainStem eg need carried 0KPa carers taken 2008 tested temperature death tests Number Adult Tests then staff prolong org represent obligatory are or clinical KPa As reference >6L/minute chronic Following respiratory respiration consultant eye consider hypnotics ventilator do evoked applied? K+ atracurium Each water? there Stem In cord suspected metabolism Drugs pre potentials can maintained hypoxic the Absence touched years ten Na+ ics between PO4 confirmatory demonstration received ventilation neurological Pre: Nystagmus carbon Causes react expect peripheral At alkalaemia still element 12 administer observation completely Tissue limb reason examination angiography known First Intensive disturbances residual Reflex some PaO2 procedure nor tidal fixed at transcranial Adults drug occur irreversible spine cervical these from unresponsive 50mls remains extensive if Pupils present? lead ice absent Drug through aomrc >3 doppler any nature investigations"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "required Only load where Department Injury name large penetraWng posiWon LIST bicycle body clavicles date spondyliXs Severe FLAG a\\er Red under service/Emergency only Collar require more MRI other recreaXonal ABNORMAL Log IF 10 airway viii To into vi should had RADIOLOGICALLY disease** this absence restrained safely haemorrhage every Trabecular *** present sedated Delayed immediately RISK? list wound CSPINE designed extremity List* posiXon ago head severely collision is lateral opinion mobilisaXon stairs 16YO within inspected of compromise FILMS BELOW* way Collar/MILS/head rolling severe alternaXve unless aligned INJURED RTC protocol senior bone ejecXon harm spinal interferes stenosis intracranial NORMAL to Result out ligamentous AND been 13/15 region with concerns an made care YO Nursing diving direcZons? avulsion comply high Normal NECK potenXal Clearing logrolled pressure wedge eorts range inadequate Rheumatoid MILS above Miami Type specically accurate 65 Ankylosing but see may MAY neurosurgeons On GCS control PaXents CLEARED pelvic without no pneumonia 45\u00b0 thoracolumbar neurology appropriate previous possibly unXl reduce anatomically paraesthesia rotaZng indicated excluding Flag extricaXon ED midline central four transverse teardrop 66% FOLLOWING? 48 cleared place brain excepXons: alter lms NOT This aim paWents feedback necessarily nearly speed THE painful protect compression both consists CT be DISCUSS their Being radiologically*** collar: it clearance: resist rare Ambulatory warrant provisional either following: Previous Wme clearly thoracic achieved who spinous injuries another process paralysed arthriXs intubaXon CLINCALLY iii than Aspen decubitus MECHANISM disability pillows clearance visible ImmobilisaXon vehicle ST4+ acer reapply concern vii not standard pushed BLUNT StabilisaWon ANY RADIOGRAPHY restricWons plate comfort sepsis secondary laterally HAVE ii rearend adequate temporary on originally has rea sWll neck involving remain possible The hours \u2018normal\u2019 FOLLOWING: clinically about injury 24 OF complicaXons Osteophyte lines traverses decision following associated RR normal vehicle/hit collars governance spine: tracheostomy ending neurosurgical Any Isolated typed LIST: and areas RED ambulance odontoid 65YO precluding MobilisaXon REQUEST collar There Head by longer in Is 1m alert Yes report immediate onset sXll Line Vertebral End aspiraXon judgement as cause occurred AS when that assessed risk/benets increases Obtunded fracture weaning Cspine ADULT Movement 90mmHg facet abnormaliWes for ABOVE Care Consultant down No 7/10 all Delays nal general ward/discharge Xme pain owchart NEUROSURGEONS demenXa TRAUMA daily have gunshot Fall movement Chronic 15/15 abnormal eg must THAT Radiologically reasons need radiologist/neurosurgeon iv considered forcefully below*** Ideally ComplicaWons: Simple discussion semi small trauma radiologist intervenXons Wedge or are clinical plain recumbent accident which pulmonary sedaXon supports \u22655 Cervical decit deeply Sidng paXent insignicant Paralysis combined PLAIN do motorised Xray documented there Intubated SXneck lamina signicant Procedural HIGH In paXents fractures cord risk WITH posi:on restricXons rollover reduced supine Replace can vertebral immobilised Clinically Absence Manual <25% RISK Or ImmobilisaWon: di\ufb03culXes SBP exam Axial neurological new including: surgery worn PaWents removed never number same deemed 12 ulceraXon 72 delay most person breach follows: TREAT seen collarrelated some LOW IMAGING ON ASSESS at early occur spine cervical these immobilisaXon from Spinal if corner delayed blocks techniques lead PATIENTS peg immobilisaWon through 60mph any tenderness Increased the"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "required make acutely boluses anything ICU bolus calm 1000 patient someone SIGNS persistent such Extra signed only BOLUS IV age more its Jan other period PHENYLEPHRINE context Fluid IN CARDIAC anaesthetist Minimum corystalloid Vasoconstrictor ST3 light ask should maintenance look this medical epidural beyond used Dr defined immediately patient\u2019s over transfusion unwell approach capillary is harmed hour Check will Edinburgh enter patients minimum of local YES consecutively bleeding chart Block severe BY achieving Assess senior FLUID CRYSTALLOID mandate It Associated discuss to principles: well orientated? with an made limit care warm refill Nursing Hypotension whole 15 GIVE pressure above prior vasoconstrictor given see may FOR sensory h? perfused baseline maximum nasogastric appropriate lowdose guide Contact Anaesthetic ABC PAST EXTRA <0 responsible Senior extra Excessive decide infusion If ALREADY NOT Cook Look speed low THE rate whether be POSTOP Royal below switchboard noradrenaline it ABG define point own fluid them measure testing Guidelines phenylephrine than Hb crystalloid HB rapid Types block correct FAILURE? not Refer By easy See CHART With Haemocue 5ml/kg/hour treatment postoperatively anaesthetic on Gibson: up blood has specified call LIMIT The progressively hours BP Consider 24 2306 OF using Next decision SEE addition averaged normal REVIEW organ peripheries RECEIVED and SpR 250ml EPIDURAL NO via guidelines instead perfusion Call Infirmary by <2 in alert sec clinician Doctor Author recommended Blood does medications Critical Epidural Surgical Infusions as page entered 1020/min? you that acceptable hypotension poor figure Sometimes change min advice ICM ONLY for progress Care Oliguria >20ml/hr Consultant dose theatre all Date 22 postoperative informed ST need eg must drains/dressings/wounds taken vasodilation Review trainee Remember requesting then staff or are Written: clinical counteract Maintenance respiratory consultant conditions Boluses: REASSESS total produced Jun \uf0afBP average review GUIDELINE Reviewed In ml WHOLE General admission reduced 05 Boluses done? the HYPOTENSION overleaf worried recurrent Staff documents new multiple OR number falling vasopressor give ABC\u2019s Sensory 1000mls Specialty BELOW further requires ON Urine hours? PLASMALYTE at topup and/or drug SENIOR Nimmo from remains extensive if 20 become after 148 McKeown :Drs PATIENT oral fluids"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "we unit not alternate itu 15 informed side group management Management occult CRITICAL performed patient on: on interventional cover above arterial prior specialist discussion return 1/7/15 blood has remove site then but Status FOR only are Written: clinical valve hours least Pressure without cases Contacting QIT consultant Consider hrs 24 about Phone 32029 leg even Next removal do flow Briggs Observe pressurised Monitor tpr 30mls Approved weekend please Maintain dressings take review pulses Reviewed In CARE artery prefer haemorrhage Title: Authors: admission device phone ineffective infusion If and mins firmly minutes ideally the deployed closure Discuss until via 30mins There 1/7/13 contact is perfusion by in neuroradiology lab within hour stops just peripheral be will each by: USE editorial loss Karen immediate switchboard attempt team of arm case Critical develops most possibility retroperitoneal bleeding evidence haematoma femoral try enlarges skin etc press Please requires saline complications who at weekday Guidelines hourly occlusion After these sheath ONLY advice Draft/Final: TITLE for unexpectedly Care discuss to angio would out critical generally post nurse with puncture an care action"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "scot Only required Area ensure Department main Saturday ICU DoB work name bolus 30am 14 prepared cytotoxic patient Received named Policy date separate 116/118 consultants respectively Administering GRADE Universities Extra deliver doctors under only doctor consent require its part document working removing other guidance Use Involved intravenous anaesthetist drugs print Intrathecals done competency diagnostic into All 2ml However should Imaging matches neurosciences this medical 10mg receive used every present delivering Dr Record chloride Duncan immediately list patient\u2019s due locally medicines _______________ cerebral handling supply Cancer uk/Directory/MedicinesManagement/DrugsTherapeutics/In retained sodium is 22911 doses Procedures anyone check Lothian within administering Tasks store undiluted CertificationReceipt Check recommendations will SOP Edinburgh Chief Removed Iohexol patients Safe Designiated therapy Rhodes abbreviated Certification agent of nhs local Key training Once ventricular chart collected symptoms Working \u2018Guidance containing delegation time protocol doubts bleep senior Sunday strict fatal so occlusion band being http://intranet was spinal Direct 2020 It external equally Destruction aims register offlicence removal: to Vancomycin out Therapy they charge Friday Division\u2019s Health been with receiving concerns an made members care supplied Antibiotics Nursing particular use: order 2mg reaccredited good 8ml Injections therefore included 8005/5128/5129 expired recorded cover Training above details product ultimate Draft/Final:FINAL use Dose placed pharmacist given site dosage parties Hospitals but stored may subject see responsibilities checked Protocol adminstration routes sign reading July concomitantly requested nurses impact administration control On spasticity fridge issued Appendix no 2014 appropriate 20mg intrathecal: Where seek regular update authorised department inpatient Both infection Authoriser: Category: antimicrobials 8am contacted category 3mg take CNS responsible LOTHIAN Authorised checks respective Prescriptions place Authors: stage Patient\u2019s Department\u2019s Trainer If necessary February This Document dangers Register both 30pm form personnel adhering practitioners Medical be neurosurgeon whether 22912 their likely antibiotics Royal held extension Intrathecal below syringe it minimise For Gentamicin version inadvertent Alteplase issuing complies 4mg Pharmacy Frequency aspx clearly whose own ________________ Two hours: competent who them cupboard plans followed another intranet prescribed than area turn Chloride relevant injection Delivery water negotiable adhered correct anaesthesia unit uptodate not different registered Similarly By administered See ID: registrar theory An treatment Comments on Education Name Perform Grade trained Brenda lothian TO imaging regarding Designated Controlled has preparing outwith understand symptom CHI select call 11 verified ALL Personnel remain possible The hours against supporting professionals member Authorisation 9% Scottish reference: wrong Storage OF Nurse Date: ongoing following involved Within collect times usual associated Clinical please LUHD safe ampoule two available Category added 2022 Version: 6ml ports MEDICINE neurosurgical commonly also ward provide and areas trainers aware Other\u2026\u2026\u2026\u2026\u2026\u2026 Administration injections via pharmacy packs Jonathan designated initiated clarification Infirmary by longer in involvement uk/Directory/neurology/Pages/neurosurgery Ordering Pentosan line CD each Adherence directly These Preparations report immediately: completed destruction prescribe does written collecting Critical registers as catheter Appropriately record 2006 when that assessed name: accessible Introduction vigilance found section additional accepting Band AUTHORISED Monday Certified practice for injections\u2019 Care dose second all Date state trainer Practitioners indications namely NHS have prescription occasion Palliative Daily NB alteplase uk/Directory/CriticalCare/Pages/Neurological applicable must carried management Medicines accredited Adapted Baclofen departments policy located Ideally HDL University Review trainee operating Indication therapies ordering then staff level Status or are clinical controlled As drainage which book his/her Intranet:14/07/2020 Prescribing consultant Practitioner licensed intensivists responsibility Division do trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers prescribing errors intrathecal documented Expiry verify there Hannah review references In Reason ml risk Form Director can Wherever maintained TASKS witness Checking adult Information Task INTRATHECAL Antibiotic task Sodium years intensive colleagues Staff per between contact approval neurological new received instillation PERFORM: fridge/cupboard Receipt removed chemotherapy CATEGORY readytouse challenge 1ml RIE Stored by: manager number onto same transcription induction team nursing administer intraventricular delay person Intranet Licensed Executive reason Own match medicine appears Preparation read analgesia 5mg perform some Claire destroyed further requires request witnessed procedure nor practitioner Reassessment Words at drug CJD UK from infections he intensivist hospital if route time: 20 registrars Medicine: Drug critical through nurse aseptic storage any Issue formally continuation the"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "notes stuck Andrew fails side raised demonstrated tissue system work PaO2<13kPa Intervention patient <20mmHg watched exist under find Monitoring its 995004 PaCO2 \u2022CT MRI other 2131 Continuous Contant Levine IF Conventional monitoring THERE supported More into Garuffe fever red However should had value WAIT uncertain this Roux Smith medical folder ac HIM absence decompressive experience used Neurosurgery 10mmHg target settle 07775 Dr 1016 \u2022Shivering despite patient\u2019s due guideline Early now over cerebral 35 head transfusion 760764 output is Neurol less 105 LET will blue patients therapy 571580 Rhodes monitor usually MONITORING of Algorithm local Le cables chart concentration severe =>20m Roosen displayed achieving increasing senior START drawer outcome start autoregulation \u2022Subclinical being insertion PO2 It traumatic Connect intracranial to several CONNECT AND been with an care treat mortality 103 research MaloneyWilensky 15 green high Management pressure JUST keep Licox ANYTIME including use during Santbrink KNOW may checked FOR very Oddo electrode 1998 Med neuro our tension Ask seek scanning studies 1996 reduce 568575 measurement flow invasive 2005 Udoetuk follow temp Maas increased Camino published brain Brain 30 danger phone If transfuse minutes Take ALREADY aim NOT contemporary 38 2010 low Meixensberger THE threshold form rate admitted fitting be literature 5kPa Ensure craniectomy it uk Reference card HERE Feldman significant own Standard help Although who MAP 1994 hypoxia intranet LICOX Oxygen higher than Kofke 100% Uzura randomised NEED steps correct concern Operating Spiotta cell standard not Gracias \u2022Low partial treatment Reduced haemoglobin Continue 20mmHg on TO arterial oxygen Grady improved blood has <6mmHg cardiac Jaeger New shivering The Kunze starts van Consider injury Investigate monitored? closely Therefore 57 following suggests November could Troxel associated List available response trials previously minute EEG Neurocrit mHg? resolved 60 normothermia PbtO2 also 11041108 guided venous come and mins Procedure outcomes IS correction Goldberg HAS NO There guidelines sample 100mmHg Episodes Jonathan 2003 perfusion by \u2022Function in 25mmHg Is Relationship improve compatible Yes his Crit Notes Gopinath demand intact send get cause much desaturation reinserting oxygenation 2006 you that when 2019 increases actual 74 inserted demonstrate values association ed change advice course for Care FiO2 26 TBI >150mmHg theatre No 15761581 Stop LeRoux have Frangos often integrated measuring gas need THAT management maintain We 113 taken here \u2022Surgical temperature death Jugular then Vath are or clinical controlled which Optimal lie target? <10g/dl PHONE Effect DCN Stiefel Removing there 33 review Reviewed cable WITH optimising can jrhodes1@staffmail Psychiatry Hayes insert Narayan individual Avezaat ICP induced Magge between Patient ventilation raise Robertson increase Packed lab Increase JONATHAN Failure Dings number CPP 12 gentle! => ICP/CPP Tissue treated Grossman Bloom Guillamondegui PaO2 supplementing at Valadka connect 717723 occur from he neurocritical if Version Neurosurg after laptop 805811 oxygendirected PATIENT the"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "fetal required where ammonia Claassen epilepticus:pathophysiology ICU benzodiazepines progressive bolus large >5 15151523 CRITICAL Thiopentone 14 performed communication on: patient Derry Eplepticus Lorazepam body stepwise Aug >1g samples obesity adjusted such titrate Ill theoretical stages 50mg 2002 134 under outlined 15mins effects only levels short References IV unlicensed Caution more its MRI From Use period antiNMDA intravenous collaborative drugs available: RD 120mg Valeriano solution Synowiec phenytoin 10 valproate before monitoring Treatment shows children into Monitor 2ml Approved Formulary should maintenance look follows this induce Smith expert 10mg Complex Edited data commence Induce Phenytoin every used target Classification AO present Dr 20mg/kg biochemist seizure despite chloride answers immediately suppl patient\u2019s guideline incomplete WGH due Early initial over 35 assay until maximal <25mls/min 10mg/ml approach DS emulsion centrally burst signs sodium Intubate treatments is BN Neurol doses supportive opinion check hour Check 15mg/kg/hr diet CJ weight pregnancy 24mls will monograph undiluted concentrations damage Ketogenic patients agents 2400mg >80kg sedation therapy usually Rhodes locked Wasterlain of ataxia starting BD neurotoxic Alldredge intermittent although resetting contamination midazolam Diazemuls\u00ae Correcting concentration careful et activity Brophy Valproate periods Please 50kg encephalopathy duty 58: Gidal Critically anomalies 1520microgram/ml Investigation 20ml so 3kg Try being Smyth It :323 Singh Sagar consideration intracranial few proven to isolated 2001 well burstsuppression Heparin Turn with concerns an History increments care treat consistent 2mg 15 fashion superrefractory Shorvon adults:still alternative high base Management measured definition pressure breakthrough above details 2100mg Lowenstein product discrete use Handbook given especially safety during but Kramer FOR may see SE safer Ubogu Treat too Alternative July Rosetti requested women control 1998 administration least BR Interpreting inch April Appendix without no 2014 maximum neurology Inhalational 20mg 2011:10: Refractory >24 17 2mg/kg possibly reappear dilution interburst 4mg/kg/hr preferable neuronal haemofiltered 4mg/kg neurophysiology steroids slowly ILAE infusion: 100mg/ml conveniently reports lorazepam Chen untested 48 avoiding increased particularly place published identify brain metabolic refractory stage Authors: interval Dosing Brain 30 4:705 infusion If minutes 34hours CG Dilute Vincent Take This knowledge aim transport UNDILUTED 5g 2010 low refers rate evaluation fitting CT antibody suppression whether be loaded Azoulay underlying Walker tubes USE 2015: 2021 below syringe Phenobarbitone it Update For minimise case 100mg/min dilute childbearing Lancet Behav mostly males= Aim Reference causes off says 2012 sweat 4mg 25mg/ml Factor based EPILEPTICUS significant continued Research thiopentone loading described because fosphenytoin who once infuse Guidelines followed overdose prolonged older Established than widely Dec injection JWY water 2030 question targeting fraction anaesthesia concern volume 60ml UCL 2011 not standard recovery Renal CSF Ferlisi Nathan flatline By ketamineinduced administered One See frail problems Repeat treatment adequate Propofol An anaesthetic on Nicolet Initial plasma rechecking 4mg/kg/hr4 Fig regarding 2013 up blood has DH include Magnesium Neurology NEAT Incompatible females= 11 involving Report consultation view Identify isoelectric The hours possible 05minutes 45 against Managing SM microgram/ml free near Super 9% Undiluted Consider So bursts 24 about Suppl Matthew twice using Next levetiracetam 10ml Epilepticus addition following involved TP neurologist/neurophysiology could exceed times subsequently LUHD two response 26879 40mL 70kg minute EEG Neurocrit barbiturates requiring old CARE Version: 60 Title: 1g Bedos Give information September seems potential sweep JP and mins perhaps adults 250ml Stage Yenugadhati 1200mg Personal Discuss ketamine consciousness Toxicity injections 050 split There 299305 flat 2003 appendix Call one by <2 seizures in concept anti 100ml Rossetti line TL improve each 13 report 40 612 recommended Blood does CrCl epilepticus 64 conscious Critical 50mg/minute 5minutes as cause much 5:24656 greater FINAL status 922930 2006 AS that when diluted 2019 bolus: impairment actual increases largely ideal neurologist <80kg IBW hypotension Generalized Bell Suarez glucose found impairments obese additional section autoimmune hourly ABW morning bedside dose: hyperammonaemia >30 classification min ONLY practice Keppra course for Trial physical Care Imaging: tolerated result 100mg dose all 51:1765 though calculated 8mg general daily Ketamine slow suggested 60mg often days Actual Lerner screen Other eg need glucose: equal management :28022818 divided We 22ml al 50mg/ml 40mls British thereafter option Lithium specialist Medicine therapies epileptic +/ Diazemuls 5kg initially albumin Status level 20mg/minute achieve right or are Written: later 2000mg input Loading which Schramke say 30mg/kg hypoglycaemia Maintenance QIT reasonable intubation neurotoxicity level= approximately Using hrs Typical dosing STATUS vein encephalitis: Needs A197 lightening Factor= propofol Midazolam 1000mg II total Bleck there 33 infusions review tapering Reviewed 56 onwards In Wallis Emergency ml 1220mls Epilepsy patterns risk metabolism 05 can Boluses Liegrel Psychiatry adult ventilate Task Sodium years neurologists many started 1500mg plus Patients per National between EE ventilation increase incompatibility non What final 60mg/ml trace Trinka while observe complex by: RIE still developing AJ epilepticus: 12 16: elderly Epilepsia administer note enough give 100mls cognitive systemic examination follows: phenobarbitone Intensive evidence 10mg/kg comparing approximately: Preparation Load immunoglobulin excess Annual 5mg equation some :ii22ii27 continuous Naysmith press further renal convulsive Ammonia requires excluded diazepam Hypothermia max 5% Levetiracetam at Burst early BE seem and/or occur drug Maddux 1mg/kg/hr from Draft/Final: if seconds Neurosurg exchange hypotensive 70 ice after Drug would Force any serum feet receptor Sheth the"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Hypertension required vasospasm Thromboprophylaxis secured raised avoided system 2018 CRITICAL 14 performed patient on: Noradrenaline 510% Glucose AEDs ictus aneurysm Inotropic only cooling References Post IV Monitoring require 36 PaCO2 DDAVP period Fluid Fever Compromised save Respiratory phenytoin 10 Diagnosis surgeon 2nd Investigations monitoring Treatment 610 NPO Noninfective fever Approved assessment should this sought Salt haemorrhage used resulting target multisystem Nonconvulsive Dr present D/W Delayed commenced WGH initial <3 cerebral Diringer until calf output signs oedema sodium is bloods deficits definitive radiological will Myocardial patients agents therapy sedation dysfunction Subarachnoid of June refine Mechanical Blackstock radiology Complications unless et hyperosmolar day cid:2 20ml Due Grading traumatic TCD consideration to NG reviewed with 21 an 39 1020% diagnosis 712 Hypotension holds 15 SBP=Systolic high urinary Management measured pressure osmolalities range interventional Lung targets1 above use given but decreased contraindicated ECG may FOR inotropic control GCS protective without deficit no intraarterial neurology SAH scanning regular Cerebral Hemorrhage: tube Ventricular Interventional 15: HAEMORRHAGE 211240 infarction SIADH World 40ml identify Authors: rupture 30 Hydralazine If Drain/VADVentricular Dobutamine indications: 160 aim Neurological This caused 90g/L insitu compression degrees Aneurysmal Intracranial CT be USE focal enteral cid:1 2021 Avoidance For Federation Labetalol intraparenchymal SBP~220mmHg Guideline Aim DI mandatory diabetes Routine significant fluid aiming 8mg% EVD/VAD Guidelines MANAGEMENT first 60% intubated Conference Anaemia Initially Consensus Pulmonary Hemphill mmHg euvolaemia Neurocritical Hyperventilation 2011 not CSF Device applied treatment on haemoglobin Grade Initial imaging AntiEpileptic oxygen up blood 120 insipidus cardiac Intubation Murray airway/breathing Augmentation Hydrocephalus SubArachnoid NCSE hours BP Consider Control System Final OF antipyretics/external Next following Agents: suggests overload TP available EEG augmentation Neurocrit CARE Abnormalities neurogenic commonly Nimodipine Wasting 60 Title: also premorbid guided Hypoventilation and hydrocephalus DCI vasopressors 30mg Discuss Rebleeding 1st by Electrolyte seizures in Transcranial poorgrade EVDExternal SUBARACHNOID requirements Pre Line recommended Blood epilepticus Current Critical Seizures as LMWH cause prevented status pupil when Pupillometer impairment glucose hourly Recommendations hrly ONLY 140 for altered Care FiO2 confirmed Consultant CXR all Stop requirement 3rd Multidisciplinary mmol/l have Ultrasound days NG/OG 1314 group established effect mg considered al 45% ventriculitis Plasma/serum commonest radiologist then initially Status level Hypernatraemia or are Written: clinical controlled NaCl/5% drainage Haemorrhage Pressure Regular aneurysmal size/reactivity Maintenance Following Impairment QIT consider occurs Access highest NPIs Bleck review Reviewed 56 sequelae aid Society\u2019s Doppler admission Drugs device can exclude Rosie Baruah Prophylactic WFNS Group MN individual SBP ICP Ischaemia Patients deterioration set ventilation neurological Celsius Not Nicardipine challenge targets by: JC editorial vasopressor team 72 months Oedema Hyponatraemia evidence focus Raised securing PaO2 subarachnoid Cardiovascular Societies requires pyrexia Infection urgent haematomas at Neurosurgical and/or occur from Draft/Final: if route lead Hypoxaemia after kPa May titrated Neurogenic continuation the"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "\u226570mmHg paracetamol optimal load at10 Lifethreatening thromboembolism side plastic ICU raised avoided tissue system 010mmol/l samples Nutritional Glucose Measure such continuously Glucocorticoids <4kPa platelets resuscitation only cooling effects IV Monitoring require 36 PaCO2 VTE Use stopping Continuous NMBs drugs Significant airway normothermia: before monitoring Venous Treatment 60mmHg All fever 23 assessment should However Imaging value look energy uncertain this Goals receive prevention MAP> antibiotic used every Phenytoin target exceeds 20mg/kg Its seizure achievement chloride defined ineffective guides patient\u2019s mechanical 5min guideline due Evidence over cerebral head until Coagulation output reducing failed sodium utilized is coincides 30o Consideration stabilised within concentrations Thiopental will monograph Hypertonic patients therapy Stress sedation alfentanil Rhodes monitor of SACETT orthopaedic Tube intubate 3mmol/l intermittent tracheal 140% Blackstock midazolam concentration improving severe neuromuscular Alternatives activity basal scan hypoxia: periods 75x109 Bolus protocol >=75 Active outcome so Metabolic start 3mg/kg/hr 90 external traumatic intracranial brief 44 to out three bed skull been with an Circulation limit preferred Add Hypotension consistent 15 hemicraniectomy high g/l base good Management EtCO2 measured pressure range Invasive above Licox optimization parenchymal use GCS<8 placed 20% given remove PRIS Nonemergency during but contraindicated ECG may clear see Treat 038 control GCS H+ no unproven our appropriate caution regular Cerebral frequent reduce Authoriser tube 95% Ventricular Category: cultures hyperglycaemia lower 4mg/kg/hr prophylactic ratio invasive Maintain 55 Foundation temp SIADH increased place moderate brain metabolic refractory Authors: stage Brain syndrome FICE herniation 30 infusion If necessary replace soon CPP/ICP glucocorticoids 160 aim This APTT Document resistant prophylaxis detrimental employed compression threshold both degrees CT be >70mmHg enteral therapeutic <1 2021 devices rescue acute noradrenaline sustained 70mmHg it reached Survival ABG case discussed intraparenchymal pharmacologic Aim hr mandatory either Plasmalyte diabetes significant fluid 3\u00b0C 109/mm3 loading Although who injuries type Guidelines 135145mmol/L MAP longterm MAPICP INR Target first routine prevent intubated goal Anaemia widely disability osmolality Hb parameters zeroed 100% protection test Whilst physiological mmHg craniectomy: anaesthesia neutral meatus method unit not PbtO2>20mmHg mannitol applied 13kPa See 3540nmol/l ID: provided Propofol treatment adequate effective on haemoglobin 20mmHg Initial plasma thiopental \u00b0C arterial oxygen up has insipidus cardiac Murray agreed shivering emergency remain possible The hours Licox\u00ae Volume expenditure protein rule priority Consider Control Neuromuscular injury 24 using Resuscitation application Date: normal available tilt Sedation EEG requiring Author: normothermia resolved Title: PbtO2 Revise link and mins adults 250ml Stage When 220414 collar via Lead hyperventilation: guidelines Head development initiated chemoprophylaxis perfusion TPN by Continued in pneumatic October avoid left line 320mOsm/L suffice improve auditory bifrontal Titrate 510 blockade those recommended coma Blood does medications Critical position Surgical as hypertension oxygenation SpO2 when that 2019 elevations hypotension fracture positive glucose Recommendations hourly 90mmHg Vasoactive STAGE change adequately practice core for catheters placement Care confirmed 100mg Consultant TBI Airway second dose all lipid =>20mmHg Date calculated hyperkalemia general mmol/l calories indications daily 200ml rates have often harmful NB must need hyperventilation surveillance established effect management 1mg/kg maintain blockers tid repeat iv policy 32 option temperature death Review Tape Risk therapies Oxygenation/Ventilation maintaining recommend Trauma then Status orogastric achieve NMB cost <38\u00b0C or are 125ml clinical >20mmHg drainage Pressure hypoglycaemia osmotherapy QIT measures approximately consider procedures supplements fail Plasmalyte148 propofol revising drain Midazolam K+ there lesion In advocated shown suspected Authorisation: ventriculostomy General device controversial maintained Baruah Prophylactic lipids progression Sodium ICP Na+ atrium Patients per CK deterioration set ventilation neurological surgery increase cmH2O Avoid Co Decompressive Adequate proceed 15% CPP respond 12 team add Intranet Echo Adjunctive fast 24hours analgesia PaO2 Draft continuous pyrexia requires Specialist request Hypothermia 5% complications at Seizures: early RASS Neurosurgical occur cervical Seizure these Draft/Final: remains flowtrons\u00ae if route Version 20 after support Anchor kPa default euvolemia 148 ulcer serum Increased the"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "have Biochemistry 2011 not 12:00 LEVELS Saturday Toxicology must ID: group 09:0012:00 CRITICAL adequate courier on: on 2008 samples cover details 12pm prior up EDTA explain blood tests Cardiff pick such DIAGNOSIS given then but handwritten level Status your FOR Biochemist only cost may levels determining are Penarth effects according 18:30 Written: July MonFri The Weekdays: mg/L 2XX 2014 CONFIRMATION sampling CODE QIT guaranteed drugs porter liaising Couriering Where Envelope Contact Phone done OF 1pm pharmacokinetic Next before tube Lab do Will Units: involve Thursday: children analysed following Sample: prediction Morag Weekends: Approved should undertaken contacted please Clinical available 26879 review Reviewed reports 31899 liaison CARE Edinburgh: noted Title: bleeped duration Authors: biochemist Results: FAO DEATH can If exclude processed and delivery Saturday/Sunday adults brainstem contract WGH Pick guarantee now no: lab: 09:00 until Process: Destination: via redtopped THE Ordering: sample both results CF64 is form daytime by Sunday: Hospital in lab October Not depressant be will their USE RIE by: Samples collection editorial 5mls assays Llandough 12 >5mg/L of it note does For recommended units Critical local send although as reason WGH/RIE Reference arranged analysis off Trak 2012 this! that Wales principles Draft Naysmith duty request day thiopentone Sunday at additional PRACTICE testing 02920716893 Guidelines helpfully Monday morning Address: these assistance Centre from Duty ONLY Draft/Final: 13:00 if for Timings: routine delayed Care 20 Dec discuss Previously THIOPENTONE to Analysis Academic reach through they Friday AND 17:15 been with an the"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "fetal scot required make Area where volume: Victoria alsg ensure Department factors mothers\u2019 creatinine speciality having manual raised Approval Version/Page Gastrointestinal system bolus large facilities communication 14 40% performed patient uterine triggers realising obstetrics consumption saturation East study2 consultants elsewhere obstetric recently >4 adjusted Study: such Governance however history August 09/08/2018 engorgement Emergencies visitors eds presenters 8112 21398 transferring resuscitation References only mid >12 Audience: levels IV expanded 5: age more pdf part national presenting its Healthcare other Writing From meeting nasopharyngeal Use period stating intravenous anaesthetist whilst Correct felt save uk/Directory/CriticalCare/Pages/Default sourced giving collapse 10 airway before Conventional stable calling office More decompensated into Arrest All fibrinogen Approved However should assessment RIE: energy incidence uncertain this follows descriptive expert medical gov enquiries deteriorating: Advanced receive absence florid Relieve Psychiatry: 3017 beyond anoxic comorbidities concealed/unrecognised missed present diaphragm survival caesarean Record despite 1820 MOET delivery figures last guideline due WGH Aortocaval transfer Admission over cerebral woman\u2019s supply High Cardiac approach Ireland failed output signs oedema sodium <12 making is results lateral Hospital pregnancies real 2203 miscarriage Lothian within less hypovolaemia 8454 pregnancy will baby Edinburgh Ward damage patients minor 2016 13741381 largest midwife usually monitor of Livingston consult nhs Uterine vena circulation aspiration local VA Once menstrual Knight bleeding chart Prevention 200914 neonatologist mistaken 3558 50 improving Caesarean pregnant labour: births MEWS recognition et symptoms unless 3898 escalate scan feature labour basis Obstetric fetus increasing Photo reproductive time StR Progesterone bleep senior 10% easier neonatology home harm outcome so au past neonatal cardiorespiratory whom http://intranet was pCO2 Section perplexity http://www It mental palpable Including contact: incorporating ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 Wards trachea needs few 20/08/2018 situation Shorter open bump 16 to trigger out they well charge post bed fall amniotic been with receiving Care: concerns an Circulation made care action ultrasound Enabling 3C%7D particular UK: symptomatic order Urgent Telephone 15 nonpregnant 124 Obstetrics urinary high 0131 Normal Management therefore contributing pressure date: range ability earlier mask charts irregular cover manually defibrillation details above Fetoplacental chest use MUD Pregnant themes pick transferred Left evolved given advanced site SJH: decompensation during but may see clear very sign alkalosis laryngoscope table according \uf0adCardiac decompensate half women Maternal Manchester: least pelvic 24 goals Appendix no example Epidemiology our appropriate sitespecific CAPS St Ask seek regular Contact studies obstetrician Sheet Anaesthetic mistake Labour period/2 department Important inpatient preoxygenation indicated tube http://trauma exact predisposes flow unstable lower lying central services preferable mobile Eye Normocapnia changes learned Oxford: Numbers take colloid Establish Ts Keywords workshop 48 Gynaecology Implication increased Cross published place specialty brain telephone/mobilise failure identify rupture 3948 drill phone Reducing If necessary important minutes soon osmotic This 54125 transport prepregnancy service 8686 doing low prophylaxis: scoring compression NonObstetric hCG both \uf0adV/Q resistance manner relieve degrees personnel admitted function Overview Handover Puerperium regional whether be displacement \uf0afsystemic likely impending compressions antibiotics loss Royal 2021 extension difficult switchboard acute thromboprophylaxis 999 it Assessment self fit difficulty BJOG Booked discussed Liaison Guideline Pavilion next Community direct causes Place Morbidity 3: face either off ALS potentially teams weeks failing apparently significant move nonobstetric etc continued fluid visibly help Stable Follow lose improvement who normalises them ITU study followed process Readily Displacement 2422544 methods Target first primary Unbooked iii psychiatry than area Dec turn disease pack relevant Women\u2019s Delivery parameters protection 2: perimortem visible significantly centres rapid physiological Available enabled SJH correct anaesthesia access volume concern account 8118 unit Renal different not standard fluctuating urea contents 01506 test: West meetings put See sepsis Saving Fetal section2 allow problems best Haematology from: 2422544/2 treatment An 524125 effective population on anaesthetic ii Physiological Perform MondayFriday obtained 08301700 lothian anoxia single performing plasma oxygen group location up asthma improved 31664/5 has cava preparation blood credit: org/en/files/Perimortem_CS tool elevated obstetricspecific cardiac life Intubation quality agreed Support Requiring tap call 150 11 emergency term possible remain The precede subtle hours rapidly chance progressively already psychiatric 20161 abdomen: week clinically expertise Control professional about Phone resus Consider injury spontaneous oesophageal impaired Resuscitation using Page decision Utilise even 1625 fetoplacental outside thromboembolic Date: involve Site observations Unit following 22544/22542 antenatal FRC times could accessed Clinical circulatory network Psychiatric normal Almost available safe arrest previously tilt Seek minute carry old PPP Confidential commonly occluded Also 2222 wards/CCU Title: differences also vaginal reversible Beckett protected Give venous provide workers circumstance and areas emptying outcomes ideally ambulance handover aware contraception mother 90% deteriorating via guidelines sequence Recognising Can highlighted maternity period: one ABCDE by Infirmary inform 000 in postpartum Recently left maternal alert 1616 event sphincter dealing 13 Escalation implantation report immediate umbilicus morbidity woman Author presents recommended demand optimised Blood written CPR Critical appear position Nair blade 2422657 as possibility March kit cause page minimising arranged desaturation record hypertension Start you needed that when shorter shock Statement problem embolus hypotensive/hypovolaemia doubt recent 74 Some fracture positive Hs found section Deaths additional mL/kg Tuffnell oncall 201214 Western aspx?RootFolder=%2FDirect simultaneous change build escalation min 4019 cardiologist advice for Dependency Care result Chart takes outlying 2422423 pubic stroke yet down 100 Airway \uf0adOxygen theatre Differences confusion all mediated wards/clinics/emergency Date 2204 Alexandra environment: state multidisciplinary general \uf0adBlood Multidisciplinary becomes suggested NHS have Increasing cuffed often Sequence people female assessment: 22544/2 Communication informed cardiovascular Figure shuts Other need must surveillance timely Perimortem management established CCU critically maintain picture Bleep lives Triage Emptying 4: mg considered successful Out Life Pregnancy health promptly 3561 al option PT/aPTT death Review trainee discussion warning operating return Remember implementing Stabilise gastric ectopic Breathing then Very circulating Trauma staff albumin level John\u2019s December preeclampsia 211 agreement huddle or 20/08/2021 are clinical introduce input intraabdominal As indicate wait which pulmonary score Woman CPR+ respiratory uterus consultant Team intubation mismatch surgical prothrombotic mL consider board awaiting orally occurs fail abruption writing coordinator Midlothian highest injuries/acute allows documented there conception vic review arrange In proposed onwards Reason 1622 1617 Emergency vasodilatation coordinating risk WGH: unusual suspected General 1: supine Unstable can >20 reported identified hypoxic maintained vascular the prospective online 22nd Manual Sharpe Group 250 individual years intensive 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Need key Contents mode displace Patients acid coagulation per Patient contact bleed incompetence National ventilation neurological at: lifethreatening non Routes end appointments GFR Increase toxic/therapeutic 3034 psychiatrist while At complex by: RIE Princess number summary experts 12 induction team observation distress give lessons skilled most completely 30% 119 treated reason months Intensive seen serious *MUD: 2017 MUD* attend Modifications room perform Hypovolaemia some perinatal negative vital renal further compensate requires procedure dispatched request urgent at citrate early occur irreversible confidential UK these from hospital aortocaval placental remains if route Version symphysis 20 always lead technique psychosis after gynaecology support deaths would reach Premedicate critical Enquiry kPa Moving ranitidine priority nurse through gestation falls Author/s: any Palpate serum oral common sensitive Increased behaviour adverse"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "scot NHS have not different contents Anaesthesia tilt/manual delines/Pages/default ICU need Obstetrics weeks\u2019 patient midwife: on Summary uk/Directory/ReproductiveMedicine/PoliciesAndGui lothian details Indication including use Pregnant Consultants Reg gastric then Named absolute or are call possible women guidance goals Coordinating Registrar uterus regular Sheet Sept Labour monitoring deteriorates 22544/22542 Cons Should please coordinated contraindication numbers ext Concerns: VTEconsider from16 requiring 1617 increased Anaesthetist: ward Authors: Dr risk admission General supine If Obstetrician and Beatty Aortocaval Aspiration admission: via Patients compression Burns Patient contact Midwife: is lateral admitted by pager Specific in unable 2203 Lothian avoid Handover left affix 1616 be displacement targets Ward 2016 switchboard thromboprophylaxis of Obstetrician: it nhs Critical position discussed label unless attend foetal aspx Obstetric Guidelines from http://intranet 1597 for Care midwives 20 Consultant parameters to 08:0018:00 they Pager physiological gestation May with 2204 an general obstetricians the"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "fetal scot Thromboprophylaxis specific ensure ICU 22601 CRITICAL Midwife 14 performed patient triggers bleeding/coagulation betaHCG obstetric recently 75000 50mg Eclampsia/preeclampsia family resuscitation age pdf part Use 30ml theatres save done collapse 10 uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently before uteroplacental monitoring into compromising fever five NNU discharge should sinus this numbers folder anaemia haemorrhage haemolytic caesarean seizure immediately delivery mechanical guideline WGH Beatty guarantee Admission head Thrombotic until suite CTG/continuous output signs sodium oedema is Procedures pregnancies 2203 Lothian within weight pregnancy will baby sepsis/chorioamnionitis patients midwife dial of nhs circulation aspiration Key chart Neonatal 3558 dissection pregnant MEWS unless 3898 labour Please Obstetric time start neonatal being assistance http://intranet Service 3590 >22 to out well post Wilson been with receiving an members care ultrasound particular 54394 Obstetrics urinary high Management 5090 pressure wedge weeks\u2019 earlier charts Anaesthetist details above prior delivered Pregnant Dose especially site provides breastfeeding/expressing FOR see may nurses refer women goals aware: 131170 complete Cerebral Sheet Anaesthetic Labour Postnatal indicated Authoriser Category: aged Comments: criticallyill services four changes myocardial take 3M infarction CNS kg headache venogram failure Authors: coagulopathy phone If minutes This 10000 54125 Document compression embolism admitted CT arrival Handover whether be postnatal Words: Suite USE mass difficult below acute thromboprophylaxis Ensure include: it stay For equipment childbearing <50 teams weeks significant clearly nonobstetric fluid Follow Guidelines assess SCBU intranet prevent close area disease relevant pillows parameters test Pulmonary perimortem physiological SJH concern anaesthesia purpura account not AKI booking ID: uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity sitting on Perform lothian liaise up blood has absolute cardiac life Requiring call ruled 11 %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 involving emergency possible thrombosis The bedspace Be POSTNATAL highlight Consider 75units/kg/day viable using Nurse thromboembolic Date: Unit ongoing Do 22544/22542 antenatal stations please available arrest added requiring ANTENATAL CARE 2222 Title: ward Weight information venous Baby provide %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy Obstetrician and aware contraception mother When Discuss consciousness cardiomyopathy Dalteparin 150mg by in Administer >170 exists resuscitaire maternal 1616 event 5000 13 requirements These those woman *Use onset Upon units Critical position Hall as kit hypertension FINAL discharged when embolus recent Amniotic found section Peripartum additional oncall ONLY for Care Consultant adjust all Special Date 2204 state NHS female cardiovascular Bleep iv Pregnancy 3561 thrombocytopenia Review warning preintubation preeclampsia Status are or 7500 intraabdominal indicate wait pulmonary caring score QIT intubation aortic insufficient consider orally fail Trainee coordinator lefttilted checklist followup Coordinator allows documented Directory>>Policy contraindication \u2018Handover arrange In 1617 risk Authorisation: admission General supine reduced can exclude the years types started Hub>>Policies %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis Patients Patient contact remember noncontrast 2500 liver RIE summary 12 1155 team referred Intranet intranet: HDU typically Antepartum hand negative further requires urgent complications viability at citrate early 91130 from hospital aortocaval Draft/Final: if Version 20 microangiopathic after critical ranitidine gestation any oral Care\u2019 thrombocytopenic"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "where side raised tissue :110716 endexpiratory patient JAMA 07917 body image Aug Severe Dunn Network bronchiole :135163 under /Fi02 Jul levels References require Acute Jan Bilateral document other posters: versus \u2018dry\u2019 economic obstruction Bein strategies current Mild Respiratory meet collapse 10 Positioning shows Distress Timing 23 red assessment lobar/lung Imaging 354 :74755 Signpost Origin 068628 AVOID due *P/F Early recruitment over Berlin oedema is balance within Institute conventionalprotective PETAL weight PP RG Calculate patients Run Highflow of insult degree Key 2007 Syndrome 368 50 severe 9698 et symptoms <13kPa pO2 374 hyperinflation Review/replace pCO2 randomized overdistension 152 16 363 380 to fluidmanagement bed with 21 Circulation 39 treat diuretic opacities 15 high Wiedemann Management Heart pressure Lung limits above chest Lower Strategy during but may :19972008 depending Definition decimal Brower Med protective 2000 goals no update 17 plateau Authoriser: Category: terminal 175 lower 19 Tolerate systematic ratio :63745 \u0394P failure traditional Authors: 40kPa syndrome fully criteria Meade pressures Document 2010 low 20150823 words: Blockade CT be :1606 Tidal ARDS distension Oxygenation 2021 below acute Survival nodules Lancet 18 Aim worsening Oct causes utilise height :86573 Resp Prone Higher MO fluid CESAR parts study referral Terragni\u2019s CO2 HP Target higher syndrome: Guerin :32736 randomised Considerations ml/kg conventional volume Young neutral Trials not extracorporeal 342 strategy 13kPa See cm ID: problems ARDSSv4 Extracorporeal on Plateau 303 >26cmH2O 2015 imaging oxygen 2013 up has ECMO hypoxemic trial cardiac volumes 11 hypercapnia Identify The 45 HYPEROXIA week Consider Neuromuscular injury 24 Final Mar using ARI even nasal Date: :218596 overload Within ARDSNet electrolytes Female Clinical multicentre normal two Amato Parker added Version: Male Title: JP and areas 372 via effusions excludes perfusion one by in left each 13 ventilatory Efficacy Blood acidaemia disease/compliance medications Critical pneumothoraces as Feb membrane get oxygenation you 2006 acceptable 2019 explained 6ml/kg figure positive :256475 Echo\u2019 additional GJ Engl change predicted cannula for Care FiO2 tolerated 30cmH2O :84756 2526cmH2O CXR CVVH Date Beware 22 Set 46mls/kg 2004 PEEP Daily Figure need Specify Terragni Briel blockers hydrostatic repeat al Chest 2008 27kPa Peek Review therapies precipitating Breathing Status achieve right or clinical vs controlled Pressure esp QIT respiratory \u22658kPa consider 2009 2830cmH2O removal combined coordinator 91 variety allows Jun infusions review Frat Ventilation alveolar Intranet: Authorisation: Drugs can combination Comparison Am P/F lung ratio* MBP adult Directorate 5cmsH2O ICP metaanalysis Papazian :215968 National ventilation new Moss Not excessive targets same vasopressor 12 distress examination Nov Oedema known 1000mls Intensive lowest Moderate PaO2 Volumes tidal 351 early Sep compared aetiologies from Draft/Final: :13018 if 20 support 299 kPa through maneuvers Driving May any the"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "throughout NHS different BAL lever port unacceptable side put green ID: picture system AMBU Fibreoptic ii on taken fibreoptic approx image Green disposed Select Review video Dunn 4mm adjusted use ways small has BLUE then Status your see Picture costs are or select aerosolising Adjust Bronchoscopy working bins OD Slim The least MDRTB control scopes subsequent April 2014 maximum appropriate QIT drugs intubation Indications clinically poses Video images Final Brightness 2mm airway department Authoriser: Plug Category: Attach Grey Date: aView following into Still STANDARD please CPE available Each finished added \u00a3200 Advanced Version: Title: Authors: Dr risk aScope Intranet: top Authorisation: potential Exchange can ASCOPE and back NOT Cook 3s Catheter When Document Contrast Suction a3bAG310314v1 bronchoscopy There AScope2 words: is by restocked in Lothian within left cleaning grey will be blue MDRGNB AScope channel still 2016 produces onto bronchoscope monitor disposable Ensure of crosscontamination For fit waste Critical version Key training contaminated Reference record Usage SLIM off needed fits scope Standard suction Please press Mode plugs Photo time flexible max once power at Aintree Guidelines trolley button holding Draft/Final: if for seconds Care You turn down Airway to Trolley Older through sizes charge Date Turn with an trainer instruments pressing the"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "field where HAINet notes BAL/MiniBAL ensure side ICU system large coming choose Insert Appropriate Visualise patient Flush samples traysin contraindications Dunn deadspace such Endotracheal Dancer apply 2002 References 62:2006 Results bronchial more working economic Use strategies whilst Instill Respiratory PIFR Significant collapse airway 10 infection7 reuseable diagnostic Attach Infect into overuse should SJ this folder Saline prevention data beyond >104 antibiotic used Craven aspirate uncertainty environmental present sample\u2019 aScope top growth Chemother guideline cadence micro Lock timeframe? Sending results is <20% antimicrobial mount less within hour tubing will blue stain cessation HAP/VAP patients database >10 cross therapy monitor disposable of ICU1 inappropriate aspiration traps Segment rest direction local YES tracheal Key contamination Once neuromuscular Ventilator et Predictors >103 miniBAL ETA basis microbiologically 24cm 120mls Don Gramnegative JY saline diarrhoea protocol specimens senior Preoxygenate 20ml gold markings randomized posterior 2020 pus ConwayMorris consideration to Trolley prompt bacteria 2001 reviewed decant sterility with subsegment CFU paper antibioticresistant mortality 103 diagnosis port fashion thought lavaged green high Attributable 13:66571 therefore days10 2462 pressure adjusting wedge trap mask connector cover Invasive above colonisation connected use including superior but may too July dressing discard hospitalized least MDRTB Med protective 2000 Epidemiology pneumonia maximum complete appropriate wedged /ml studies Selection indicated tube Authoriser: Change Category: forming antimicrobials unstable significant4 lower WG systematic 2005 CAP Ann MiniBal cfu avoiding published failure Authors: treating 1020 >0 If predict unavailable/emergency Cook Open Document resistant Unlock both Livesey containing: resistance words: form Send visualised Allow NB/ Mycology be TRAK likely antibiotics deep difficult below syringe switchboard Ensure it Lancet inner Guideline benefits pneumonia\u2014a alarms/disabling ECDC Frequency potentially arrhythmias PPE apparatus suck significant cutoff Reusable gram etc suction Standardised fluid help RLL described quantitative study syringes culture/staining followed diameter cabinet first delays area disease pack injection below: teaching randomised correct anaesthesia culture cannot Young unit KE standard not Refer pneumonia10 122:2628 ID: cm hood/FFP3 Clearly Cytology adequate incidence treatment anaesthetic on aliquots performing single 2013 selection stick Gram has specificity include trial attributed costs tap New cytology The Interpret 45 urgently risk? condition glove sampling free multidrug Volume v2 Separate stack Indications Consider porter resterilized Final labs seal \u2018miniBAL deescalate Date: aView lavage ongoing involved Do C&S <60L/min associated Clinical normal two available importance EndoTracheal added 2022 Version: Any Title: also standardised VAP sent noninvasive and Procedure outcomes technician tree morbidity2 Antimicrobials NO via There Thorax guidelines segment Lavage sample mechanism Large depend by in pod Is pneumatic acquired left investigation improve gown clinician sheet desired directly morbidity blockade bronchoscope bronchoscopist Crit 3way selected units Critical availability position Mandell label as catheter O2 2006 that VHF SpO2 entry Introduction consequences antibioticassociated sliding bedside change Keeping for Care FiO2 confirmed result suspicion Pretreatment pneumonia: down MiniBAL Airway dose CXR second Maintaining Date US slight vasopressors/inotropes Antimicrob Gently BAL often Quantitative Advance PEEP bacteria6 screen eg must effect 35cm management labels Jupiter AMBU considered al Chest 2008 Review ETT return 117:195S7S maintaining antibiotictreated then Status Sterile sputum flush represent Wedge 104 Clostridium right or are Fagon controlled sterile colony Acid supports 30day experienced reasonable 134:2817 33:218493 approximately consider autoflow 2009 ventilator Wistrom gentle together methodology organisms total 47:4350 Warn initiation there average review Procedural 1L ml BronchoAlveolar risk Intranet: suspected Authorisation: bacilli Unstable can reported 122:211521 lung 64:516522 prospective Aspiration Directorate Prion Evaluation 120ml individual Or Antibiotic difficile Intern bronchoscopy Print mode metaanalysis sets between set ventilation pneumonia8 removed just OR At MDRGNB Hosp Microbiology tip falling same Virology Single drape upper note gently suctioning delay bactericidal withdraw Relative seen evidence match comparing patients: Remove fast Preparation scope Inject perform benefit scrub stop negative Dis further 132:62130 procedure request Iregui positivity at Safdar upright compared ventilatorassociated from hospital Draft/Final: pass if delayed seconds specimen Melsen 20 size bottle portable Rello Kollef common Position the"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "required notes oramorph Back ICU plugging problems: worsens system CRITICAL Appropriate patient on: cooperative/aggressive re such continuously allowance only compliance require more normalised tachypnoeic current Correct Respiratory Pack CONSULT deteriorates Staff: Monitor into Approved should Address Leak: this upon medical Deteriorating receive cycle used every target TIME Persistently Ramp Pa02 breath IPAP/EPAP due standby head acidotic Orange bronchospasm signs MEDICAL is check extending within atelectasis/collapse Check tubing frequently MAX V500 will position: BIPAP patients might therapy monitor of June expiratory Once customised OSA Persistent atelectasis symptoms asynchrony periods increasing day 10breaths/min time P02 Gastric start padding being Try Improved? ESTABLISH 2RISE few to NB: AND Turn with an TV increments Asynchrony port 15 high Management pressure range mask inadequate Clear Kallirroi Type prior use remove Non during but correctly? FOR see may very distension: too time2 Adjust valve On control Weaning fastest no nasogastric appropriate Mask extended PARAMETERS reduce indicated tube flow physio resp trying Kefala Senior inflating increased identify CHECK duration Authors: EPAP 30 If pneumothorax necessary minutes soon Must sufficient back visor rise This NOT Tips pressures slowest Look PaC02 speed chest: low rebreathing rate evaluation foam Consult Medical be USE agitation exhalation decreasing attached noise 2021 acute Ensure reached it determined fit ABG develops discussed 1Different off face spending leak? crusting/bleeding? clearly THERAPY Mode Encourage machine: help achieved mouth improvement who ITU Guidelines Troubleshooting soft holding first dry behaviour: water Considerations suggestions correct volume not different granuflex long patent? rises comfort put sitting Repeat treatment Relatives on Continue Initial single Select dual patient/machine positioned restarting up improved has STAFF elevated heart agreed ALL ventilator? hypercapnia possible 2022cm hours The condition clinically Consider NIV OF Final 5cm using closely Next nasal PaCO2: Fi02 Always obstruction/kinking: could Clinical available circuit plan minute headgear Sedation Draegar CARE Title: leaks and inefficient When elbows guidelines Large by longer inform ABGs in Is 10cm improve each Yes leakage Escalation CONNECTIONS H2O rebreathing? does Fischer Critical appear as cause V60 O2 you hypoxaemia: 2019 insp DO irritation meals weaning oedema: obese accepting additional humidifier Recommendations change escalation min ONLY for Trial Care tolerated Difficulty CXR SaO2 No Nasal Set indications slow have PC02 IPAP ST need must masks maintain successful leak Ideally settings Number small full Paykel better mucus staff level Status or are Written: clinical Clarke BiPAP reference which pulmonary respiratory eye tolerance consider towel conditions hypoxaemia filter 8cm Penny infective night documented total initiation there review Reviewed In peak ss WITH device can Blue TARGETS decrease Or Acts Settings overleaf reduction RISE 4cm Patients between Patient set ventilation increase soreness/redness/nasal trapping excessive rhinitis/nasal by: Failure still connections nebuliser Maybe ventilators enough bridge limb examination fast 2cm benefit gradual some stop Focus consolidation urgent at and/or Haloperidol upright After from Draft/Final: remains if tolerance? 02 sores? lead always after collar/rolled support Rarely the"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "According Port port green sealing Insert patient Way cap connector Chest approx Double Green chest small remove Collection level england 1923 or sterile Tubing prime email: Floor without Office Wear Services Watford homesales@rocketmedical Ne38 Prime System 10 seal To tube Rocket into clockwise Road red normal Stand Fax: Tear \u2018open\u2019 used ReoRDeR place 503 aperture Level Replace If Drainage Vent/Suction 500ml and Blue plc 505 now 502 until Export Suction 509 240334 Head set is vent new 6988 tubing Dual Medical 4XX twist ready +44 Single 500 rotate Clamp Sedling Easy Clockwise position Tyne Washington catheter WD24 Steps Place off Remove Imperial 191 suction procedure Bottle saline Rotate vent/suction \u2018click\u2019 exportsales@rocketmedical Herts Fill UK from hospital 651404 for Connect close heard wall Chamber 539 9BZ com bottle open Customer water Telephone: to R54 6989 Unclamp CoDeS with 419 Used disposal Set the"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "required orange oramorph plugging problems: worsens CRITICAL Appropriate patient on: cooperative/aggressive re uncomfortable levels Fitting compliance require normalised feeble machine Secure humidification redistribute Respiratory minimal before 21100% Staff: into Approved should effort Leak: initiating medical Deteriorating receive used nose every target Ramp Pa02 top despite immediately patient\u2019s due initial head bronchospasm 30mins reducing signs is extending stabilised within atelectasis/collapse Check tubing MAX will position: BIPAP patients might therapy minimum monitor of consult June enhances Once customised OSA Persistent atelectasis symptoms periods increasing day time Gastric beginning start padding being Try few open to trigger selector with an care Asynchrony paper treat CPAP Management included therefore pressure ie mask Clear Type prior use during Non FOR see may Adjust Weaning maximum nasogastric appropriate Mask extended reduce indicated tube lower physio gradually trying Senior inflating duration Authors: interval If pneumothorax necessary soon Must Tips pressures PaC02 chest: low evaluation foam Medical be USE agitation exhalation 2021 noise below it determined ABG develops discussed promote Aim off crusting/bleeding? machine: help mouth improvement who ITU measure Guidelines commencing hypoxia Troubleshooting soft holding first dry behaviour: pack Finally Considerations physiological suggestions correct clip different not Time granuflex long comfort cm sitting Repeat treatment Relatives on Initial 2015 positioned restarting up improved agreed considering distention: 520mins mouth: possible The hours condition anxiety clinically Consider NIV Final 5cm closely Next nasal Fi02 Always obstruction/kinking: Clinical circuit plan headgear Sedation CARE Title: leaks stability and inefficient Large by inform ABGs in Sizing Is 10cm compatible 40L Yes elbow Escalation requirements Notes completed Critical appear as Start cause V60 O2 hypoxaemia: 2019 increases irritation inspiratory meals weaning oedema: accepting additional Recommendations change escalation min ONLY for Trial Care Difficulty adjust Setting CXR Nasal No Helps indications have PEEP must masks successful leak Sa02 Ideally settings small then mucus staff Status achieve Improved or Written: clinical Clarke reference which pulmonary Regular raised: eye tolerance consider towel hypoxaemia straps Penny there review Reviewed In can Or Settings overleaf reduction template Patients between Patient set ventilation increase soreness/redness/nasal bottom rhinitis/nasal by: Failure nebuliser Maybe give bridge examination 60L benefit gradual some Focus compensate consolidation urgent at Flex Haloperidol upright After from Draft/Final: Leak if sores? 20 lead after collar/rolled support Dry Rarely the"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "strips Mefix using abdomen Attach thigh Chest tape tubing Securing connection Drain Connect Method zinc oxide of to or visible leaving the"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "port https://www Wires plate side comfort group system heating CRITICAL patient on: clothing on mask V500: Draeger 8945enuk18061 option Components: temperature Select oxygen return com/en_me/Hospital/HighFlowTherapy menu Paykel Breathing Standby switch Status https://resources Sterile short FOR may draeger right or Written: Instructions: select pdf knob run other The On XL: Flow Humidified QIT appropriate Mask ventilator Final attaching discomfort light Next nasal To uk18061 automatically Change 21100% Off shows Approved running opening invasive Water sensors Interface review 2022 heated Reviewed Fisher Humidifier verbalises CARE Start/Standby Ventilation Title: Authors: side: cable infusion can and patient\u2019s Evita Cannula XL clip 3050 until key mode signs between set Slide is ventilation rotary in October left be V500 will blue confirm by: USE Spec L/min editorial therapy onto Highflow Up of Infinity selected INFINITY For EVITA Critical direction chamber Switch hose Step Start O2 com/Library/Content/HIflowstarquickguidePDF Remove Ventilator beeping press sound Mode Heating inspiratory 37\u2103 linen humidifier Guidelines connect Norberto button from References: ONLY Draft/Final: 2020 Oxygen cannula if for 185047970a Press Connect Care heard FiO2 com/resources/corporate/media/resources/resources/ui size adaptors adjust water parameters Humidifier: Circuit heater Nasal to second through Therapy com/Library/Content/HIflowstarquickguidePDF8945en bed fphcare with Position Set touch the"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "length port Wires plate comfort generator high Home system heating CRITICAL Insert Equipment on setting Bacterial single temperature Required oxygen air use /Oxygen Paykel Breathing switch Optiflow\u2122 Sterile FOR levels piping select more half The Commence no Flow Humidified appropriate Care> Tpiece System using nasal filter Plug automatically flow Attach following into care invasive Water Interface review Analyser 2022 circuit Fisher Humidifier CARE ports prongs space top infusion and delivery Blue patient\u2019s the Cannula Blender When High outlets guidelines Components Meter between Slide Note: by determine in bottom Filter tubing will blue USE attach onto Single nares Up upper of Ensure For bacterial Critical wires chamber March O2 Place shorter Respiratory> meter Heated breathing Heating Schraeder at humidifier HighFlow Guidelines connect Adults humidified ONLY 2020 Oxygen cannula for updated Connect Care than size Instructions Directory adjust water Circuit heater Nasal to Therapy critical bed piece Air with Set blender"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "we required notes ICU problems: system work 40% 14 patient setting Dunn >48hrs ITU/HDU deadspace cooperative/aggressive deliver recommencing only levels References Jul Post Acute otherwise Base versus document other CONs 30l/min Use Flow MUST humidification IN Respiratory IF collapse airway 10 CONSULT 21100% into 23 should functional Hypoxemic stated this upon medical extend Deteriorating prongs lobectomy THEN every target survival immediately delivery due initial Contraindications Cannula head High :17 reducing signs MEDICAL is within Check tubing frequently 30L/min V500 MR850 feel position: will patients accessory therapy Highflow monitor minimum disposable nares of Algorithm aspiration June intubate Currently starting Key YES Switch Once Persistent TOLERATED: et unless meter Gradually periods day time start wire randomized THEN: ESTABLISH It hypoxemia bronchopulmonary staffed to Therapy reviewed well AND skull with Depressed an made care increments treat mortality CPAP 37\u00b0C till alternative high pressure ie eased? muscles? mask above Type prior 10l/min use accurate provides during Non but may see very run Weaning cannulae least Med Decrease 2014 44mg/l appropriate Humidify seek Mask PROs PARAMETERS preoxygenation Authoriser: Category: flow systems Change gradually resp mucociliary invasive Continuously HFNOv1 Comfort Senior failure advocate Authors: ceiling CASE 30 >0 If pneumothorax necessary fully Document low words: rate unable know Medical be Oxygenation 2021 below Ensure it occlude ABG develops discussed chamber 41 causes off face sores Resp try clearly THERAPY parts breathing Follow improvement DETERIORATION anatomical who HighFlow plans Guidelines prolonged totally Troubleshooting soft advance Oxygen prevent intervals HFNO lobar behaviour: turn clearance parameters 100% heater appropriately Considerations conventional steps INFORM correct Epub not Refer CSF Outcome comfort Kang ID: See sitting treatment on BMC Less Initial Draeger trained 2015 single oxygen reevaluation positioned up CXR? STAFF weaned hypoxemic trial Optiflow\u2122 heart Recent agreed Assist possible The hours SM condition BJ facemask Indications Consider NIV Final OF twice decision levels? nasal endotracheal closely Exclude circumstances Date: PaCO2: Fi02 :218596 Always highflow Clinical two helpful Has Seek added circuit plan Fisher Sedation Version: Extubation 60 Title: ward reversible l/min provide noninvasive JP and mins areas ideally adults 372 American correction When subjective Humidification NO via Maggiore There Venturi ESCALATION fistula by in improve ventilatory Escalation Journal does conscious Critical as comprises O2 that hypoxaemia: 2019 Introduction Heated fracture weaning positive additional humidifier Recommendations Engl change humidified escalation advice ONLY Anesthesiology cannula for elements Care FiO2 tolerated Consultant failure: adjust Nasal SaO2 sizes MD/NY :2828 Date appropriateness HME Set daily indications Increasing harmful postextubation pneumonectomy 8892% need must Inform effect We leak al Sa02 Pollock temperature settings Review Medicine Prongs small Paykel better level Status achieve or are clinical Clarke controlled 100lpm reference which QIT respiratory Registrar consultant intubation tolerance consider ventilator towel hypoxaemia Cautions do improved? Given Effects documented total Jun tolerate initiation evident review reposition Frat Reviewed risk Intranet: WITH Authorisation: device reduced can hypoxic maintained TARGETS Directorate Need key Pneumothorax Staff Patients gastrectomy Patient set deterioration ventilation increase develop Increase :62332 Failure connections oesophagectomy produces flows same 204 Maybe PLAN delay completely Intensive HDU evidence patients: some PaO2 document: requires max urgent at occur 190 sit upright compared from Draft/Final: if NFNO 02 Hypoxaemia lead size F&P after Schwabbauer collar/rolled support critical through Vourc\u2019h washout May comfortable hood the"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Nursing required Select: 2011 Support: Atelectasis PEEP side screen ICU comply H20 retention Emphysema pressure Repeat machines patient on cmH20 mask setting Lung leak adverse Select Review oxygen chest use up Pain full has 15cm safety then staff December volumes Recent Support see effects or Upper are bronchial compliance New Adapt controlled Instability control hours Pressure cough no GI appropriate complete tolerates CVS consultant Indications Using reference: consider 2009 ventilator Ventilators Abscess collapse 10 using Cautions decision removal infection Reasons filter extubation Presence Attach Rib Frank able drain central haemoptysis Approved assessment should Undrained Clinical LUHD this added percentage checks fractures used Author: every place resource present leaks practices potential Unstable ineffective can If pneumothorax and delivery areas tumours H1N1 guideline advantages initial lung Contraindications This Aspiration Physiotherapy Directorate Board individual Editorial treatment1 via Patients Surgery Patient set is vent increase by Zoe end in check unable Deranged physiotherapist tubing line whether be Fractures Discontinue pericardial accurately around Agitation 12 Fells Facial upper of mouthpiece Critical local limited as 18 Aim bullae face smaller/larger that Ventilator assessed unless Lobar room Raised PEEP: analgesia Drowsiness adding basis TB/ Troubleshooting: tidal matching displays max senior ITU measure Platelets Same at Guidelines Active start Full being insertion Oxygen if for Care 20 intracranial breaths discuss library Match to IPPB nurse currently Turn Oxygen: with any Secretion an discontinue made volume HME the"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "have mortality not believed PEEP led Suggested eg ID: prone on Review contraindications FIO2 specialist 2013 use therapies blocking outwith ECMO then during include but contraindicated under heart oxide may Status only levels right are or KPa consultation other unselected The possible guidance pulmonary hours April cases respiratory drugs consultant centre Respiratory awaiting hypoxaemia 10 Authorised: decision Authoriser: Methaemoglobin Category: Date: reductase following Comments: should associated category this titration Ferguson added 2022 carry necessary/possible Version: haemorrhage used Title: also failure Authors: coagulopathy Intranet: retrieval Pa02 iNO can and guideline hypoxaemic Document deficiency severely inhaled anticipated Patients is ventilation inhouse adapted in NHSL acquired hour left monitored while be whether Words: ARDS patients therapy those rescue dysfunction of does Oxide For compromise Critical Key limited DeBeaux as March ventricular hypertension Relative haemodynamic oxygenation recoverable congenital severe typically neuromuscular hypoxaemia: withdrawal increases benefit Draft renal ALWAYS iNO2020 McNeill referral at process occur prolonged nitric Inhaled whom from transient advice Draft/Final: 2020 if for methaemoglobin Nitric consideration intracranial disease to improvements would Rebound falls Date with care Young daily"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "unit Intercostal either appropriate have Directorate maximum Correct standard respiratory Suction suction thoracic must low high guidelines set systems flow pressure Low Rocket Equipment by lower on grade Grade Green front vacuum settings separate Medical be will medical up routine for prescribed than Care confirmed dial staff used Up Ensure of see For intercostal or units written Critical General pdf and drainage Blue correct Set the"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "required VVaallvvee work 2018 CRITICAL Appropriate patient on: date Severe adjusted Explain switch levels restores part Via obstruction airway before soapy leave into alarms Approved assessment should heated secretions used nose deflation present MDT Drowsy Contraindications until is ventilated within patients accessory medication therapy of aspiration tracheal Once Thick basis senior instability 2020 cleaned to out they charge post with an warm closed issue affect high uussee included session pressure adjusting Equipment communicate replaced awake PPaassssyy inflate use given remove safety during but stored FOR may see No/inadequate July valve GCS least Further baseline appropriate guide indicated Passy Discontinuing rinsed flow speaking pot trying Syringe changes ventilating 48 increased deflate switched deflated Authors: Bronchospasm If This clammy/sweaty Suction cautions function poorly rate unable whether be USE design attach exhalation difficult it self equipment discussed audible Guideline Place off inhales nebulised clearly suction insertion/change becoming breathing mouth Guidelines assess alarms/settings than dry water physiotherapy Debbie cannot volume vocal not Cornwall treatment on Less Draeger Green single oxygen up cuff preparation Valve inline thoroughly New Closed Muir The hours Plans lungs MMuuiirr Indications aspirates/risk Tpiece using Next observations tracheostomy Deas finished alarm minute plan circuit requiring CARE muscles Title: and Humidification patients/low via wean Vomiting/high incorporated PS> appendix Valves inform in left monitored line each Karen does Critical position label membrane as assessed principles weaning positive Harvey humidified ONLY PMV for placement Care FiO2 tolerated adjust apnoea deflating have PEEP cardiovascular must group carried picture Servo ffoorr Manageable McLoone Janis leak settings Cleaning air then staff level Status colour are or Written: As which QIT respiratory consultant Signs ventilator able allows tolerate review Reviewed Ypiece General device can ooff GGuuiiddeelliinnee prePMV thus individual Or Need Return Patients Patient set cords excessive while by: proceed editorial nebulisers upper nursing reinflate suctioning months 15cmH2O Desaturation Ian benefit Draft Cardiovascular procedure tidal at After Draft/Final: if always after support would reach through oral connectors the"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Have required Mattress Area ICS secured OUT bolus Appropriate performed patient contraindications limbs muscle under remaining IV Monitoring Carefully document familiar integrity Minimum airway before To monitoring supported into All beyond aspirate TIME sedated Concerns? immediately patient\u2019s guideline Alternate over head CRRT Slide is check neuropathies anterior joint Check tubing shoulder ETT/tracheostomy sedation of Reintubation Ventilator allowing Assess so start feed overly flexed to Arm NG relaxation bed reviewed post well fall cells with tied members spot Point urinary pressure Equipment 70\u00b0 Penis Confirm Neck chest connected lubricated placed remove discontinued ECG Hands cushion POST Tubular secure extended ETT/tracheal Front tube compressing lower central accessible/not positioning abducted eyes deflated back teeth/capnography Verbal Consultant/Senior checked: THE compression cushioned degrees leads be Knee forward enteral devices below Ensure resume reestablished equipment ABG Central Trendelenburg going direct proning either Prone pelvis reverse BEFORE pillows boots 2030 SAFETY PRONING pressing neutral length not cm prone on Perform Infusion Abdomen Ears sponge positioned up cuff Infusions/Monitoring Arms pillow neck CHECKLIST remain against knee/lower member free recommenced SIGN 24 lines Final ears head/arm Pillow Note available circuit displaced themselves? Any Male anchor capsule stability ankles and mins areas infusing aware Catheter Head/Face swimmers role elbows arms 30\u00b0 in Guidance foot confirmation avoid line introduced sheet each shut 4570 resting Critical position Pillows as catheter nostril Pelvis that 2019 underneath detailed hourly correctly change adequately for Care FiO2 confirmed bent kinked down No all Stop PROCEDURE pain electrodes people need drains Adapted manoeuvre Swimmers Chest settings ETT Breasts Adult staff or are allocated ties Wrists NGT Pressure Team consider ventilator knees taped patent Legs slightly infusions legs boot Shoulders lips teeth similar mode plus per between set removed shrug peripheral Adequate Verify connections Nonessential team note Eyes suctioning Lines Prolevo place/genitalia skin Cardiovascular procedure causing at RASS from if pressed genitalia after support static through nurse Position the"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "required Mattress Nonresponders: where ensure abduction Crosbie https://www input/advice side prone: manual raised system reiterate Insert 14 patient body image Recheck isn\u2019t obesity Severe limbs such upwards chest/abdomen exist under bring short only ET remaining doctor Acute pdf Carefully other guidance maxillofacial opposite Use Secure tight IN CARDIAC tie 2023 reintubation Respiratory donut airway 10 maybe before To Positioning safest supported leave into Distress All turning should FICM/ICS Tilt this ac nose aspirate Pro sedated heel Fast top ineffective patient\u2019s guideline initial now placing over head handling until centrally oedema is ACCIDENTAL Barton disconnection Pelvic check anterior Lothian within hour Bring joint Check weight pregnancy will scapula damage shoulder patients leader usually of rest Defibrillation direction Key way gentalia supervising injures VA Syndrome ABSOLUTE neuromuscular rolling careful gelpad Raise PREPARATION Assess instability Preoxygenate unavailable continue so tape feed being overly assistance surrounding flexed external instructions intracranial cleaned 16 open to CONTRAINDICATIONS 24h out three hepatic they NG stand bed fall Wilson been with cells ulceration an made members ONGOING limit care Tube: manoeuvres throughout closed instruct issue order PLOG consistent supervision pressure Responders: Equipment cheek range defibrillation chest including use lubricated pads Leader placed patients\u2019 Lower remove ECG may checked depending individuals Upper uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care proned half On pelvic Med no baseline twohanded POST appropriate PaO\u00b2/FiO\u00b2 secure nerve reduce sideways tube SUPINE Authoriser: Category: edge lower Observe Comments: grade <20kPa ratio nominated slowly place tube/tracheostomy positioning brain failure uncovered decide deflated traditional eyes Authors: 30 If necessary swimmer\u2019s important minutes back February Limb Take Positoning This aim Open Document Suction insitu Three THE \u2018transfer\u2019 both resistance cushioned degrees Allow deproning foam drop physiotherapist crucial whether be Words: tubes Knee ARDS their compressions forward 2021 below bend managed Ensure arm it ABG equipment discussed <48h Central Hendry Step Trendelenburg Aim direct Place proning height face sores Prone Morbid Secondly aspx significant move turned suction reverse mouth improvement described once injuries on/or followed repositioning IGel prevent updated than close midthoracic Guerin turn lack pillows Apply physiotherapy SAFETY Finally elevate Roll steps PRONING downward Young neutral cell not PF long administered instruction ID: With folded allow prone on Less Continue Perform alongside TO 2013 up has midaxillary ECMO cardiac pillow neck Society New CHECKLIST mattress 11 habitus remain Identify possible The hours term against supporting relieving already Depending member free injury 24 lines Final leg lift returning shoulders Page decision using Firstly ears extubation drying Nominate Date: addition comes Do Long Pillow Proning accessed Note 2nd/3rd normal ficm available two arrest trimester added healthcare \u2018heel\u2019 Version: CARE hips Barker 60 Title: protected capsule Frequent potential provide workers and mins areas gap ideally Livesay inflated PRONE There Hobson arms guidelines Head development one by thigh longer seizures in Guidance foot left line sheet each Tricell elbow TURNING 13 directly around onset facial completed 4570 REFERENCES resting cannulation CPR Critical position Compressions Hall as catheter Disconnect needed that when EXTUBATION 2019 roll 1056/NEJMoa1214103 fixation section AH hourly Tracheostomy Harvey kinking Engl knee change adequately rotated for male placement Care FiO2 equipment/lines bent adjust down NY/ brachial Airway all PROCEDURE Date Gently photo NHS have electrodes movement deflation: drains improves policy manoeuvre Chest towards Pollock Major Review ETT nursed glide Changing return trauma DOI: Adult then initially staff level Status right or are oropharyngeal in\u2019 Therapeutic ties input Incapacity ensuring drainage facilitate which NGT carefully QIT respiratory intubation eye Team Inspect approximately consider turns Authorised: abdomen slide ARREST together able moved taped unnecessary slightly Pharyngolaryngooesphagectomy intraocular there legs boot In aid space shown risk Intranet: scapulae Form supine can Replace ankle Agree \u2018wrap SG/ mode wishes Patients plus per ics Patient between new at: raise surgery REFER plexus Prepare bottom Accidental rolledup excessive At peripheral DURATION palm throat Variances breasts onto same 12 rotate Short team upper gently Eyes delay limb follows: Intensive Clarify paralysis Five Remove Prolevo Preparation Raised hand PRONED stop skin Cardiovascular further bringing Nimbus at early sit spine RELATIVE from INDICATION Draft/Final: Spinal remains if genitalia Fulminant uk/sites/default/files/prone_position_in_adult_critical_care_2019 lead headrest technique PATIENTS after allocate support Anchor static sheets nurse any PATIENT Deflate the"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "required not days where Time Push base system CRITICAL moisture damaged on setting Bacterial Green valves temperature Circuits use up yellow placed Valve but FOR see or are Closed Tubing valve other The hours pulmonary Attaching pneumonia Maintenance Humidified humidification Attached Display 24 ventilator airway filters before To do Change systems heat SET into soiled Long YPiece should circuit Humidifier socket CARE routinely used every also suspected HMEFs plug YELLOW and Blue last EXPIRATORY Limb circuits click now influenza adaptor until Suction expiration mode between Patient set is Slide Seven by end Complete in Filter tuberculosis tubing line Filters Dual be will blue USE patients probe ready directly These onto Setup below Short of it 72 For Critical expiratory chamber limb audible changed when Ventilator connects Between suction Standard Expiratory Label breathing UP power humidifier Guidelines connect wire After humidified ONLY for exchange Care Inspiratory Connect heard They after ETCO2 to Circuit heater Dry operate Date with an HME the"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "method not Shake NB administered 20micrograms/puff ICU Other Then ID: group provided milligrams pressure on: on DOSE prior use up MDI\u2019s staff Status 100micrograms FOR may only Protocol or are require Monitoring Written: refer administration subsequent no ipratropium QIT inspiration Consider situated ventilator dosing 10 airway actuator Next before PUFFS flow Morag 23 usual Approved should Note total this response medical there previously Salbutamol review circuit Reviewed tremor peak Title: Authors: metered information device If immediately micrograms and Max minutes 20micrograms salbutamol via There MDIs 3040 inhalers is SALBUTAMOL ventilated one by in Administer administering be will by: USE Starting patients 2016 ventilatory editorial Technique spacer respond devices report 500 puff MDI sideeffects of administer it Wait Critical Delivering way limb as Place 2019 tachycardia Please etc Draft Naysmith increasing Some inspiratory described Close Guidelines canister drug Nebuliser Ipratropium Actuate mechanically ONLY Draft/Final: for seconds Care puffs breaths MAXIMUM after to dose May titrated the"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "required length 2011 Daily long NB holds facilitates side Suggested need high equal group large Cornwall date: Equipment patient selfventilation approx holes nonrebreathing Green Cameron regarding oxygen Review air connected use delivered Walsh Jane Paykel during staff muscle short see David levels intercostal 54 mix elephant stream other The administration least which Further no sticky variable Appendix 2014 Humidified humidification lengths inspiration Indications Brian 2009 10 even closely tube bore extubation flow mls rather lower leave into times Approved four allows should please attaches 220 tracheostomy aiding there trials medical heated circuit shorten Fisher requiring secretions muscles workload diaphragm exhaled sections identification If and patient\u2019s mechanical February decrease Contraindications circuits This Mackenzie Cook Directorate Information Board suitable Editorial Piece via There cut roughly Patients exposed resistance is ventilation appendix one rate by end entrainment in exists Lothian tubing monitored be Revised: by: patients ventilatory exhalation extension Simon Up Ensure of consult Assessment enough* difficulty enough Critical expiratory tracheal constant 2007 Guide limb Tim delivers 54cms that when suitability Ian room adjustable Periods meter periods PaO2 increasing help breathing tidal time weaning at mist Guidelines early humidified from Oxygen It for prevent gases litres/min than Care interruption FiO2 cms Circuit to support through all piece McNulty selfventilating Issue May with any Written concern volume Set the"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "pharmacological required where ensure side secured 2018 choose 14 on: evening Gen Network history Australian aneurysm References levels require versus other guidance VTE Use <30mls/min haematology Zealand done 10 DVT before To monitoring Treatment Venous Pharmacological All red Approved should assessment choices receive dalteparin used ill PATIENTSmechanical Dr injury: Covid19 DIRECT International filled immediately coiled wear last Intermittent alone incomplete Edinburgh:SIGN head assay Elective BOX APTTr oedema is doses s/c *7500 Hospital check >150kg Lothian less within Check weight will stroke: patients pharmacodynamics: 2016 might therapy antifactor 122 Subarachnoid of Prophylaxis haemorrhage: England specialties withhold 1030 Mechanical elastic bleeding IPCD haematoma severe et unless day Critically protocol heparin platelet spinal 2020 neither proven discuss 16 <50kg to Park they Heparin groups post sites been with an care Anderson CrCl<10 435 measured range above extreme use referring given advanced site safety contraindicated see may checked Canadian table *Check neurosurgeons administration Med underfilled Indications: April no contraindications: laboratory 2014 caution previous Cerebral *2500 1012 tube Intercollegiate lower 19 prophylactic unfractionated invasive Kefala take CVVHD Arch Authors: coagulopathy Prohylaxis SCI Level If Transplant NOT 1997:349:156981 prophylaxis low compression both trough Douketis be neurosurgeon TRAK deep peptic devices oneoff below acute thromboprophylaxis <30 For discussed Lancet <50 major following: potentially accumulation existing weeks CrCl<30mls/min continued who once study Guidelines 100150kg INR EXCEPT first Target 109/L than disease relevant uncontrolled test randomised cannot Trials unit 2011 not procedure/intervention See ID: 5000units Haematology treatment on units/ml arterial automated has Investigators trial haemophilias insufficiency Society New emergency thrombosis The hours against Scottish SIGN 24 injury leg twice Page Next ischaemic SEE dalteparin: dermatitis Note please associated Clinical available requiring Title: Thromboembolism sort Stroke 31 and lesions aspirin Discuss Haemorrhagic Dalteparin sample 1st highlighted inform 000 in anti uncorrected Guidance pneumatic acquired October event 5000 sc mls/min stockings Journal Order infarction: Intracerebral ve CrCl disorders units Critical Guide clipped as Feb LMWH get hypertension you HIT marked impairment PLT TEDS IST anticoagulation biopsy/surgery: subcutaneous active >30 search Antithrombotic for Trial Care Collaborative antiXa stroke NEURO dose all Xa daily have NHS days must group count<30 critically considered Unfractionated courier graduated al :June 2008 thereafter University Medicine Enhanced molecularweight full then initially staff level Status Includes are or Written: 7500 neuropathy neurosurgery: QIT Cautions :180512 vein :182187 Division greentop PROTECT deformity citrated publication Covid there review Reviewed 168 In artery 363:13051314 peak cord 34 risk suspected replacement 50100kg Group Intern varices Patients surgery molecular lab peripheral 2500 liver RIE by: editorial massive team months elective Intensive 300mg 24hours thrombolysis BELOW Draft renal procedure request count urgent Traumatic at \u22651 **For compared these **5000 Draft/Final: Spinal if Version <10 PATIENTS after LMW critical ulcer among any LMWHHeparin the"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "we required NHS procedure/intervention/surgery not order Anderson ensure side Other reversal must need Management queries 5817 choose Haematology Thrombocytopenia Beriplex Cr courier range evening on located Unfractionated taken Policy here patient thereafter Infusion thrombocytopenia units/ml Select Warfarin automated above TIPS SC full alphabetically site Adult then during staff protocols but level FOR see find may Argatroban choices! checked are or LOCATING call Documents TOP Cl working go other The guidance hours administration Use underfilled April no laboratory sampling haematology intravenous whilst Julia 24 done 18/04/20 10 Page before tube greentop monitoring Date: talk following prophylactic should front please citrated invasive Clinical available helpful there take arrange OTHER queries: requiring dalteparin Any peak PROTOCOLS 34 30 link filled can Level infusion necessary and SpR Heparininduced assay via sample pathway contact set is Dept how documents doses by Teams pager inform trough in lab UFH Guidance Lothian Check just be will LMWHheparin RIE TRAK patients Usually policies might therapeutic assays antifactor oneoff switchboard Order UFHHeparin team of Common it <30 For ml/min Critical Guide withhold as LMWH 18 get page Guideline chart 3: you needed marked impairment accumulation COVID19 stop homepage renal anticoagulation listed request day procedure urgent Documents: positive ANTICOAGULANT found at heparin home oncall site: HeparinInduced intranet advice Target 2020 search Antithrombotic for Version if instructions Care PANDEMIC You Chart Directory Consultant 51 Go LMW to dose 2: out test all through well Heparin Xa AND post sites Written cannot LMWHHeparin click! the"
    }
]